source,citation,relation,ID,title,authors,journal,year,fulltext_online_link,fulltext_location
10.1016~S0140-6736(00)02288-1,Schoenbaum SC. Economic impact of influenza: the individual’s perspective. Am J Med 1987; 82 (suppl 6A): 26–30.,references,10.1016/0002-9343(87)90557-2,Economic impact of influenza The individual's perspective,"[[u'S', u'', u'SCHOENBAUM']]",American Journal of Medicine,1987,[u'http://linkinghub.elsevier.com/retrieve/pii/0002934387905572'],./output/10.1016~S0140-6736(00)02288-1/10.1016~0002-9343(87)90557-2
10.1016/0002-9343(87)90557-2,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1016/0002-9343(87)90557-2,"Meltzer, M., Cox, N., Fukuda, K., , The Economic Impact of Pandemic Influenza in the United States: Priorities for Intervention, Emerging Infectious Diseases, 1999",cited-by,10.3201/eid0505.990507,The Economic Impact of Pandemic Influenza in the United States: Priorities for Intervention,"[['Martin', 'I.', 'Meltzer'], ['Nancy', 'J.', 'Cox'], ['Keiji', '', 'Fukuda']]",Emerging Infectious Diseases,1999,"[u'http://www.cdc.gov/ncidod/eid/vol5no5/meltzer.htm', u'http://cphfoundation.org/documents/econimpactofpandemicflu_000.pdf']"
10.1016/0002-9343(87)90557-2,"Monto, A., Gravenstein, S., Elliott, M., et. al, Clinical Signs and Symptoms Predicting Influenza Infection, , 2000",cited-by,14312063Clinical Signs and Symptoms Predicting Influenza Infection,Clinical Signs and Symptoms Predicting Influenza Infection,"[['Arnold', 'S.', 'Monto'], ['Stefan', '', 'Gravenstein'], ['Michael', '', 'Elliott'], ['Michael', '', 'Colopy'], ['Jo', '', 'Schweinle']]",,2000,[u'http://archinte.ama-assn.org/cgi/reprint/160/21/3243.pdf']
10.1016/0002-9343(87)90557-2,"Simonsen, L., , The global impact of influenza on morbidity and mortality, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00099-7,The global impact of influenza on morbidity and mortality,"[['Lone', '', 'Simonsen']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99000997', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-20.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99000997']"
10.1016/0002-9343(87)90557-2,"Mäkelä, M., Pauksens, K., Rostila, T., et. al, Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study, Journal of Infection, 2000",cited-by,10.1053/jinf.1999.0602,"Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study","[['M.', 'J.', 'M\xc3\xa4kel\xc3\xa4'], ['K.', '', 'Pauksens'], ['T.', '', 'Rostila'], ['D.', 'M.', 'Fleming'], ['C.', 'Y.', 'Man'], ['O.', 'N.', 'Keene'], ['A.', '', 'Webster']]",Journal of Infection,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0163445399906023', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445399906023', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-15.pdf']"
10.1016/0002-9343(87)90557-2,"Chapman, G., Coups, E., , Predictors of Influenza Vaccine Acceptance among Healthy Adults, Preventive Medicine, 1999",cited-by,10.1006/pmed.1999.0535,Predictors of Influenza Vaccine Acceptance among Healthy Adults,"[['Gretchen', 'B.', 'Chapman'], ['Elliot', 'J.', 'Coups']]",Preventive Medicine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0091743599905352', u'http://linkinghub.elsevier.com/retrieve/pii/S0091743599905352']"
10.1016/0002-9343(87)90557-2,"Doebbeling, B., Edmond, M., Davis, C., et. al, Influenza Vaccination of Health Care Workers: Evaluation of Factors That Are Important in Acceptance, Preventive Medicine, 1997",cited-by,10.1006/pmed.1996.9991,Influenza Vaccination of Health Care Workers: Evaluation of Factors That Are Important in Acceptance,"[['Bradley', 'N.', 'Doebbeling'], ['Michael', 'B.', 'Edmond'], ['Charles', 'S.', 'Davis'], ['James', 'R.', 'Woodin'], ['Rodney', 'R.', 'Zeitler']]",Preventive Medicine,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0091743596999910', u'http://linkinghub.elsevier.com/retrieve/pii/S0091743596999910']"
10.1016/0002-9343(87)90557-2,"Lee, P., Matchar, D., Clements, D., et. al, Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, , 2002",cited-by,5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,"[['Patrick', 'Y.', 'Lee'], ['David', 'B.', 'Matchar'], ['Dennis', 'A.', 'Clements'], ['Joel', '', 'Huber'], ['John', 'D.', 'Hamilton'], ['Eric', 'D.', 'Peterson']]",,2002,[u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Lee_2002.pdf']
10.1016/0002-9343(87)90557-2,"Meier, C., Napalkov, P., Wegmüller, Y., et. al, Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom, European Journal of Clinical Microbiology & Infectious Diseases, 2000",cited-by,10.1007/s100960000376,"Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom","[['C.', 'R.', 'Meier'], ['P.', 'N.', 'Napalkov'], ['Y.', '', 'Wegm\xc3\xbcller'], ['T.', '', 'Jefferson'], ['H.', '', 'Jick']]",European Journal of Clinical Microbiology & Infectious Diseases,2000,"[u'http://www.springerlink.com/index/twlnr6d64q7pk6n1.pdf', u'http://www.springerlink.com/content/twlnr6d64q7pk6n1', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s100960000376', u'http://www.springerlink.com/index/pdf/10.1007/s100960000376']"
10.1016/0002-9343(87)90557-2,"Kitler, M., Gavinio, P., Lavanchy, D., , Influenza and the work of the World Health Organization, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00121-4,Influenza and the work of the World Health Organization,"[['M.', 'E', 'Kitler'], ['P', '', 'Gavinio'], ['D', '', 'Lavanchy']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02001214', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001214']"
10.1016/0002-9343(87)90557-2,"Ballada, D., Biasio, L., Cascio, G., et. al, Attitudes and behavior of health care personnel regarding influenza vaccination, European Journal of Epidemiology, 1994",cited-by,10.1007/BF01717454,Attitudes and behavior of health care personnel regarding influenza vaccination,"[['D.', '', 'Ballada'], ['L.', 'R.', 'Biasio'], ['G.', '', 'Cascio'], ['D.', '', ""D'Alessandro""], ['I.', '', 'Donatelli'], ['G.', 'M.', 'Fara'], ['T.', '', 'Pozzi'], ['M.', 'L.', 'Profeta'], ['S.', '', 'Squarcione'], ['D.', '', 'Ricc\xc3\xb2'], ['T.', '', 'Todisco'], ['F.', '', 'Vacca']]",European Journal of Epidemiology,1994,"[u'http://www.springerlink.com/index/w470r3844354xh41.pdf', u'http://www.springerlink.com/content/w470r3844354xh41', u'http://www.springerlink.com/index/10.1007/BF01717454', u'http://www.springerlink.com/index/pdf/10.1007/BF01717454']"
10.1016/0002-9343(87)90557-2,"O'Reilly, F., Stevens, A., , Sickness absence due to influenza, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.265,Sickness absence due to influenza,"[['F.', 'W.', ""O'Reilly""], ['A.', 'B.', 'Stevens']]",Occupational Medicine-oxford,2002,"[u'http://www.cepis.ops-oms.org/bvsacd/cd49/265.pdf', u'http://www.cepis.ops-oms.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://www.bvsde.ops-oms.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://bvsde.per.paho.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://bvsde.per.paho.org/bvsacd/cd49/265.pdf', u'http://www.bvsde.paho.org/bvsacd/cd49/265.pdf', u'http://www.opas.org.br/gentequefazsaude/bvsde/bvsacd/cd49/265.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.265']"
10.1016/0002-9343(87)90557-2,", Implications of Pandemic Influenza for Bioterrorism Response, Clinical Infectious Diseases, 2000",cited-by,10.1086/317493,Implications of Pandemic Influenza for Bioterrorism Response,[],Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/317493']
10.1016/0002-9343(87)90557-2,"Sebastiani, P., Mandl, K., Szolovits, P., et. al, A Bayesian Dynamic Model for Influenza Surveillance, , 2005",cited-by,5059456A Bayesian Dynamic Model for Influenza Surveillance,A Bayesian Dynamic Model for Influenza Surveillance,"[['Paola', '', 'Sebastiani'], ['Kenneth', 'D', 'Mandl'], ['Peter', '', 'Szolovits'], ['Isaac', 'S', 'Kohane'], ['Marco', '', 'F']]",,2005,[u'http://groups.csail.mit.edu/medg/ftp/sebastiani/Sebastiani2006-submission.pdf']
10.1016/0002-9343(87)90557-2,"Gavin, P., Thomson, R., , Review of Rapid Diagnostic Tests for Influenza, , 2003",cited-by,5357707Review of Rapid Diagnostic Tests for Influenza,Review of Rapid Diagnostic Tests for Influenza,"[['Patrick', 'J', 'Gavin'], ['Richard', 'B', 'Thomson']]",,2003,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/diagnosis/diagnosis-4.pdf']
10.1016/0002-9343(87)90557-2,"Hamilton, M., Abel, D., Ballam, Y., et. al, Clinical Evaluation of the ZstatFlu-II Test: a Chemiluminescent Rapid Diagnostic Test for Influenza Virus, , 2002",cited-by,6773696Clinical Evaluation of the ZstatFlu-II Test: a Chemiluminescent Rapid Diagnostic Test for Influenza Virus,Clinical Evaluation of the ZstatFlu-II Test: a Chemiluminescent Rapid Diagnostic Test for Influenza Virus,"[['Marilyn', 'S.', 'Hamilton'], ['David', 'M.', 'Abel'], ['Yolanda', 'J.', 'Ballam'], ['Mary', 'K.', 'Otto'], ['Angela', 'F.', 'Nickell'], ['Lisa', 'M.', 'Pence'], ['James', 'R.', 'Appleman'], ['Craig', 'D.', 'Shimasaki'], ['Komandoor', 'E.', 'Achyuthan']]",,2002,[]
10.1016/0002-9343(87)90557-2,"Henderson, D., Inglesby, T., O'Toole, T., et. al, Implications of Pandemic Influenza for Bioterrorism Response, , 2000",cited-by,5599204Implications of Pandemic Influenza for Bioterrorism Response,Implications of Pandemic Influenza for Bioterrorism Response,"[['Donald', 'A.', 'Henderson'], ['Thomas', 'V.', 'Inglesby'], ['Tara', '', ""O'Toole""], ['Monica', '', 'Schoch-Spana']]",,2000,"[u'http://birdflubook.com/resources/Henderson1409.pdf', u'http://birdflubook.org/resources/Henderson1409.pdf']"
10.1016/0002-9343(87)90557-2,"Sebastiani, P., Mandl, K., Szolovits, P., et. al, A Bayesian dynamic model for influenza surveillance, Statistics in Medicine, 2006",cited-by,10.1002/sim.2566,A Bayesian dynamic model for influenza surveillance,"[['Paola', '', 'Sebastiani'], ['Kenneth', 'D.', 'Mandl'], ['Peter', '', 'Szolovits'], ['Isaac', 'S.', 'Kohane'], ['Marco', 'F.', 'Ramoni']]",Statistics in Medicine,2006,[u'http://doi.wiley.com/10.1002/sim.2566']
10.1016/0002-9343(87)90557-2,"Takase, H., Murakami, Y., Endo, A., et. al, Antibody responses and protection in mice immunized orally against influenza virus, Vaccine, 1996",cited-by,10.1016/S0264-410X(96)00128-4,Antibody responses and protection in mice immunized orally against influenza virus,"[['Hiroyuki', '', 'Takase'], ['Yoichi', '', 'Murakami'], ['Atsushi', '', 'Endo'], ['Tohru', '', 'Ikeuchi']]",Vaccine,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X96001284', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X96001284']"
10.1016/0002-9343(87)90557-2,"Pachucki, C., , Rapid tests for influenza, Current Infectious Disease Reports, 2005",cited-by,10.1007/s11908-005-0033-x,Rapid tests for influenza,"[['Constance', 'T.', 'Pachucki']]",Current Infectious Disease Reports,2005,"[u'http://www.springerlink.com/index/0383227661823303.pdf', u'http://www.springerlink.com/content/0383227661823303', u'http://www.springerlink.com/index/10.1007/s11908-005-0033-x', u'http://www.springerlink.com/index/pdf/10.1007/s11908-005-0033-x']"
10.1016/0002-9343(87)90557-2,"Postma, M., Baltussen, R., Heijnen, M., et. al, Pharmacoeconomics of Influenza Vaccination in the Elderly: Reviewing the Available Evidence, Drugs & Aging, 2000",cited-by,10.2165/00002512-200017030-00005,Pharmacoeconomics of Influenza Vaccination in the Elderly: Reviewing the Available Evidence,"[['Maarten', 'J.', 'Postma'], ['Rob', 'M. P. M.', 'Baltussen'], ['Marie-Louise', 'A.', 'Heijnen'], ['Lolkje', 'T. W. de Jong-van den', 'Berg'], ['Johannes', 'C.', 'Jager']]",Drugs & Aging,2000,"[u'http://www.sff.fmns.rug.nl/downloads/2000/16_postma_2000.pdf', u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002512-200017030-00005']"
10.1016/0002-9343(87)90557-2,"Merkel, P., Caputo, G., , Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate, Journal of General Internal Medicine, 1994",cited-by,10.1007/BF02599008,Evaluation of a simple office-based strategy for increasing influenza vaccine administration and the effect of differing reimbursement plans on the patient acceptance rate,"[['Peter', 'A.', 'Merkel'], ['G.', 'Craig', 'Caputo']]",Journal of General Internal Medicine,1994,"[u'http://www.springerlink.com/index/g1935365h32621n3.pdf', u'http://www.springerlink.com/content/g1935365h32621n3', u'http://www.springerlink.com/index/10.1007/BF02599008', u'http://www.springerlink.com/index/pdf/10.1007/BF02599008']"
10.1016/0002-9343(87)90557-2,"Gavin, P., Thomson, R., , Review of Rapid Diagnostic Tests for Influenza, Clinical and Applied Immunology Reviews, 2004",cited-by,10.1016/S1529-1049(03)00064-3,Review of Rapid Diagnostic Tests for Influenza,"[['Patrick', 'J.', 'Gavin'], ['Richard', 'B.', 'Thomson']]",Clinical and Applied Immunology Reviews,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1529104903000643', u'http://linkinghub.elsevier.com/retrieve/pii/S1529104903000643']"
10.1016/0002-9343(87)90557-2,"Ehrlich, J., Burleson, G., , Enhanced and prolonged pulmonary influenza virus infection following phosgene inhalation, Journal of Toxicology and Environmental Health-part A-current Issues, 1991",cited-by,10.1080/15287399109531565,Enhanced and prolonged pulmonary influenza virus infection following phosgene inhalation,"[['Jeffrey', 'P.', 'Ehrlich'], ['Gary', 'R.', 'Burleson']]",Journal of Toxicology and Environmental Health-part A-current Issues,1991,"[u'http://www.informaworld.com/openurl?genre=article&doi=10.1080/15287399109531565&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3', u'http://dx.doi.org/10.1080/15287399109531565']"
10.1016/0002-9343(87)90557-2,"Wood, S., Nguyen, V., , Effectiveness and economical impact of vaccination against influenza among a working population in Moscow, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00299-6,Effectiveness and economical impact of vaccination against influenza among a working population in Moscow,"[['Susan', 'C', 'Wood'], ['Van', 'Hung', 'Nguyen']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99002996', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99002996']"
10.1016/0002-9343(87)90557-2,"Lee, B., Tai, J., Bailey, R., et. al, The timing of influenza vaccination for older adults (65 years and older), Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.09.056,The timing of influenza vaccination for older adults (65 years and older),"[['Bruce', 'Y.', 'Lee'], ['Julie', 'H. Y.', 'Tai'], ['Rachel', 'R.', 'Bailey'], ['Kenneth', 'J.', 'Smith']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09013905', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09013905']"
10.1016/0002-9343(87)90557-2,"Miller, M., , Considerations for adding pneumonia and influenza vaccines to public health programmes, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00115-2,Considerations for adding pneumonia and influenza vaccines to public health programmes,"[['Mark', 'A', 'Miller']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001152', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001152']"
10.1016/0002-9343(87)90557-2,"Brownstein, A., Roizen, M., , A compelling rationale for using preoperative visits to complete adult immunizations, Journal of Clinical Anesthesia, 1998",cited-by,10.1016/S0952-8180(98)00040-3,A compelling rationale for using preoperative visits to complete adult immunizations,"[['Alice', 'B', 'Brownstein'], ['Michael', 'F', 'Roizen']]",Journal of Clinical Anesthesia,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0952818098000403', u'http://linkinghub.elsevier.com/retrieve/pii/S0952818098000403']"
10.1016/0002-9343(87)90557-2,"Brownstein, J., Mandl, K., , Pediatric Population Size Is Associated With Geographic Patterns of Acute Respiratory Infections Among Adults, Annals of Emergency Medicine, 2008",cited-by,10.1016/j.annemergmed.2008.02.009,Pediatric Population Size Is Associated With Geographic Patterns of Acute Respiratory Infections Among Adults,"[['John', 'S.', 'Brownstein'], ['Kenneth', 'D.', 'Mandl']]",Annals of Emergency Medicine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0196064408004903', u'http://linkinghub.elsevier.com/retrieve/pii/S0196064408004903']"
10.1016/0002-9343(87)90557-2,"Crovari, P., Garbarino, E., Bruzzone, B., et. al, Intranasal influenza vaccine: protective efficacy in children and adults, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00371-5,Intranasal influenza vaccine: protective efficacy in children and adults,"[['Pietro', '', 'Crovari'], ['Elio', '', 'Garbarino'], ['Bianca', '', 'Bruzzone'], ['Christian', '', 'Herzog'], ['Reinhard', '', 'Gl\xc3\xbcck']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003715', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003715']"
10.1016/0002-9343(87)90557-2,"Lee, J., Wee, S., Kwon, M., et. al, Strategic dispersion of carbon black and its application to ink-jet-printed lithium cobalt oxide electrodes for lithium ion batteries, Lancet, 2011",cited-by,10.1016/j.jpowsour.2011.03.041,Strategic dispersion of carbon black and its application to ink-jet-printed lithium cobalt oxide electrodes for lithium ion batteries,"[['Jin-Hyon', '', 'Lee'], ['Sung-Bok', '', 'Wee'], ['Moon-Seok', '', 'Kwon'], ['Hyun-Ho', '', 'Kim'], ['Jae-Man', '', 'Choi'], ['Min', 'Sang', 'Song'], ['Ho', 'Bum', 'Park'], ['Hansu', '', 'Kim'], ['Ungyu', '', 'Paik']]",Lancet,2011,[u'http://www.sciencedirect.com/science/article/pii/S0378775311006562']
10.1016/0002-9343(87)90557-2,"Smith, N., Strikas, R., , Approaches for Improving Influenza Prevention and Control, , 2006",cited-by,5817909Approaches for Improving Influenza Prevention and Control,Approaches for Improving Influenza Prevention and Control,"[['Nicole', '', 'Smith'], ['Raymond', 'A.', 'Strikas']]",,2006,[u'http://www.naccho.org/topics/HPDP/infectious/influenza/upload/2006JPHMP-Smith-Approachesforimprovinginfluenzapreventionandcontrol.pdf']
10.1016/0002-9343(87)90557-2,"Anis, A., Sun, H., Singh, S., et. al, PCV17 A COST-UTILITY ANALYSIS OF LOSARTAN VERSUS ATENOLOL IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION, Value in Health, 2004",cited-by,10.1016/S1098-3015(10)62383-2,PCV17 A COST-UTILITY ANALYSIS OF LOSARTAN VERSUS ATENOLOL IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION,"[['AH', '', 'Anis'], ['H', '', 'Sun'], ['S', '', 'Singh'], ['JC', '', 'Woolcott'], ['B', '', 'Nosyk']]",Value in Health,2004,[u'http://www.sciencedirect.com/science/article/pii/S1098301510623832']
10.1016/0002-9343(87)90557-2,"ZIZZA, A., GUIDO, M., QUATTROCCHI, M., et. al, Surveillance of influenza in Apulia, Italy, in the 1999- 2000, 2000-2001 and 2001-2002 influenza seasons, , 2003",cited-by,"13729458Surveillance of influenza in Apulia, Italy, in the 1999- 2000, 2000-2001 and 2001-2002 influenza seasons","Surveillance of influenza in Apulia, Italy, in the 1999- 2000, 2000-2001 and 2001-2002 influenza seasons","[['A.', '', 'ZIZZA'], ['M.', '', 'GUIDO'], ['M.', '', 'QUATTROCCHI'], ['A.', 'DE', 'DONNO'], ['P.', '', 'LAI'], ['P.', '', 'MORELLI'], ['R.', '', 'PRATO']]",,2003,[u'http://www.jpmh.org/issues/200344107.pdf']
10.1016/0002-9343(87)90557-2,"Hampson, A., , Adult immunization for influenza and pneumococcal infections, International Journal of Infectious Diseases, 1997",cited-by,10.1016/S1201-9712(97)90081-3,Adult immunization for influenza and pneumococcal infections,"[['Alan', 'W.', 'Hampson']]",International Journal of Infectious Diseases,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1201971297900813', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971297900813']"
10.1016/0002-9343(87)90557-2,"Quintas, C., , Importancia de la gripe en la salud laboral, , 0",cited-by,10092602Importancia de la gripe en la salud laboral,Importancia de la gripe en la salud laboral,"[['C.', '', 'Quintas']]",,0,[u'http://www.infogripe.com/infogripe/paramedic/pdfvacunas/09salulaboral.pdf']
10.1016/0002-9343(87)90557-2,"Çavdar, C., Sifil, A., Çamsan, T., , INFLUENZA İNFEKSİYONU VE INFLUENZADAN KORUNMA INFLUENZA INFECTION AND PREVENTION OF INFLUENZA, , 0",cited-by,10761594INFLUENZA İNFEKSİYONU VE INFLUENZADAN KORUNMA INFLUENZA INFECTION AND PREVENTION OF INFLUENZA,INFLUENZA İNFEKSİYONU VE INFLUENZADAN KORUNMA INFLUENZA INFECTION AND PREVENTION OF INFLUENZA,"[['Caner', '', '\xc3\x87avdar'], ['Aykut', '', 'Sifil'], ['Taner', '', '\xc3\x87amsan']]",,0,[u'http://www.tsn.org.tr/documents/TND_dergisi/TND1999S3C8Sf100-107.pdf']
10.1016/0002-9343(87)90557-2,"Wolff, M., Marcy, S., Iacuzio, D., et. al, of Influenza in Healthy Children Cost-Effectiveness Analysis of an Intranasal Influenza Vaccine for the Prevention, , 0",cited-by,12782419of Influenza in Healthy Children Cost-Effectiveness Analysis of an Intranasal Influenza Vaccine for the Prevention,of Influenza in Healthy Children Cost-Effectiveness Analysis of an Intranasal Influenza Vaccine for the Prevention,"[['Mark', 'C.', 'Wolff'], ['S.', 'Michael', 'Marcy'], ['Dominick', '', 'Iacuzio'], ['Robert', 'B.', 'Bryan'], ['R.', '', 'Luce'], ['Kenneth', 'M.', 'Zangwill'], ['Cynthia', 'S.', 'Palmer'], ['Paul', 'M.', 'Mendelman']]",,0,[]
10.1016~S0140-6736(00)02288-1,Sullivan KM. Health impact of influenza in the United States. Pharmacoeconomics 1996; 9 (suppl 3): 26–33.,references,10.2165/00019053-199600093-00008,Health Impact of Influenza in the United States,"[[u'Kevin', u'M.', u'Sullivan']]",Pharmacoeconomics,1996,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019053-199600093-00008'],
10.2165/00019053-199600093-00008,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.2165/00019053-199600093-00008,"Weycker, D., Edelsberg, J., Halloran, M., et. al, Population-wide benefits of routine vaccination of children against influenza, Vaccine, 2005",cited-by,10.1016/j.vaccine.2004.08.044,Population-wide benefits of routine vaccination of children against influenza,"[['Derek', '', 'Weycker'], ['John', '', 'Edelsberg'], ['M.', 'Elizabeth', 'Halloran'], ['Ira', 'M.', 'Longini'], ['Azhar', '', 'Nizam'], ['Vincent', '', 'Ciuryla'], ['Gerry', '', 'Oster']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X04006784', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X04006784']"
10.2165/00019053-199600093-00008,"Keech, M., Scott, A., Ryan, P., , The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population, Occupational Medicine-oxford, 1998",cited-by,10.1093/occmed/48.2.85,The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population,"[['M.', '', 'Keech'], ['A.', 'J.', 'Scott'], ['P.', 'J. J.', 'Ryan']]",Occupational Medicine-oxford,1998,"[u'http://occmed.oxfordjournals.org/cgi/reprint/48/2/85.pdf', u'http://occmed.oxfordjournals.org/cgi/doi/10.1093/occmed/48.2.85']"
10.2165/00019053-199600093-00008,"Scuffham, P., West, P., , Economic evaluation of strategies for the control and management of influenza in Europe, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00154-8,Economic evaluation of strategies for the control and management of influenza in Europe,"[['P.', 'A.', 'Scuffham'], ['P.', 'A.', 'West']]",Vaccine,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/prevention/prevention-2.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X02001548', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/preparedness/preparedness-17.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001548']"
10.2165/00019053-199600093-00008,"Meltzer, M., Neuzil, K., Griffin, M., et. al, An economic analysis of annual influenza vaccination of children, Vaccine, 2005",cited-by,10.1016/j.vaccine.2004.07.040,An economic analysis of annual influenza vaccination of children,"[['Martin', 'I.', 'Meltzer'], ['Kathleen', 'M.', 'Neuzil'], ['Marie', 'R.', 'Griffin'], ['Keiji', '', 'Fukuda']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X04006255', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X04006255']"
10.2165/00019053-199600093-00008,"Ryan, J., Zoellner, Y., Gradl, B., et. al, Establishing the health and economic impact of influenza vaccination within the European Union 25 countries, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.07.042,Establishing the health and economic impact of influenza vaccination within the European Union 25 countries,"[['James', '', 'Ryan'], ['York', '', 'Zoellner'], ['Birgit', '', 'Gradl'], ['Bram', '', 'Palache'], ['Jeroen', '', 'Medema']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06008954', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06008954']"
10.2165/00019053-199600093-00008,"Gasparini, R., Lucioni, C., Lai, P., et. al, Cost–benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00507-8,Cost–benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria,"[['R', '', 'Gasparini'], ['C', '', 'Lucioni'], ['P', '', 'Lai'], ['P', '', 'Maggioni'], ['L', '', 'Sticchi'], ['P', '', 'Durando'], ['P', '', 'Morelli'], ['I', '', 'Comino'], ['S', '', 'Calderisi'], ['P', '', 'Crovari']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02005078', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02005078']"
10.2165/00019053-199600093-00008,"King, J., Cummings, G., Stoddard, J., et. al, A Pilot Study of the Effectiveness of a School-Based Influenza Vaccination Program, , 2010",cited-by,10706617A Pilot Study of the Effectiveness of a School-Based Influenza Vaccination Program,A Pilot Study of the Effectiveness of a School-Based Influenza Vaccination Program,"[['James', 'C.', 'King'], ['Ginny', 'E.', 'Cummings'], ['Jeffrey', '', 'Stoddard'], ['Bernard', 'X.', 'Readmond'], ['Laurence', 'S.', 'Magder'], ['Mary', '', 'Stong'], ['Margaret', '', 'Hoffmaster'], ['Judith', '', 'Rubin'], ['Theodore', '', 'Tsai'], ['Elizabeth', '', 'Ruff']]",,2010,[u'http://pediatrics.aappublications.org/cgi/reprint/116/6/e868.pdf']
10.2165/00019053-199600093-00008,"Luce, B., Nichol, K., Belshe, R., et. al, Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.03.046,Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States,"[['Bryan', 'R.', 'Luce'], ['Kristin', 'L.', 'Nichol'], ['Robert', 'B.', 'Belshe'], ['Kevin', 'D.', 'Frick'], ['Su', 'Xia', 'Li'], ['Audra', '', 'Boscoe'], ['Matthew', 'D.', 'Rousculp'], ['Parthiv', 'J.', 'Mahadevia']]",Vaccine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08003800', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08003800']"
10.2165/00019053-199600093-00008,"Hibbert, C., Piedra, P., McLaurin, K., et. al, Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres, Vaccine, 2007",cited-by,10.1016/j.vaccine.2007.09.018,"Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres","[['Clare', 'L.', 'Hibbert'], ['Pedro', 'A.', 'Piedra'], ['Kimmie', 'K.', 'McLaurin'], ['Timo', '', 'Vesikari'], ['Josephine', '', 'Mauskopf'], ['Parthiv', 'J.', 'Mahadevia']]",Vaccine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X07010407', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X07010407']"
10.2165/00019053-199600093-00008,"Davis, M., King, J., Cummings, G., et. al, Countywide School-Based Influenza Immunization: Direct and Indirect Impact on Student Absenteeism, , 2010",cited-by,11920507Countywide School-Based Influenza Immunization: Direct and Indirect Impact on Student Absenteeism,Countywide School-Based Influenza Immunization: Direct and Indirect Impact on Student Absenteeism,"[['Mollie', 'M.', 'Davis'], ['James', 'C.', 'King'], ['Ginny', '', 'Cummings'], ['Laurence', 'S.', 'Magder']]",,2010,[u'http://pediatrics.aappublications.org/cgi/reprint/122/1/e260.pdf']
10.2165/00019053-199600093-00008,"Drinka, P., Krause, P., Nest, L., et. al, The Effect of Culture-Positive Influenza Type A on Resource Use and Adverse Events in Nursing Home Residents, Journal of The American Geriatrics Society, 2002",cited-by,10.1046/j.1532-5415.2002.50364.x,The Effect of Culture-Positive Influenza Type A on Resource Use and Adverse Events in Nursing Home Residents,"[['Paul', 'J.', 'Drinka'], ['Peggy', '', 'Krause'], ['Lori', '', 'Nest'], ['Margaret', '', 'Dissing'], ['Stefan', '', 'Gravenstein'], ['Brian', 'M.', 'Goodman']]",Journal of The American Geriatrics Society,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2002.50364.x']
10.2165/00019053-199600093-00008,"Mishin, V., Hayden, F., Signorelli, K., et. al, Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.02.006,Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection,"[['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Kathy', 'L.', 'Signorelli'], ['Larisa', 'V.', 'Gubareva']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0166354206000623', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206000623']"
10.2165/00019053-199600093-00008,"King, C., Kao, C., Liu, D., et. al, Seven integrated influenza surveillance systems in Taiwan, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00331-4,Seven integrated influenza surveillance systems in Taiwan,"[['Chwan-Chuen', '', 'King'], ['Chuan-Liang', '', 'Kao'], ['Ding-Ping', '', 'Liu'], ['Min-Chu', '', 'Cheng'], ['Hui-Lin', '', 'Yen'], ['Min-Shiuh', '', 'Lee'], ['Ching-Ping', '', 'Tsai'], ['Shin-Ru', '', 'Shih'], ['Happy', 'K', 'Shieh'], ['Jen-Pang', '', 'Hsiu'], ['Shu-Fang', '', 'Li'], ['Hsu-Mei', '', 'Hsu'], ['Shing-Jer', '', 'Twu'], ['Nancy', 'J', 'Cox'], ['Robert', 'G', 'Webster']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003314', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003314']"
10.2165/00019053-199600093-00008,"Smith, S., Gums, J., , Antivirals for Influenza, Pediatric Drugs, 2010",cited-by,10.2165/11532530-000000000-00000,Antivirals for Influenza,"[['Steven', 'M.', 'Smith'], ['John', 'G.', 'Gums']]",Pediatric Drugs,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00148581-201012050-00002']
10.2165/00019053-199600093-00008,"Lee, D., Kim, J., Kim, C., et. al, Characteristics of Diagnosed Novel Influenza A (H1N1) Cases in the Community Sentinel Hospital and Usefulness of Clinical Diagnosis, Korean Journal of Family Medicine, 2010",cited-by,10.4082/kjfm.2010.31.2.115,Characteristics of Diagnosed Novel Influenza A (H1N1) Cases in the Community Sentinel Hospital and Usefulness of Clinical Diagnosis,"[['Dong', 'Hun', 'Lee'], ['Jun-Su', '', 'Kim'], ['Chan', 'Woong', 'Kim'], ['Sung', 'Eun', 'Kim'], ['Sang', 'Jin', 'Lee'], ['Yong', 'Soon', 'Park']]",Korean Journal of Family Medicine,2010,[u'http://synapse.koreamed.org/DOIx.php?id=10.4082/kjfm.2010.31.2.115']
10.2165/00019053-199600093-00008,"Talbird, S., Brogan, A., Winiarski, A., , Oseltamivir for Influenza Postexposure Prophylaxis, American Journal of Preventive Medicine, 2009",cited-by,10.1016/j.amepre.2009.08.012,Oseltamivir for Influenza Postexposure Prophylaxis,"[['Sandra', 'E.', 'Talbird'], ['Anita', 'J.', 'Brogan'], ['Aleksander', 'P.', 'Winiarski']]",American Journal of Preventive Medicine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0749379709005273', u'http://linkinghub.elsevier.com/retrieve/pii/S0749379709005273']"
10.2165/00019053-199600093-00008,"Diseases, I., , The Economic Impact of Influenza in Switzerland - Interpandemic situation, , 0",cited-by,10284137The Economic Impact of Influenza in Switzerland - Interpandemic situation,The Economic Impact of Influenza in Switzerland - Interpandemic situation,"[['Infectious', '', 'Diseases']]",,0,[u'http://www.bag.admin.ch/themen/medizin/00682/00686/02314/index.html?lang=de&download=M3wBUQCu/8ulmKDu36WenojQ1NTTjaXZnqWfVpzLhmfhnapmmc7Zi6rZnqCkkIV6fnuBbKbXrZ2lhtTN34al3p6YrY7P1oah162apo3X1cjYh2+hoJVn6w==']
10.2165/00019053-199600093-00008,"GASPARINI, R., CILIBERTI, A., GULINO, M., et. al, Patient information, attitude and behaviour concerning influenza vaccination at the polyclinic of Siena, , 0",cited-by,"11680325Patient information, attitude and behaviour concerning influenza vaccination at the polyclinic of Siena","Patient information, attitude and behaviour concerning influenza vaccination at the polyclinic of Siena","[['R.', '', 'GASPARINI'], ['A.', '', 'CILIBERTI'], ['M.', '', 'GULINO'], ['E.', '', 'MONTOMOLI'], ['P.', '', 'DURANDO'], ['L.', '', 'STICCHI'], ['P.', '', 'CROVARI']]",,0,[u'http://www.jpmh.org/issues/200344104.pdf']
10.2165/00019053-199600093-00008,"Liu, D., Cheng, M., Yen, H., et. al, INTEGRATED SEVEN INFLUENZA SURVEILLANCE SYSTEMS IN TAIWAN, , 0",cited-by,11918154INTEGRATED SEVEN INFLUENZA SURVEILLANCE SYSTEMS IN TAIWAN,INTEGRATED SEVEN INFLUENZA SURVEILLANCE SYSTEMS IN TAIWAN,"[['Ding-Ping', '', 'Liu'], ['Min-Chu', '', 'Cheng'], ['Hui-Lin', '', 'Yen'], ['Min-Shiuh', '', 'Lee'], ['Ching-Ping', '', 'Tsai'], ['Shin-Ru', '', 'Shih'], ['Happy', 'K', 'Shieh'], ['SF', '', 'Li'], ['Hsu-Mei', '', 'Hsu'], ['ShingJen', '', 'Twu'], ['J.', '', 'Cox'], ['Robert', 'G.', 'Webster']]",,0,[u'http://www.hsph.harvard.edu/research/takemi/files/rp170.pdf']
10.2165/00019053-199600093-00008,"Rousculp, M., Quon, P., Belshe, R., et. al, Saving Costs from Influenza Immunization Among Young Children — Economic Benefits of Using Live Attenuated vs. Inactivated Influenza Vaccination to Payers, , 0",cited-by,14109936Saving Costs from Influenza Immunization Among Young Children — Economic Benefits of Using Live Attenuated vs. Inactivated Influenza Vaccination to Payers,Saving Costs from Influenza Immunization Among Young Children — Economic Benefits of Using Live Attenuated vs. Inactivated Influenza Vaccination to Payers,"[['M.', 'D.', 'Rousculp'], ['P.', '', 'Quon'], ['R.', 'B.', 'Belshe'], ['T.', 'C.', 'Woodward'], ['B.', 'R.', 'Luce'], ['P.', 'J.', 'Mahadevia']]",,0,[u'http://unitedbiosource.com/pdfs/2009%20posters/ispor/quon_saving.pdf']
10.1016~S0140-6736(00)02288-1,"Keech M, Scott AJ, Ryan PJJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med 1998; 48: 85–90.",references,10.1093/occmed/48.2.85,The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population,"[[u'M.', u'', u'Keech'], [u'A.', u'J.', u'Scott'], [u'P.', u'J. J.', u'Ryan']]",Occupational Medicine-oxford,1998,"[u'http://occmed.oxfordjournals.org/cgi/reprint/48/2/85.pdf', u'http://occmed.oxfordjournals.org/cgi/doi/10.1093/occmed/48.2.85']",./output/10.1016~S0140-6736(00)02288-1/10.1093~occmed~48.2.85
10.1093/occmed/48.2.85,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1093/occmed/48.2.85,"Nichol, K., , Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza, , 2001",cited-by,2905336Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,"[['Kristin', 'L.', 'Nichol']]",,2001,"[u'http://archinte.ama-assn.org/cgi/reprint/161/5/749.pdf', u'http://tudor.szote.u-szeged.hu/webtext/letolt/anyag/CASPi_200212/day4/4.2.3.%20nichol%20paper.pdf']"
10.1093/occmed/48.2.85,"HEDRICK, J., BARZILAI, A., BEHRE, U., et. al, Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial, Pediatric Infectious Disease Journal, 2000",cited-by,10.1097/00006454-200005000-00005,Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial,"[['JAMES', 'A.', 'HEDRICK'], ['ASHER', '', 'BARZILAI'], ['ULRICH', '', 'BEHRE'], ['FREDERICK', 'W.', 'HENDERSON'], ['JANET', '', 'HAMMOND'], ['LUCY', '', 'REILLY'], ['OLIVER', '', 'KEENE']]",Pediatric Infectious Disease Journal,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200005000-00005']
10.1093/occmed/48.2.85,"Neuzil, K., Hohlbein, C., Zhu, Y., , Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families, , 2002",cited-by,"13610716Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families","Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families","[['Kathleen', 'M.', 'Neuzil'], ['Cynthia', '', 'Hohlbein'], ['Yuwei', '', 'Zhu']]",,2002,"[u'http://archpedi.ama-assn.org/cgi/reprint/156/10/986.pdf', u'http://archpedi.highwire.org/cgi/reprint/156/10/986.pdf']"
10.1093/occmed/48.2.85,"Nichol, K., Mallon, K., Mendelman, P., , Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00029-X,"Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine","[['Kristin', 'L', 'Nichol'], ['Kenneth', 'P', 'Mallon'], ['Paul', 'M', 'Mendelman']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0300029X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0300029X']"
10.1093/occmed/48.2.85,"Lee, P., Matchar, D., Clements, D., et. al, Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, , 2002",cited-by,5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,"[['Patrick', 'Y.', 'Lee'], ['David', 'B.', 'Matchar'], ['Dennis', 'A.', 'Clements'], ['Joel', '', 'Huber'], ['John', 'D.', 'Hamilton'], ['Eric', 'D.', 'Peterson']]",,2002,[u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Lee_2002.pdf']
10.1093/occmed/48.2.85,"Rothberg, M., Rose, D., , Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis, American Journal of Medicine, 2005",cited-by,10.1016/j.amjmed.2004.03.044,Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis,"[['Michael', 'B.', 'Rothberg'], ['David', 'N.', 'Rose']]",American Journal of Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0002934304006291', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-5.pdf', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/vaccination/vaccination-8.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934304006291']"
10.1093/occmed/48.2.85,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']"
10.1093/occmed/48.2.85,"Khan, K., , Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults, Clinical Infectious Diseases, 2001",cited-by,10.1086/324491,Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults,"[['Kamran', '', 'Khan']]",Clinical Infectious Diseases,2001,"[u'http://www.pceo.org/pubs/CID%20Article.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/324491']"
10.1093/occmed/48.2.85,"Akazawa, M., Sindelar, J., Paltiel, A., , Economic Costs of Influenza-Related Work Absenteeism, Value in Health, 2003",cited-by,10.1046/j.1524-4733.2003.00209.x,Economic Costs of Influenza-Related Work Absenteeism,"[['Manabu', '', 'Akazawa'], ['Jody', 'L.', 'Sindelar'], ['A.', 'David', 'Paltiel']]",Value in Health,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1098301510601404', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1524-4733.2003.00209.x']"
10.1093/occmed/48.2.85,"Simmerman, J., Lertiendumrong, J., Dowell, S., et. al, The cost of influenza in Thailand, Vaccine, 2006",cited-by,10.1016/j.vaccine.2005.12.060,The cost of influenza in Thailand,"[['James', 'Mark', 'Simmerman'], ['Jongkol', '', 'Lertiendumrong'], ['Scott', 'F.', 'Dowell'], ['Timothy', '', 'Uyeki'], ['Sonja', 'J.', 'Olsen'], ['Malinee', '', 'Chittaganpitch'], ['Supamit', '', 'Chunsutthiwat'], ['Viroj', '', 'Tangcharoensathien']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0600020X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0600020X']"
10.1093/occmed/48.2.85,"Ryan, J., Zoellner, Y., Gradl, B., et. al, Establishing the health and economic impact of influenza vaccination within the European Union 25 countries, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.07.042,Establishing the health and economic impact of influenza vaccination within the European Union 25 countries,"[['James', '', 'Ryan'], ['York', '', 'Zoellner'], ['Birgit', '', 'Gradl'], ['Bram', '', 'Palache'], ['Jeroen', '', 'Medema']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06008954', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06008954']"
10.1093/occmed/48.2.85,"Thompson, W., Meltzer, M., Reeve, G., et. al, Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults, , 2007",cited-by,5478601Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults,Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults,"[['William', 'W.', 'Thompson'], ['Martin', 'I.', 'Meltzer'], ['Gordon', 'R.', 'Reeve'], ['Walter', 'J.', 'Talamonti'], ['Nancy', 'J.', 'Cox'], ['Heather', 'A.', 'Lilac'], ['Keiji', '', 'Fukuda']]",,2007,[u'http://www.beforeyoutakethatpill.com/2008/12/bridges_flu_shots.pdf']
10.1093/occmed/48.2.85,"Hannouna, C., Megas, F., Piercy, J., , Immunogenicity and protective efficacy of influenza vaccination, Virus Research, 2004",cited-by,10.1016/S0168-1702(04)00124-8,Immunogenicity and protective efficacy of influenza vaccination,"[['Claude', '', 'Hannouna'], ['Francoise', '', 'Megas'], ['James', '', 'Piercy']]",Virus Research,2004,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-21.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001248']"
10.1093/occmed/48.2.85,"Barringer, T., Kirk, J., Santaniello, A., et. al, Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life A Randomized, Double-Blind, Placebo-Controlled Trial, , 0",cited-by,"11019403Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life A Randomized, Double-Blind, Placebo-Controlled Trial","Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life A Randomized, Double-Blind, Placebo-Controlled Trial","[['Thomas', 'A.', 'Barringer'], ['Julienne', 'K.', 'Kirk'], ['Amy', 'C.', 'Santaniello'], ['Kristie', 'Long', 'Foley'], ['Robert', '', 'Michielutte']]",,0,"[u'http://www.annals.org/content/138/5/365.full.pdf', u'http://www.spectracell.com/media/082fullpaper2003annintmedmicronutrient-deficiency-and-infectious-disease.pdf']"
10.1093/occmed/48.2.85,"Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']"
10.1093/occmed/48.2.85,"Nichol, K., D’Heilly, S., Ehlinger, E., , Colds and Influenza‐Like Illnesses in University Students: Impact on Health, Academic and Work Performance, and Health Care Use, Clinical Infectious Diseases, 2005",cited-by,10.1086/429237,"Colds and Influenza‐Like Illnesses in University Students: Impact on Health, Academic and Work Performance, and Health Care Use","[['Kristin', 'L.', 'Nichol'], ['Sarah', '', 'D\xe2\x80\x99Heilly'], ['Edward', '', 'Ehlinger']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/429237']
10.1093/occmed/48.2.85,"O'Reilly, F., Stevens, A., , Sickness absence due to influenza, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.265,Sickness absence due to influenza,"[['F.', 'W.', ""O'Reilly""], ['A.', 'B.', 'Stevens']]",Occupational Medicine-oxford,2002,"[u'http://www.cepis.ops-oms.org/bvsacd/cd49/265.pdf', u'http://www.cepis.ops-oms.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://www.bvsde.ops-oms.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://bvsde.per.paho.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://bvsde.per.paho.org/bvsacd/cd49/265.pdf', u'http://www.bvsde.paho.org/bvsacd/cd49/265.pdf', u'http://www.opas.org.br/gentequefazsaude/bvsde/bvsacd/cd49/265.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.265']"
10.1093/occmed/48.2.85,"Keech, M., Beardsworth, P., , The Impact of Influenza on Working Days Lost: A Review of the Literature, Pharmacoeconomics, 2008",cited-by,10.2165/00019053-200826110-00004,The Impact of Influenza on Working Days Lost: A Review of the Literature,"[['Martin', '', 'Keech'], ['Paul', '', 'Beardsworth']]",Pharmacoeconomics,2008,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019053-200826110-00004', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200826110-00004.htm', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/pdfhandler.00019053-200826110-00004.pdf']"
10.1093/occmed/48.2.85,"Aballéa, S., Chancellor, J., Martin, M., et. al, The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model, Value in Health, 2007",cited-by,10.1111/j.1524-4733.2006.00157.x,The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model,"[['Samuel', '', 'Aball\xc3\xa9a'], ['Jeremy', '', 'Chancellor'], ['Monique', '', 'Martin'], ['Peter', '', 'Wutzler'], ['Fabrice', '', 'Carrat'], ['Roberto', '', 'Gasparini'], ['Joao', '', 'Toniolo-Neto'], ['Michael', '', 'Drummond'], ['Milton', '', 'Weinstein']]",Value in Health,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1098301510604585', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4733.2006.00157.x']"
10.1093/occmed/48.2.85,"Postma, M., Jansema, P., Genugten, M., , Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults, Vaccine, 2005",cited-by,10.1016/j.vaccine.2005.06.007,Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults,"[['Maarten', 'J.', 'Postma'], ['Paul', '', 'Jansema'], ['Marianne', 'L. L. van', 'Genugten']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05005852', u'http://www.sff.fmns.rug.nl/downloads/2005/401_postma_2005.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05005852']"
10.1093/occmed/48.2.85,"Ehlinger, E., , Burden of Influenza‐Like Illness and Effectiveness of Influenza Vaccination among Working Adults Aged 50–64 Years, Clinical Infectious Diseases, 2009",cited-by,10.1086/595842,Burden of Influenza‐Like Illness and Effectiveness of Influenza Vaccination among Working Adults Aged 50–64 Years,"[['Edward', '', 'Ehlinger']]",Clinical Infectious Diseases,2009,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/595842']
10.1093/occmed/48.2.85,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.1093/occmed/48.2.85,"Morales, A., Martinez, M., Tasset-Tisseau, A., et. al, Costs and Benefits of Influenza Vaccination and Work Productivity in a Colombian Company from the Employer's Perspective, Value in Health, 2004",cited-by,10.1111/j.1524-4733.2004.74006.x,Costs and Benefits of Influenza Vaccination and Work Productivity in a Colombian Company from the Employer's Perspective,"[['Alvaro', '', 'Morales'], ['Maria', 'M.', 'Martinez'], ['Anne', '', 'Tasset-Tisseau'], ['Elena', '', 'Rey'], ['Florence', '', 'Baron-Papillon'], ['Alain', '', 'Follet']]",Value in Health,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1098301510602033', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1524-4733.2004.74006.x']"
10.1093/occmed/48.2.85,"Holm, M., Gyldmark, M., Hansen, E., , Pharmacoeconomic assessment of oseltamivir in treating influenza – the case of otherwise healthy Danish adolescents and adults, Pharmacy World & Science, 2004",cited-by,10.1007/s11096-004-0559-2,Pharmacoeconomic assessment of oseltamivir in treating influenza – the case of otherwise healthy Danish adolescents and adults,"[['Majbrit', 'Vindt', 'Holm'], ['Marlene', '', 'Gyldmark'], ['Ebba', 'Holme', 'Hansen']]",Pharmacy World & Science,2004,"[u'http://www.springerlink.com/content/m52624t326485235', u'http://www.springerlink.com/index/m52624t326485235.pdf', u'http://www.springerlink.com/index/10.1007/s11096-004-0559-2', u'http://www.springerlink.com/index/pdf/10.1007/s11096-004-0559-2']"
10.1093/occmed/48.2.85,"Poland, G., Johnson, D., , Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season, American Journal of Medicine, 2008",cited-by,10.1016/j.amjmed.2008.05.002,Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season,"[['Gregory', 'A.', 'Poland'], ['David', 'R.', 'Johnson']]",American Journal of Medicine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0002934308004658', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934308004658']"
10.1093/occmed/48.2.85,"Larson, E., , Warned, but Not Well Armed: Preventing Viral Upper Respiratory Infections in Households, Public Health Nursing, 2007",cited-by,10.1111/j.1525-1446.2006.00607.x,"Warned, but Not Well Armed: Preventing Viral Upper Respiratory Infections in Households","[['Elaine', 'L.', 'Larson']]",Public Health Nursing,2007,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1525-1446.2006.00607.x']
10.1093/occmed/48.2.85,"Samad, A., Usul, M., Zakaria, D., et. al, Workplace Vaccination against Influenza in Malaysia: Does the Employer Benefit?, Journal of Occupational Health, 2006",cited-by,10.1539/joh.48.1,Workplace Vaccination against Influenza in Malaysia: Does the Employer Benefit?,"[['Abu', 'H.', 'Samad'], ['Mohd', 'H. B. H. J.', 'Usul'], ['Dalilah', '', 'Zakaria'], ['Raman', '', 'Ismail'], ['Anne', '', 'Tasset-Tisseau'], ['Florence', '', 'Baron-Papillon'], ['Alain', '', 'Follet']]",Journal of Occupational Health,2006,"[u'http://joh.med.uoeh-u.ac.jp/pdf/E48/E48_1_01.pdf', u'http://joi.jlc.jst.go.jp/JST.JSTAGE/joh/48.1?from=CrossRef']"
10.1093/occmed/48.2.85,"Groth, N., Montomoli, E., Gentile, C., et. al, Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial, Vaccine, 2009",cited-by,10.1016/j.vaccine.2008.11.003,"Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial","[['N.', '', 'Groth'], ['E.', '', 'Montomoli'], ['C.', '', 'Gentile'], ['I.', '', 'Manini'], ['R.', '', 'Bugarini'], ['A.', '', 'Podda']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08015065', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08015065']"
10.1093/occmed/48.2.85,"Gums, J., Pelletier, E., Blumentals, W., , Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children, Expert Opinion on Pharmacotherapy, 2008",cited-by,10.1517/14656566.9.2.151,"Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children","[['John', 'G', 'Gums'], ['Elise', 'M', 'Pelletier'], ['William', 'A', 'Blumentals']]",Expert Opinion on Pharmacotherapy,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.9.2.151']
10.1093/occmed/48.2.85,"Newall, A., Scuffham, P., Kelly, H., et. al, The cost-effectiveness of a universal influenza vaccination program for adults aged 50–64 years in Australia, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.01.050,The cost-effectiveness of a universal influenza vaccination program for adults aged 50–64 years in Australia,"[['Anthony', 'T.', 'Newall'], ['Paul', 'A.', 'Scuffham'], ['Heath', '', 'Kelly'], ['Stuart', '', 'Harsley'], ['C.', 'Raina', 'MacIntyre']]",Vaccine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08001205', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08001205']"
10.1093/occmed/48.2.85,"D’Heilly, S., Nichol, K., , Work‐Site–Based Influenza Vaccination in Healthcare and Non‐Healthcare Settings, Infection Control and Hospital Epidemiology, 2004",cited-by,10.1086/502324,Work‐Site–Based Influenza Vaccination in Healthcare and Non‐Healthcare Settings,"[['Sarah', 'J.', 'D\xe2\x80\x99Heilly'], ['Kristin', 'L.', 'Nichol']]",Infection Control and Hospital Epidemiology,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502324']
10.1093/occmed/48.2.85,"Narasimhan, S., Harish, M., , A new spectral estimator based on discrete cosine transform and modified group delay, , 2003",cited-by,10.1109/TENCON.2003.1273436,A new spectral estimator based on discrete cosine transform and modified group delay,"[['S.', 'V.', 'Narasimhan'], ['M.', '', 'Harish']]",,2003,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1273436', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01273436']"
10.1093/occmed/48.2.85,"Lovell, V., , Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act, , 0",cited-by,10821395Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act,Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act,"[['Vicky', '', 'Lovell']]",,0,"[u'http://www.iwpr.org/pdf/PrePub_B248.pdf', u'http://paidsickdaysca.org/learn/IWPR_ValuingGoodHealth.pdf', u'http://www.iwpr.org/pdf/B248.pdf']"
10.1093/occmed/48.2.85,"Engler, R., Nelson, M., Klote, M., et. al, Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses, , 0",cited-by,"13620392Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses","Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses","[['Renata', 'J. M.', 'Engler'], ['Michael', 'R.', 'Nelson'], ['Mary', 'M.', 'Klote'], ['Mark', 'J.', 'VanRaden'], ['Chiung-Yu', '', 'Huang'], ['Nancy', 'J.', 'Cox'], ['Alexander', '', 'Klimov'], ['Wendy', 'A.', 'Keitel'], ['Kristin', 'L.', 'Nichol'], ['Warner', 'W.', 'Carr'], ['John', 'J.', 'Treanor']]",,0,[u'http://archinte.highwire.org/cgi/reprint/168/22/2405.pdf']
10.1093/occmed/48.2.85,"Vernet, G., , Use of molecular assays for the diagnosis of influenza, Expert Review of Anti-infective Therapy, 2007",cited-by,10.1586/14787210.5.1.89,Use of molecular assays for the diagnosis of influenza,"[['Guy', '', 'Vernet']]",Expert Review of Anti-infective Therapy,2007,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.5.1.89']
10.1093/occmed/48.2.85,"Newton, D., Treanor, J., Menegus, M., , Clinical and Laboratory Diagnosis of Influenza Virus Infections, , 0",cited-by,12962526Clinical and Laboratory Diagnosis of Influenza Virus Infections,Clinical and Laboratory Diagnosis of Influenza Virus Infections,"[['Duane', 'W.', 'Newton'], ['John', 'J.', 'Treanor'], ['Marilyn', 'A.', 'Menegus']]",,0,[u'http://www.hcplive.com/_micro/ajmc/_picture/folder_12/AMSub5_2000NewtS265_75.pdf']
10.1093/occmed/48.2.85,"Monto, A., , Preventing Influenza in Healthy Adults: The Evolving Story, , 2010",cited-by,13512707Preventing Influenza in Healthy Adults: The Evolving Story,Preventing Influenza in Healthy Adults: The Evolving Story,"[['Arnold', 'S.', 'Monto']]",,2010,"[u'http://jama.ama-assn.org/cgi/reprint/284/13/1655.pdf', u'http://jama.highwire.org/cgi/reprint/284/13/1655.pdf']"
10.1093/occmed/48.2.85,"Lovell, V., , Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008, , 2008",cited-by,"5137586Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008","Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008","[['Vicky', '', 'Lovell']]",,2008,"[u'http://paidsickdaysca.org/learn/IWPR_CA_report.pdf', u'http://www.iwpr.org/pdf/B259capsd.pdf']"
10.1093/occmed/48.2.85,"Palmer, L., Rousculp, M., Johnston, S., et. al, Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.05.011,Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study,"[['Liisa', 'A.', 'Palmer'], ['Matthew', 'D.', 'Rousculp'], ['Stephen', 'S.', 'Johnston'], ['Parthiv', 'J.', 'Mahadevia'], ['Kristin', 'L.', 'Nichol']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10006766', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10006766']"
10.1093/occmed/48.2.85,"Colombo, G., Ferro, A., Vinci, M., et. al, Cost-benefit analysis of influenza vaccination in a public healthcare unit, Therapeutics and Clinical Risk Management, 2006",cited-by,10.2147/tcrm.2006.2.2.219,Cost-benefit analysis of influenza vaccination in a public healthcare unit,"[['Giorgio', 'L', 'Colombo'], ['Antonio', '', 'Ferro'], ['Marta', '', 'Vinci'], ['Maria', '', 'Zordan'], ['Giulio', '', 'Serra']]",Therapeutics and Clinical Risk Management,2006,[u'http://www.extenza-eps.com/DMP/doi/abs/10.2147/tcrm.2006.2.2.219']
10.1093/occmed/48.2.85,"Fleming, D., , The management of influenza in people of working age, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.259,The management of influenza in people of working age,"[['D.', 'M.', 'Fleming']]",Occupational Medicine-oxford,2002,"[u'http://occmed.oxfordjournals.org/cgi/reprint/52/5/259.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.259']"
10.1093/occmed/48.2.85,"Hübner, N., Hübner, C., Wodny, M., et. al, Effectiveness of alcohol-based hand disinfectants in a public administration: Impact on health and work performance related to acute respiratory symptoms and diarrhoea, BMC Infectious Diseases, 2010",cited-by,10.1186/1471-2334-10-250,Effectiveness of alcohol-based hand disinfectants in a public administration: Impact on health and work performance related to acute respiratory symptoms and diarrhoea,"[['Nils-Olaf', '', 'H\xc3\xbcbner'], ['Claudia', '', 'H\xc3\xbcbner'], ['Michael', '', 'Wodny'], ['G\xc3\xbcnter', '', 'Kampf'], ['Axel', '', 'Kramer']]",BMC Infectious Diseases,2010,"[u'http://www.biomedcentral.com/1471-2334/10/250', u'http://www.biomedcentral.com/content/pdf/1471-2334-10-250.pdf', u'http://www.springerlink.com/content/24775762m4h34468', u'http://www.springerlink.com/index/24775762m4h34468.pdf']"
10.1093/occmed/48.2.85,"Lee, B., Bailey, R., Wiringa, A., et. al, Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.07.003,Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza,"[['Bruce', 'Y.', 'Lee'], ['Rachel', 'R.', 'Bailey'], ['Ann', 'E.', 'Wiringa'], ['Abena', '', 'Afriyie'], ['Angela', 'R.', 'Wateska'], ['Kenneth', 'J.', 'Smith'], ['Richard', 'K.', 'Zimmerman']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10009783', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10009783']"
10.1093/occmed/48.2.85,"Xue, Y., Kristiansen, I., Blasio, B., , Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave, BMC Public Health, 2010",cited-by,10.1186/1471-2458-10-724,Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave,"[['Yiting', '', 'Xue'], ['Ivar', 'S\xc3\xb8nb\xc3\xb8', 'Kristiansen'], ['Birgitte', 'Freiesleben de', 'Blasio']]",BMC Public Health,2010,"[u'http://www.springerlink.com/index/u5362057p8412881.pdf', u'http://www.springerlink.com/content/u5362057p8412881', u'http://www.biomedcentral.com/content/pdf/1471-2458-10-724.pdf', u'http://www.biomedcentral.com/1471-2458/10/724']"
10.1093/occmed/48.2.85,"Sendi, P., Locher, R., Bucheli, B., et. al, The decision to get vaccinated against influenza, American Journal of Medicine, 2004",cited-by,10.1016/j.amjmed.2004.02.023,The decision to get vaccinated against influenza,"[['Pedram', '', 'Sendi'], ['Rebecca', '', 'Locher'], ['Bruno', '', 'Bucheli'], ['Manuel', '', 'Battegay']]",American Journal of Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S000293430400169X', u'http://linkinghub.elsevier.com/retrieve/pii/S000293430400169X']"
10.1093/occmed/48.2.85,"Liu, Y., Huang, L., Wang, J., , Reduction of Acute Respiratory Illness (ARI) due to a Voluntary Workplace Influenza Vaccination Program: Who are More Likely to Get the Benefit?, Journal of Occupational Health, 2004",cited-by,10.1539/joh.46.455,Reduction of Acute Respiratory Illness (ARI) due to a Voluntary Workplace Influenza Vaccination Program: Who are More Likely to Get the Benefit?,"[['Yi-Hung', '', 'Liu'], ['Li-Min', '', 'Huang'], ['Jung-Der', '', 'Wang']]",Journal of Occupational Health,2004,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/joh/46.455?from=CrossRef']
10.1093/occmed/48.2.85,"Lovell, V., , Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy, , 0",cited-by,5311694Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy,Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy,"[['Vicky', '', 'Lovell']]",,0,[u'http://www.iwpr.org/pdf/B252.pdf']
10.1093/occmed/48.2.85,"Lovell, V., , Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1, , 0",cited-by,10818092Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1,Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1,"[['Vicky', '', 'Lovell']]",,0,"[u'http://www.iwpr.org/pdf/B249.pdf', u'http://www.gbls.org/employment/PDS_Acostest_3_may_05.pdf']"
10.1093/occmed/48.2.85,"Souza, M., , Influenza, Journal of Exotic Pet Medicine, 2011",cited-by,10.1053/j.jepm.2010.11.003,Influenza,"[['Marcy', 'J.', 'Souza']]",Journal of Exotic Pet Medicine,2011,"[u'http://www.sheffield.ac.uk/content/1/c6/01/28/99/flu1.pdf', u'http://www.sciencedirect.com/science/article/pii/S1557506310002090']"
10.1093/occmed/48.2.85,"Wang, L., Zhang, R., Liu, G., et. al, Chinese herbs in treatment of influenza: A randomized, double-blind, placebo-controlled trial, Respiratory Medicine, 2010",cited-by,10.1016/j.rmed.2010.05.015,"Chinese herbs in treatment of influenza: A randomized, double-blind, placebo-controlled trial","[['Lei', '', 'Wang'], ['Rui-Ming', '', 'Zhang'], ['Gui-Ying', '', 'Liu'], ['Bao-Lin', '', 'Wei'], ['Yang', '', 'Wang'], ['Hong-Yan', '', 'Cai'], ['Feng-Sen', '', 'Li'], ['Yan-Ling', '', 'Xu'], ['Si-Ping', '', 'Zheng'], ['Gang', '', 'Wang']]",Respiratory Medicine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0954611110002519', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611110002519']"
10.1093/occmed/48.2.85,"JANCIN, B., , Screening Key to Managing Hepatic Risks in Rheumatology, , 2010",cited-by,10.1016/S1541-9800(10)70193-9,Screening Key to Managing Hepatic Risks in Rheumatology,"[['BRUCE', '', 'JANCIN']]",,2010,[u'http://www.sciencedirect.com/science/article/pii/S1541980010701939']
10.1093/occmed/48.2.85,"Li, O., Chan, M., Leung, C., et. al, Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation, PLOS One, 2009",cited-by,10.1371/journal.pone.0005658,Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation,"[['Olive', 'T. W.', 'Li'], ['Michael', 'C. W.', 'Chan'], ['Cynthia', 'S. W.', 'Leung'], ['Renee', 'W. Y.', 'Chan'], ['Yi', '', 'Guan'], ['John', 'M.', 'Nicholls'], ['Leo', 'L. M.', 'Poon'], ['Ding', 'Xiang', 'Liu']]",PLOS One,2009,"[u'http://adsabs.harvard.edu/abs/2009PLoSO...4.5658L', u'http://dx.doi.org/10.1371/journal.pone.0005658']"
10.1093/occmed/48.2.85,"Fernández, J., , Análisis de un modelo económico de una estrategia poblacional de vacunación gripal en trabajadores sanos, Revista Espanola De Salud Publica, 2006",cited-by,10.1590/S1135-57272006000300002,Análisis de un modelo económico de una estrategia poblacional de vacunación gripal en trabajadores sanos,"[['Jesus', 'Mart\xc3\xadn', 'Fern\xc3\xa1ndez']]",Revista Espanola De Salud Publica,2006,"[u'http://redalyc.uaemex.mx/redalyc/pdf/170/17080302.pdf', u'http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272006000300002&lng=es&nrm=iso&tlng=es']"
10.1093/occmed/48.2.85,"Llach, X., Gamisans, M., Tudel, J., et. al, Estudio de costes de la gripe, Atencion Primaria, 2006",cited-by,10.1157/13092984,Estudio de costes de la gripe,"[['Xavier', 'Badia', 'Llach'], ['Montserrat', 'Roset', 'Gamisans'], ['Jos\xc3\xa9', 'M. Franc\xc3\xa9s', 'Tudel'], ['Concha', '\xc3\x81lvarez', 'Sanz'], ['Carlos', 'Rubio', 'Terr\xc3\xa9s']]",Atencion Primaria,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0212656706704954', u'http://linkinghub.elsevier.com/retrieve/pii/S0212656706704954']"
10.1093/occmed/48.2.85,"Schwarzinger, M., Housset, B., Carrat, F., , Rapid flu test and neuraminidase inhibitors in healthy adults: a cost-benefit analysis, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00328-4,Rapid flu test and neuraminidase inhibitors in healthy adults: a cost-benefit analysis,"[['Michael', '', 'Schwarzinger'], ['Bruno', '', 'Housset'], ['Fabrice', '', 'Carrat']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003284', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003284']"
10.1093/occmed/48.2.85,"Mrabkt, N., Lahlou, H., Benjilali, B., , Effet de quelques extraits du ciste ladanifère du Maroc ( Cistus ladaniferus L.) sur la croissance de quatre champignons, Cryptogamie Mycologie, 1999",cited-by,10.1016/S0181-1584(99)80005-0,Effet de quelques extraits du ciste ladanifère du Maroc ( Cistus ladaniferus L.) sur la croissance de quatre champignons,"[['Najat', '', 'Mrabkt'], ['Houria', '', 'Lahlou'], ['Bachir', '', 'Benjilali']]",Cryptogamie Mycologie,1999,[u'http://www.sciencedirect.com/science/article/pii/S0181158499800050']
10.1093/occmed/48.2.85,"Miller, K., Williams, C., , Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days, , 0",cited-by,10127171Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days,Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days,"[['Kevin', '', 'Miller'], ['Claudia', '', 'Williams']]",,0,"[u'http://www.nhwomen.org/pdf/B276NH.pdf', u'http://www.iwpr.org/pdf/B276NH.pdf', u'http://www.iwpr.org/pdf/B281Maine.pdf', u'http://www.iwpr.org/pdf/B268Mass.pdf']"
10.1093/occmed/48.2.85,"Miller, K., Williams, C., , Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days, , 0",cited-by,11590495Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days,Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days,"[['Kevin', '', 'Miller'], ['Claudia', '', 'Williams']]",,0,[u'http://www.iwpr.org/pdf/B273NCCBA.pdf']
10.1093/occmed/48.2.85,"Whyne, D., Pass, P., , PANDEMIC INFLUENZA: A CALL TO ACTION, , 0",cited-by,12385527PANDEMIC INFLUENZA: A CALL TO ACTION,PANDEMIC INFLUENZA: A CALL TO ACTION,"[['Diane', 'M.', 'Whyne'], ['Peggy', 'A.', 'Pass']]",,0,[u'http://www.jhasin.com/files/articlefiles/pdf/ASN_5_2_p43_61.pdf']
10.1093/occmed/48.2.85,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
10.1093/occmed/48.2.85,"Tutt, A., , A THEORY OF OPTIMAL SICK PAY, , 0",cited-by,13129195A THEORY OF OPTIMAL SICK PAY,A THEORY OF OPTIMAL SICK PAY,"[['Andrew', '', 'Tutt']]",,0,[u'http://dukespace.lib.duke.edu/dspace/bitstream/10161/1428/1/Tutt%2c%20Andrew.pdf']
10.1093/occmed/48.2.85,"HMED, F., INGLETON, J., RANKS, D., , INFLUENZA VACCINATION FOR HEALTHY YOUNG ADULTS, , 0",cited-by,13495419INFLUENZA VACCINATION FOR HEALTHY YOUNG ADULTS,INFLUENZA VACCINATION FOR HEALTHY YOUNG ADULTS,"[['F', 'ARUQUE A', 'HMED'], ['J', 'AMES A. S', 'INGLETON'], ['DELE', 'L. F', 'RANKS']]",,0,[u'http://content.nejm.org/cgi/reprint/345/21/1543.pdf?ck=nck']
10.1093/occmed/48.2.85,"Liu, J., Shi, L., Khan, M., et. al, Trends of out-of-pocket expenditure for influenza in China health and nutrition survey during 1989–2006, International Journal of Public Health, 0",cited-by,10.1007/s00038-011-0251-y,Trends of out-of-pocket expenditure for influenza in China health and nutrition survey during 1989–2006,"[['Jinan', '', 'Liu'], ['Lizheng', '', 'Shi'], ['Mahmud', '', 'Khan'], ['Lingzhong', '', 'Xu'], ['Liya', '', 'Wang']]",International Journal of Public Health,0,"[u'http://www.springerlink.com/index/8q14143356h42208.pdf', u'http://www.springerlink.com/content/8q14143356h42208']"
10.1016~S0140-6736(00)02288-1,Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998; 47 (RR-6): 1–26.,references,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[[u'David', u'K.', u'Shay'], [u'Karen', u'', u'Broder'], [u'John', u'K.', u'Iskander'], [u'Timothy', u'M.', u'Uyeki'], [u'Joseph', u'S.', u'Bresee'], [u'Nancy', u'J.', u'Cox'], [u'James', u'', u'LeDuc'], [u'Stephen', u'', u'Cochi'], [u'Gina', u'', u'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']",./output/10.1016~S0140-6736(00)02288-1/13129215
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Jamieson, D., Honein, M., Rasmussen, S., et. al, H1N1 2009 influenza virus infection during pregnancy in the USA, Lancet, 2009",cited-by,10.1016/S0140-6736(09)61304-0,H1N1 2009 influenza virus infection during pregnancy in the USA,"[['Denise', 'J', 'Jamieson'], ['Margaret', 'A', 'Honein'], ['Sonja', 'A', 'Rasmussen'], ['Jennifer', 'L', 'Williams'], ['David', 'L', 'Swerdlow'], ['Matthew', 'S', 'Biggerstaff'], ['Stephen', '', 'Lindstrom'], ['Janice', 'K', 'Louie'], ['Cara', 'M', 'Christ'], ['Susan', 'R', 'Bohm'], ['Vincent', 'P', 'Fonseca'], ['Kathleen', 'A', 'Ritger'], ['Daniel', 'J', 'Kuhles'], ['Paula', '', 'Eggers'], ['Hollianne', '', 'Bruce'], ['Heidi', 'A', 'Davidson'], ['Emily', '', 'Lutterloh'], ['Meghan', 'L', 'Harris'], ['Colleen', '', 'Burke'], ['Noelle', '', 'Cocoros'], ['Lyn', '', 'Finelli'], ['Kitty', 'F', 'MacFarlane'], ['Bo', '', 'Shu'], ['Sonja', 'J', 'Olsen']]",Lancet,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0140673609613040', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673609613040']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Belshe, R., Edwards, K., Vesikari, T., et. al, Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children, New England Journal of Medicine, 2007",cited-by,10.1056/NEJMoa065368,Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children,"[['Robert', 'B.', 'Belshe'], ['Kathryn', 'M.', 'Edwards'], ['Timo', '', 'Vesikari'], ['Steven', 'V.', 'Black'], ['Robert', 'E.', 'Walker'], ['Micki', '', 'Hultquist'], ['George', '', 'Kemble'], ['Edward', 'M.', 'Connor']]",New England Journal of Medicine,2007,"[u'http://www.preventinfluenza.org/newsletters/Belshe_NEJM.pdf', u'http://www.michigan.gov/documents/mdch/NewEnglandJournalofMedicineFeb15_208751_7.pdf', u'https://content.nejm.org/cgi/reprint/356/7/685.pdf', u'http://www.skane.se/upload/Webbplatser/UMAS/VERKSAMHETER%20UMAS/Barn%20och%20Ungdomscentrum/Dokument%20BUC/NEJM%2002-09-07.pdf', u'http://content.nejm.org/cgi/reprint/356/7/685.pdf', u'http://michigan.michigan.gov/documents/mdch/NewEnglandJournalofMedicineFeb15_208751_7.pdf', u'http://intl-content.nejm.org/cgi/reprint/356/7/685.pdf', u'http://www.nejm.org/doi/abs/10.1056/NEJMoa065368']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Shinde, V., Bridges, C., Uyeki, T., et. al, Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009, New England Journal of Medicine, 2009",cited-by,10.1056/NEJMoa0903812,"Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009","[['Vivek', '', 'Shinde'], ['Carolyn', 'B.', 'Bridges'], ['Timothy', 'M.', 'Uyeki'], ['Bo', '', 'Shu'], ['Amanda', '', 'Balish'], ['Xiyan', '', 'Xu'], ['Stephen', '', 'Lindstrom'], ['Larisa', 'V.', 'Gubareva'], ['Varough', '', 'Deyde'], ['Rebecca', 'J.', 'Garten'], ['Meghan', '', 'Harris'], ['Susan', '', 'Gerber'], ['Susan', '', 'Vagasky'], ['Forrest', '', 'Smith'], ['Neal', '', 'Pascoe'], ['Karen', '', 'Martin'], ['Deborah', '', 'Dufficy'], ['Kathy', '', 'Ritger'], ['Craig', '', 'Conover'], ['Patricia', '', 'Quinlisk'], ['Alexander', '', 'Klimov'], ['Joseph', 'S.', 'Bresee'], ['Lyn', '', 'Finelli']]",New England Journal of Medicine,2009,"[u'http://content.nejm.org/cgi/reprint/NEJMoa0903812v1.pdf', u'http://www.camfilfarr.info/library_files/1-2009bh.pdf', u'http://fazd.tamu.edu/flulitfolder/NEJMoa0903812v1.pdf', u'http://content.nejm.org/cgi/reprint/360/25/2616.pdf', u'http://content.nejm.org/cgi/reprint/NEJMoa0903812.pdf', u'http://intl-content.nejm.org/cgi/reprint/360/25/2616.pdf', u'http://nejm.highwire.org/cgi/reprint/360/25/2616.pdf', u'http://www.medpagetoday.com/upload/2009/5/7/NEJMoa0903812.pdf', u'http://www.nejm.org/doi/abs/10.1056/NEJMoa0903812']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Taubenberger, J., Morens, D., , The Pathology of Influenza Virus Infections, Annual Review of Pathology-mechanisms of Disease, 2008",cited-by,10.1146/annurev.pathmechdis.3.121806.154316,The Pathology of Influenza Virus Infections,"[['Jeffery', 'K.', 'Taubenberger'], ['David', 'M.', 'Morens']]",Annual Review of Pathology-mechanisms of Disease,2008,"[u'http://cmgm.stanford.edu/biochem/biochem230/lectures2008/influenza/background/InfluenzaPathology.pdf', u'http://biochem.stanford.edu/biochem/biochem230/lectures2008/influenza/background/InfluenzaPathology.pdf', u'http://biochem.stanford.edu/biochem230/lectures2008/influenza/background/InfluenzaPathology.pdf', u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.pathmechdis.3.121806.154316']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Roush, S., Murphy, T., , Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States, , 2007",cited-by,5521679Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States,Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States,"[['Sandra', 'W.', 'Roush'], ['Trudy', 'V.', 'Murphy']]",,2007,"[u'http://michigan.michigan.gov/documents/mdch/Historical_Comparisons_of_VPDs_215688_7.pdf', u'https://michigan.michigan.gov/documents/mdch/Historical_Comparisons_of_VPDs_215688_7.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Gravenstein, S., , Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America, Clinical Infectious Diseases, 2009",cited-by,10.1086/598513,"Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America","[['Stefan', '', 'Gravenstein']]",Clinical Infectious Diseases,2009,"[u'http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/idsainfluenza2009.pdf', u'http://linmed.files.wordpress.com/2009/05/flu_guideline_2009.pdf', u'http://maladiesinfectieuses.hug-ge.ch/_library/pdf/influenza.pdf', u'http://www.srlf.org/Data/upload/file/Grippe%20A/(26)%20-%20Recos%20Flu%20IDSA%202009.pdf', u'http://www.maine.gov/dhhs/boh/ddc/epi/influenzatoolkit/Supporting%20documents/IDSA%20Seasonal%20Guidelines.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/598513']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Graham, J., Christian, L., Kiecolt-Glaser, J., , Stress, Age, and Immune Function: Toward a Lifespan Approach, Journal of Behavioral Medicine, 2006",cited-by,10.1007/s10865-006-9057-4,"Stress, Age, and Immune Function: Toward a Lifespan Approach","[['Jennifer', 'E.', 'Graham'], ['Lisa', 'M.', 'Christian'], ['Janice', 'K.', 'Kiecolt-Glaser']]",Journal of Behavioral Medicine,2006,"[u'http://bbh.hhdev.psu.edu/labs/stressandhealth/images/grahamstressageimmune.pdf', u'http://www.springerlink.com/content/a1k2k025qu772l05', u'http://www.springerlink.com/index/a1k2k025qu772l05.pdf', u'http://www.springerlink.com/index/10.1007/s10865-006-9057-4', u'http://www.springerlink.com/index/pdf/10.1007/s10865-006-9057-4']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Zaman, K., Roy, E., Arifeen, S., et. al, Effectiveness of Maternal Influenza Immunization in Mothers and Infants, , 2010",cited-by,5342252Effectiveness of Maternal Influenza Immunization in Mothers and Infants,Effectiveness of Maternal Influenza Immunization in Mothers and Infants,"[['K.', '', 'Zaman'], ['Eliza', '', 'Roy'], ['Shams', 'E.', 'Arifeen'], ['Mahbubur', '', 'Rahman'], ['Rubhana', '', 'Raqib'], ['Emily', '', 'Wilson'], ['Saad', 'B.', 'Omer'], ['Nigar', 'S.', 'Shahid'], ['Robert', 'F.', 'Breiman'], ['Mark', 'C.', 'Steinhoff']]",,2010,"[u'http://nejm.highwire.org/cgi/reprint/359/15/1555.pdf', u'https://content.nejm.org/cgi/reprint/NEJMoa0708630v1.pdf', u'http://content.nejm.org/cgi/reprint/359/15/1555.pdf', u'http://content.nejm.org/cgi/reprint/NEJMoa0708630v1.pdf', u'http://171.66.123.143/cgi/reprint/359/15/1555.pdf', u'http://nejm.highwire.org/cgi/reprint/NEJMoa0708630v1.pdf', u'http://intl-content.nejm.org/cgi/reprint/359/15/1555.pdf', u'https://content.nejm.org/cgi/reprint/359/15/1555.pdf', u""http://www.conseil-departemental-34.medecin.fr/ordre_medecin_34_web/docs/lespecial/h1n1%20interet%20de%20la%20vaccination%20des%20femmes%20enceintes%20et%20des%20enfants%20jusqu'a%20six%20ans%20nejm%202008.pdf""]"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Tanaka, T., Nakajima, K., Murashima, A., et. al, Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women, , 2009",cited-by,13194948Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women,Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women,"[['Toshihiro', '', 'Tanaka'], ['Ken', '', 'Nakajima'], ['Atsuko', '', 'Murashima'], ['Facundo', '', 'Garcia-Bournissen'], ['Gideon', '', 'Koren'], ['Shinya', '', 'Ito']]",,2009,"[u'http://www.health.nt.gov.au/library/scripts/objectifymedia.aspx?file=pdf/37/88.pdf&amp;siteid=1&amp;str_title=use%20of%20antivirals%20in%20pregnancy%20cmaj%20jun09.pdf', u'http://www.cmaj.ca/cgi/rapidpdf/cmaj.090866v1.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Tomblyn, M., Chiller, T., Einsele, H., et. al, Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective, Biology of Blood and Marrow Transplantation, 2009",cited-by,10.1016/j.bbmt.2009.06.019,Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective,"[['Marcie', '', 'Tomblyn'], ['Tom', '', 'Chiller'], ['Hermann', '', 'Einsele'], ['Ronald', '', 'Gress'], ['Kent', '', 'Sepkowitz'], ['Jan', '', 'Storek'], ['John', 'R.', 'Wingard'], ['Jo-Anne', 'H.', 'Young'], ['Michael', 'A.', 'Boeckh']]",Biology of Blood and Marrow Transplantation,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1083879109003000', u'http://linkinghub.elsevier.com/retrieve/pii/S1083879109003000']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Rothberg, M., Haessler, S., Brown, R., , Complications of Viral Influenza, , 0",cited-by,6410610Complications of Viral Influenza,Complications of Viral Influenza,"[['Michael', 'B.', 'Rothberg'], ['Sarah', 'D.', 'Haessler'], ['Richard', 'B.', 'Brown']]",,0,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/pathogenesis/pathogenesis-8.pdf']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Serres, G., , Rapid Decline of Influenza Vaccine–Induced Antibody in the Elderly: Is It Real, or Is It Relevant?, Journal of Infectious Diseases, 2008",cited-by,10.1086/524146,"Rapid Decline of Influenza Vaccine–Induced Antibody in the Elderly: Is It Real, or Is It Relevant?","[['Gaston', 'De', 'Serres']]",Journal of Infectious Diseases,2008,"[u'http://www.pathwayhealth.com/industry/influenza%20immunity%20JID%202008.pdf', u'http://www.immunize.org/journalarticles/skowronski_21508.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/524146']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Lapinsky, S., , H1N1 novel influenza A in pregnant and immunocompromised patients, Critical Care Medicine, 2010",cited-by,10.1097/CCM.0b013e3181c85d5f,H1N1 novel influenza A in pregnant and immunocompromised patients,"[['Stephen', 'E.', 'Lapinsky']]",Critical Care Medicine,2010,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-201004001-00007', u'http://www.sopemi.org.pe/file/articulos/201004/H1N1 novel influenza A in pregnant and immunocompromised patients.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Hanshaoworakul, W., Simmerman, J., Narueponjirakul, U., et. al, Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome, PLOS One, 2009",cited-by,10.1371/journal.pone.0006051.t003,Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome,"[['Wanna', '', 'Hanshaoworakul'], ['James', 'Mark', 'Simmerman'], ['Ubolrat', '', 'Narueponjirakul'], ['Wiwan', '', 'Sanasuttipun'], ['Vivek', '', 'Shinde'], ['Suchada', '', 'Kaewchana'], ['Darin', '', 'Areechokechai'], ['Jens', '', 'Levy'], ['Kumnuan', '', 'Ungchusak']]",PLOS One,2009,"[u'http://www.srlf.org/Data/upload/file/Grippe%20A/104%20-%20Grippe%20Tha%C3%AFlande%20Tamiflu%20-%20PlosOne%2009.pdf', u'http://dx.plos.org/10.1371/journal.pone.0006051', u'http://dx.plos.org/10.1371/journal.pone.0006051.g001', u'http://dx.plos.org/10.1371/journal.pone.0006051.g002', u'http://dx.plos.org/10.1371/journal.pone.0006051.t001', u'http://dx.plos.org/10.1371/journal.pone.0006051.t002', u'http://dx.plos.org/10.1371/journal.pone.0006051.t003']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Mehlmann, M., Bonner, A., Williams, J., et. al, Comparison of the MChip to Viral Culture, Reverse Transcription-PCR, and the QuickVue Influenza AB Test for Rapid Diagnosis of Influenza, , 2007",cited-by,"6807365Comparison of the MChip to Viral Culture, Reverse Transcription-PCR, and the QuickVue Influenza AB Test for Rapid Diagnosis of Influenza","Comparison of the MChip to Viral Culture, Reverse Transcription-PCR, and the QuickVue Influenza AB Test for Rapid Diagnosis of Influenza","[['Martin', '', 'Mehlmann'], ['Aleta', 'B.', 'Bonner'], ['John', 'V.', 'Williams'], ['Daniela', 'M.', 'Dankbar'], ['Chad', 'L.', 'Moore'], ['Robert', 'D.', 'Kuchta'], ['Amy', 'B.', 'Podsiad'], ['John', 'D.', 'Tamerius'], ['Erica', 'D.', 'Dawson'], ['Kathy', 'L.', 'Rowlen']]",,2007,[u'http://jcm.asm.org/cgi/reprint/45/4/1234.pdf']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Nolan, T., Richmond, P., Formica, N., et. al, Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.08.046,Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children,"[['Terry', '', 'Nolan'], ['Peter', 'C.', 'Richmond'], ['Neil', 'T.', 'Formica'], ['Katja', '', 'H\xc3\xb6schler'], ['Maryanne', 'V.', 'Skeljo'], ['Tanya', '', 'Stoney'], ['Jodie', '', 'McVernon'], ['Gunter', '', 'Hartel'], ['Daphne', 'C.', 'Sawlwin'], ['Jillian', '', 'Bennet'], ['David', '', 'Ryan'], ['Russell', 'L.', 'Basser'], ['Maria', 'C.', 'Zambon']]",Vaccine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08012085', u'http://mathmodelling.sph.unimelb.edu.au/publications/Nolan-Vaccine-2008.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08012085']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Vellozzi, C., Burwen, D., Dobardzic, A., et. al, Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.01.125,Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring,"[['Claudia', '', 'Vellozzi'], ['Dale', 'R.', 'Burwen'], ['Azra', '', 'Dobardzic'], ['Robert', '', 'Ball'], ['Kimp', '', 'Walton'], ['Penina', '', 'Haber']]",Vaccine,2009,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-3.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X09002047', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09002047']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Yamashita, M., Tomozawa, T., Kakuta, M., et. al, CS8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.00333-08,"CS8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity","[['Makoto', '', 'Yamashita'], ['Takanori', '', 'Tomozawa'], ['Masayo', '', 'Kakuta'], ['Akane', '', 'Tokumitsu'], ['Hatsumi', '', 'Nasu'], ['Shuku', '', 'Kubo']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.asm.org/cgi/reprint/53/1/186.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00333-08']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Schwarzinger, M., Verger, P., Guerville, M., et. al, Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: A missed opportunity to increase vaccination uptakes in the general public?, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.01.027,Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: A missed opportunity to increase vaccination uptakes in the general public?,"[['Micha\xc3\xabl', '', 'Schwarzinger'], ['Pierre', '', 'Verger'], ['Marc-Andr\xc3\xa9', '', 'Guerville'], ['Catherine', '', 'Aubry'], ['Sophie', '', 'Rolland'], ['Yolande', '', 'Obadia'], ['Jean-Paul', '', 'Moatti']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10000599', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10000599']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Bouvier, N., Lowen, A., Palese, P., , Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol, Journal of Virology, 2008",cited-by,10.1128/JVI.01226-08,Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol,"[['Nicole', 'M.', 'Bouvier'], ['Anice', 'C.', 'Lowen'], ['Peter', '', 'Palese']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10052.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01226-08']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Wicker, S., Rabenau, H., Doerr, H., et. al, Influenza Vaccination Compliance Among Health Care Workers in a German University Hospital, Infection, 2009",cited-by,10.1007/s15010-008-8200-2,Influenza Vaccination Compliance Among Health Care Workers in a German University Hospital,"[['S.', '', 'Wicker'], ['H.', 'F.', 'Rabenau'], ['H.', 'W.', 'Doerr'], ['R.', '', 'Allwinn']]",Infection,2009,"[u'http://www.springerlink.com/index/cwt417g267741342.pdf', u'http://www.springerlink.com/content/cwt417g267741342', u'http://www.springerlink.com/index/10.1007/s15010-008-8200-2', u'http://www.springerlink.com/index/pdf/10.1007/s15010-008-8200-2']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Vesikari, T., Groth, N., Karvonen, A., et. al, MF59 ®-adjuvanted influenza vaccine (FLUAD ®) in children: Safety and immunogenicity following a second year seasonal vaccination, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.02.004,MF59 ®-adjuvanted influenza vaccine (FLUAD ®) in children: Safety and immunogenicity following a second year seasonal vaccination,"[['T.', '', 'Vesikari'], ['N.', '', 'Groth'], ['A.', '', 'Karvonen'], ['A.', '', 'Borkowski'], ['M.', '', 'Pellegrini']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09002138', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09002138']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Likos, A., Kelvin, D., Cameron, C., et. al, Influenza viremia and the potential for blood-borne transmission, Transfusion, 2007",cited-by,10.1111/j.1537-2995.2007.01264.x,Influenza viremia and the potential for blood-borne transmission,"[['Anna', 'M.', 'Likos'], ['David', 'J.', 'Kelvin'], ['Cheryl', 'M.', 'Cameron'], ['Thomas', '', 'Rowe'], ['Matthew', 'J.', 'Kuehnert'], ['Philip', 'J.', 'Norris']]",Transfusion,2007,"[u'http://www.mhlw.go.jp/shingi/2009/12/dl/s1210-8i08.pdf', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1537-2995.2007.01264.x']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Marshall, D., Reisdorf, E., Harms, G., et. al, Evaluation of a Multiplexed PCR Assay for Detection of Respiratory Viral Pathogens in a Public Health Laboratory Setting, , 2007",cited-by,6636381Evaluation of a Multiplexed PCR Assay for Detection of Respiratory Viral Pathogens in a Public Health Laboratory Setting,Evaluation of a Multiplexed PCR Assay for Detection of Respiratory Viral Pathogens in a Public Health Laboratory Setting,"[['David', 'J.', 'Marshall'], ['Erik', '', 'Reisdorf'], ['Gerda', '', 'Harms'], ['Edward', '', 'Beaty'], ['Michael', 'J.', 'Moser'], ['Wai-Ming', '', 'Lee'], ['James', 'E.', 'Gern'], ['Frederick', 'S.', 'Nolte'], ['Pete', '', 'Shult'], ['James', 'R.', 'Prudent']]",,2007,[u'http://jcm.asm.org/cgi/reprint/45/12/3875.pdf']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Rand, C., Szilagyi, P., Yoo, B., et. al, Additional Visit Burden for Universal Influenza Vaccination of US School-Aged Children and Adolescents, , 2008",cited-by,13897637Additional Visit Burden for Universal Influenza Vaccination of US School-Aged Children and Adolescents,Additional Visit Burden for Universal Influenza Vaccination of US School-Aged Children and Adolescents,"[['Cynthia', 'M.', 'Rand'], ['Peter', 'G.', 'Szilagyi'], ['Byung-Kwang', '', 'Yoo'], ['Peggy', '', 'Auinger'], ['Christina', '', 'Albertin'], ['Margaret', 'S.', 'Coleman']]",,2008,[u'http://archpedi.highwire.org/cgi/reprint/162/11/1048.pdf']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Meury, S., Zeller, S., Heininger, U., , Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents, European Journal of Pediatrics, 2004",cited-by,10.1007/s00431-004-1445-6,Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents,"[['Susanne', '', 'Meury'], ['Sven', '', 'Zeller'], ['Ulrich', '', 'Heininger']]",European Journal of Pediatrics,2004,"[u'http://www.springerlink.com/content/5jm7e6egqvfd4b07', u'http://www.springerlink.com/index/5jm7e6egqvfd4b07.pdf', u'http://springerlink.metapress.com/openurl.asp?genre=article&id=doi:10.1007/s00431-004-1445-6', u'http://www.springerlink.com/index/pdf/10.1007/s00431-004-1445-6']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Akker, I., Delden, J., Verheij, T., et. al, Which determinants should be targeted to increase influenza vaccination uptake among health care workers in nursing homes?, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.05.013,Which determinants should be targeted to increase influenza vaccination uptake among health care workers in nursing homes?,"[['I.', 'Looijmans-van den', 'Akker'], ['J.', 'J. M. van', 'Delden'], ['Th.', 'J. M.', 'Verheij'], ['G.', 'A. van', 'Essen'], ['M.', 'E. J. L.', 'Hulscher'], ['E.', '', 'Haka']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09006756', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-56.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09006756']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Beran, J., Ambrozaitis, A., Laiskonis, A., et. al, Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial, BMC Medicine, 2009",cited-by,10.1186/1741-7015-7-13,Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial,"[['Jiri', '', 'Beran'], ['Arvydas', '', 'Ambrozaitis'], ['Alvydas', '', 'Laiskonis'], ['Narseta', '', 'Mickuviene'], ['Patrick', '', 'Bacart'], ['Yvan', '', 'Calozet'], ['Etienne', '', 'Demanet'], ['Stephane', '', 'Heijmans'], ['Paul', 'Van', 'Belle'], ['Fran\xc3\xa7oise', '', 'Weber'], ['Camille', '', 'Salamand']]",BMC Medicine,2009,"[u'http://www.biomedcentral.com/1741-7015/7/13', u'http://www.springerlink.com/content/85466p227355tlk6', u'http://www.springerlink.com/index/85466p227355tlk6.pdf', u'http://www.biomedcentral.com/content/pdf/1741-7015-7-13.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Helms, C., Polgreen, P., , Should influenza immunisation be mandatory for healthcare workers? Yes, British Medical Journal, 2008",cited-by,10.1136/bmj.a2142,Should influenza immunisation be mandatory for healthcare workers? Yes,"[['Charles', 'M', 'Helms'], ['Philip', 'M', 'Polgreen']]",British Medical Journal,2008,"[u'http://dx.doi.org/10.1136/bmj.a2142', u'http://www.bmj.com/cgi/doi/10.1136/bmj.a2142']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Sambhara, S., McElhaney, J., , Immunosenescence and Influenza Vaccine Efficacy, , 0",cited-by,10.1007/978-3-540-92165-3_20,Immunosenescence and Influenza Vaccine Efficacy,"[['Suryaprakash', '', 'Sambhara'], ['Janet', 'E.', 'McElhaney']]",,0,"[u'http://www.springerlink.com/content/xwg27j84w1036v4p', u'http://www.springerlink.com/index/xwg27j84w1036v4p.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Chung, E., Huang, L., Schneider, L., , Safety of Influenza Vaccine Administration in Egg-Allergic Patients, Pediatrics, 2010",cited-by,10.1542/peds.2009-2512,Safety of Influenza Vaccine Administration in Egg-Allergic Patients,"[['Erica', 'Y.', 'Chung'], ['Lin', '', 'Huang'], ['Lynda', '', 'Schneider']]",Pediatrics,2010,"[u'http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2009-2512', u'http://www.siaip.it/upload/937.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Doshi, P., , Neuraminidase inhibitors—the story behind the Cochrane review, British Medical Journal, 2009",cited-by,10.1136/bmj.b5164,Neuraminidase inhibitors—the story behind the Cochrane review,"[['Peter', '', 'Doshi']]",British Medical Journal,2009,"[u'http://www.bmj.com/cgi/doi/10.1136/bmj.b5164', u'http://dx.doi.org/10.1136/bmj.b5164']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Durando, P., Fenoglio, D., Boschini, A., et. al, Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1Seropositive and Seronegative Adults, Clinical and Vaccine Immunology, 2008",cited-by,10.1128/CVI.00316-07,"Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1Seropositive and Seronegative Adults","[['P.', '', 'Durando'], ['D.', '', 'Fenoglio'], ['A.', '', 'Boschini'], ['F.', '', 'Ansaldi'], ['G.', '', 'Icardi'], ['L.', '', 'Sticchi'], ['A.', '', 'Renzoni'], ['P.', '', 'Fabbri'], ['A.', '', 'Ferrera'], ['A.', '', 'Parodi'], ['B.', '', 'Bruzzone'], ['G.', '', 'Gabutti'], ['A.', '', 'Podda'], ['G.', 'Del', 'Giudice'], ['E.', '', 'Fragapane'], ['F.', '', 'Indiveri'], ['P.', '', 'Crovari'], ['R.', '', 'Gasparini']]",Clinical and Vaccine Immunology,2008,"[u'http://cvi.asm.org/cgi/reprint/15/2/253.pdf', u'http://cdli.asm.org/cgi/doi/10.1128/CVI.00316-07']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Lau, J., Kim, J., Tsui, H., et. al, Perceptions Related to Bird-to-Human Avian Influenza, Influenza Vaccination, and Use of Face Mask, Infection, 2008",cited-by,10.1007/s15010-008-7277-y,"Perceptions Related to Bird-to-Human Avian Influenza, Influenza Vaccination, and Use of Face Mask","[['J.', 'T. F.', 'Lau'], ['J.', 'H.', 'Kim'], ['H.', 'Y.', 'Tsui'], ['S.', '', 'Griffiths']]",Infection,2008,"[u'http://www.springerlink.com/content/423022m187u392n4', u'http://www.springerlink.com/index/423022m187u392n4.pdf', u'http://www.springerlink.com/index/10.1007/s15010-008-7277-y', u'http://www.springerlink.com/index/pdf/10.1007/s15010-008-7277-y']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Mozdzanowska, K., Zharikova, D., Cudic, M., et. al, Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse, Virology Journal, 2007",cited-by,10.1186/1743-422X-4-118,Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse,"[['Krystyna', '', 'Mozdzanowska'], ['Darya', '', 'Zharikova'], ['Mare', '', 'Cudic'], ['Laszlo', '', 'Otvos'], ['Walter', '', 'Gerhard']]",Virology Journal,2007,"[u'http://www.biomedcentral.com/content/pdf/1743-422X-4-118.pdf', u'http://www.springerlink.com/content/14351h2468538t09', u'http://www.springerlink.com/index/14351h2468538t09.pdf', u'http://www.virologyj.com/content/4/1/118']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Poehling, K., Talbot, H., Williams, J., et. al, Impact of a school-based influenza immunization program on disease burden: Comparison of two Tennessee counties, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.02.043,Impact of a school-based influenza immunization program on disease burden: Comparison of two Tennessee counties,"[['Katherine', 'A.', 'Poehling'], ['H.', 'Keipp', 'Talbot'], ['John', 'V.', 'Williams'], ['Yuwei', '', 'Zhu'], ['John', '', 'Lott'], ['Lori', '', 'Patterson'], ['Kathryn', 'M.', 'Edwards'], ['Marie', 'R.', 'Griffin']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09002849', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09002849']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Eick, A., Wang, Z., Hughes, H., et. al, Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.03.088,Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members,"[['Angelia', 'A.', 'Eick'], ['Zhong', '', 'Wang'], ['Hayley', '', 'Hughes'], ['Stephen', 'M.', 'Ford'], ['Steven', 'K.', 'Tobler']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09004836', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09004836']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Redelings, M., McCoy, L., Sorvillo, F., , Multiple Sclerosis Mortality and Patterns of Comorbidity in the United States from 1990 to 2001, Neuroepidemiology, 2006",cited-by,10.1159/000090444,Multiple Sclerosis Mortality and Patterns of Comorbidity in the United States from 1990 to 2001,"[['Matthew', 'D.', 'Redelings'], ['Lucie', '', 'McCoy'], ['Frank', '', 'Sorvillo']]",Neuroepidemiology,2006,"[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000090444', u'http://www.karger.com/doi/10.1159/000090444']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Wasan, S., Baker, S., Skolnik, P., et. al, A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient, American Journal of Gastroenterology, 2010",cited-by,10.1038/ajg.2009.733,A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient,"[['Sharmeel', 'K', 'Wasan'], ['Stacey', 'E', 'Baker'], ['Paul', 'R', 'Skolnik'], ['Francis', 'A', 'Farraye']]",American Journal of Gastroenterology,2010,"[u'http://dx.doi.org/10.1038/ajg.2009.733', u'http://www.nature.com/doifinder/10.1038/ajg.2009.733']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Hallauer, J., Neuschaefer-Rube, N., , Influenza vaccination of hospital staff in Germany: a five-year survey on vaccination coverage and policies: identified deficits in influenza immunisation campaigns for hospital employees, Sozial-und Praventivmedizin, 2005",cited-by,10.1007/s00038-004-3103-1,Influenza vaccination of hospital staff in Germany: a five-year survey on vaccination coverage and policies: identified deficits in influenza immunisation campaigns for hospital employees,"[['Johannes', 'F.', 'Hallauer'], ['Nils', '', 'Neuschaefer-Rube']]",Sozial-und Praventivmedizin,2005,"[u'http://www.springerlink.com/index/q0q0370401881467.pdf', u'http://www.springerlink.com/content/q0q0370401881467', u'http://www.springerlink.com/index/10.1007/s00038-004-3103-1', u'http://www.springerlink.com/index/pdf/10.1007/s00038-004-3103-1']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Schmidt, C., Futami, F., Watanabe, S., et. al, Complete optical sampling system with broad gap-free spectral range for 160 Gbit/s and 320 Gbit/s and its application in a transmission system, , 2002",cited-by,10.1109/OFC.2002.1036533,Complete optical sampling system with broad gap-free spectral range for 160 Gbit/s and 320 Gbit/s and its application in a transmission system,"[['C.', '', 'Schmidt'], ['F.', '', 'Futami'], ['S.', '', 'Watanabe'], ['T.', '', 'Yamamoto'], ['C.', '', 'Schubert'], ['J.', '', 'Berger'], ['M.', '', 'Kroh'], ['H.-J.', '', 'Ehrke'], ['E.', '', 'Dietrich'], ['C.', '', 'Burner'], ['R.', '', 'Ludwig'], ['H.', 'G.', 'Weber']]",,2002,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1036533', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01036533']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Pearton, M., Kang, S., Song, J., et. al, Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.05.055,Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin,"[['Marc', '', 'Pearton'], ['Sang-Moo', '', 'Kang'], ['Jae-Min', '', 'Song'], ['Yeu-Chun', '', 'Kim'], ['Fu-Shi', '', 'Quan'], ['Alexander', '', 'Anstey'], ['Matthew', '', 'Ivory'], ['Mark', 'R.', 'Prausnitz'], ['Richard', 'W.', 'Compans'], ['James', 'C.', 'Birchall']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10007644', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10007644']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Lu, C., Shao, P., Chang, L., et. al, Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.06.059,Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents,"[['Chun-Yi', '', 'Lu'], ['Pei-Lan', '', 'Shao'], ['Luan-Yin', '', 'Chang'], ['Yhu-Chering', '', 'Huang'], ['Cheng-Hsun', '', 'Chiu'], ['Yu-Chia', '', 'Hsieh'], ['Tzou-Yien', '', 'Lin'], ['Li-Min', '', 'Huang']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10008819', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10008819']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Ortiz, J., Sotomayor, V., Uez, O., et. al, Strategy to Enhance Influenza Surveillance Worldwide, Emerging Infectious Diseases, 2009",cited-by,10.3201/eid1508.081422,Strategy to Enhance Influenza Surveillance Worldwide,"[['Justin', 'R.', 'Ortiz'], ['Viviana', '', 'Sotomayor'], ['Osvaldo', 'C.', 'Uez'], ['Otavio', '', 'Oliva'], ['Deborah', '', 'Bettels'], ['Margaret', '', 'McCarron'], ['Joseph', 'S.', 'Bresee'], ['Anthony', 'W.', 'Mounts']]",Emerging Infectious Diseases,2009,"[u'http://www.cdc.gov/eid/content/15/8/pdfs/08-1422.pdf', u'http://www.cdc.gov/eid/content/15/8/1271.htm']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Kelso, J., Li, J., Nicklas, R., et. al, Adverse reactions to vaccines, Annals of Allergy Asthma & Immunology, 2009",cited-by,10.1016/S1081-1206(10)60350-X,Adverse reactions to vaccines,"[['John', 'M.', 'Kelso'], ['James', 'T.', 'Li'], ['Richard', 'A.', 'Nicklas'], ['Joann', '', 'Blessing-Moore'], ['Linda', '', 'Cox'], ['David', 'M.', 'Lang'], ['John', '', 'Oppenheimer'], ['Jay', 'M.', 'Portnoy'], ['Christopher', '', 'Randolph'], ['Diane', 'E.', 'Schuller'], ['Sheldon', 'L.', 'Spector'], ['Stephen', '', 'Tilles'], ['Dana', '', 'Wallace'], ['Zuhair', 'K.', 'Ballas'], ['James', 'R.', 'Baker'], ['Joseph', 'A.', 'Bellanti'], ['Daniel', '', 'Ein'], ['Leslie', 'C.', 'Grammer']]",Annals of Allergy Asthma & Immunology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S108112061060350X', u'http://linkinghub.elsevier.com/retrieve/pii/S108112061060350X']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Sauerbrei, A., Schmidt-Ott, R., Hoyer, H., et. al, Seroprevalence of influenza A and B in German infants and adolescents, Medical Microbiology and Immunology, 2009",cited-by,10.1007/s00430-009-0108-7,Seroprevalence of influenza A and B in German infants and adolescents,"[['Andreas', '', 'Sauerbrei'], ['R.', '', 'Schmidt-Ott'], ['H.', '', 'Hoyer'], ['P.', '', 'Wutzler']]",Medical Microbiology and Immunology,2009,"[u'http://www.springerlink.com/index/q111g88615088512.pdf', u'http://www.springerlink.com/content/q111g88615088512', u'http://www.springerlink.com/index/10.1007/s00430-009-0108-7', u'http://www.springerlink.com/index/pdf/10.1007/s00430-009-0108-7']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Esposito, S., Bosis, S., Pelucchi, C., et. al, Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy, BMC Public Health, 2008",cited-by,10.1186/1471-2458-8-422,Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy,"[['Susanna', '', 'Esposito'], ['Samantha', '', 'Bosis'], ['Claudio', '', 'Pelucchi'], ['Elena', '', 'Tremolati'], ['Caterina', '', 'Sabatini'], ['Margherita', '', 'Semino'], ['Paola', '', 'Marchisio'], ['Francesco', 'della', 'Croce'], ['Nicola', '', 'Principi']]",BMC Public Health,2008,"[u'http://www.springerlink.com/index/u54g0g5k351614u5.pdf', u'http://www.biomedcentral.com/1471-2458/8/422', u'http://www.biomedcentral.com/content/pdf/1471-2458-8-422.pdf', u'http://www.springerlink.com/content/u54g0g5k351614u5']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Llupià, A., García-Basteiro, A., Olivé, V., et. al, New interventions to increase influenza vaccination rates in health care workers, American Journal of Infection Control, 2010",cited-by,10.1016/j.ajic.2010.01.013,New interventions to increase influenza vaccination rates in health care workers,"[['Anna', '', 'Llupi\xc3\xa0'], ['Alberto', 'L.', 'Garc\xc3\xada-Basteiro'], ['Victoria', '', 'Oliv\xc3\xa9'], ['Laura', '', 'Costas'], ['Jose', '', 'R\xc3\xados'], ['Sebastiana', '', 'Quesada'], ['Pilar', '', 'Varela'], ['Jose', 'M.', 'Bayas'], ['Antoni', '', 'Trilla']]",American Journal of Infection Control,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0196655310001793', u'http://linkinghub.elsevier.com/retrieve/pii/S0196655310001793']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Rello, J., Pop-Vicas, A., , Clinical review: Primary influenza viral pneumonia, Critical Care, 2009",cited-by,10.1186/cc8183,Clinical review: Primary influenza viral pneumonia,"[['Jordi', '', 'Rello'], ['Aurora', '', 'Pop-Vicas']]",Critical Care,2009,"[u'http://www.springerlink.com/index/p2376780h56k6415.pdf', u'http://www.springerlink.com/content/p2376780h56k6415', u'http://ccforum.com/content/13/6/235']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Moran, K., Maaten, S., Guttmann, A., et. al, Influenza vaccination rates in Ontario children: Implications for universal childhood vaccination policy, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.02.017,Influenza vaccination rates in Ontario children: Implications for universal childhood vaccination policy,"[['Kathy', '', 'Moran'], ['Sarah', '', 'Maaten'], ['Astrid', '', 'Guttmann'], ['David', '', 'Northrup'], ['Jeffrey', 'C.', 'Kwong']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09002333', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09002333']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Grijalva, C., Zhu, Y., Griffin, M., , Evidence of effectiveness from a large county-wide school-based influenza immunization campaign, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.02.039,Evidence of effectiveness from a large county-wide school-based influenza immunization campaign,"[['Carlos', 'G.', 'Grijalva'], ['Yuwei', '', 'Zhu'], ['Marie', 'R.', 'Griffin']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09002904', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09002904']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Ortiz, J., Wallis, T., Katz, M., et. al, No Evidence of Avian Influenza A H5N1 among Returning US Travelers, Emerging Infectious Diseases, 2007",cited-by,10.3201/eid1302.061052,No Evidence of Avian Influenza A H5N1 among Returning US Travelers,"[['Justin', 'R.', 'Ortiz'], ['Teresa', 'R.', 'Wallis'], ['Mark', 'A.', 'Katz'], ['LaShondra', 'S.', 'Berman'], ['Amanda', '', 'Balish'], ['Stephen', 'E.', 'Lindstrom'], ['Vic', '', 'Veguilla'], ['Kathryn', 'S.', 'Teates'], ['Jacqueline', 'M.', 'Katz'], ['Alexander', '', 'Klimov'], ['Timothy', 'M.', 'Uyeki']]",Emerging Infectious Diseases,2007,"[u'http://www.cdc.gov/eid/content/13/2/pdfs/294.pdf', u'http://origin.cdc.gov/eid/content/13/2/pdfs/294.pdf', u'http://www.cdc.gov/eid/content/13/2/294.htm']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Więsik-Szewczyk, E., Romanowska, M., Mielnik, P., et. al, Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety, Clinical Rheumatology, 2010",cited-by,10.1007/s10067-010-1373-y,Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety,"[['Ewa', '', 'Wi\xc4\x99sik-Szewczyk'], ['Magdalena', '', 'Romanowska'], ['Pawe\xc5\x82', '', 'Mielnik'], ['Hanna', '', 'Chwali\xc5\x84ska-Sadowska'], ['Lidia', 'B.', 'Brydak'], ['Marzena', '', 'Olesi\xc5\x84ska'], ['Jakub', '', 'Z\xc4\x85bek']]",Clinical Rheumatology,2010,"[u'http://www.springerlink.com/content/m72859492206w765', u'http://www.springerlink.com/index/m72859492206w765.pdf', u'http://www.springerlink.com/index/10.1007/s10067-010-1373-y', u'http://www.springerlink.com/index/pdf/10.1007/s10067-010-1373-y']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Raviv, Y., Blumenthal, R., Tompkins, S., et. al, Hydrophobic Inactivation of Influenza Viruses Confers Preservation of Viral Structure with Enhanced Immunogenicity, Journal of Virology, 2008",cited-by,10.1128/JVI.02233-07,Hydrophobic Inactivation of Influenza Viruses Confers Preservation of Viral Structure with Enhanced Immunogenicity,"[['Yossef', '', 'Raviv'], ['Robert', '', 'Blumenthal'], ['S.', 'Mark', 'Tompkins'], ['Jennifer', '', 'Humberd'], ['Robert', 'J.', 'Hogan'], ['Mathias', '', 'Viard']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/9/4612.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02233-07']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Vlahov, D., Coady, M., Ompad, D., et. al, Strategies for Improving Influenza Immunization Rates among Hard-to-Reach Populations, Journal of Urban Health-bulletin of The New York Academy of Medicine, 2007",cited-by,10.1007/s11524-007-9197-z,Strategies for Improving Influenza Immunization Rates among Hard-to-Reach Populations,"[['David', '', 'Vlahov'], ['Micaela', 'H.', 'Coady'], ['Danielle', 'C.', 'Ompad'], ['Sandro', '', 'Galea']]",Journal of Urban Health-bulletin of The New York Academy of Medicine,2007,"[u'http://deepblue.lib.umich.edu/bitstream/2027.42/55425/1/vlahov_strategies%20for%20improving%20influenza%20vaccination_2007.pdf', u'http://www.springerlink.com/index/w13441302uvpu4n0.pdf', u'http://www.springerlink.com/content/w13441302uvpu4n0', u'http://www.springerlink.com/index/10.1007/s11524-007-9197-z', u'http://www.springerlink.com/index/pdf/10.1007/s11524-007-9197-z']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Bardenheier, B., Strikas, R., Kempe, A., et. al, Influenza vaccine supply, 2005–2006: did we come up short?, BMC Health Services Research, 2007",cited-by,10.1186/1472-6963-7-66,"Influenza vaccine supply, 2005–2006: did we come up short?","[['Barbara', 'H', 'Bardenheier'], ['Raymond', '', 'Strikas'], ['Allison', '', 'Kempe'], ['Shannon', '', 'Stokley'], ['Jean', '', 'Ellis']]",BMC Health Services Research,2007,"[u'http://www.biomedcentral.com/content/pdf/1472-6963-7-66.pdf', u'http://www.biomedcentral.com/1472-6963/7/66', u'http://www.springerlink.com/content/dg95218185l1m7lg', u'http://www.springerlink.com/index/dg95218185l1m7lg.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Mann, E., Koller, M., Mann, C., et. al, Comprehensive Geriatric Assessment (CGA) in general practice: Results from a pilot study in Vorarlberg, Austria, BMC Geriatrics, 2004",cited-by,10.1186/1471-2318-4-4,"Comprehensive Geriatric Assessment (CGA) in general practice: Results from a pilot study in Vorarlberg, Austria","[['Eva', '', 'Mann'], ['Michael', '', 'Koller'], ['Christian', '', 'Mann'], ['Tischa', 'van der', 'Cammen'], ['Johann', '', 'Steurer']]",BMC Geriatrics,2004,"[u'http://www.biomedcentral.com/1471-2318/4/4', u'http://www.biomedcentral.com/content/pdf/1471-2318-4-4.pdf', u'http://www.springerlink.com/index/2001451175n0k665.pdf', u'http://www.springerlink.com/content/2001451175n0k665']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Jackson, L., Neuzil, K., Baggs, J., et. al, Compliance With the Recommendations for 2 Doses of Trivalent Inactivated Influenza Vaccine in Children Less Than 9 Years of Age Receiving Influenza Vaccine for the First Time: A Vaccine Safety Datalink Study, , 0",cited-by,11910349Compliance With the Recommendations for 2 Doses of Trivalent Inactivated Influenza Vaccine in Children Less Than 9 Years of Age Receiving Influenza Vaccine for the First Time: A Vaccine Safety Datalink Study,Compliance With the Recommendations for 2 Doses of Trivalent Inactivated Influenza Vaccine in Children Less Than 9 Years of Age Receiving Influenza Vaccine for the First Time: A Vaccine Safety Datalink Study,"[['Lisa', 'A.', 'Jackson'], ['Kathleen', 'M.', 'Neuzil'], ['James', '', 'Baggs'], ['Robert', 'L.', 'Davis'], ['Kristi', 'M.', 'Yamasaki'], ['Ed', '', 'Belongia'], ['Kenneth', 'M.', 'Zangwill'], ['John', '', 'Mullooly'], ['James', '', 'Nordin'], ['S.', 'Michael', 'Marcy'], ['Frank', '', 'DeStefano']]",,0,[u'http://pediatrics.aappublications.org/cgi/reprint/118/5/2032.pdf']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Monto, A., , Seasonal influenza and vaccination coverage, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.08.027,Seasonal influenza and vaccination coverage,"[['Arnold', 'S.', 'Monto']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10011369', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10011369']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","DVM, R., Kreijtz, J., , Yearly influenza vaccinations: a double-edged sword?, Lancet Infectious Diseases, 2009",cited-by,10.1016/S1473-3099(09)70263-4,Yearly influenza vaccinations: a double-edged sword?,"[['Rogier', 'Bodewes', 'DVM'], ['Joost', 'HCM', 'Kreijtz']]",Lancet Infectious Diseases,2009,"[u'http://www.thinktwice.com/lancet.pdf', u'http://www.sciencedirect.com/science/article/pii/S1473309909702634', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-78.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309909702634']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Laplante, J., Marshall, S., Shudt, M., et. al, Influenza Antiviral Resistance Testing in New York and Wisconsin, 2006 to 2008: Methodology and Surveillance Data, Journal of Clinical Microbiology, 2009",cited-by,10.1128/JCM.01993-08,"Influenza Antiviral Resistance Testing in New York and Wisconsin, 2006 to 2008: Methodology and Surveillance Data","[['Jennifer', 'M.', 'Laplante'], ['Steven', 'A.', 'Marshall'], ['Matthew', '', 'Shudt'], ['Tam', 'T.', 'Van'], ['Erik', 'S.', 'Reisdorf'], ['Lisa', 'A.', 'Mingle'], ['Peter', 'A.', 'Shult'], ['K.', 'St.', 'George']]",Journal of Clinical Microbiology,2009,"[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.01993-08', u'http://jcm.asm.org/cgi/reprint/47/5/1372.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Chevat, C., Viala-Danten, M., Dias-Barbosa, C., et. al, Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI©) questionnaire, Health and Quality of Life Outcomes, 2009",cited-by,10.1186/1477-7525-7-21,Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI©) questionnaire,"[['Catherine', '', 'Chevat'], ['Muriel', '', 'Viala-Danten'], ['Carla', '', 'Dias-Barbosa'], ['Van', 'Hung', 'Nguyen']]",Health and Quality of Life Outcomes,2009,"[u'http://www.biomedcentral.com/content/pdf/1477-7525-7-21.pdf', u'http://www.springerlink.com/index/000t64325r28744j.pdf', u'http://www.hqlo.com/content/7/1/21', u'http://www.springerlink.com/content/000t64325r28744j']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Wen, Z., Ye, L., Gao, Y., et. al, Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2009.09.005,Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge,"[['Zhiyuan', '', 'Wen'], ['Ling', '', 'Ye'], ['Yulong', '', 'Gao'], ['Lei', '', 'Pan'], ['Ke', '', 'Dong'], ['Zhigao', '', 'Bu'], ['Richard', 'W.', 'Compans'], ['Chinglai', '', 'Yang']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354209004586', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354209004586']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Cohen, S., Naumova, E., , Population Dynamics in the Elderly: The Need for Age-Adjustment in National BioSurveillance Systems, , 2007",cited-by,10.1007/978-3-540-72608-1_5,Population Dynamics in the Elderly: The Need for Age-Adjustment in National BioSurveillance Systems,"[['Steven', 'A.', 'Cohen'], ['Elena', 'N.', 'Naumova']]",,2007,"[u'http://www.springerlink.com/content/n23617183x2u86w0', u'http://www.springerlink.com/index/n23617183x2u86w0.pdf', u'http://www.informatik.uni-trier.de/~ley/db/conf/biosurveillance/biosurveillance2007.html#CohenN07', u'http://dx.doi.org/10.1007/978-3-540-72608-1_5']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Shevchuk, N., Radoja, S., , Possible stimulation of anti-tumor immunity using repeated cold stress: a hypothesis, Infectious Agents and Cancer, 2007",cited-by,10.1186/1750-9378-2-20,Possible stimulation of anti-tumor immunity using repeated cold stress: a hypothesis,"[['Nikolai', 'A', 'Shevchuk'], ['Sasa', '', 'Radoja']]",Infectious Agents and Cancer,2007,"[u'http://www.biomedcentral.com/content/pdf/1750-9378-2-20.pdf', u'http://www.infectagentscancer.com/content/2/1/20', u'http://www.springerlink.com/content/c5382xj8n7846355', u'http://www.springerlink.com/index/c5382xj8n7846355.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Wilkinson, D., Buttery, J., Andersen, C., , Influenza in the neonatal intensive care unit, Journal of Perinatology, 2006",cited-by,10.1038/sj.jp.7211625,Influenza in the neonatal intensive care unit,"[['D', 'J', 'Wilkinson'], ['J', 'P', 'Buttery'], ['C', 'C', 'Andersen']]",Journal of Perinatology,2006,"[u'http://dx.doi.org/10.1038/sj.jp.7211625', u'http://www.nature.com/doifinder/10.1038/sj.jp.7211625']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Damme, P., Arnou, R., Kafeja, F., et. al, Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study, BMC Infectious Diseases, 2010",cited-by,10.1186/1471-2334-10-134,Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study,"[['Pierre', 'Van', 'Damme'], ['Robert', '', 'Arnou'], ['Froukje', '', 'Kafeja'], ['Anne', '', 'Fiquet'], ['Patrick', '', 'Richard'], ['St\xc3\xa9phane', '', 'Thomas'], ['Gilles', '', 'Meghlaoui'], ['Sandrine', 'Isabelle', 'Samson'], ['Emilio', '', 'Ledesma']]",BMC Infectious Diseases,2010,"[u'http://www.springerlink.com/index/6n3jj4113w268u70.pdf', u'http://www.springerlink.com/content/6n3jj4113w268u70', u'http://www.biomedcentral.com/1471-2334/10/134', u'http://www.biomedcentral.com/content/pdf/1471-2334-10-134.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Yancy, W., McDuffie, J., Stechuchak, K., et. al, Obesity and Receipt of Clinical Preventive Services in Veterans, Obesity, 2010",cited-by,10.1038/oby.2010.40,Obesity and Receipt of Clinical Preventive Services in Veterans,"[['William', 'S.', 'Yancy'], ['Jennifer', 'R.', 'McDuffie'], ['Karen', 'M.', 'Stechuchak'], ['Maren', 'K.', 'Olsen'], ['Eugene', 'Z.', 'Oddone'], ['Linda', 'S.', 'Kinsinger'], ['Santanu', 'K.', 'Datta'], ['Deborah', 'A.', 'Fisher'], ['Katrina', 'M.', 'Krause'], ['Truls', '', '\xc3\xb8stbye']]",Obesity,2010,"[u'http://dx.doi.org/10.1038/oby.2010.40', u'http://www.nature.com/doifinder/10.1038/oby.2010.40']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Ranjan, P., Jayashankar, L., Deyde, V., et. al, 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication, Virology Journal, 2010",cited-by,10.1186/1743-422X-7-102,5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication,"[['Priya', '', 'Ranjan'], ['Lakshmi', '', 'Jayashankar'], ['Varough', '', 'Deyde'], ['Hui', '', 'Zeng'], ['William', 'G', 'Davis'], ['Melissa', 'B', 'Pearce'], ['John', 'B', 'Bowzard'], ['Mary', 'A', 'Hoelscher'], ['Victoria', '', 'Jeisy-Scott'], ['Mayim', 'E', 'Wiens'], ['Shivaprakash', '', 'Gangappa'], ['Larisa', '', 'Gubareva'], ['Adolfo', '', 'Garc\xc3\xada-Sastre'], ['Jacqueline', 'M', 'Katz'], ['Terrence', 'M', 'Tumpey'], ['Takashi', '', 'Fujita'], ['Suryaprakash', '', 'Sambhara']]",Virology Journal,2010,"[u'http://www.virologyj.com/content/7/1/102', u'http://www.springerlink.com/index/5x631562g4237729.pdf', u'http://www.biomedcentral.com/content/pdf/1743-422X-7-102.pdf', u'http://www.springerlink.com/content/5x631562g4237729']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Hammitt, L., Bartlett, J., Li, S., et. al, Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.09.041,Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine,"[['Laura', 'L.', 'Hammitt'], ['Julie', 'Patterson', 'Bartlett'], ['Shaobing', '', 'Li'], ['Jeremy', '', 'Rahkola'], ['Nancy', '', 'Lang'], ['Edward', 'N.', 'Janoff'], ['Myron', 'J.', 'Levin'], ['Adriana', '', 'Weinberg']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09013759', u'http://www.ucdenver.edu/academics/colleges/medicine/research/mavrc/documents/hammitt%20ll_vaccine%202009_kinetics%20of%20viral%20shedding.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09013759']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Harris, K., Maurer, J., Lurie, N., , Do People Who Intend to Get a Flu Shot Actually Get One?, Journal of General Internal Medicine, 2009",cited-by,10.1007/s11606-009-1126-2,Do People Who Intend to Get a Flu Shot Actually Get One?,"[['Katherine', 'M.', 'Harris'], ['J\xc3\xbcrgen', '', 'Maurer'], ['Nicole', '', 'Lurie']]",Journal of General Internal Medicine,2009,"[u'http://www.springerlink.com/content/g715x9581844161m', u'http://www.springerlink.com/index/g715x9581844161m.pdf', u'http://www.springerlink.com/index/10.1007/s11606-009-1126-2', u'http://www.springerlink.com/index/pdf/10.1007/s11606-009-1126-2']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Ballestas, T., McEvoy, S., Doyle, J., , Co-ordinated approach to healthcare worker influenza vaccination in an area health service, Journal of Hospital Infection, 2009",cited-by,10.1016/j.jhin.2009.07.028,Co-ordinated approach to healthcare worker influenza vaccination in an area health service,"[['T.', '', 'Ballestas'], ['S.', 'P.', 'McEvoy'], ['J.', '', 'Doyle']]",Journal of Hospital Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0195670109003442', u'http://linkinghub.elsevier.com/retrieve/pii/S0195670109003442']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Jiang, Y., Wang, Y., Kuang, Y., et. al, Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activity, Archives of Virology, 2009",cited-by,10.1007/s00705-009-0352-6,Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activity,"[['Yan', '', 'Jiang'], ['Yueling', '', 'Wang'], ['Yu', '', 'Kuang'], ['Baoning', '', 'Wang'], ['Wanyi', '', 'Li'], ['Tianxiang', '', 'Gong'], ['Zhonghua', '', 'Jiang'], ['De', '', 'Yang'], ['Mingyuan', '', 'Li']]",Archives of Virology,2009,"[u'http://www.springerlink.com/content/np1228h0855rg7u3', u'http://www.springerlink.com/index/np1228h0855rg7u3.pdf', u'http://www.springerlink.com/index/10.1007/s00705-009-0352-6', u'http://www.springerlink.com/index/pdf/10.1007/s00705-009-0352-6']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Coady, M., Galea, S., Ompad, D., et. al, Project VIVA: A Multilevel Community-Based Intervention to Increase Influenza Vaccination Rates Among Hard-to-Reach Populations in New York City, , 2008",cited-by,14258683Project VIVA: A Multilevel Community-Based Intervention to Increase Influenza Vaccination Rates Among Hard-to-Reach Populations in New York City,Project VIVA: A Multilevel Community-Based Intervention to Increase Influenza Vaccination Rates Among Hard-to-Reach Populations in New York City,"[['Micaela', 'H.', 'Coady'], ['Sandro', '', 'Galea'], ['Danielle', 'C.', 'Ompad'], ['Sarah', '', 'Sisco'], ['David', '', 'Vlahov']]",,2008,[u'http://www.dialogue4health.org/webforums/PDFs_11_23_09/COADY_et_al.pdf']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Laplante, J., Marshall, S., Shudt, M., et. al, Influenza Antiviral Resistance Testing in New York and Wisconsin, 2006 to 2008: Methodology and Surveillance Data, , 0",cited-by,"6128517Influenza Antiviral Resistance Testing in New York and Wisconsin, 2006 to 2008: Methodology and Surveillance Data","Influenza Antiviral Resistance Testing in New York and Wisconsin, 2006 to 2008: Methodology and Surveillance Data","[['Jennifer', 'M.', 'Laplante'], ['Steven', 'A.', 'Marshall'], ['Matthew', '', 'Shudt'], ['Tam', 'T.', 'Van'], ['Erik', 'S.', 'Reisdorf'], ['Lisa', 'A.', 'Mingle'], ['Peter', 'A.', 'Shult']]",,0,[u'http://jcm.asm.org/cgi/reprint/47/5/1372.pdf']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Cheng, A., Starr, M., Korman, T., et. al, ASID/TSANZ guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents, , 0",cited-by,10212496ASID/TSANZ guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents,ASID/TSANZ guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents,"[['Allen', 'C', 'Cheng'], ['Mike', '', 'Starr'], ['Tony', 'M', 'Korman'], ['Jim', 'P', 'Buttery'], ['Christine', 'R', 'Jenkins'], ['Vicki', 'L', 'Krause']]",,0,"[u'http://www.mja.com.au/public/rop/cheng/che10661_fm.pdf', u'https://www.mja.com.au/public/rop/cheng/che10661_fm.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Effler, P., Chu, C., He, H., et. al, Statewide School-located Influenza Vaccination Program for Children 5–13 Years of Age, Hawaii, USA, Emerging Infectious Diseases, 2010",cited-by,10.3201/eid1602.091375,"Statewide School-located Influenza Vaccination Program for Children 5–13 Years of Age, Hawaii, USA","[['Paul', 'V.', 'Effler'], ['Carl', '', 'Chu'], ['Howard', '', 'He'], ['Kate', '', 'Gaynor'], ['Steve', '', 'Sakamoto'], ['Marcia', '', 'Nagao'], ['Lisa', '', 'Mendez'], ['Sarah', 'Y.', 'Park']]",Emerging Infectious Diseases,2010,"[u'http://www.cdc.gov/eid/content/16/2/pdfs/09-1375.pdf', u'http://origin.cdc.gov/eid/content/16/2/pdfs/09-1375.pdf', u'http://www.cdc.gov/eid/content/16/2/244.htm']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Suzuki, Y., Saito, R., Zaraket, H., et. al, Rapid and Specific Detection of Amantadine-Resistant Influenza A Viruses with a Ser31Asn Mutation by the Cycling Probe Method, , 2010",cited-by,13526070Rapid and Specific Detection of Amantadine-Resistant Influenza A Viruses with a Ser31Asn Mutation by the Cycling Probe Method,Rapid and Specific Detection of Amantadine-Resistant Influenza A Viruses with a Ser31Asn Mutation by the Cycling Probe Method,"[['Yasushi', '', 'Suzuki'], ['Reiko', '', 'Saito'], ['Hassan', '', 'Zaraket'], ['Clyde', '', 'Dapat'], ['Isolde', '', 'Caperig-Dapat'], ['Hiroshi', '', 'Suzuki']]",,2010,[u'http://jcm.highwire.org/cgi/reprint/48/1/57.pdf']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Mak, D., Daly, A., Armstrong, P., et. al, Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia, , 2010",cited-by,14209671Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia,Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia,"[['Donna', 'B', 'Mak'], ['Alison', 'M', 'Daly'], ['Paul', 'K', 'Armstrong'], ['Paul', 'V', 'Effler']]",,2010,"[u'http://www.mja.com.au/public/issues/193_07_041010/mak10281_fm.pdf', u'http://researchonline.nd.edu.au/med_article/294', u'http://www.mja.com.au/public/issues/193_07_041010/contents_041010.html']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Yazdany, J., Tonner, C., Trupin, L., et. al, Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study, Arthritis Research & Therapy, 2010",cited-by,10.1186/ar3011,Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study,"[['Jinoos', '', 'Yazdany'], ['Chris', '', 'Tonner'], ['Laura', '', 'Trupin'], ['Pantelis', '', 'Panopalis'], ['Joann', 'Z', 'Gillis'], ['Aimee', 'O', 'Hersh'], ['Laura', 'J', 'Julian'], ['Patricia', 'P', 'Katz'], ['Lindsey', 'A', 'Criswell'], ['Edward', 'H', 'Yelin']]",Arthritis Research & Therapy,2010,"[u'http://www.springerlink.com/content/b6h5855410720387', u'http://www.springerlink.com/index/b6h5855410720387.pdf', u'http://arthritis-research.com/content/12/3/124', u'http://www.biomedcentral.com/content/pdf/ar3011.pdf', u'http://arthritis-research.com/content/12/3/R84']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Winther, B., Block, S., Reisinger, K., et. al, Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza, International Journal of Pediatric Otorhinolaryngology, 2010",cited-by,10.1016/j.ijporl.2010.03.024,Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza,"[['Birgit', '', 'Winther'], ['Stan', 'L.', 'Block'], ['Keith', '', 'Reisinger'], ['Regina', '', 'Dutkowski']]",International Journal of Pediatric Otorhinolaryngology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0165587610001199', u'http://linkinghub.elsevier.com/retrieve/pii/S0165587610001199']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Esposito, S., Cecinati, V., Scicchitano, B., et. al, Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy, Vaccine, 2010",cited-by,10.1016/j.vaccine.2009.11.055,Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy,"[['Susanna', '', 'Esposito'], ['Valerio', '', 'Cecinati'], ['Barbara', '', 'Scicchitano'], ['Giovanni', 'Carlo', 'Delvecchio'], ['Nicola', '', 'Santoro'], ['Doriana', '', 'Amato'], ['Claudio', '', 'Pelucchi'], ['Momcilo', '', 'Jankovic'], ['Domenico', 'De', 'Mattia'], ['Nicola', '', 'Principi']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09018581', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09018581']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Sy, L., Liu, I., Solano, Z., et. al, Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.05.061,Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization,"[['Lina', 'S.', 'Sy'], ['In-Lu', 'Amy', 'Liu'], ['Zendi', '', 'Solano'], ['T.', 'Craig', 'Cheetham'], ['Marlene', 'M.', 'Lugg'], ['Sharon', 'K.', 'Greene'], ['Eric', 'S.', 'Weintraub'], ['Steven', 'J.', 'Jacobsen']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10007826', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10007826']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Amendola, A., Pariani, E., Viganò, A., et. al, Influenza surveillance in a cohort of HIV-infected children and adolescents immunized against seasonal influenza, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.01.021,Influenza surveillance in a cohort of HIV-infected children and adolescents immunized against seasonal influenza,"[['Antonella', '', 'Amendola'], ['Elena', '', 'Pariani'], ['Alessandra', '', 'Vigan\xc3\xb2'], ['Paola', '', 'Erba'], ['Alessandra', '', 'Zappa'], ['Vania', '', 'Giacomet'], ['Elisabetta', '', 'Tanzi'], ['Gian', 'Vincenzo', 'Zuccotti'], ['Alessandro', '', 'Zanetti']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10000538', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10000538']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Hashem, A., Flaman, A., Farnsworth, A., et. al, Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases, PLOS One, 2009",cited-by,10.1371/journal.pone.0008350.t001,Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases,"[['Anwar', 'M.', 'Hashem'], ['Anathea', 'S.', 'Flaman'], ['Aaron', '', 'Farnsworth'], ['Earl', 'G.', 'Brown'], ['Gary', 'Van', 'Domselaar'], ['Runtao', '', 'He'], ['Xuguang', '', 'Li']]",PLOS One,2009,"[u'http://www.med.uottawa.ca/bmi/assets/documents/dr%20brown/dr_brown11.pdf', u'http://www.medicine.uottawa.ca/bmi/assets/documents/dr%20brown/dr_brown11.pdf', u'http://dx.plos.org/10.1371/journal.pone.0008350', u'http://dx.plos.org/10.1371/journal.pone.0008350.g001', u'http://dx.plos.org/10.1371/journal.pone.0008350.g002', u'http://dx.plos.org/10.1371/journal.pone.0008350.g003', u'http://dx.plos.org/10.1371/journal.pone.0008350.g004', u'http://dx.plos.org/10.1371/journal.pone.0008350.g005', u'http://dx.plos.org/10.1371/journal.pone.0008350.g006', u'http://dx.plos.org/10.1371/journal.pone.0008350.g007', u'http://dx.plos.org/10.1371/journal.pone.0008350.g008', u'http://dx.plos.org/10.1371/journal.pone.0008350.g009', u'http://dx.plos.org/10.1371/journal.pone.0008350.g010', u'http://dx.plos.org/10.1371/journal.pone.0008350.t001']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Uddin, M., Cherkowski, G., Liu, G., et. al, Demographic and socioeconomic determinants of influenza vaccination disparities among university students, Journal of Epidemiology and Community Health, 2009",cited-by,10.1136/jech.2009.090852,Demographic and socioeconomic determinants of influenza vaccination disparities among university students,"[['M.', '', 'Uddin'], ['G.', 'C.', 'Cherkowski'], ['G.', '', 'Liu'], ['J.', '', 'Zhang'], ['A.', 'S.', 'Monto'], ['A.', 'E.', 'Aiello']]",Journal of Epidemiology and Community Health,2009,"[u'http://dx.doi.org/10.1136/jech.2009.090852', u'http://jech.bmj.com/cgi/doi/10.1136/jech.2009.090852']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Levy, D., Ambrose, C., Oleka, N., et. al, A survey of pediatricians' attitudes regarding influenza immunization in children, BMC Pediatrics, 2009",cited-by,10.1186/1471-2431-9-8,A survey of pediatricians' attitudes regarding influenza immunization in children,"[['Daniel', 'J', 'Levy'], ['Christopher', 'S', 'Ambrose'], ['Napoleon', '', 'Oleka'], ['Edward', 'B', 'Lewin']]",BMC Pediatrics,2009,"[u'http://www.springerlink.com/content/5747542834018483', u'http://www.springerlink.com/index/5747542834018483.pdf', u'http://www.biomedcentral.com/content/pdf/1471-2431-9-8.pdf', u'http://www.biomedcentral.com/1471-2431/9/8']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Picone, O., Ami, O., Vauloup-Fellous, C., et. al, Pandémie de grippe A H1N1 2009 et grossesse : épidémiologie, diagnostic et prise en charge, Journal De Gynecologie Obstetrique Et Biologie De La Reproduction, 2009",cited-by,10.1016/j.jgyn.2009.09.016,"Pandémie de grippe A H1N1 2009 et grossesse : épidémiologie, diagnostic et prise en charge","[['O.', '', 'Picone'], ['O.', '', 'Ami'], ['C.', '', 'Vauloup-Fellous'], ['V.', '', 'Martinez'], ['M.', '', 'Guillet'], ['C.', '', 'Dupont-Bernab\xc3\xa9'], ['A.-C.', '', 'Donnadieu'], ['C.', '', 'Trichot'], ['M.-V.', '', 'Senat'], ['H.', '', 'Fernandez'], ['R.', '', 'Frydman']]",Journal De Gynecologie Obstetrique Et Biologie De La Reproduction,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0368231509002592', u'http://linkinghub.elsevier.com/retrieve/pii/S0368231509002592']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Madjid, M., Curkendall, S., Blumentals, W., , The Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection, Cardiology, 2009",cited-by,10.1159/000172796,The Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection,"[['Mohammad', '', 'Madjid'], ['Suellen', '', 'Curkendall'], ['William', 'A.', 'Blumentals']]",Cardiology,2009,"[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000172796', u'http://www.karger.com/doi/10.1159/000172796']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Viboud, C., Miller, M., , Health Benefits of Universal Influenza Vaccination Strategy, PLOS Medicine, 2008",cited-by,10.1371/journal.pmed.0050216,Health Benefits of Universal Influenza Vaccination Strategy,"[['C\xc3\xa9cile', '', 'Viboud'], ['Mark', '', 'Miller']]",PLOS Medicine,2008,"[u'http://origem.info/FIC/pdf/Viboud_Miller_HealthBenefits_PLoS08.pdf', u'http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0050216', u'http://dx.doi.org/10.1371/journal.pmed.0050216']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Casajuana, J., Iglesias, B., Fàbregas, M., et. al, Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial, BMC Blood Disorders, 2008",cited-by,10.1186/1471-2326-8-1,Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial,"[['Josep', '', 'Casajuana'], ['Bego\xc3\xb1a', '', 'Iglesias'], ['Mireia', '', 'F\xc3\xa0bregas'], ['Francesc', '', 'Fina'], ['Joan-Antoni', '', 'Vall\xc3\xa8s'], ['Rosa', '', 'Aragon\xc3\xa8s'], ['M\xc3\xa8ncia', '', 'Ben\xc3\xadtez'], ['Edurne', '', 'Zabaleta']]",BMC Blood Disorders,2008,"[u'http://www.springerlink.com/content/2w616142728042l0', u'http://www.biomedcentral.com/content/pdf/1471-2326-8-1.pdf', u'http://www.biomedcentral.com/1471-2326/8/1', u'http://www.springerlink.com/index/2w616142728042l0.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Breban, R., Vardavas, R., Blower, S., , Inductive Reasoning Games as Influenza Vaccination Models: Mean Field Analysis, , 2006",cited-by,12738931Inductive Reasoning Games as Influenza Vaccination Models: Mean Field Analysis,Inductive Reasoning Games as Influenza Vaccination Models: Mean Field Analysis,"[['Romulus', '', 'Breban'], ['Raffaele', '', 'Vardavas'], ['Sally', '', 'Blower']]",,2006,"[u'http://arxiv.org/abs/q-bio/0608016', u'http://adsabs.harvard.edu/abs/2006q.bio.....8016B']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Nardo, G., Tilli, S., Pessione, E., et. al, Structural roles of the active site iron(III) ions in catechol 1,2-dioxygenases and differential secondary structure changes in isoenzymes A and B from Acinetobacter radioresistens S13, Archives of Biochemistry and Biophysics, 2004",cited-by,10.1016/j.abb.2004.07.024,"Structural roles of the active site iron(III) ions in catechol 1,2-dioxygenases and differential secondary structure changes in isoenzymes A and B from Acinetobacter radioresistens S13","[['Giovanna', 'Di', 'Nardo'], ['Silvia', '', 'Tilli'], ['Enrica', '', 'Pessione'], ['Maria', '', 'Cavaletto'], ['Carlo', '', 'Giunta'], ['Fabrizio', '', 'Briganti']]",Archives of Biochemistry and Biophysics,2004,[u'http://www.sciencedirect.com/science/article/pii/S000398610400414X']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Lorenz, R., Sachwitz, M., Schreiber, H., et. al, First operating experiences of beam position monitors in the TELSA Test Facility Linac, , 1997",cited-by,10.1109/PAC.1997.751133,First operating experiences of beam position monitors in the TELSA Test Facility Linac,"[['R.', '', 'Lorenz'], ['M.', '', 'Sachwitz'], ['H.', 'J.', 'Schreiber'], ['E.', '', 'Tonisch'], ['M.', '', 'Castellano'], ['P.', '', 'Patteri'], ['E.', '', 'Tazzioli'], ['L.', '', 'Catani']]",,1997,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00751133', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=751133', u'http://adsabs.harvard.edu/abs/1997APS..PAC..9P90L']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Jamieson, D., Honein, M., Rasmussen, S., et. al, the USA, , 0",cited-by,10325978the USA,the USA,"[['Denise', 'J', 'Jamieson'], ['Margaret', 'A', 'Honein'], ['Sonja', 'A', 'Rasmussen'], ['Jennifer', 'L', 'Williams'], ['David', 'L', 'Swerdlow'], ['Matthew', 'S', 'Biggerstaff'], ['Stephen', '', 'Lindstrom'], ['Janice', 'K', 'Louie'], ['Cara', 'M', 'Christ'], ['Susan', 'R', 'Bohm'], ['Vincent', 'P', 'Fonseca'], ['Kathleen', 'A', 'Ritger'], ['Daniel', 'J', 'Kuhles'], ['Paula', '', 'Eggers'], ['Hollianne', '', 'Bruce'], ['Heidi', 'A', 'Davidson'], ['Emily', '', 'Lutterloh'], ['Meghan', 'L', 'Harris'], ['Colleen', '', 'Burke'], ['Noelle', '', 'Cocoros'], ['Lyn', '', 'Finelli'], ['Kitty', 'F', 'MacFarlane'], ['Bo', '', 'Shu'], ['Sonja', 'J', 'Olsen'], ['S', 'A', 'Rasmussen']]",,0,"[u'http://www.amchp.org/MCH-Topics/H-N/Documents/h1n1-pregnancy-usa.pdf', u'http://publish.amchp.org/MCH-Topics/H-N/Documents/h1n1-pregnancy-usa.pdf', u'http://www.degam.de/H1N1/H1N1%202009%20influenza%20virus%20infection%20during%20pregnancy%20in%20the%20USA-Lancet2009.pdf', u'http://www.srlf.org/Data/upload/file/Grippe%20A/100%20-%20H1N1%20pregnant%20-%20Lancet%2029%20july%2009.pdf', u'http://hospitals.unm.edu/h1n1/documents/Jamieson_2009_The-Lancet.pdf', u'http://www.jaog.or.jp/News/influ/H1N1_Lancet_article.pdf', u'http://www.fertilitas.it/centrale/doc/h1n1%202009%20influenza%20virus%20infection%20during%20pregnancy%20in%20the%20usa.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-72.pdf', u'http://www.apt.ubc.ca/__shared/assets/h1n1_and_pregnancy11927.pdf', u'http://195.134.113.71/hygiene/images/jamieson%20lancet%202009.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Brooks, W., Erdman, D., Terebuh, P., et. al, Human Metapneumovirus Infection among Children, Bangladesh, , 0",cited-by,"10702226Human Metapneumovirus Infection among Children, Bangladesh","Human Metapneumovirus Infection among Children, Bangladesh","[['W.', 'Abdullah', 'Brooks'], ['Dean', '', 'Erdman'], ['Pauline', '', 'Terebuh'], ['Alexander', '', 'Klimov'], ['Doli', '', 'Goswami'], ['Amina', 'Tahia', 'Sharmeen'], ['Tasnim', '', 'Azim'], ['Stephen', '', 'Luby'], ['Carolyn', '', 'Bridges'], ['Robert', '', 'Breiman']]",,0,"[u'http://origin.cdc.gov/eid/content/13/10/pdfs/1611.pdf', u'http://www.cdc.gov/EID/content/13/10/pdfs/1611.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Nailescu, C., Xu, X., Zhou, H., et. al, Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study, Pediatric Nephrology, 2011",cited-by,10.1007/s00467-010-1729-1,Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study,"[['Corina', '', 'Nailescu'], ['Xiyan', '', 'Xu'], ['Hong', '', 'Zhou'], ['Henrietta', '', 'Hall'], ['Amy', 'C.', 'Wilson'], ['Jeffrey', 'D.', 'Leiser'], ['Deepa', 'H.', 'Chand'], ['Rudolph', 'P.', 'Valentini'], ['Diane', '', 'Hebert'], ['John', 'D.', 'Mahan']]",Pediatric Nephrology,2011,"[u'http://www.springerlink.com/content/0487kr46q6v02v11', u'http://www.springerlink.com/index/0487kr46q6v02v11.pdf']"
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Yi, H., Kim, M., Back, S., et. al, A novel rat forelimb model of neuropathic pain produced by partial injury of the median and ulnar nerves, European Journal of Pain, 2011",cited-by,10.1016/j.ejpain.2010.09.014,A novel rat forelimb model of neuropathic pain produced by partial injury of the median and ulnar nerves,"[['Hanju', '', 'Yi'], ['Myung', 'Ah', 'Kim'], ['Seung', 'Keun', 'Back'], ['Jong', 'Shin', 'Eun'], ['Heung', 'Sik', 'Na']]",European Journal of Pain,2011,[u'http://www.sciencedirect.com/science/article/pii/S1090380110002405']
"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Saha, D., , Dismembered ophiolites in Paleoproterozoic nappe complexes of Kandra and Gurramkonda, South India, Journal of Asian Earth Sciences, 2011",cited-by,10.1016/j.jseaes.2011.04.024,"Dismembered ophiolites in Paleoproterozoic nappe complexes of Kandra and Gurramkonda, South India","[['Dilip', '', 'Saha']]",Journal of Asian Earth Sciences,2011,"[u'http://www.sciencedirect.com/science/article/pii/S1367912011002057', u'http://adsabs.harvard.edu/abs/2011JAESc..42..158S']"
10.1016~S0140-6736(00)02288-1,"Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate- and high-risk senior citizens. Arch Intern Med 1998; 158: 1769–76.",references,"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","[[u'Kristin', u'L.', u'Nichol'], [u'J.', u'', u'Wuorenma'], [u'T.', u'von', u'Sternberg']]",,1998,"[u'http://archinte.highwire.org/cgi/reprint/158/16/1769.pdf', u'http://archinte.ama-assn.org/cgi/reprint/158/16/1769.pdf']",./output/10.1016~S0140-6736(00)02288-1/13513741
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Thompson, W., Shay, D., Weintraub, E., et. al, Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States, , 2003",cited-by,3416156Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States,Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States,"[['William', 'W.', 'Thompson'], ['David', 'K.', 'Shay'], ['Eric', '', 'Weintraub'], ['Nancy', '', 'Cox'], ['Larry', 'J.', 'Anderson'], ['Keiji', '', 'Fukuda']]",,2003,[u'http://otorrinobrasilia.com/h1n1/mortality_influenza_rsv_us.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Carman, W., Elder, A., Wallace, L., et. al, Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(99)05190-9,Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial,"[['William', 'F', 'Carman'], ['Alexander', 'G', 'Elder'], ['Lesley', 'A', 'Wallace'], ['Karen', '', 'McAulay'], ['Andrew', '', 'Walker'], ['Gordon', 'D', 'Murray'], ['David', 'J', 'Stott']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699051909', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699051909']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nicholson, K., Wood, J., Zambon, M., , Influenza, Lancet, 2003",cited-by,10.1016/S0140-6736(03)14854-4,Influenza,"[['Karl', 'G', 'Nicholson'], ['John', 'M', 'Wood'], ['Maria', '', 'Zambon']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603148544', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603148544']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Saaddine, J., Engelgau, M., Beckles, G., et. al, A Diabetes Report Card for the United States: Quality of Care in the 1990s, , 2002",cited-by,6635980A Diabetes Report Card for the United States: Quality of Care in the 1990s,A Diabetes Report Card for the United States: Quality of Care in the 1990s,"[['Jinan', 'B.', 'Saaddine'], ['Michael', 'M.', 'Engelgau'], ['Gloria', 'L.', 'Beckles'], ['Edward', 'W.', 'Gregg'], ['Theodore', 'J.', 'Thompson'], ['K.', 'M. Venkat', 'Narayan']]",,2002,[u'http://www.annals.org/content/136/8/565.full.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Jefferson, T., Rivetti, D., Rivetti, A., et. al, Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review, Lancet, 2005",cited-by,10.1016/S0140-6736(05)67339-4,Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review,"[['T', '', 'Jefferson'], ['D', '', 'Rivetti'], ['A', '', 'Rivetti'], ['M', '', 'Rudin'], ['C', 'Di', 'Pietrantonj'], ['V', '', 'Demicheli']]",Lancet,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0140673605673394', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/vaccination/vaccination-17.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673605673394']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Woodhead, M., Blasi, F., Ewig, S., et. al, Guidelines for the management of adult lower respiratory tract infections, European Respiratory Journal, 2005",cited-by,10.1183/09031936.05.00055705,Guidelines for the management of adult lower respiratory tract infections,"[['M.', '', 'Woodhead'], ['F.', '', 'Blasi'], ['S.', '', 'Ewig'], ['G.', '', 'Huchon'], ['M.', '', 'Leven'], ['A.', '', 'Ortqviste'], ['T.', '', 'Schaberg'], ['A.', '', 'Torres'], ['G.', 'van der', 'Heijden'], ['T.', 'J. M.', 'Verheij']]",European Respiratory Journal,2005,"[u'http://www.sginf.ch/ssi-home/guidelines/cap-guidelines/pdf/eur_resp_j_2005.pdf', u'http://www.pneumonologia.gr/articlefiles/20070117_ERS_pneumonia.pdf', u'http://erj.ersjournals.com/cgi/reprint/26/6/1138.pdf', u'http://www.escmid.org/fileadmin/src/media/PDFs/4ESCMID_Library/2Medical_Guidelines/ESCMID_Guidelines/Guidelines_Adult_LRTI.pdf', u'http://erj.ersjournals.com/cgi/doi/10.1183/09031936.05.00055705']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nichol, K., Baken, L., Nelson, A., , Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease, , 1999",cited-by,"5884544Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease","Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease","[['Kristin', 'L.', 'Nichol'], ['Leslie', '', 'Baken'], ['Andrew', '', 'Nelson']]",,1999,"[u'http://www.separ.es/guia_epoc/gecarp/gepubli/publdoc/041-040-nicholkl-relation-between-influenza-vaccination-and-outpatient-visits.pdf', u'http://www.taiss.com/gepoc/gecarp/gepubli/publdoc/041-040-nicholkl-relation-between-influenza-vaccination-and-outpatient-visits.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Thompson, W., Shay, D., Weintraub, E., et. al, Influenza-Associated Hospitalizations in the United States, , 2010",cited-by,13356481Influenza-Associated Hospitalizations in the United States,Influenza-Associated Hospitalizations in the United States,"[['William', 'W.', 'Thompson'], ['David', 'K.', 'Shay'], ['Eric', '', 'Weintraub'], ['Carolyn', 'B.', 'Bridges'], ['Nancy', 'J.', 'Cox'], ['Keiji', '', 'Fukuda']]",,2010,[u'http://jama.ama-assn.org/cgi/reprint/292/11/1333.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nichol, K., Nordin, J., Nelson, D., et. al, Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly, New England Journal of Medicine, 2007",cited-by,10.1056/NEJMoa070844,Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly,"[['Kristin', 'L.', 'Nichol'], ['James', 'D.', 'Nordin'], ['David', 'B.', 'Nelson'], ['John', 'P.', 'Mullooly'], ['Eelko', '', 'Hak']]",New England Journal of Medicine,2007,"[u'http://intl-content.nejm.org/cgi/reprint/357/14/1373.pdf', u'http://content.nejm.org/cgi/reprint/357/14/1373.pdf', u'http://nejm.highwire.org/cgi/reprint/357/14/1373.pdf', u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Nichol_2007.pdf', u'http://www.preventinfluenza.org/newsletters/nejm.pdf', u'https://content.nejm.org/cgi/reprint/357/14/1373.pdf', u'http://www.nejm.org/doi/abs/10.1056/NEJMoa070844']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nichol, K., , The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00070-7,"The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines","[['Kristin', 'L.', 'Nichol']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03000707', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-22.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03000707']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nichol, K., Nordin, J., Mullooly, J., et. al, Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly, , 2010",cited-by,10720471Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly,Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly,"[['Kristin', 'L.', 'Nichol'], ['James', '', 'Nordin'], ['John', '', 'Mullooly'], ['Richard', '', 'Lask'], ['Kelly', '', 'Fillbrandt'], ['Marika', '', 'Iwane']]",,2010,"[u'http://content.nejm.org/cgi/reprint/348/14/1322.pdf', u'http://intl-content.nejm.org/cgi/reprint/348/14/1322.pdf', u'http://171.66.123.143/cgi/reprint/348/14/1322.pdf', u'http://nejm.highwire.org/cgi/reprint/348/14/1322.pdf', u'https://content.nejm.org/cgi/reprint/348/14/1322.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Fiore, A., Uyeki, T., Broder, K., et. al, Prevention and Control of Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010, , 2010",cited-by,"14014609Prevention and Control of Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","Prevention and Control of Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","[['Anthony', 'E.', 'Fiore'], ['Timothy', 'M.', 'Uyeki'], ['Karen', '', 'Broder'], ['Gary', 'L.', 'Euler'], ['James', 'A.', 'Singleton'], ['John', 'K.', 'Iskander'], ['Pascale', 'M.', 'Wortley'], ['David', 'K.', 'Shay'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox']]",,2010,"[u'http://www.cdc.gov/mmwr/pdf/rr/rr59e0729.pdf', u'http://www.city.milwaukee.gov/ImageLibrary/Groups/healthAuthors/DCP/PDFs/Flu2010/MMWR_ACIP_Flu_Recommendations_1011.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Cox, R., Brokstad, K., Ogra, P., , Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines, Scandinavian Journal of Immunology, 2004",cited-by,10.1111/j.0300-9475.2004.01382.x,"Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines","[['R.', 'J.', 'Cox'], ['K.', 'A.', 'Brokstad'], ['P.', '', 'Ogra']]",Scandinavian Journal of Immunology,2004,"[u'http://biologie.univ-mrs.fr/upload/p270/3_La_grippe.pdf', u'http://cmbi.bjmu.cn/news/report/2005/flu/54.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.0300-9475.2004.01382.x']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","McCullers, J., , Insights into the Interaction between Influenza Virus and Pneumococcus, Clinical Microbiology Reviews, 2006",cited-by,10.1128/CMR.00058-05,Insights into the Interaction between Influenza Virus and Pneumococcus,"[['Jonathan', 'A.', 'McCullers']]",Clinical Microbiology Reviews,2006,"[u'http://cmr.asm.org/cgi/reprint/19/3/571.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.00058-05']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Kaiser, L., Wat, C., Mills, T., et. al, Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations, , 2003",cited-by,14206164Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations,Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations,"[['Laurent', '', 'Kaiser'], ['Cynthia', '', 'Wat'], ['Tracy', '', 'Mills'], ['Paul', '', 'Mahoney'], ['Penelope', '', 'Ward'], ['Frederick', '', 'Hayden']]",,2003,[u'http://archinte.ama-assn.org/cgi/reprint/163/14/1667.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nichol, K., Baken, L., Wuorenma, J., et. al, The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease, , 1999",cited-by,13652494The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease,The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease,"[['Kristin', 'L.', 'Nichol'], ['Leslie', '', 'Baken'], ['Janet', '', 'Wuorenma'], ['Andrew', '', 'Nelson']]",,1999,"[u'http://archinte.ama-assn.org/cgi/reprint/159/20/2437.pdf', u'http://archinte.highwire.org/cgi/reprint/159/20/2437.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Simonsen, L., Reichert, T., Viboud, C., et. al, Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population, , 0",cited-by,6234833Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population,Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population,"[['Lone', '', 'Simonsen'], ['Thomas', 'A.', 'Reichert'], ['Cecile', '', 'Viboud'], ['William', 'C.', 'Blackwelder'], ['Robert', 'J.', 'Taylor'], ['Mark', 'A.', 'Miller']]",,0,"[u'http://origem.info/FIC/pdf/Simonson%20et%20al%20Impact%20of%20Influ_Arch%20Intern%20Med%2005.pdf', u'http://archinte.ama-assn.org/cgi/reprint/165/3/265.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Christenson, B., Lundbergh, P., Hedlund, J., et. al, Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study, Lancet, 2001",cited-by,10.1016/S0140-6736(00)04237-9,Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study,"[['Brith', '', 'Christenson'], ['Per', '', 'Lundbergh'], ['Jonas', '', 'Hedlund'], ['\xc3\x85ke', '', '\xc3\x96rtqvist']]",Lancet,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600042379', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600042379']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Jackson, L., Jackson, M., Nelson, J., et. al, Evidence of bias in estimates of influenza vaccine effectiveness in seniors, , 2005",cited-by,6126510Evidence of bias in estimates of influenza vaccine effectiveness in seniors,Evidence of bias in estimates of influenza vaccine effectiveness in seniors,"[['Lisa', 'A', 'Jackson'], ['Michael', 'L', 'Jackson'], ['Jennifer', 'C', 'Nelson'], ['Kathleen', 'M', 'Neuzil'], ['Noel', 'S', 'Weiss']]",,2005,"[u'http://ije.oxfordjournals.org/cgi/reprint/dyi274v1.pdf', u'http://ije.oxfordjournals.org/cgi/reprint/35/2/337.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Trzonkowski, P., Myśliwska, J., Szmit, E., et. al, Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination—an impact of immunosenescence, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00309-8,"Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination—an impact of immunosenescence","[['Piotr', '', 'Trzonkowski'], ['Jolanta', '', 'My\xc5\x9bliwska'], ['Ewa', '', 'Szmit'], ['Joanna', '', 'Wi'], ['Krzysztof', '', '\xc5\x81ukaszuk'], ['Lidia', 'B.', 'Brydak'], ['Magdalena', '', 'Macha\xc5\x82a'], ['Andrzej', '', 'My\xc5\x9bliwski']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03003098', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03003098']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Bakris, G., Fonseca, V., Katholi, R., , Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial, Acc Current Journal Review, 2005",cited-by,10.1016/j.accreview.2004.12.136,Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial,"[['George', 'L.', 'Bakris'], ['Vivian', '', 'Fonseca'], ['Richard', 'E.', 'Katholi']]",Acc Current Journal Review,2005,"[u'http://www.dm2nb.ca/pdf/physician_resources/hypertension/carvedilol_vs_metoprolol_in_pts_with_dm2_and_htn_jama_2004.pdf', u'http://www.sciencedirect.com/science/article/pii/S106214580401181X', u'http://linkinghub.elsevier.com/retrieve/pii/S106214580401181X']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Gregg, E., Gu, Q., Cheng, Y., et. al, Mortality Trends in Men and Women with Diabetes, 1971 to 2000, , 2007",cited-by,"6440583Mortality Trends in Men and Women with Diabetes, 1971 to 2000","Mortality Trends in Men and Women with Diabetes, 1971 to 2000","[['Edward', 'W.', 'Gregg'], ['Qiuping', '', 'Gu'], ['Yiling', 'J.', 'Cheng'], ['K.', 'M. Venkat', 'Narayan'], ['Catherine', 'C.', 'Cowie']]",,2007,[u'http://stanfordhospital.org/clinicsmedServices/COE/heart/HeartCenterServices/womenHeartHealth/documents/SexDiffJournalClubArticle8_07.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Jackson, L., Nelson, J., Benson, P., et. al, Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors, , 2005",cited-by,6116077Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors,Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors,"[['Lisa', 'A', 'Jackson'], ['Jennifer', 'C', 'Nelson'], ['Patti', '', 'Benson'], ['Kathleen', 'M', 'Neuzil'], ['Robert', 'J', 'Reid'], ['Bruce', 'M', 'Psaty'], ['Susan', 'R', 'Heckbert'], ['Eric', 'B', 'Larson'], ['Noel', 'S', 'Weiss']]",,2005,"[u'http://ije.oxfordjournals.org/cgi/reprint/dyi275v1.pdf', u'http://ije.oxfordjournals.org/cgi/reprint/35/2/345.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Christenson, B., Hedlund, J., Lundbergh, P., et. al, Additive preventive effect of influenza and pneumococcal vaccines in elderly persons, European Respiratory Journal, 2004",cited-by,10.1183/09031936.04.00063504,Additive preventive effect of influenza and pneumococcal vaccines in elderly persons,"[['B.', '', 'Christenson'], ['J.', '', 'Hedlund'], ['P.', '', 'Lundbergh'], ['A.', '', 'Ortqvist']]",European Respiratory Journal,2004,"[u'http://erj.ersjournals.com/cgi/reprint/23/3/363.pdf', u'http://erj.ersjournals.com/cgi/doi/10.1183/09031936.04.00063504']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Narayan, K., Gregg, E., Fagot-Campagna, A., et. al, Diabetes — a common, growing, serious, costly, and potentially preventable public health problem, Diabetes Research and Clinical Practice, 2000",cited-by,10.1016/S0168-8227(00)00183-2,"Diabetes — a common, growing, serious, costly, and potentially preventable public health problem","[['K.', 'M Venkat', 'Narayan'], ['Edward', 'W', 'Gregg'], ['Anne', '', 'Fagot-Campagna'], ['Michael', 'M', 'Engelgau'], ['Frank', '', 'Vinicor']]",Diabetes Research and Clinical Practice,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168822700001832', u'http://linkinghub.elsevier.com/retrieve/pii/S0168822700001832']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Scuffham, P., West, P., , Economic evaluation of strategies for the control and management of influenza in Europe, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00154-8,Economic evaluation of strategies for the control and management of influenza in Europe,"[['P.', 'A.', 'Scuffham'], ['P.', 'A.', 'West']]",Vaccine,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/prevention/prevention-2.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X02001548', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/preparedness/preparedness-17.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001548']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Zanetti, A., Amendola, A., Besana, S., et. al, Safety and immunogenicity of influenza vaccination in individuals infected with HIV, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00511-X,Safety and immunogenicity of influenza vaccination in individuals infected with HIV,"[['Alessandro', 'R.', 'Zanetti'], ['Antonella', '', 'Amendola'], ['Silvia', '', 'Besana'], ['Antonio', '', 'Boschini'], ['Elisabetta', '', 'Tanzi']]",Vaccine,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-26.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X0200511X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0200511X']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nichol, K., , The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00114-0,The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease,"[['Kristin', 'L.', 'Nichol']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001140', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001140']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Jackson, M., Nelson, J., Weiss, N., et. al, Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61160-5,"Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study","[['Michael', 'L', 'Jackson'], ['Jennifer', 'C', 'Nelson'], ['Noel', 'S', 'Weiss'], ['Kathleen', 'M', 'Neuzil'], ['William', '', 'Barlow'], ['Lisa', 'A', 'Jackson']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611605', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611605']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nichol, K., Goodman, M., , Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00124-X,Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years,"[['Kristin', 'L', 'Nichol'], ['Michael', '', 'Goodman']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0200124X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0200124X']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Quinson, M., , Dynamic performance forecasting for network-enabled servers in a metacomputing environment, , 2002",cited-by,10.1109/IPDPS.2002.1016679,Dynamic performance forecasting for network-enabled servers in a metacomputing environment,"[['Martin', '', 'Quinson']]",,2002,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1016679', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01016679']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Marin, M., Johanson, W., Salas-Lopez, D., , Influenza Vaccination among Minority Populations in the United States, Preventive Medicine, 2002",cited-by,10.1006/pmed.2001.0983,Influenza Vaccination among Minority Populations in the United States,"[['Matthew', 'G.', 'Marin'], ['Waldemar', 'G.', 'Johanson'], ['Debbie', '', 'Salas-Lopez']]",Preventive Medicine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0091743501909831', u'http://linkinghub.elsevier.com/retrieve/pii/S0091743501909831']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Gilbertson, D., Unruh, M., Mcbean, A., et. al, Influenza vaccine delivery and effectiveness in end-stage renal disease, Kidney International, 2003",cited-by,10.1046/j.1523-1755.2003.00787.x,Influenza vaccine delivery and effectiveness in end-stage renal disease,"[['David', 'T', 'Gilbertson'], ['Mark', '', 'Unruh'], ['A', 'Marshall', 'Mcbean'], ['Annamaria', 'T', 'Kausz'], ['Jon', 'J', 'Snyder'], ['Allan', 'J', 'Collins']]",Kidney International,2003,"[u'http://dx.doi.org/10.1046/j.1523-1755.2003.00787.x', u'http://www.nature.com/doifinder/10.1046/j.1523-1755.2003.00787.x']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Belshe, R., Newman, F., Wilkins, K., et. al, Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults, Vaccine, 2007",cited-by,10.1016/j.vaccine.2007.06.066,Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults,"[['Robert', 'B.', 'Belshe'], ['Frances', 'K.', 'Newman'], ['Ken', '', 'Wilkins'], ['Irene', 'L.', 'Graham'], ['Elizabeth', '', 'Babusis'], ['Marian', '', 'Ewell'], ['Sharon', 'E.', 'Frey']]",Vaccine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X07007621', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X07007621']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Ge, Q., Eisen, H., Chen, J., , Use of siRNAs to prevent and treat influenza virus infection, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.01.013,Use of siRNAs to prevent and treat influenza virus infection,"[['Qing', '', 'Ge'], ['Herman', 'N', 'Eisen'], ['Jianzhu', '', 'Chen']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204000309', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204000309']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Murphy, N., Simpson, C., McAlister, F., et. al, National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland, Heart, 2004",cited-by,10.1136/hrt.2003.029553,"National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland","[['N', 'F', 'Murphy'], ['C', 'R', 'Simpson'], ['F', 'A', 'McAlister'], ['S', '', 'Stewart'], ['K', '', 'MacIntyre'], ['M', '', 'Kirkpatrick'], ['J', '', 'Chalmers'], ['A', '', 'Redpath'], ['S', '', 'Capewell'], ['J', 'J V', 'McMurray']]",Heart,2004,"[u'http://eprints.gla.ac.uk/4447/1/Enlighten_copy4.pdf', u'http://testservice-eprints.gla.ac.uk/4447/1/Enlighten_copy4.pdf', u'http://heart.bmj.com/cgi/doi/10.1136/hrt.2003.029553']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Blank, P., Schwenkglenks, M., Szucs, T., , Vaccination coverage rates in eleven European countries during two consecutive influenza seasons, Journal of Infection, 2009",cited-by,10.1016/j.jinf.2009.04.001,Vaccination coverage rates in eleven European countries during two consecutive influenza seasons,"[['Patricia', 'R.', 'Blank'], ['Matthias', '', 'Schwenkglenks'], ['Thomas', 'D.', 'Szucs']]",Journal of Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0163445309001157', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445309001157']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Turner, D., Wailoo, A., Cooper, N., et. al, The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age, Vaccine, 2006",cited-by,10.1016/j.vaccine.2004.12.033,The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age,"[['D.', 'A.', 'Turner'], ['A.', 'J.', 'Wailoo'], ['N.', 'J.', 'Cooper'], ['A.', 'J.', 'Sutton'], ['K.', 'R.', 'Abrams'], ['K.', 'G.', 'Nicholson']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0500890X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0500890X']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Schaad, U., Buhlmann, U., Burger, R., et. al, Comparison of Immunogenicity and Safety of a Virosome Influenza Vaccine with Those of a Subunit Influenza Vaccine in Pediatric Patients with Cystic Fibrosis, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.5.1163-1167.2000,Comparison of Immunogenicity and Safety of a Virosome Influenza Vaccine with Those of a Subunit Influenza Vaccine in Pediatric Patients with Cystic Fibrosis,"[['U.', 'B.', 'Schaad'], ['U.', '', 'Buhlmann'], ['R.', '', 'Burger'], ['A.', '', 'Ruedeberg'], ['A.', '', 'Wilder-Smith'], ['M.', '', 'Rutishauser'], ['F.', '', 'Sennhauser'], ['C.', '', 'Herzog'], ['M.', '', 'Zellmeyer'], ['R.', '', 'Gluck']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/reprint/44/5/1163.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.5.1163-1167.2000']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Poehling, K., Speroff, T., Dittus, R., et. al, Predictors of Influenza Virus Vaccination Status in Hospitalized Children, , 2010",cited-by,5516438Predictors of Influenza Virus Vaccination Status in Hospitalized Children,Predictors of Influenza Virus Vaccination Status in Hospitalized Children,"[['Katherine', 'A.', 'Poehling'], ['Theodore', '', 'Speroff'], ['Robert', 'S.', 'Dittus'], ['Marie', 'R.', 'Griffin'], ['Gerald', 'B.', 'Hickson'], ['Kathryn', 'M.', 'Edwards']]",,2010,[]
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Rothberg, M., Haessler, S., , Complications of seasonal and pandemic influenza, Critical Care Medicine, 2010",cited-by,10.1097/CCM.0b013e3181c92eeb,Complications of seasonal and pandemic influenza,"[['Michael', 'B.', 'Rothberg'], ['Sarah', 'D.', 'Haessler']]",Critical Care Medicine,2010,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-201004001-00011', u'http://www.sopemi.org.pe/file/articulos/201004/Complications of seasonal and pandemic influenza.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Hannouna, C., Megas, F., Piercy, J., , Immunogenicity and protective efficacy of influenza vaccination, Virus Research, 2004",cited-by,10.1016/S0168-1702(04)00124-8,Immunogenicity and protective efficacy of influenza vaccination,"[['Claude', '', 'Hannouna'], ['Francoise', '', 'Megas'], ['James', '', 'Piercy']]",Virus Research,2004,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-21.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001248']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Hedlund, J., Christenson, B., Lundbergh, P., et. al, Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00296-2,Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up,"[['J.', '', 'Hedlund'], ['B.', '', 'Christenson'], ['P.', '', 'Lundbergh'], ['\xc3\x85.', '', '\xc3\x96rtqvist']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03002962', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03002962']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Mieczkowski, T., Wilson, S., , Adult pneumococcal vaccination: a review of physician and patient barriers, Vaccine, 2002",cited-by,10.1016/S0264-410X(01)00463-7,Adult pneumococcal vaccination: a review of physician and patient barriers,"[['Tammy', 'A', 'Mieczkowski'], ['Stephen', 'A', 'Wilson']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01004637', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01004637']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Poland, G., Shefer, A., McCauley, M., et. al, Standards for adult immunization practices, American Journal of Preventive Medicine, 2003",cited-by,10.1016/S0749-3797(03)00120-X,Standards for adult immunization practices,"[['Gregory', 'A', 'Poland'], ['Abigail', 'M', 'Shefer'], ['Mary', '', 'McCauley'], ['Peggy', 'S', 'Webster'], ['Patricia', 'N', 'Whitley-Williams'], ['Georges', '', 'Peter']]",American Journal of Preventive Medicine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S074937970300120X', u'http://linkinghub.elsevier.com/retrieve/pii/S074937970300120X']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Vellozzi, C., Burwen, D., Dobardzic, A., et. al, Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.01.125,Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring,"[['Claudia', '', 'Vellozzi'], ['Dale', 'R.', 'Burwen'], ['Azra', '', 'Dobardzic'], ['Robert', '', 'Ball'], ['Kimp', '', 'Walton'], ['Penina', '', 'Haber']]",Vaccine,2009,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-3.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X09002047', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09002047']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Herrera, G., Iwane, M., Cortese, M., et. al, Influenza vaccine effectiveness among 50–64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003–2004, Vaccine, 2007",cited-by,10.1016/j.vaccine.2006.05.129,"Influenza vaccine effectiveness among 50–64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003–2004","[['Guillermo', 'A.', 'Herrera'], ['Marika', 'K.', 'Iwane'], ['Margaret', '', 'Cortese'], ['Cedric', '', 'Brown'], ['Ken', '', 'Gershman'], ['Alyson', '', 'Shupe'], ['Francisco', '', 'Averhoff'], ['Sandra', 'S.', 'Chaves'], ['Paul', '', 'Gargiullo'], ['Carolyn', 'B.', 'Bridges']]",Vaccine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06008838', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06008838']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Wang, C., Wang, S., Lai, C., et. al, Impact of influenza vaccination on major cause-specific mortality, Vaccine, 2007",cited-by,10.1016/j.vaccine.2006.10.015,Impact of influenza vaccination on major cause-specific mortality,"[['Chong-Shan', '', 'Wang'], ['Shan-Tair', '', 'Wang'], ['Ching-Te', '', 'Lai'], ['Li-Jen', '', 'Lin'], ['Pesus', '', 'Chou']]",Vaccine,2007,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-35.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X06011340', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06011340']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Jiménez, R., Larrauri, A., Carrasco, P., et. al, Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50–64 years, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00425-0,Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50–64 years,"[['Rodrigo', '', 'Jim\xc3\xa9nez'], ['Amparo', '', 'Larrauri'], ['Pilar', '', 'Carrasco'], ['Jes\xc3\xbas', '', 'Esteban'], ['Luis', 'Ignacio', 'G\xc3\xb3mez-L\xc3\xb3pez'], ['\xc3\x81ngel', '', 'Gil']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03004250', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03004250']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Martinez-Selles, M., Robles, J., Munoz, R., et. al, Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations, , 2004",cited-by,"6685156Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations","Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations","[['Manuel', '', 'Martinez-Selles'], ['Jose', 'A. Garcia', 'Robles'], ['Roberto', '', 'Munoz'], ['Jose', 'A.', 'Serrano'], ['Elisa', '', 'Frades'], ['Marta', 'Dominguez', 'Munoa'], ['Jesus', '', 'Almendral']]",,2004,[u'http://eurjhf.oxfordjournals.org/cgi/reprint/6/2/219.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Myśliwska, J., Trzonkowski, P., Szmit, E., et. al, Immunomodulating effect of influenza vaccination in the elderly differing in health status, Experimental Gerontology, 2004",cited-by,10.1016/j.exger.2004.08.005,Immunomodulating effect of influenza vaccination in the elderly differing in health status,"[['J.', '', 'My\xc5\x9bliwska'], ['P.', '', 'Trzonkowski'], ['E.', '', 'Szmit'], ['L.', 'B.', 'Brydak'], ['M.', '', 'Macha\xc5\x82a'], ['A.', '', 'My\xc5\x9bliwski']]",Experimental Gerontology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0531556504002475', u'http://linkinghub.elsevier.com/retrieve/pii/S0531556504002475']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Bruijn, I., Nauta, J., Cramer, W., et. al, Clinical experience with inactivated, virosomal influenza vaccine, Vaccine, 2005",cited-by,10.1016/j.vaccine.2005.04.020,"Clinical experience with inactivated, virosomal influenza vaccine","[['I.', 'A. de', 'Bruijn'], ['J.', '', 'Nauta'], ['W.', 'C. M.', 'Cramer'], ['L.', '', 'Gerez'], ['A.', 'M.', 'Palache']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05004615', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05004615']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Bonito, A., Lenfestey, N., Eicheldinger, C., et. al, Disparities in immunizations among elderly Medicare beneficiaries, 2000 to 2002, American Journal of Preventive Medicine, 2004",cited-by,10.1016/j.amepre.2004.04.004,"Disparities in immunizations among elderly Medicare beneficiaries, 2000 to 2002","[['Arthur', 'J', 'Bonito'], ['Nancy', 'F', 'Lenfestey'], ['Celia', '', 'Eicheldinger'], ['Vincent', 'G', 'Iannacchione'], ['Larry', '', 'Campbell']]",American Journal of Preventive Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0749379704000790', u'http://linkinghub.elsevier.com/retrieve/pii/S0749379704000790']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","ENGELGAU, M., NARAYAN, K., SAADDINE, J., et. al, Addressing the Burden of Diabetes in the 21st Century: Better Care and Primary Prevention, , 2003",cited-by,14279979Addressing the Burden of Diabetes in the 21st Century: Better Care and Primary Prevention,Addressing the Burden of Diabetes in the 21st Century: Better Care and Primary Prevention,"[['MICHAEL', 'M.', 'ENGELGAU'], ['K.', 'M. VENKAT', 'NARAYAN'], ['JINAN', 'B.', 'SAADDINE'], ['FRANK', '', 'VINICOR']]",,2003,[]
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Gorse, G., O’Connor, T., Young, S., et. al, Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study, Vaccine, 2003",cited-by,10.1016/S0264-410X(02)00748-X,"Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study","[['Geoffrey', 'J', 'Gorse'], ['Theresa', 'Z', 'O\xe2\x80\x99Connor'], ['Stephen', 'L', 'Young'], ['Paul', 'M', 'Mendelman'], ['Suzanne', 'F', 'Bradley'], ['Kristin', 'L', 'Nichol'], ['James', 'H', 'Strickland'], ['Daniel', 'M', 'Paulson'], ['Kathryn', 'L', 'Rice'], ['Runi', 'A', 'Foster'], ['Ashok', 'M', 'Fulambarker'], ['John', 'W', 'Shigeoka'], ['Ware', 'G', 'Kuschner'], ['Richard', 'P', 'Goodman'], ['Kathleen', 'M', 'Neuzil'], ['Janet', '', 'Wittes'], ['Kathy', 'D', 'Boardman'], ['Peter', 'N', 'Peduzzi']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0200748X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0200748X']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Hsieh, Y., Yen, J., Liu, D., et. al, Influenza in Taiwan: seasonality and vaccine strain match, , 2005",cited-by,5782832Influenza in Taiwan: seasonality and vaccine strain match,Influenza in Taiwan: seasonality and vaccine strain match,"[['Yu-Chia', '', 'Hsieh'], ['Jer-Jea', '', 'Yen'], ['Ding-Ping', '', 'Liu'], ['Luan-Yin', '', 'Chang'], ['Chun-Yi', '', 'Lu'], ['Pei-Lan', '', 'Shao'], ['Chin-Yun', '', 'Lee'], ['Li-Min', '', 'Huang']]",,2005,[u'http://www.jmii.org/content/pdf/v38n4p238.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Ben-Yehuda, A., Joseph, A., Barenholz, Y., et. al, Immunogenicity and safety of a novel IL2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00251-2,Immunogenicity and safety of a novel IL2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents,"[['Arie', '', 'Ben-Yehuda'], ['Aviva', '', 'Joseph'], ['Yechezkel', '', 'Barenholz'], ['Evelyne', '', 'Zeira'], ['Simcha', '', 'Even-Chen'], ['Igal', '', 'Louria-Hayon'], ['Ilan', '', 'Babai'], ['Zichria', '', 'Zakay-Rones'], ['Evgenia', '', 'Greenbaum'], ['Ilia', '', 'Galprin'], ['Reinhard', '', 'Gl\xc3\xbcck'], ['Rinaldo', '', 'Zurbriggen'], ['Eli', '', 'Kedar']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03002512', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03002512']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Østbye, T., Taylor, D., Lee, A., et. al, Racial differences in influenza vaccination among older americans 1996–2000: longitudinal analysis of the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) survey, BMC Public Health, 2003",cited-by,10.1186/1471-2458-3-41,Racial differences in influenza vaccination among older americans 1996–2000: longitudinal analysis of the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) survey,"[['Truls', '', '\xc3\x98stbye'], ['Donald', 'H', 'Taylor'], ['Ann', 'Marie M', 'Lee'], ['Gary', '', 'Greenberg'], ['Lynn', 'van', 'Scoyoc']]",BMC Public Health,2003,"[u'http://www.springerlink.com/index/d661552p67p5565p.pdf', u'http://www.biomedcentral.com/content/pdf/1471-2458-3-41.pdf', u'http://www.biomedcentral.com/1471-2458/3/41', u'http://www.springerlink.com/content/d661552p67p5565p']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Hak, E., Wei, F., Grobbee, D., et. al, A nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysis, Journal of Clinical Epidemiology, 2004",cited-by,10.1016/j.jclinepi.2004.01.019,A nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysis,"[['E.', '', 'Hak'], ['F.', '', 'Wei'], ['D.', 'E.', 'Grobbee'], ['K.', 'L.', 'Nichol']]",Journal of Clinical Epidemiology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0895435604001180', u'http://linkinghub.elsevier.com/retrieve/pii/S0895435604001180']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Gasparini, R., Lucioni, C., Lai, P., et. al, Cost–benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00507-8,Cost–benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria,"[['R', '', 'Gasparini'], ['C', '', 'Lucioni'], ['P', '', 'Lai'], ['P', '', 'Maggioni'], ['L', '', 'Sticchi'], ['P', '', 'Durando'], ['P', '', 'Morelli'], ['I', '', 'Comino'], ['S', '', 'Calderisi'], ['P', '', 'Crovari']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02005078', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02005078']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Kittel, C., Ferko, B., Kurz, M., et. al, Generation of an Influenza A Virus Vector Expressing Biologically Active Human Interleukin2 from the NS Gene Segment, Journal of Virology, 2005",cited-by,10.1128/JVI.79.16.10672-10677.2005,Generation of an Influenza A Virus Vector Expressing Biologically Active Human Interleukin2 from the NS Gene Segment,"[['Christian', '', 'Kittel'], ['Boris', '', 'Ferko'], ['Martina', '', 'Kurz'], ['Regina', '', 'Voglauer'], ['Sabine', '', 'Sereinig'], ['Julia', '', 'Romanova'], ['Gabriela', '', 'Stiegler'], ['Hermann', '', 'Katinger'], ['Andrej', '', 'Egorov']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/16/10672.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.16.10672-10677.2005']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Hak, E., Hoes, A., Grobbee, D., et. al, Conventional Influenza Vaccination Is Not Associated with Complications in Working-Age Patients with Asthma or Chronic Obstructive Pulmonary Disease, American Journal of Epidemiology, 2003",cited-by,10.1093/aje/kwg027,Conventional Influenza Vaccination Is Not Associated with Complications in Working-Age Patients with Asthma or Chronic Obstructive Pulmonary Disease,"[['E.', '', 'Hak'], ['A.', 'W.', 'Hoes'], ['D.', 'E.', 'Grobbee'], ['J.', 'W. J.', 'Lammers'], ['G.', 'A. van', 'Essen'], ['A.', 'M. van', 'Loon'], ['T.', 'J. M.', 'Verheij']]",American Journal of Epidemiology,2003,"[u'http://aje.oxfordjournals.org/cgi/reprint/157/8/692.pdf', u'http://aje.oupjournals.org/cgi/doi/10.1093/aje/kwg027']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Schmidt, A., Couch, R., Galasso, G., et. al, Current research on respiratory viral infections: Third International Symposium, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00136-X,Current research on respiratory viral infections: Third International Symposium,"[['Alexander', 'C', 'Schmidt'], ['Robert', 'B', 'Couch'], ['George', 'J', 'Galasso'], ['Frederick', 'G', 'Hayden'], ['John', '', 'Mills'], ['Brian', 'R', 'Murphy'], ['Robert', 'M', 'Chanock']]",Antiviral Research,2001,"[u'http://birdflubook.com/resources/Ison227.pdf', u'http://www.sciencedirect.com/science/article/pii/S016635420100136X', u'http://cmbi.bjmu.edu.cn/cmbidata/sars/pdf/16.pdf', u'http://www.lmbe.seu.edu.cn/sars/references/ison02.pdf', u'http://cmbi.bjmu.edu.cn/cmbidata/sars/pdf/viralinfect.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420100136X', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354202000554', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354204000038']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Rhew, D., , Quality Indicators for the Management of Pneumonia in Vulnerable Elders, , 2001",cited-by,13550426Quality Indicators for the Management of Pneumonia in Vulnerable Elders,Quality Indicators for the Management of Pneumonia in Vulnerable Elders,"[['David', 'C.', 'Rhew']]",,2001,[u'http://www.annals.org/content/135/8_Part_2/736.full.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Morshedi, A., Cutler, C., Skrovanek, T., , Optimal Solution of Dynamic Matrix Control with Linear Programing Techniques (LDMC), , 1985",cited-by,49834508Optimal Solution of Dynamic Matrix Control with Linear Programing Techniques (LDMC),Optimal Solution of Dynamic Matrix Control with Linear Programing Techniques (LDMC),"[['A.', 'M.', 'Morshedi'], ['C.', 'R.', 'Cutler'], ['T.', 'A.', 'Skrovanek']]",,1985,[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=4788606']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nelson, J., Jacksonsupasup, M., Weiss, N., et. al, New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors, Journal of Clinical Epidemiology, 2009",cited-by,10.1016/j.jclinepi.2008.06.014,New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors,"[['Jennifer', 'Clark', 'Nelson'], ['Michael', 'L.', 'Jacksonsupasup'], ['Noel', 'S.', 'Weiss'], ['Lisa', 'A.', 'Jackson']]",Journal of Clinical Epidemiology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0895435608001844', u'http://linkinghub.elsevier.com/retrieve/pii/S0895435608001844']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Kee, S., Lee, J., Cheong, H., et. al, Influenza vaccine coverage rates and perceptions on vaccination in South Korea, Journal of Infection, 2007",cited-by,10.1016/j.jinf.2007.04.354,Influenza vaccine coverage rates and perceptions on vaccination in South Korea,"[['Sae', 'Yoon', 'Kee'], ['Jin', 'Soo', 'Lee'], ['Hee', 'Jin', 'Cheong'], ['Byung', 'Chul', 'Chun'], ['Joon', 'Young', 'Song'], ['Won', 'Suk', 'Choi'], ['Yu', 'Mi', 'Jo'], ['Yoo', 'Bin', 'Seo'], ['Woo', 'Joo', 'Kim']]",Journal of Infection,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0163445307006287', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445307006287']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Medema, J., Zoellner, Y., Ryan, J., et. al, Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.006,Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply,"[['Jeroen', 'K.', 'Medema'], ['York', 'F.', 'Zoellner'], ['James', '', 'Ryan'], ['Abraham', 'M.', 'Palache']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204001054', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001054']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Fiore, A., Bridges, C., Cox, N., , Seasonal Influenza Vaccines, , 0",cited-by,10.1007/978-3-540-92165-3_3,Seasonal Influenza Vaccines,"[['Anthony', 'E.', 'Fiore'], ['Carolyn', 'B.', 'Bridges'], ['Nancy', 'J.', 'Cox']]",,0,"[u'http://www.springerlink.com/content/l157756160304643', u'http://www.springerlink.com/index/l157756160304643.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Nichol, K., Nordin, J., Mullooly, J., , Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons, Vaccine, 2006",cited-by,10.1016/j.vaccine.2005.10.004,Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons,"[['K.', 'L.', 'Nichol'], ['J.', '', 'Nordin'], ['J.', '', 'Mullooly']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05010406', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05010406']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Hara, M., Sakamoto, T., Tanaka, K., , Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: Population-based cohort study in Japan, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.04.027,Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: Population-based cohort study in Japan,"[['Megumi', '', 'Hara'], ['Tatsuhiko', '', 'Sakamoto'], ['Keitaro', '', 'Tanaka']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06004634', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06004634']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Ahmed, F., Janes, G., Baron, R., et. al, Preferred provider organization claims showed high predictive value but missed substantial proportion of adults with high-risk conditions, Journal of Clinical Epidemiology, 2005",cited-by,10.1016/j.jclinepi.2004.11.020,Preferred provider organization claims showed high predictive value but missed substantial proportion of adults with high-risk conditions,"[['Faruque', '', 'Ahmed'], ['Gail', 'R.', 'Janes'], ['Roy', '', 'Baron'], ['Lisa', 'M.', 'Latts']]",Journal of Clinical Epidemiology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0895435604003695', u'http://linkinghub.elsevier.com/retrieve/pii/S0895435604003695']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Allsup, S., Gosney, M., Regan, M., et. al, Side Effects of Influenza Vaccination in Healthy Older People: A Randomised Single-Blind Placebo-Controlled Trial, Gerontology, 2001",cited-by,10.1159/000052820,Side Effects of Influenza Vaccination in Healthy Older People: A Randomised Single-Blind Placebo-Controlled Trial,"[['Stephen', 'James', 'Allsup'], ['Margot', '', 'Gosney'], ['Martyn', '', 'Regan'], ['Alan', '', 'Haycox'], ['Simon', '', 'Fear'], ['Fiona', 'C. W.', 'Johnstone']]",Gerontology,2001,"[u'http://www.karger.com/doi/10.1159/000052820', u'http://www.online.karger.com/doi/10.1159/000052820']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Kapasouris, P., Athans, M., , Multivariable Control Systems with Saturating Actuators Antireset Windup Strategies, American Journal of Preventive Medicine, 1985",cited-by,49834751Multivariable Control Systems with Saturating Actuators Antireset Windup Strategies,Multivariable Control Systems with Saturating Actuators Antireset Windup Strategies,"[['Petros', '', 'Kapasouris'], ['Michael', '', 'Athans']]",American Journal of Preventive Medicine,1985,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=4788866', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=04788866']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Poland, G., Shefer, A., McCauley, M., et. al, Standards for Adult Immunization Practices, , 0",cited-by,5503338Standards for Adult Immunization Practices,Standards for Adult Immunization Practices,"[['Gregory', 'A.', 'Poland'], ['Abigail', 'M.', 'Shefer'], ['Mary', '', 'McCauley'], ['Peggy', 'S.', 'Webster'], ['Patricia', 'N.', 'Whitley-Williams'], ['Georges', '', 'Peter']]",,0,"[u'http://www.immunizeflorida.org/Adult_Standards.pdf', u'http://www.wahsa.org/immun.pdf', u'http://www.cdc.gov/vaccines/recs/downloads/rev_stds_adult_AJPM.pdf', u'http://www.ohiokepro.com/providers/physician/changepacket/Immunization/ImmunizationAdultStandards.pdf', u'http://www.ohiokepro.com/pdfs/projects/prevention/preventionservice/immunizationadultstandards_508.pdf', u'http://www.doh.state.fl.us/Disease_ctrl/immune/Adult_Standards.pdf', u'http://www.floridashealth.com/Disease_ctrl/immune/Adult_Standards.pdf', u'http://origin.cdc.gov/vaccines/recs/downloads/rev_stds_adult_AJPM.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Jackson, M., Nelson, J., Weiss, N., et. al, Infl uenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study, , 2008",cited-by,"6416873Infl uenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study","Infl uenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study","[['Michael', 'L', 'Jackson'], ['Jennifer', 'C', 'Nelson'], ['Noel', 'S', 'Weiss'], ['Kathleen', 'M', 'Neuzil'], ['William', '', 'Barlow'], ['Lisa', 'A', 'Jackson']]",,2008,"[u'http://multimedia.thelancet.com/pdf/press/vaccination.pdf', u'http://www.drclaudiaanrig.com/research/Lancet%202008%20influenza%20vaccination%20and%20risk%20of%20pneumonia%20elderly.pdf']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","High, K., , Immunizations in Older Adults, Clinics in Geriatric Medicine, 2007",cited-by,10.1016/j.cger.2007.03.007,Immunizations in Older Adults,"[['Kevin', '', 'High']]",Clinics in Geriatric Medicine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0749069007000262', u'http://linkinghub.elsevier.com/retrieve/pii/S0749069007000262']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Maciosek, M., Solberg, L., Coffield, A., et. al, Influenza Vaccination, American Journal of Preventive Medicine, 2006",cited-by,10.1016/j.amepre.2006.03.008,Influenza Vaccination,"[['Michael', 'V.', 'Maciosek'], ['Leif', 'I.', 'Solberg'], ['Ashley', 'B.', 'Coffield'], ['Nichol', 'M.', 'Edwards'], ['Michael', 'J.', 'Goodman']]",American Journal of Preventive Medicine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0749379706001206', u'http://linkinghub.elsevier.com/retrieve/pii/S0749379706001206']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Chen, Y., Liou, S., Chou, C., et. al, Influenza and pneumococcal vaccination of the elderly in Taiwan, Vaccine, 2004",cited-by,10.1016/j.vaccine.2004.01.003,Influenza and pneumococcal vaccination of the elderly in Taiwan,"[['Yeong-Hwang', '', 'Chen'], ['Saou-Hsing', '', 'Liou'], ['Chih-Chieh', '', 'Chou'], ['Wen-Lin', '', 'Su'], ['Ching-Hui', '', 'Loh'], ['Shih-Ha', '', 'Lin']]",Vaccine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X04000313', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X04000313']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Tacken, M., Braspenning, J., Spreeuwenberg, P., et. al, Patient Characteristics Determine Differences in the Influenza Vaccination Rate More so Than Practice Features, Preventive Medicine, 2002",cited-by,10.1006/pmed.2002.1083,Patient Characteristics Determine Differences in the Influenza Vaccination Rate More so Than Practice Features,"[['Margot', '', 'Tacken'], ['Joz\xc3\xa9', '', 'Braspenning'], ['Peter', '', 'Spreeuwenberg'], ['Henk', 'van den', 'Hoogen'], ['Gerrit', 'van', 'Essen'], ['Dinny', 'de', 'Bakker'], ['Richard', '', 'Grol']]",Preventive Medicine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0091743502910832', u'http://linkinghub.elsevier.com/retrieve/pii/S0091743502910832']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Postma, M., Baltussen, R., Heijnen, M., et. al, Pharmacoeconomics of Influenza Vaccination in the Elderly: Reviewing the Available Evidence, Drugs & Aging, 2000",cited-by,10.2165/00002512-200017030-00005,Pharmacoeconomics of Influenza Vaccination in the Elderly: Reviewing the Available Evidence,"[['Maarten', 'J.', 'Postma'], ['Rob', 'M. P. M.', 'Baltussen'], ['Marie-Louise', 'A.', 'Heijnen'], ['Lolkje', 'T. W. de Jong-van den', 'Berg'], ['Johannes', 'C.', 'Jager']]",Drugs & Aging,2000,"[u'http://www.sff.fmns.rug.nl/downloads/2000/16_postma_2000.pdf', u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002512-200017030-00005']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Menec, V., MacWilliam, L., Aoki, F., , Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents, , 0",cited-by,"11896331Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents","Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents","[['Verena', 'H.', 'Menec'], ['Leonard', '', 'MacWilliam'], ['Fred', 'Y.', 'Aoki']]",,0,[u'http://biomed.gerontologyjournals.org/cgi/reprint/57/10/M629.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Jansen, A., Sanders, E., Nichol, K., et. al, Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.08.003,Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program,"[['Angelique', 'G. S. C.', 'Jansen'], ['Elisabeth', 'A. M.', 'Sanders'], ['Kristin', 'L.', 'Nichol'], ['Anton', 'M. van', 'Loon'], ['Arno', 'W.', 'Hoes'], ['Eelko', '', 'Hak']]",Vaccine,2008,"[u'http://igitur-archive.library.uu.nl/dissertations/2007-0920-200432/c4.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X08010682', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08010682']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Gavazzi, G., Wazieres, B., Lejeune, B., et. al, Influenza and Pneumococcal Vaccine Coverages in Geriatric Health Care Settings in France, Gerontology, 2007",cited-by,10.1159/000105166,Influenza and Pneumococcal Vaccine Coverages in Geriatric Health Care Settings in France,"[['Ga\xc3\xabtan', '', 'Gavazzi'], ['Benoit', '', 'Wazieres'], ['Benoist', '', 'Lejeune'], ['Monique', '', 'Rothan-Tondeur']]",Gerontology,2007,"[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000105166', u'http://www.karger.com/doi/10.1159/000105166']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Okamoto, S., Yoshii, H., Akagi, T., et. al, Influenza hemagglutinin vaccine with poly(γ-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity, Vaccine, 2007",cited-by,10.1016/j.vaccine.2007.09.051,Influenza hemagglutinin vaccine with poly(γ-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity,"[['Shigefumi', '', 'Okamoto'], ['Hironori', '', 'Yoshii'], ['Takami', '', 'Akagi'], ['Mitsuru', '', 'Akashi'], ['Toyokazu', '', 'Ishikawa'], ['Yoshinobu', '', 'Okuno'], ['Michiaki', '', 'Takahashi'], ['Koichi', '', 'Yamanishi'], ['Yasuko', '', 'Mori']]",Vaccine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X07010985', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X07010985']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Bruijn, I., Meyer, I., Gerez, L., et. al, Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly, Vaccine, 2007",cited-by,10.1016/j.vaccine.2007.10.051,"Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly","[['Iris', 'de', 'Bruijn'], ['Ingo', '', 'Meyer'], ['Lisya', '', 'Gerez'], ['Jos', '', 'Nauta'], ['Katinka', '', 'Giezeman'], ['Bram', '', 'Palache']]",Vaccine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X07012248', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X07012248']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Shefer, A., McKibben, L., Bardenheier, B., et. al, Characteristics of long-term care facilities associated with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2004.12.020,Characteristics of long-term care facilities associated with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states,"[['Abigail', '', 'Shefer'], ['Linda', '', 'McKibben'], ['Barbara', '', 'Bardenheier'], ['Dale', '', 'Bratzler'], ['Henry', '', 'Roberts']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861004000210', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861004000210']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Okamoto, S., Kawabata, S., Fujitaka, H., et. al, Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection, Vaccine, 2004",cited-by,10.1016/j.vaccine.2003.12.024,Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection,"[['Shigefumi', '', 'Okamoto'], ['Shigetada', '', 'Kawabata'], ['Hideaki', '', 'Fujitaka'], ['Takashi', '', 'Uehira'], ['Yoshinobu', '', 'Okuno'], ['Shigeyuki', '', 'Hamada']]",Vaccine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X04000246', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X04000246']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Allsup, S., Gosney, M., Haycox, A., et. al, Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age, , 2003",cited-by,13342033Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age,Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age,"[['S', '', 'Allsup'], ['M', '', 'Gosney'], ['A', '', 'Haycox'], ['M', '', 'Regan']]",,2003,[u'http://www.ppge.ufrgs.br/ats/disciplinas/9/allsup-gosney-haycox-2003.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Okamoto, S., Matsuura, M., Akagi, T., et. al, Poly(γ-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.07.037,Poly(γ-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice,"[['Shigefumi', '', 'Okamoto'], ['Masaaki', '', 'Matsuura'], ['Takami', '', 'Akagi'], ['Mitsuru', '', 'Akashi'], ['Takeshi', '', 'Tanimoto'], ['Toyokazu', '', 'Ishikawa'], ['Michiaki', '', 'Takahashi'], ['Koichi', '', 'Yamanishi'], ['Yasuko', '', 'Mori']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X09010445', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09010445']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Donowitz, G., Cox, H., , Bacterial Community-Acquired Pneumonia in Older Patients, Clinics in Geriatric Medicine, 2007",cited-by,10.1016/j.cger.2007.03.006,Bacterial Community-Acquired Pneumonia in Older Patients,"[['Gerald', 'R.', 'Donowitz'], ['Heather', 'L.', 'Cox']]",Clinics in Geriatric Medicine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0749069007000250', u'http://linkinghub.elsevier.com/retrieve/pii/S0749069007000250']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Straits-Tröster, K., Kahwati, L., Kinsinger, L., et. al, Racial/Ethnic Differences in Influenza Vaccination in the Veterans Affairs Healthcare System, American Journal of Preventive Medicine, 2006",cited-by,10.1016/j.amepre.2006.07.018,Racial/Ethnic Differences in Influenza Vaccination in the Veterans Affairs Healthcare System,"[['Kristy', 'A.', 'Straits-Tr\xc3\xb6ster'], ['Leila', 'C.', 'Kahwati'], ['Linda', 'S.', 'Kinsinger'], ['Jean', '', 'Orelien'], ['Mary', 'B.', 'Burdick'], ['Steven', 'J.', 'Yevich']]",American Journal of Preventive Medicine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0749379706002741', u'http://linkinghub.elsevier.com/retrieve/pii/S0749379706002741']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Wouden, J., Bueving, H., Poole, P., , Preventing influenza: An overview of systematic reviews, Respiratory Medicine, 2005",cited-by,10.1016/j.rmed.2005.07.001,Preventing influenza: An overview of systematic reviews,"[['J.', 'C. van der', 'Wouden'], ['H.', 'J.', 'Bueving'], ['P.', '', 'Poole']]",Respiratory Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0954611105002684', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611105002684']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Okoro, C., Mokdad, A., Ford, E., et. al, Are persons with diabetes practicing healthier behaviors in the year 2001? Results from the Behavioral Risk Factor Surveillance System, Preventive Medicine, 2004",cited-by,10.1016/j.ypmed.2003.09.039,Are persons with diabetes practicing healthier behaviors in the year 2001? Results from the Behavioral Risk Factor Surveillance System,"[['Catherine', 'A', 'Okoro'], ['Ali', 'H', 'Mokdad'], ['Earl', 'S', 'Ford'], ['Barbara', 'A', 'Bowman'], ['Frank', '', 'Vinicor'], ['Wayne', 'H', 'Giles']]",Preventive Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0091743503002573', u'http://linkinghub.elsevier.com/retrieve/pii/S0091743503002573']"
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Humair, J., Buchs, C., Stalder, H., , Promoting influenza vaccination of elderly patients in primary care, , 2002",cited-by,6705299Promoting influenza vaccination of elderly patients in primary care,Promoting influenza vaccination of elderly patients in primary care,"[['Jean-Paul', '', 'Humair'], ['Cristina', 'Rizzi', 'Buchs'], ['Hans', '', 'Stalder']]",,2002,[u'http://fampra.oxfordjournals.org/cgi/reprint/19/4/383.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Bogdanovic, B., Soodeen, B., Chateau, D., , Using Administrative Data to Develop Indicators of Quality in Family Practice, , 0",cited-by,4049563Using Administrative Data to Develop Indicators of Quality in Family Practice,Using Administrative Data to Develop Indicators of Quality in Family Practice,"[['Bogdan', '', 'Bogdanovic'], ['BA', 'Ruth-Ann', 'Soodeen'], ['Dan', '', 'Chateau']]",,0,[u'http://mchp-appserv.cpe.umanitoba.ca/reference/quality_wo.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Zheng, B., Zhang, Y., He, H., et. al, Rectification of Age-Associated Deficiency in Cytotoxic T Cell Response to Influenza A Virus by Immunization with Immune Complexes, , 0",cited-by,6340774Rectification of Age-Associated Deficiency in Cytotoxic T Cell Response to Influenza A Virus by Immunization with Immune Complexes,Rectification of Age-Associated Deficiency in Cytotoxic T Cell Response to Influenza A Virus by Immunization with Immune Complexes,"[['Biao', '', 'Zheng'], ['Yongxin', '', 'Zhang'], ['Hongxia', '', 'He'], ['Ekaterina', '', 'Marinova'], ['Kirsten', '', 'Switzer'], ['Daniel', '', 'Wansley'], ['Innocent', '', 'Mbawuike'], ['Shuhua', '', 'Han']]",,0,[u'http://www.jimmunol.org/cgi/reprint/179/9/6153.pdf']
"13513741Benefits of Influenza Vaccination for Low, Intermediate, and High-Risk Senior Citizens","Wallace, S., Gutiérrez, V., Castañeda, X., , Access to Preventive Services for Adults of Mexican Origin, Journal of Immigrant and Minority Health, 2008",cited-by,10.1007/s10903-007-9093-3,Access to Preventive Services for Adults of Mexican Origin,"[['Steven', 'P.', 'Wallace'], ['Ver\xc3\xb3nica', 'F.', 'Guti\xc3\xa9rrez'], ['X\xc3\xb3chitl', '', 'Casta\xc3\xb1eda']]",Journal of Immigrant and Minority Health,2008,"[u'http://www.springerlink.com/content/x4r88288n45rwr55', u'http://www.springerlink.com/index/x4r88288n45rwr55.pdf', u'http://www.springerlink.com/index/10.1007/s10903-007-9093-3', u'http://www.springerlink.com/index/pdf/10.1007/s10903-007-9093-3']"
10.1016~S0140-6736(00)02288-1,Nicholson KG. Use of antivirals in influenza in the elderly: prophylaxis and therapy. Gerontology 1996; 42: 280-89.,references,10.1159/000213804,Use of Antivirals in Influenza in the Elderly: Prophylaxis and Therapy,"[[u'Karl', u'G.', u'Nicholson']]",Gerontology,1996,"[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000213804', u'http://www.karger.com/doi/10.1159/000213804']",./output/10.1016~S0140-6736(00)02288-1/10.1159~000213804
10.1159/000213804,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
10.1159/000213804,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1159/000213804,"Tablan, O., Anderson, L., Besser, R., et. al, GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By, , 0",cited-by,"13520052GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By","GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By","[['Ofelia', 'C.', 'Tablan'], ['Larry', 'J.', 'Anderson'], ['Richard', '', 'Besser'], ['Carolyn', '', 'Bridges'], ['Rana', '', 'Hajjeh']]",,0,"[u'http://origin.cdc.gov/hicpac/pdf/guidelines/hapneu2003guidelines.pdf', u'http://www.cdc.gov/hicpac/pdf/guidelines/hapneu2003guidelines.pdf']"
10.1159/000213804,"Tisdale, M., , Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors, Reviews in Medical Virology, 2000",cited-by,10.1002/(SICI)1099-1654(200001/02)10:1<45::AID-RMV265>3.0.CO;2-R,Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors,"[['Margaret', '', 'Tisdale']]",Reviews in Medical Virology,2000,[u'http://doi.wiley.com/10.1002/%28SICI%291099-1654%28200001/02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R']
10.1159/000213804,"Barnett, J., Lewis, A., Cadman, A., et. al, Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.1.78-87.2000,Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies,"[['J.', 'M.', 'Barnett'], ['A.', 'P.', 'Lewis'], ['A.', '', 'Cadman'], ['D.', '', 'Gor'], ['M.', '', 'Dempsey'], ['M.', '', 'Walters'], ['A.', '', 'Candlin'], ['M.', '', 'Tisdale'], ['Groot', 'de', 'R'], ['P.', 'J.', 'Morley'], ['I.', 'J.', 'Owens'], ['G.', 'F.', 'Rimmelzwaan'], ['R.', 'J.', 'Fenton'], ['E.', 'C. J.', 'Claas'], ['A.', 'D. M. E.', 'Osterhaus']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/reprint/44/1/78.pdf', u'http://publishing.eur.nl/ir/repub/asset/9217/10602727.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.1.78-87.2000']"
10.1159/000213804,"Turner, D., Wailoo, A., Nicholson, K., et. al, Systematic review and economic decision modelling for the prevention and treatment of influenza A and B, , 2003",cited-by,14317005Systematic review and economic decision modelling for the prevention and treatment of influenza A and B,Systematic review and economic decision modelling for the prevention and treatment of influenza A and B,"[['D', '', 'Turner'], ['A', '', 'Wailoo'], ['K', '', 'Nicholson'], ['N', '', 'Cooper'], ['A', '', 'Sutton'], ['K', '', 'Abrams']]",,2003,[u'http://www.col.ops-oms.org/prevencion/influenza/vacunacion/prev_tratamiento.pdf']
10.1159/000213804,"Monto, A., Rotthoff, J., Teich, E., et. al, Detection and Control of Influenza Outbreaks in Well‐Vaccinated Nursing Home Populations, Clinical Infectious Diseases, 2004",cited-by,10.1086/422646,Detection and Control of Influenza Outbreaks in Well‐Vaccinated Nursing Home Populations,"[['Arnold', 'S.', 'Monto'], ['Judy', '', 'Rotthoff'], ['Esther', '', 'Teich'], ['M.', 'Louise', 'Herlocher'], ['Rachel', '', 'Truscon'], ['Stephanie', '', 'Elias'], ['Suzanne', 'E.', 'Ohmit']]",Clinical Infectious Diseases,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/422646']
10.1159/000213804,"Lalezari, J., Campion, K., Keene, O., et. al, Zanamivir for the Treatment of Influenza A and B Infection in High-Risk Patients A Pooled Analysis of Randomized Controlled Trials, , 2001",cited-by,13863052Zanamivir for the Treatment of Influenza A and B Infection in High-Risk Patients A Pooled Analysis of Randomized Controlled Trials,Zanamivir for the Treatment of Influenza A and B Infection in High-Risk Patients A Pooled Analysis of Randomized Controlled Trials,"[['Jacob', '', 'Lalezari'], ['Katrina', '', 'Campion'], ['Oliver', '', 'Keene'], ['Chris', '', 'Silagy']]",,2001,"[u'http://archinte.highwire.org/cgi/reprint/161/2/212.pdf', u'http://archinte.ama-assn.org/cgi/reprint/161/2/212.pdf']"
10.1159/000213804,"Sansom, M., Forrest, L., Bull, R., , Viral ion channels: molecular modeling and simulation, Bioessays, 1999",cited-by,10.1002/(SICI)1521-1878(199812)20:12<992::AID-BIES5>3.0.CO;2-7,Viral ion channels: molecular modeling and simulation,"[['Mark', 'S. P.', 'Sansom'], ['Lucy', 'R.', 'Forrest'], ['Richard', '', 'Bull']]",Bioessays,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291521-1878%28199812%2920%3A12%3C992%3A%3AAID-BIES5%3E3.0.CO%3B2-7']
10.1159/000213804,"Fitzner, K., McGhee, S., Hedley, A., et. al, Influenza surveillance in Hong Kong: results of a trial Physician Sentinel Programme, , 1999",cited-by,13541152Influenza surveillance in Hong Kong: results of a trial Physician Sentinel Programme,Influenza surveillance in Hong Kong: results of a trial Physician Sentinel Programme,"[['KA', '', 'Fitzner'], ['SM', '', 'McGhee'], ['AJ', '', 'Hedley'], ['KF', '', 'Shortridge']]",,1999,[u'http://www.hkmj.org/article_pdfs/hkm9903p87.pdf']
10.1159/000213804,"Holdiness, M., , Adverse cutaneous reactions to influenza vaccinations and chemotherapy, International Journal of Dermatology, 2001",cited-by,10.1046/j.1365-4362.2001.01218.x,Adverse cutaneous reactions to influenza vaccinations and chemotherapy,"[['Mack', 'R.', 'Holdiness']]",International Journal of Dermatology,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-4362.2001.01218.x']
10.1159/000213804,"Cate, T., , Viral Pneumonia Due to Influenza and Parainfluenza Viruses and Adenoviruses, , 0",cited-by,10.1007/0-306-46834-4_37,Viral Pneumonia Due to Influenza and Parainfluenza Viruses and Adenoviruses,"[['Thomas', 'R.', 'Cate']]",,0,"[u'http://www.springerlink.com/index/h860r628k58wv366.pdf', u'http://www.springerlink.com/content/h860r628k58wv366']"
10.1016~S0140-6736(00)02288-1,"Colman PM, Varghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 1983; 303: 41–44.",references,10.1038/303041a0,Structure of the catalytic and antigenic sites in influenza virus neuraminidase,"[[u'P.', u'M.', u'Colman'], [u'J.', u'N.', u'Varghese'], [u'W.', u'G.', u'Laver']]",Nature,1983,[u'http://www.nature.com/doifinder/10.1038/303041a0'],./output/10.1016~S0140-6736(00)02288-1/10.1038~303041a0
10.1038/303041a0,"Skehel, J., Wiley, D., , RECEPTOR BINDING AND MEMBRANE FUSION IN VIRUS ENTRY: The Influenza Hemagglutinin, Annual Review of Biochemistry, 2000",cited-by,10.1146/annurev.biochem.69.1.531,RECEPTOR BINDING AND MEMBRANE FUSION IN VIRUS ENTRY: The Influenza Hemagglutinin,"[['John', 'J.', 'Skehel'], ['Don', 'C.', 'Wiley']]",Annual Review of Biochemistry,2000,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.biochem.69.1.531']
10.1038/303041a0,"Varghese, J., Laver, W., Colman, P., , Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution, Nature, 1983",cited-by,10.1038/303035a0,Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution,"[['J.', 'N.', 'Varghese'], ['W.', 'G.', 'Laver'], ['P.', 'M.', 'Colman']]",Nature,1983,[u'http://www.nature.com/doifinder/10.1038/303035a0']
10.1038/303041a0,"Xu, X., Subbarao, K., Cox, N., et. al, Genetic Characterization of the Pathogenic Influenza A/Goose/Guangdong/1/96 (H5N1) Virus: Similarity of Its Hemagglutinin Gene to Those of H5N1 Viruses from the 1997 Outbreaks in Hong Kong, Virology, 1999",cited-by,10.1006/viro.1999.9820,Genetic Characterization of the Pathogenic Influenza A/Goose/Guangdong/1/96 (H5N1) Virus: Similarity of Its Hemagglutinin Gene to Those of H5N1 Viruses from the 1997 Outbreaks in Hong Kong,"[['Xiyan', '', 'Xu'], ['Kanta', '', 'Subbarao'], ['Nancy', 'J.', 'Cox'], ['Yuanji', '', 'Guo']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299998203', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299998203']"
10.1038/303041a0,"ZHOU, N., SENNE, D., LANDGRAF, J., et. al, Genetic Reassortment of Avian, Swine, and Human Influenza A Viruses in American Pigs, , 1999",cited-by,"5506799Genetic Reassortment of Avian, Swine, and Human Influenza A Viruses in American Pigs","Genetic Reassortment of Avian, Swine, and Human Influenza A Viruses in American Pigs","[['NAN', 'NAN', 'ZHOU'], ['DENNIS', 'A.', 'SENNE'], ['JOHN', 'S.', 'LANDGRAF'], ['SABRINA', 'L.', 'SWENSON'], ['GENE', '', 'ERICKSON'], ['KURT', '', 'ROSSOW'], ['LIN', '', 'LIU'], ['KYOUNG-JIN', '', 'YOON'], ['SCOTT', '', 'KRAUSS'], ['ROBERT', 'G.', 'WEBSTER']]",,1999,"[u'http://birdflubook.com/resources/ZHOU8851.pdf', u'http://jvi.asm.org/cgi/reprint/73/10/8851.pdf']"
10.1038/303041a0,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1038/303041a0,"Russell, R., Haire, L., Stevens, D., et. al, The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design, Nature, 2006",cited-by,10.1038/nature05114,The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design,"[['Rupert', 'J.', 'Russell'], ['Lesley', 'F.', 'Haire'], ['David', 'J.', 'Stevens'], ['Patrick', 'J.', 'Collins'], ['Yi', 'Pu', 'Lin'], ['G.', 'Michael', 'Blackburn'], ['Alan', 'J.', 'Hay'], ['Steven', 'J.', 'Gamblin'], ['John', 'J.', 'Skehel']]",Nature,2006,"[u'http://www.nature.com/doifinder/10.1038/nature05114', u'http://dx.doi.org/10.1038/nature05114']"
10.1038/303041a0,"Ghedin, E., Sengamalay, N., Shumway, M., et. al, Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution, Nature, 2005",cited-by,10.1038/nature04239,Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution,"[['Elodie', '', 'Ghedin'], ['Naomi', 'A.', 'Sengamalay'], ['Martin', '', 'Shumway'], ['Jennifer', '', 'Zaborsky'], ['Tamara', '', 'Feldblyum'], ['Vik', '', 'Subbu'], ['David', 'J.', 'Spiro'], ['Jeff', '', 'Sitz'], ['Hean', '', 'Koo'], ['Pavel', '', 'Bolotov'], ['Dmitry', '', 'Dernovoy'], ['Tatiana', '', 'Tatusova'], ['Yiming', '', 'Bao'], ['Kirsten', 'St', 'George'], ['Jill', '', 'Taylor'], ['Claire', 'M.', 'Fraser'], ['Jeffery', 'K.', 'Taubenberger'], ['Steven', 'L.', 'Salzberg']]",Nature,2005,"[u'http://www.vcu.edu/csbc/bnfo420/papers_10/large_scale.pdf', u'http://www.nature.com/doifinder/10.1038/nature04239', u'http://www.ccbb.pitt.edu/bbsi/2008/jc_paper/khana.pdf', u'http://microvet.arizona.edu/courses/mic438/influenza%20sequencing%20.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/58.pdf', u'http://gen677.weebly.com/uploads/8/6/5/7/865764/ghedin2005.pdf', u'http://dx.doi.org/10.1038/nature04239', u'http://adsabs.harvard.edu/abs/2005Natur.437.1162G']"
10.1038/303041a0,"Holmes, E., Ghedin, E., Miller, N., et. al, Whole-Genome Analysis of Human Influenza A Virus Reveals Multiple Persistent Lineages and Reassortment among Recent H3N2 Viruses, PLOS Biology, 2005",cited-by,10.1371/journal.pbio.0030300.st002,Whole-Genome Analysis of Human Influenza A Virus Reveals Multiple Persistent Lineages and Reassortment among Recent H3N2 Viruses,"[['Edward', 'C.', 'Holmes'], ['Elodie', '', 'Ghedin'], ['Naomi', '', 'Miller'], ['Jill', '', 'Taylor'], ['Yiming', '', 'Bao'], ['Kirsten', 'St.', 'George'], ['Bryan', 'T.', 'Grenfell'], ['Steven', 'L.', 'Salzberg'], ['Claire', 'M.', 'Fraser'], ['Jeffery', 'K.', 'Taubenberger']]",PLOS Biology,2005,"[u'http://cbcb.umd.edu/papers/PLoS_influenza_reprint.pdf', u'http://biology.plosjournals.org/perlserv/?request=get-document&doi=10.1371%2Fjournal.pbio.0030300', u'http://www.plosbiology.org/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pbio.0030300.sg001', u'http://www.plosbiology.org/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pbio.0030300.st001', u'http://www.plosbiology.org/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pbio.0030300.st002']"
10.1038/303041a0,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']"
10.1038/303041a0,"Varghese, J., McKimm-Breschkin, J., Caldwell, J., et. al, The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor, Proteins-structure Function and Bioinformatics, 1992",cited-by,10.1002/prot.340140302,"The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor","[['Joseph', 'N.', 'Varghese'], ['Jennifer', 'L.', 'McKimm-Breschkin'], ['James', 'B.', 'Caldwell'], ['Alexander', 'A.', 'Kortt'], ['Peter', 'M.', 'Colman']]",Proteins-structure Function and Bioinformatics,1992,[u'http://doi.wiley.com/10.1002/prot.340140302']
10.1038/303041a0,"Asano, N., , Glycosidase inhibitors: update and perspectives on practical use, Glycobiology, 2003",cited-by,10.1093/glycob/cwg090,Glycosidase inhibitors: update and perspectives on practical use,"[['Naoki', '', 'Asano']]",Glycobiology,2003,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwg090v1.pdf', u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/cwg090']"
10.1038/303041a0,"Air, G., Laver, W., , The neuraminidase of influenza virus, Proteins-structure Function and Bioinformatics, 1989",cited-by,10.1002/prot.340060402,The neuraminidase of influenza virus,"[['Gillian', 'M.', 'Air'], ['W.', 'Graeme', 'Laver']]",Proteins-structure Function and Bioinformatics,1989,[u'http://doi.wiley.com/10.1002/prot.340060402']
10.1038/303041a0,"KATZ, J., LU, X., TUMPEY, T., et. al, Molecular Correlates of Influenza A H5N1 Virus Pathogenesis in Mice, Journal of Virology, 2000",cited-by,10.1128/JVI.74.22.10807-10810.2000,Molecular Correlates of Influenza A H5N1 Virus Pathogenesis in Mice,"[['JACQUELINE', 'M.', 'KATZ'], ['XIUHUA', '', 'LU'], ['TERRENCE', 'M.', 'TUMPEY'], ['CATHERINE', 'B.', 'SMITH'], ['MICHAEL', 'W.', 'SHAW'], ['KANTA', '', 'SUBBARAO']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/22/10807.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.22.10807-10810.2000']"
10.1038/303041a0,"GUBAREVA, L., BETHELL, R., HART, G., et. al, Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en, , 1996",cited-by,6119882Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en,Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en,"[['L.', 'V.', 'GUBAREVA'], ['R.', '', 'BETHELL'], ['G.', 'J.', 'HART'], ['K.', 'G.', 'MURTI'], ['C.', 'R.', 'PENN'], ['ANDR.', 'G.', 'WEBSTER']]",,1996,[u'http://jvi.asm.org/cgi/reprint/70/3/1818.pdf']
10.1038/303041a0,"Colman, P., , Influenza virus neuraminidase: Structure, antibodies, and inhibitors, Protein Science, 1994",cited-by,10.1002/pro.5560031007,"Influenza virus neuraminidase: Structure, antibodies, and inhibitors","[['P.', 'M.', 'Colman']]",Protein Science,1994,[u'http://doi.wiley.com/10.1002/pro.5560031007']
10.1038/303041a0,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
10.1038/303041a0,"Varghese, J., Smith, P., Sollis, S., et. al, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, Structure, 1998",cited-by,10.1016/S0969-2126(98)00075-6,Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase,"[['Joseph', 'N', 'Varghese'], ['Paul', 'W', 'Smith'], ['Steven', 'L', 'Sollis'], ['Tony', 'J', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Jennifer', 'L', 'McKimm-Breschkin'], ['Peter', 'M', 'Colman']]",Structure,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0969212698000756', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212698000756']"
10.1038/303041a0,"Lawrence, M., Borg, N., Streltsov, V., et. al, Structure of the Haemagglutinin-neuraminidase from Human Parainfluenza Virus Type III, Journal of Molecular Biology, 2004",cited-by,10.1016/j.jmb.2003.11.032,Structure of the Haemagglutinin-neuraminidase from Human Parainfluenza Virus Type III,"[['Michael', 'C.', 'Lawrence'], ['Natalie', 'A.', 'Borg'], ['Victor', 'A.', 'Streltsov'], ['Patricia', 'A.', 'Pilling'], ['V.', 'Chandana', 'Epa'], ['Joseph', 'N.', 'Varghese'], ['Jennifer', 'L.', 'McKimm-Breschkin'], ['Peter', 'M.', 'Colman']]",Journal of Molecular Biology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S002228360301444X', u'http://linkinghub.elsevier.com/retrieve/pii/S002228360301444X']"
10.1038/303041a0,"ZHOU, N., SHORTRIDGE, K., CLAAS, E., et. al, Rapid Evolution of H5N1 Influenza Viruses in Chickens in Hong Kong, , 1999",cited-by,5509512Rapid Evolution of H5N1 Influenza Viruses in Chickens in Hong Kong,Rapid Evolution of H5N1 Influenza Viruses in Chickens in Hong Kong,"[['NAN', 'NAN', 'ZHOU'], ['KENNEDY', 'F.', 'SHORTRIDGE'], ['ERIC', 'C. J.', 'CLAAS'], ['SCOTT', 'L.', 'KRAUSS'], ['ROBERT', 'G.', 'WEBSTER']]",,1999,"[u'http://birdflubook.com/resources/0ZHOU3366.pdf', u'http://jvi.asm.org/cgi/reprint/73/4/3366.pdf']"
10.1038/303041a0,"Morris, S., Price, G., Barnett, J., et. al, Role of neuraminidase in influenza virus-induced apoptosis, , 1999",cited-by,6297657Role of neuraminidase in influenza virus-induced apoptosis,Role of neuraminidase in influenza virus-induced apoptosis,"[['Susan', 'J.', 'Morris'], ['Graeme', 'E.', 'Price'], ['Jacqueline', 'M.', 'Barnett'], ['Steven', 'A.', 'Hiscox'], ['Harry', '', 'Smith'], ['Clive', '', 'Sweet']]",,1999,[u'http://vir.sgmjournals.org/cgi/reprint/80/1/137.pdf']
10.1038/303041a0,"Itzstein, M., , The war against influenza: discovery and development of sialidase inhibitors, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2400,The war against influenza: discovery and development of sialidase inhibitors,"[['Mark', 'von', 'Itzstein']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2400', u'http://www.nature.com/doifinder/10.1038/nrd2400']"
10.1038/303041a0,"Lindstrom, S., Cox, N., Klimov, A., , Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957–1972: evidence for genetic divergence and multiple reassortment events, Virology, 2004",cited-by,10.1016/j.virol.2004.06.009,"Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957–1972: evidence for genetic divergence and multiple reassortment events","[['Stephen', 'E.', 'Lindstrom'], ['Nancy', 'J.', 'Cox'], ['Alexander', '', 'Klimov']]",Virology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0042682204003939', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682204003939']"
10.1038/303041a0,"Varghese, J., Epa, V., Colman, P., , Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase, Protein Science, 2008",cited-by,10.1002/pro.5560040606,Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase,"[['Joseph', 'N.', 'Varghese'], ['V.', 'Chandana', 'Epa'], ['Peter', 'M.', 'Colman']]",Protein Science,2008,[u'http://doi.wiley.com/10.1002/pro.5560040606']
10.1038/303041a0,"Holzmann, H., Stiasny, K., Ecker, M., et. al, Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice, , 1997",cited-by,6745846Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice,Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice,"[['Heidemarie', '', 'Holzmann'], ['Karin', '', 'Stiasny'], ['Michael', '', 'Ecker'], ['Christian', '', 'Kun'], ['Franz', 'X.', 'Heinz']]",,1997,[u'http://vir.sgmjournals.org/cgi/reprint/78/1/31.pdf']
10.1038/303041a0,", Antiviral Management of Seasonal and Pandemic Influenza, Journal of Infectious Diseases, 2006",cited-by,10.1086/507552,Antiviral Management of Seasonal and Pandemic Influenza,[],Journal of Infectious Diseases,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/507552']
10.1038/303041a0,"Reid, A., Taubenberger, J., Fanning, T., , The 1918 Spanish influenza:integrating history and biology, Microbes and Infection, 2001",cited-by,10.1016/S1286-4579(00)01351-4,The 1918 Spanish influenza:integrating history and biology,"[['Ann', 'H.', 'Reid'], ['Jeffery', 'K.', 'Taubenberger'], ['Thomas', 'G.', 'Fanning']]",Microbes and Infection,2001,"[u'http://birdflubook.com/resources/reid81.pdf', u'http://www.sciencedirect.com/science/article/pii/S1286457900013514', u'http://birdflubook.org/resources/reid81.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-18.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457900013514']"
10.1038/303041a0,"Lentz, T., , The recognition event between virus and host cell receptor: a target for antiviral agents, Journal of General Virology, 1990",cited-by,10.1099/0022-1317-71-4-751,The recognition event between virus and host cell receptor: a target for antiviral agents,"[['Thomas', 'L.', 'Lentz']]",Journal of General Virology,1990,"[u'http://vir.sgmjournals.org/cgi/reprint/71/4/751.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-71-4-751']"
10.1038/303041a0,"Ferraris, O., Lina, B., , Mutations of neuraminidase implicated in neuraminidase inhibitors resistance, Journal of Clinical Virology, 2008",cited-by,10.1016/j.jcv.2007.10.020,Mutations of neuraminidase implicated in neuraminidase inhibitors resistance,"[['Olivier', '', 'Ferraris'], ['Bruno', '', 'Lina']]",Journal of Clinical Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1386653207003903', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653207003903']"
10.1038/303041a0,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']"
10.1038/303041a0,"Bouvier, N., Palese, P., , The biology of influenza viruses, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.07.039,The biology of influenza viruses,"[['Nicole', 'M.', 'Bouvier'], ['Peter', '', 'Palese']]",Vaccine,2008,"[u'http://www3.botany.ubc.ca/biol430/influenza%20biology.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X08009377', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08009377']"
10.1038/303041a0,"Gregory, V., Bennett, M., Orkhan, M., et. al, Emergence of Influenza A H1N2 Reassortant Viruses in the Human Population during 2001, Virology, 2002",cited-by,10.1006/viro.2002.1513,Emergence of Influenza A H1N2 Reassortant Viruses in the Human Population during 2001,"[['V.', '', 'Gregory'], ['M.', '', 'Bennett'], ['M.', 'H.', 'Orkhan'], ['S.', 'Al', 'Hajjar'], ['N.', '', 'Varsano'], ['E.', '', 'Mendelson'], ['M.', '', 'Zambon'], ['J.', '', 'Ellis'], ['A.', '', 'Hay'], ['Y.', 'P.', 'Lin']]",Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0042682202915138', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682202915138']"
10.1038/303041a0,"Johansson, B., Matthews, J., Kilbourne, E., , Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response, Vaccine, 1998",cited-by,10.1016/S0264-410X(97)00279-X,Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response,"[['Bert', 'E.', 'Johansson'], ['James', 'T.', 'Matthews'], ['Edwin', 'D.', 'Kilbourne']]",Vaccine,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X9700279X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X9700279X']"
10.1038/303041a0,"Chambers, P., Pringle, C., Easton, A., , Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins, Journal of General Virology, 1992",cited-by,10.1099/0022-1317-73-7-1717,Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins,"[['Philip', '', 'Chambers'], ['Craig', 'R.', 'Pringle'], ['Andrew', 'J.', 'Easton']]",Journal of General Virology,1992,"[u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-73-7-1717', u'http://vir.sgmjournals.org/cgi/reprint/73/7/1717.pdf']"
10.1038/303041a0,"Dunham, E., Dugan, V., Kaser, E., et. al, Different Evolutionary Trajectories of European Avian-Like and Classical Swine H1N1 Influenza A Viruses, Journal of Virology, 2009",cited-by,10.1128/JVI.02565-08,Different Evolutionary Trajectories of European Avian-Like and Classical Swine H1N1 Influenza A Viruses,"[['Eleca', 'J.', 'Dunham'], ['Vivien', 'G.', 'Dugan'], ['Emilee', 'K.', 'Kaser'], ['Sarah', 'E.', 'Perkins'], ['Ian', 'H.', 'Brown'], ['Edward', 'C.', 'Holmes'], ['Jeffery', 'K.', 'Taubenberger']]",Journal of Virology,2009,"[u'http://www.ctcd.edu/science/tanderson/documents/EvolutionaryH1N1.pdf', u'http://virion.ucsd.edu/JClub/Jclub2009-05-01.pdf', u'http://jvi.asm.org/cgi/reprint/83/11/5485.pdf', u'http://168.160.60.201/zlg/kjwx/wwwx/200905/P020090501322098272331.pdf', u'http://jvi.asm.org/cgi/reprint/JVI.02565-08v1.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02565-08']"
10.1038/303041a0,"Moscona, A., , Medical Management of Influenza Infection, Annual Review of Medicine, 2008",cited-by,10.1146/annurev.med.59.061506.213121,Medical Management of Influenza Infection,"[['Anne', '', 'Moscona']]",Annual Review of Medicine,2008,"[u'http://www.cornellpediatrics.org/bm~doc/medical-management-of-inf.pdf', u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.med.59.061506.213121']"
10.1038/303041a0,"Knossow, M., Skehel, J., , Variation and infectivity neutralization in influenza, Immunology, 2006",cited-by,10.1111/j.1365-2567.2006.02421.x,Variation and infectivity neutralization in influenza,"[['Marcel', '', 'Knossow'], ['John', 'J.', 'Skehel']]",Immunology,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2567.2006.02421.x']
10.1038/303041a0,"Yen, H., Hoffmann, E., Taylor, G., et. al, Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses, Journal of Virology, 2006",cited-by,10.1128/JVI.00477-06,Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses,"[['Hui-Ling', '', 'Yen'], ['Erich', '', 'Hoffmann'], ['Garry', '', 'Taylor'], ['Christoph', '', 'Scholtissek'], ['Arnold', 'S.', 'Monto'], ['Robert', 'G.', 'Webster'], ['Elena', 'A.', 'Govorkova']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00477-06', u'http://jvi.asm.org/cgi/reprint/80/17/8787.pdf']"
10.1038/303041a0,"Amano, Y., Cheng, Q., , Detection of influenza virus: traditional approaches and development of biosensors, Analytical and Bioanalytical Chemistry, 2005",cited-by,10.1007/s00216-004-2927-0,Detection of influenza virus: traditional approaches and development of biosensors,"[['Yoshihisa', '', 'Amano'], ['Quan', '', 'Cheng']]",Analytical and Bioanalytical Chemistry,2005,"[u'http://www.springerlink.com/content/rp5371unktklm597', u'http://www.springerlink.com/index/rp5371unktklm597.pdf', u'http://www.springerlink.com/index/10.1007/s00216-004-2927-0', u'http://www.springerlink.com/index/pdf/10.1007/s00216-004-2927-0']"
10.1038/303041a0,"Elinav, E., Strowig, T., Henao-Mejia, J., et. al, NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis, Cell, 2011",cited-by,10.1016/j.cell.2011.04.022,NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis,"[['Eran', '', 'Elinav'], ['Till', '', 'Strowig'], ['Jorge', '', 'Henao-Mejia'], ['John', '', 'Bertin']]",Cell,2011,[u'http://www.sciencedirect.com/science/article/pii/S0092867411004806']
10.1038/303041a0,"Knossow, M., Daniels, R., Douglas, A., et. al, Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin, Nature, 1984",cited-by,10.1038/311678a0,Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin,"[['M.', '', 'Knossow'], ['R.', 'S.', 'Daniels'], ['A.', 'R.', 'Douglas'], ['J.', 'J.', 'Skehel'], ['D.', 'C.', 'Wiley']]",Nature,1984,"[u'http://www.nature.com/doifinder/10.1038/311678a0', u'http://adsabs.harvard.edu/abs/1984Natur.311..678K']"
10.1038/303041a0,"Bragstad, K., Nielsen, L., Fomsgaard, A., , The evolution of human influenza A viruses from 1999 to 2006: A complete genome study, Virology Journal, 2008",cited-by,10.1186/1743-422X-5-40,The evolution of human influenza A viruses from 1999 to 2006: A complete genome study,"[['Karoline', '', 'Bragstad'], ['Lars', 'P', 'Nielsen'], ['Anders', '', 'Fomsgaard']]",Virology Journal,2008,"[u'http://www.springerlink.com/index/6l373r1082660773.pdf', u'http://www.biomedcentral.com/content/pdf/1743-422X-5-40.pdf', u'http://www.springerlink.com/content/6l373r1082660773', u'http://www.virologyj.com/content/5/1/40']"
10.1038/303041a0,"BANTIA, S., GHATE, A., ANANTH, S., et. al, Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140, , 1998",cited-by,13869212Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140,Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140,"[['SHANTA', '', 'BANTIA'], ['ANITA', 'A.', 'GHATE'], ['SANDYA', 'L.', 'ANANTH'], ['Y.', 'SUDHAKAR', 'BABU'], ['GILLIAN', 'M.', 'AIR'], ['GERALD', 'M.', 'WALSH']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/4/801.pdf']
10.1038/303041a0,"Fanning, T., Reid, A., Taubenberger, J., , Influenza A Virus Neuraminidase: Regions of the Protein Potentially Involved in Virus–Host Interactions, Virology, 2000",cited-by,10.1006/viro.2000.0578,Influenza A Virus Neuraminidase: Regions of the Protein Potentially Involved in Virus–Host Interactions,"[['Thomas', 'G.', 'Fanning'], ['Ann', 'H.', 'Reid'], ['Jeffery', 'K.', 'Taubenberger']]",Virology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0042682200905786', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682200905786']"
10.1038/303041a0,"Noah, D., Krug, R., , Influenza Virus Virulence and Its Molecular Determinants, Advances in Virus Research, 2005",cited-by,10.1016/S0065-3527(05)65004-X,Influenza Virus Virulence and Its Molecular Determinants,"[['Diana', 'L.', 'Noah'], ['Robert', 'M.', 'Krug']]",Advances in Virus Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S006535270565004X', u'http://linkinghub.elsevier.com/retrieve/pii/S006535270565004X']"
10.1038/303041a0,"Bouvier, N., Lowen, A., Palese, P., , Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol, Journal of Virology, 2008",cited-by,10.1128/JVI.01226-08,Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol,"[['Nicole', 'M.', 'Bouvier'], ['Anice', 'C.', 'Lowen'], ['Peter', '', 'Palese']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10052.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01226-08']"
10.1038/303041a0,"Shibasaki, M., Kanai, M., , Synthetic Strategies for Oseltamivir Phosphate, European Journal of Organic Chemistry, 2008",cited-by,10.1002/ejoc.200800033,Synthetic Strategies for Oseltamivir Phosphate,"[['Masakatsu', '', 'Shibasaki'], ['Motomu', '', 'Kanai']]",European Journal of Organic Chemistry,2008,[u'http://doi.wiley.com/10.1002/ejoc.200800033']
10.1038/303041a0,"Markussen, T., Jonassen, C., Numanovic, S., et. al, Evolutionary mechanisms involved in the virulence of infectious salmon anaemia virus (ISAV), a piscine orthomyxovirus, Virology, 2008",cited-by,10.1016/j.virol.2008.01.019,"Evolutionary mechanisms involved in the virulence of infectious salmon anaemia virus (ISAV), a piscine orthomyxovirus","[['Turhan', '', 'Markussen'], ['Christine', 'Monceyron', 'Jonassen'], ['Sanela', '', 'Numanovic'], ['Stine', '', 'Braaen'], ['Monika', '', 'Hjortaas'], ['Hanne', '', 'Nilsen'], ['Siri', '', 'Mjaaland']]",Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0042682208000123', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682208000123', u'http://www.osti.gov/servlets/purl/21140987']"
10.1038/303041a0,"Oxford, J., Bossuyt, S., Balasingam, S., et. al, Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors, Clinical Microbiology and Infection, 2003",cited-by,10.1046/j.1469-0691.2003.00564.x,Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors,"[['J.', 'S.', 'Oxford'], ['S.', '', 'Bossuyt'], ['S.', '', 'Balasingam'], ['A.', '', 'Mann'], ['P.', '', 'Novelli'], ['R.', '', 'Lambkin']]",Clinical Microbiology and Infection,2003,"[u'http://birdflubook.com/resources/Oxford1.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1469-0691.2003.00564.x']"
10.1038/303041a0,"Varghese, J., , Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Development Research, 1999",cited-by,10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6,Development of neuraminidase inhibitors as anti-influenza virus drugs,"[['Joseph', 'N.', 'Varghese']]",Drug Development Research,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291098-2299%28199903/04%2946%3A3/4%3C176%3A%3AAID-DDR4%3E3.0.CO%3B2-6']
10.1038/303041a0,"Goto, H., Bethell, R., Kawaoka, Y., , Mutations Affecting the Sensitivity of the Influenza Virus Neuraminidase to 4Guanidino2,4-dideoxy-2,3-dehydro- N-acetylneuraminic Acid, Virology, 1997",cited-by,10.1006/viro.1997.8810,"Mutations Affecting the Sensitivity of the Influenza Virus Neuraminidase to 4Guanidino2,4-dideoxy-2,3-dehydro- N-acetylneuraminic Acid","[['Hideo', '', 'Goto'], ['Richard', 'C', 'Bethell'], ['Yoshihiro', '', 'Kawaoka']]",Virology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0042682297988103', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682297988103']"
10.1038/303041a0,"AYEB, M., DARBON, H., BAHRAOUI, E., et. al, Differential effects of defined chemical modifications on antigenic and pharmacological activities of scorpion alpha and beta toxins, European Journal of Biochemistry, 1986",cited-by,10.1111/j.1432-1033.1986.tb09488.x,Differential effects of defined chemical modifications on antigenic and pharmacological activities of scorpion alpha and beta toxins,"[['Mohamed', 'EL', 'AYEB'], ['Herve', '', 'DARBON'], ['El', 'Mostafa', 'BAHRAOUI'], ['Orietta', '', 'VARGAS'], ['Herve', '', 'ROCHAT']]",European Journal of Biochemistry,1986,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1432-1033.1986.tb09488.x']
10.1038/303041a0,"Likos, A., Kelvin, D., Cameron, C., et. al, Influenza viremia and the potential for blood-borne transmission, Transfusion, 2007",cited-by,10.1111/j.1537-2995.2007.01264.x,Influenza viremia and the potential for blood-borne transmission,"[['Anna', 'M.', 'Likos'], ['David', 'J.', 'Kelvin'], ['Cheryl', 'M.', 'Cameron'], ['Thomas', '', 'Rowe'], ['Matthew', 'J.', 'Kuehnert'], ['Philip', 'J.', 'Norris']]",Transfusion,2007,"[u'http://www.mhlw.go.jp/shingi/2009/12/dl/s1210-8i08.pdf', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1537-2995.2007.01264.x']"
10.1038/303041a0,"Paris, G., Cremona, M., Amaya, M., et. al, Probing molecular function of trypanosomal sialidases: single point mutations can change substrate specificity and increase hydrolytic activity, Glycobiology, 2001",cited-by,10.1093/glycob/11.4.305,Probing molecular function of trypanosomal sialidases: single point mutations can change substrate specificity and increase hydrolytic activity,"[['Gaston', '', 'Paris'], ['M', 'aria Laura', 'Cremona'], ['M', 'aria Fernanda', 'Amaya'], ['Alejandro', '', 'Buschiazzo'], ['Susana', '', 'Giambiagi'], ['Alberto', 'C. C.', 'Frasch'], ['Pedro', 'M.', 'Alzari']]",Glycobiology,2001,[u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/11.4.305']
10.1038/303041a0,"Nurizzo, D., Silvestrini, M., Mathieu, M., et. al, N-terminal arm exchange is observed in the 2.15 Å crystal structure of oxidized nitrite reductase from Pseudomonas aeruginosa, Structure, 1997",cited-by,10.1016/S0969-2126(97)00267-0,N-terminal arm exchange is observed in the 2.15 Å crystal structure of oxidized nitrite reductase from Pseudomonas aeruginosa,"[['Didier', '', 'Nurizzo'], ['Maria-Chiara', '', 'Silvestrini'], ['Magali', '', 'Mathieu'], ['Francesca', '', 'Cutruzzol\xc3\xa0'], ['Dominique', '', 'Bourgeois'], ['Vilmos', '', 'F\xc3\xbcl\xc3\xb6p'], ['Janos', '', 'Hajdu'], ['Maurizio', '', 'Brunori'], ['Mariella', '', 'Tegoni'], ['Christian', '', 'Cambillau']]",Structure,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0969212697002670', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212697002670']"
10.1038/303041a0,"Hung, H., Tseng, C., Yang, J., et. al, Aurintricarboxylic acid inhibits influenza virus neuraminidase, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.006,Aurintricarboxylic acid inhibits influenza virus neuraminidase,"[['Hui-Chen', '', 'Hung'], ['Ching-Ping', '', 'Tseng'], ['Jinn-Moon', '', 'Yang'], ['Yi-Wei', '', 'Ju'], ['Sung-Nain', '', 'Tseng'], ['Yen-Fu', '', 'Chen'], ['Yu-Sheng', '', 'Chao'], ['Hsing-Pang', '', 'Hsieh'], ['Shin-Ru', '', 'Shih'], ['John', 'T.-A.', 'Hsu']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004300', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004300']"
10.1038/303041a0,"Wu, G., Yan, S., , Prediction of mutation trend in hemagglutinins and neuraminidases from influenza A viruses by means of cross-impact analysis, Biochemical and Biophysical Research Communications, 2005",cited-by,10.1016/j.bbrc.2004.11.052,Prediction of mutation trend in hemagglutinins and neuraminidases from influenza A viruses by means of cross-impact analysis,"[['Guang', '', 'Wu'], ['Shaomin', '', 'Yan']]",Biochemical and Biophysical Research Communications,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0006291X0402618X', u'http://linkinghub.elsevier.com/retrieve/pii/S0006291X0402618X']"
10.1038/303041a0,"Guo, C., Sun, X., Kanie, O., et. al, An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses, Glycobiology, 2002",cited-by,10.1093/glycob/12.3.183,An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses,"[['Chao-Tan', '', 'Guo'], ['Xue-Long', '', 'Sun'], ['Osamu', '', 'Kanie'], ['Kennedy', 'Francis', 'Shortridge'], ['Takashi', '', 'Suzuki'], ['Daisei', '', 'Miyamoto'], ['Kazuya', 'I.-P. Jwa', 'Hidari'], ['Chi-Huey', '', 'Wong'], ['Yasuo', '', 'Suzuki']]",Glycobiology,2002,[u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/12.3.183']
10.1038/303041a0,"Pond, S., Poon, A., Brown, A., et. al, A Maximum Likelihood Method for Detecting Directional Evolution in Protein Sequences and Its Application to Influenza A Virus, Molecular Biology and Evolution, 2008",cited-by,10.1093/molbev/msn123,A Maximum Likelihood Method for Detecting Directional Evolution in Protein Sequences and Its Application to Influenza A Virus,"[['Sergei', 'L. Kosakovsky', 'Pond'], ['A.', 'F. Y.', 'Poon'], ['Andrew', 'J. Leigh', 'Brown'], ['Simon', 'D. W.', 'Frost']]",Molecular Biology and Evolution,2008,"[u'http://homepages.ed.ac.uk/eang09/AJLB.Publications.(.pdf.files)/Kosakovsky_Pond_SL_etal_2008_DEPS_MBE.pdf', u'http://mbe.oxfordjournals.org/cgi/reprint/25/9/1809.pdf', u'http://mbe.oxfordjournals.org/cgi/doi/10.1093/molbev/msn123']"
10.1038/303041a0,"Colman, P., , Virus versus antibody, Structure, 1997",cited-by,10.1016/S0969-2126(97)00214-1,Virus versus antibody,"[['PM', '', 'Colman']]",Structure,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0969212697002141', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212697002141']"
10.1038/303041a0,"Aramini, J., Ma, L., Krug, R., et. al, Structures of influenza A proteins and insights into antiviral drug targets, Nature Structural & Molecular Biology, 2010",cited-by,10.1038/nsmb.1779,Structures of influenza A proteins and insights into antiviral drug targets,"[['James', 'M', 'Aramini'], ['Li-Chung', '', 'Ma'], ['Robert', 'M', 'Krug'], ['Eddy', '', 'Arnold'], ['Kalyan', '', 'Das']]",Nature Structural & Molecular Biology,2010,"[u'http://www.nature.com/doifinder/10.1038/nsmb.1779', u'http://dx.doi.org/10.1038/nsmb.1779']"
10.1038/303041a0,"Collins, P., Haire, L., Lin, Y., et. al, Structural basis for oseltamivir resistance of influenza viruses, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.07.017,Structural basis for oseltamivir resistance of influenza viruses,"[['P.', 'J.', 'Collins'], ['L.', 'F.', 'Haire'], ['Y.', 'P.', 'Lin'], ['J.', '', 'Liua'], ['R.', 'J.', 'Russell'], ['P.', 'A.', 'Walker'], ['S.', 'R.', 'Martin'], ['R.', 'S.', 'Daniels'], ['V.', '', 'Gregory'], ['J.', 'J.', 'Skehel'], ['S.', 'J.', 'Gamblin'], ['A.', 'J.', 'Hay']]",Vaccine,2009,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-51.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X09010299', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-53.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09010299']"
10.1038/303041a0,"Li, Y., Li, C., Liu, L., et. al, Characterization of An Avian Influenza Virus of Subtype H7N2 Isolated from Chickens in Northern China, Virus Genes, 2006",cited-by,10.1007/s11262-005-0042-8,Characterization of An Avian Influenza Virus of Subtype H7N2 Isolated from Chickens in Northern China,"[['Yanbing', '', 'Li'], ['Chengjun', '', 'Li'], ['Liling', '', 'Liu'], ['Hongwei', '', 'Wang'], ['Chuanbin', '', 'Wang'], ['Guobing', '', 'Tian'], ['Robert', 'G.', 'Webster'], ['Kangzhen', '', 'Yu'], ['Hualan', '', 'Chen']]",Virus Genes,2006,"[u'http://www.springerlink.com/content/034207281w65g036', u'http://www.springerlink.com/index/034207281w65g036.pdf', u'http://www.springerlink.com/index/10.1007/s11262-005-0042-8', u'http://www.springerlink.com/index/pdf/10.1007/s11262-005-0042-8']"
10.1038/303041a0,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']"
10.1038/303041a0,"Taubenberger, J., , The virulence of the 1918 pandemic influenza virus: unraveling the enigma, , 0",cited-by,10.1007/3-211-29981-5_9,The virulence of the 1918 pandemic influenza virus: unraveling the enigma,"[['J.', 'K.', 'Taubenberger']]",,0,"[u'http://www.springerlink.com/content/nt45442057g28674', u'http://www.springerlink.com/index/nt45442057g28674.pdf']"
10.1038/303041a0,"MARU, I., OHNISHI, J., OHTA, Y., et. al, Why Is Sialic Acid Attracting Interest Now? Complete Enzymatic Synthesis of Sialic Acid with N-Acylglucosamine 2Epimerase, Journal of Bioscience and Bioengineering, 2002",cited-by,10.1263/jbb.93.258,Why Is Sialic Acid Attracting Interest Now? Complete Enzymatic Synthesis of Sialic Acid with N-Acylglucosamine 2Epimerase,"[['ISAFUMI', '', 'MARU'], ['JUN', '', 'OHNISHI'], ['YASUHIRO', '', 'OHTA'], ['YOJI', '', 'TSUKADA']]",Journal of Bioscience and Bioengineering,2002,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/jbb/93.258?from=CrossRef']
10.1038/303041a0,"Sullivan, B., Carrera, I., Drouin, M., et. al, Symmetry-Based Design for the Chemoenzymatic Synthesis of Oseltamivir (Tamiflu) from Ethyl Benzoate, Angewandte Chemie-international Edition, 2009",cited-by,10.1002/anie.200901345,Symmetry-Based Design for the Chemoenzymatic Synthesis of Oseltamivir (Tamiflu) from Ethyl Benzoate,"[['Bradford', '', 'Sullivan'], ['Ignacio', '', 'Carrera'], ['Melissa', '', 'Drouin'], ['Tomas', '', 'Hudlicky']]",Angewandte Chemie-international Edition,2009,"[u'http://www.brocku.ca/chemistry/faculty/Hudlicky/ACIE-2009,48,23,4229-4231.pdf', u'http://doi.wiley.com/10.1002/anie.200901345']"
10.1038/303041a0,"Young, A., , Structural insights into the clathrin coat, Seminars in Cell & Developmental Biology, 2007",cited-by,10.1016/j.semcdb.2007.07.006,Structural insights into the clathrin coat,"[['Anna', '', 'Young']]",Seminars in Cell & Developmental Biology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1084952107000961', u'http://linkinghub.elsevier.com/retrieve/pii/S1084952107000961']"
10.1038/303041a0,"Ellis, J., Alvarez-Aguero, A., Gregory, V., et. al, Influenza AH1N2 Viruses, United Kingdom, 2001-02 Influenza Season, , 2003",cited-by,"14264181Influenza AH1N2 Viruses, United Kingdom, 2001-02 Influenza Season","Influenza AH1N2 Viruses, United Kingdom, 2001-02 Influenza Season","[['Joanna', 'S.', 'Ellis'], ['Adriana', '', 'Alvarez-Aguero'], ['Vicky', '', 'Gregory'], ['Yi', 'Pu', 'Lin'], ['A.', '', 'Hay'], ['Maria', 'C.', 'Zambon']]",,2003,[u'http://www.cdc.gov/ncidod/EID/vol9no3/pdfs/02-0404.pdf']
10.1038/303041a0,"Seth, S., Shaila, M., , The hemagglutinin–neuraminidase protein of peste des petits ruminants virus is biologically active when transiently expressed in mammalian cells, Virus Research, 2001",cited-by,10.1016/S0168-1702(01)00238-6,The hemagglutinin–neuraminidase protein of peste des petits ruminants virus is biologically active when transiently expressed in mammalian cells,"[['Shaguna', '', 'Seth'], ['M.', 'S.', 'Shaila']]",Virus Research,2001,"[u'http://mcbl.iisc.ernet.in/Welcome%20to%20MCBL/Faculty/Shaila/publications/shaguna.pdf', u'http://www.sciencedirect.com/science/article/pii/S0168170201002386', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170201002386']"
10.1038/303041a0,", New Strategies for Protein Crystal Growth, Annual Review of Biomedical Engineering, 1999",cited-by,10.1146/annurev.bioeng.1.1.505,New Strategies for Protein Crystal Growth,[],Annual Review of Biomedical Engineering,1999,[u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.bioeng.1.1.505']
10.1038/303041a0,"Seong, S., Park, S., Huh, M., et. al, Mapping of Antigenic Determinant Regions of the Bor56 Protein of Orientia tsutsugamushi, , 1997",cited-by,5554636Mapping of Antigenic Determinant Regions of the Bor56 Protein of Orientia tsutsugamushi,Mapping of Antigenic Determinant Regions of the Bor56 Protein of Orientia tsutsugamushi,"[['Seung-yong', '', 'Seong'], ['Sae-gwang', '', 'Park'], ['Myung-suk', '', 'Huh'], ['Won-jong', '', 'Jang'], ['Hang-rae', '', 'Kim'], ['Tae-hee', '', 'Han'], ['Myung-sik', '', 'Choi'], ['Woo-hyun', '', 'Chang'], ['Ik-sang', '', 'Kim']]",,1997,"[u'http://iai.asm.org/cgi/reprint/65/12/5250.pdf', u'http://iai.highwire.org/cgi/reprint/65/12/5250.pdf']"
10.1038/303041a0,"White, M., Adams, D., Murray, J., et. al, Characterization of scaled SONOS EEPROM memory devices for space and military systems, , 2004",cited-by,10.1109/NVMT.2004.1380804,Characterization of scaled SONOS EEPROM memory devices for space and military systems,"[['Marvin', 'H.', 'White'], ['Dennis', 'A.', 'Adams'], ['James', 'R.', 'Murray'], ['S.', '', 'Wrazien'], ['Yijie', '', 'Zhao'], ['Yu', '', 'Wang'], ['B.', '', 'Khan'], ['W.', '', 'Miller'], ['R.', '', 'Mehrotra']]",,2004,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1380804', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01380804']"
10.1038/303041a0,"Hausmann, J., Kretzschmar, E., Garten, W., et. al, Biosynthesis, intracellular transport and enzymatic activity of an avian influenza A virus neuraminidase: role of unpaired cysteines and individual oligosaccharides, , 1997",cited-by,"6593119Biosynthesis, intracellular transport and enzymatic activity of an avian influenza A virus neuraminidase: role of unpaired cysteines and individual oligosaccharides","Biosynthesis, intracellular transport and enzymatic activity of an avian influenza A virus neuraminidase: role of unpaired cysteines and individual oligosaccharides","[['J.', '', 'Hausmann'], ['E.', '', 'Kretzschmar'], ['W.', '', 'Garten'], ['H.-D.', '', 'Klenk']]",,1997,[u'http://vir.sgmjournals.org/cgi/reprint/78/12/3233.pdf']
10.1038/303041a0,"Smith, L., Uemura, H., Eichinger, D., , Isolation and expression of an open reading frame encoding sialidase from Trypanosoma rangeli, Molecular and Biochemical Parasitology, 1996",cited-by,10.1016/0166-6851(96)02634-5,Isolation and expression of an open reading frame encoding sialidase from Trypanosoma rangeli,"[['Lynne', 'E.', 'Smith'], ['Haruki', '', 'Uemura'], ['Daniel', '', 'Eichinger']]",Molecular and Biochemical Parasitology,1996,"[u'http://www.sciencedirect.com/science/article/pii/0166685196026345', u'http://linkinghub.elsevier.com/retrieve/pii/0166685196026345']"
10.1038/303041a0,"LaForce, C., Man, C., Henderson, F., et. al, Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial, Clinical Therapeutics, 2007",cited-by,10.1016/j.clinthera.2007.08.023,"Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","[['Craig', '', 'LaForce'], ['Choy', 'Y.', 'Man'], ['Frederick', 'W.', 'Henderson'], ['Janet', 'E.', 'McElhaney'], ['Frank', 'C.', 'Hampel'], ['Robert', '', 'Bettis'], ['Laila', '', 'Kudule'], ['Julia', '', 'Harris'], ['Philip', '', 'Yates'], ['Margaret', '', 'Tisdale'], ['Alison', '', 'Webster']]",Clinical Therapeutics,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0149291807002585', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291807002585']"
10.1038/303041a0,"Schreier, E., Roeske, H., Driesel, G., et. al, Complete nucleotide sequence of the neuraminidase gene of the human influenza virus A/Chile/1/83 (H1N1), Archives of Virology, 1988",cited-by,10.1007/BF01311076,Complete nucleotide sequence of the neuraminidase gene of the human influenza virus A/Chile/1/83 (H1N1),"[['E.', '', 'Schreier'], ['H.', '', 'Roeske'], ['G.', '', 'Driesel'], ['U.', '', 'K\xc3\xbcnkel'], ['D.', 'R.', 'Petzold'], ['R.', '', 'Berlinghoff'], ['S.', '', 'Michel']]",Archives of Virology,1988,"[u'http://www.springerlink.com/index/k160478l5j158123.pdf', u'http://www.springerlink.com/content/k160478l5j158123', u'http://www.springerlink.com/index/10.1007/BF01311076', u'http://www.springerlink.com/index/pdf/10.1007/BF01311076']"
10.1038/303041a0,"Patel, K., Pasternak, C., , Ca 2+ -sensitive permeability changes caused by influenza virus, Bioscience Reports, 1983",cited-by,10.1007/BF01120986,Ca 2+ -sensitive permeability changes caused by influenza virus,"[['Kalpana', '', 'Patel'], ['Charles', 'A.', 'Pasternak']]",Bioscience Reports,1983,"[u'http://www.springerlink.com/index/nlur51643wk73747.pdf', u'http://www.springerlink.com/content/nlur51643wk73747', u'http://www.bioscirep.org/bsr/003/bsr0030749.htm']"
10.1038/303041a0,"Malaisree, M., Rungrotmongkol, T., Nunthaboot, N., et. al, Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation, Amino Acids, 2009",cited-by,10.1007/s00726-008-0201-z,Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation,"[['Maturos', '', 'Malaisree'], ['Thanyada', '', 'Rungrotmongkol'], ['Nadtanet', '', 'Nunthaboot'], ['Ornjira', '', 'Aruksakunwong'], ['Pathumwadee', '', 'Intharathep'], ['Panita', '', 'Decha'], ['Pornthep', '', 'Sompornpisut'], ['Supot', '', 'Hannongbua']]",Amino Acids,2009,"[u'http://www.springerlink.com/index/66n133894532636u.pdf', u'http://www.springerlink.com/content/66n133894532636u', u'http://www.springerlink.com/index/10.1007/s00726-008-0201-z', u'http://www.springerlink.com/index/pdf/10.1007/s00726-008-0201-z']"
10.1038/303041a0,"Venkatramani, L., Bochkareva, E., Lee, J., et. al, An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA–Antibody Complex, Journal of Molecular Biology, 2006",cited-by,10.1016/j.jmb.2005.11.061,An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA–Antibody Complex,"[['Lalitha', '', 'Venkatramani'], ['Elena', '', 'Bochkareva'], ['Janis', 'T.', 'Lee'], ['Upma', '', 'Gulati'], ['W.', 'Graeme', 'Laver'], ['Alexey', '', 'Bochkarev'], ['Gillian', 'M.', 'Air']]",Journal of Molecular Biology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0022283605014646', u'http://linkinghub.elsevier.com/retrieve/pii/S0022283605014646']"
10.1038/303041a0,"Colman, P., , Zanamivir: an influenza virus neuraminidase inhibitor, Expert Review of Anti-infective Therapy, 2005",cited-by,10.1586/14787210.3.2.191,Zanamivir: an influenza virus neuraminidase inhibitor,"[['PM', '', 'Colman']]",Expert Review of Anti-infective Therapy,2005,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.3.2.191']
10.1038/303041a0,"Montagna, G., Cremona, M., Amaya, M., et. al, The trans-sialidase from the african trypanosome Trypanosoma brucei: The trans-sialidase of African trypanosomes, European Journal of Biochemistry, 2003",cited-by,10.1046/j.1432-1033.2002.02968.x,The trans-sialidase from the african trypanosome Trypanosoma brucei: The trans-sialidase of African trypanosomes,"[['Georgina', '', 'Montagna'], ['M.', 'Laura', 'Cremona'], ['M.', 'Fernanda', 'Amaya'], ['Alejandro', '', 'Buschiazzo'], ['Pedro', 'M.', 'Alzari'], ['Alberto', 'C. C.', 'Frasch']]",European Journal of Biochemistry,2003,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1432-1033.2002.02968.x']
10.1038/303041a0,"Sahasrabudhe, A., Lawrence, L., Epa, V., et. al, Substrate, Inhibitor, or Antibody Stabilizes the Glu 119 Gly Mutant Influenza Virus Neuraminidase, Virology, 1998",cited-by,10.1006/viro.1998.9222,"Substrate, Inhibitor, or Antibody Stabilizes the Glu 119 Gly Mutant Influenza Virus Neuraminidase","[['Anjali', '', 'Sahasrabudhe'], ['Lynne', '', 'Lawrence'], ['V.', 'Chandana', 'Epa'], ['Joseph', 'N.', 'Varghese'], ['Peter', 'M.', 'Colman'], ['Jennifer', 'L.', 'McKimm-Breschkin']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0042682298992224', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682298992224']"
10.1038/303041a0,"Itzstein, M., Thomson, R., , Anti-Influenza Drugs: The Development of Sialidase Inhibitors, , 0",cited-by,10.1007/978-3-540-79086-0_5,Anti-Influenza Drugs: The Development of Sialidase Inhibitors,"[['Mark', 'von', 'Itzstein'], ['Robin', '', 'Thomson']]",,0,"[u'http://www.springerlink.com/index/q7q766196t171341.pdf', u'http://www.springerlink.com/content/q7q766196t171341']"
10.1038/303041a0,"Zhirnov, O., Vorobjeva, I., Saphonova, O., et. al, Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2009.05.030,"Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells","[['O.', 'P.', 'Zhirnov'], ['I.', 'V.', 'Vorobjeva'], ['O.', 'A.', 'Saphonova'], ['S.', 'V.', 'Poyarkov'], ['A.', 'V.', 'Ovcharenko'], ['D.', '', 'Anhlan'], ['N.', 'A.', 'Malyshev']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1386653209002364', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653209002364']"
10.1038/303041a0,"Wu, Z., Ethen, C., Hickey, G., et. al, Active 1918 pandemic flu viral neuraminidase has distinct N-glycan profile and is resistant to trypsin digestion, Biochemical and Biophysical Research Communications, 2009",cited-by,10.1016/j.bbrc.2008.12.139,Active 1918 pandemic flu viral neuraminidase has distinct N-glycan profile and is resistant to trypsin digestion,"[['Zhengliang', 'L.', 'Wu'], ['Cheryl', '', 'Ethen'], ['Gregg', 'E.', 'Hickey'], ['Weiping', '', 'Jiang']]",Biochemical and Biophysical Research Communications,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0006291X08025400', u'http://linkinghub.elsevier.com/retrieve/pii/S0006291X08025400']"
10.1038/303041a0,"Perk, S., Banet-Noach, C., Golender, N., et. al, Molecular characterization of the glycoprotein genes of H5N1 influenza A viruses isolated in Israel and the Gaza Strip during 2006 outbreaks, Virus Genes, 2007",cited-by,10.1007/s11262-007-0120-1,Molecular characterization of the glycoprotein genes of H5N1 influenza A viruses isolated in Israel and the Gaza Strip during 2006 outbreaks,"[['Shimon', '', 'Perk'], ['Caroline', '', 'Banet-Noach'], ['Natalia', '', 'Golender'], ['Lubov', '', 'Simanov'], ['Ezra', '', 'Rozenblut'], ['Sagit', '', 'Nagar'], ['Shimon', '', 'Pokamunski'], ['Michael', '', 'Pirak'], ['Yevgenii', '', 'Tendler'], ['Maricarmen', '', 'Garc\xc3\xada'], ['Alexander', '', 'Panshin']]",Virus Genes,2007,"[u'http://www.springerlink.com/index/h886024333687363.pdf', u'http://www.springerlink.com/content/h886024333687363', u'http://www.springerlink.com/index/10.1007/s11262-007-0120-1', u'http://www.springerlink.com/index/pdf/10.1007/s11262-007-0120-1']"
10.1038/303041a0,"Zhou, J., Fu, J., Fang, D., et. al, Molecular characterization of the surface glycoprotein genes of an H5N1 influenza virus isolated from a human in Guangdong, China, Archives of Virology, 2007",cited-by,10.1007/s00705-007-0985-2,"Molecular characterization of the surface glycoprotein genes of an H5N1 influenza virus isolated from a human in Guangdong, China","[['J.-J.', '', 'Zhou'], ['J.', '', 'Fu'], ['D.-Y.', '', 'Fang'], ['H.-J.', '', 'Yan'], ['J.', '', 'Tian'], ['J.-M.', '', 'Zhou'], ['J.-P.', '', 'Tao'], ['Y.', '', 'Liang'], ['L.-F.', '', 'Jiang']]",Archives of Virology,2007,"[u'http://www.springerlink.com/index/b6533450117v17vt.pdf', u'http://www.springerlink.com/content/b6533450117v17vt', u'http://www.springerlink.com/index/10.1007/s00705-007-0985-2', u'http://www.springerlink.com/index/pdf/10.1007/s00705-007-0985-2']"
10.1038/303041a0,"Li, X., Fang, F., Song, Y., et. al, Essential Sequence of Influenza Neuraminidase DNA to Provide Protection Against Lethal Viral Infection, Dna and Cell Biology, 2006",cited-by,10.1089/dna.2006.25.197,Essential Sequence of Influenza Neuraminidase DNA to Provide Protection Against Lethal Viral Infection,"[['Xiangzhong', '', 'Li'], ['Fang', '', 'Fang'], ['Yunlong', '', 'Song'], ['Hongli', '', 'Yan'], ['Haiyan', '', 'Chang'], ['Shuhan', '', 'Sun'], ['Ze', '', 'Chen']]",Dna and Cell Biology,2006,[u'http://www.liebertonline.com/doi/abs/10.1089/dna.2006.25.197']
10.1038/303041a0,"Colman, P., , Neuraminidase inhibitors as antivirals, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00132-9,Neuraminidase inhibitors as antivirals,"[['P.', 'M', 'Colman']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02001329', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001329']"
10.1038/303041a0,"Wang, G., , Recent advances in the discovery and development of anti-influenza drugs, Expert Opinion on Therapeutic Patents, 2002",cited-by,10.1517/13543776.12.6.845,Recent advances in the discovery and development of anti-influenza drugs,"[['Gary', 'T', 'Wang']]",Expert Opinion on Therapeutic Patents,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.12.6.845']
10.1038/303041a0,"Richard, M., Deléage, C., Barthélémy, M., et. al, Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors, Journal of Clinical Virology, 2008",cited-by,10.1016/j.jcv.2007.10.021,"Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors","[['Mathilde', '', 'Richard'], ['Claire', '', 'Del\xc3\xa9age'], ['Mendy', '', 'Barth\xc3\xa9l\xc3\xa9my'], ['Yi', 'Pu', 'Lin'], ['Alan', '', 'Hay'], ['Bruno', '', 'Lina'], ['Olivier', '', 'Ferraris']]",Journal of Clinical Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1386653207003915', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653207003915']"
10.1038/303041a0,"SAITO, T., TAYLOR, G., WEBSTER, A., , Steps in Maturation of Influenza A Virus Neuraminidase, , 1995",cited-by,13889567Steps in Maturation of Influenza A Virus Neuraminidase,Steps in Maturation of Influenza A Virus Neuraminidase,"[['TAKEHIKO', '', 'SAITO'], ['GARRY', '', 'TAYLOR'], ['ANDROBERT', 'G.', 'WEBSTER']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/8/5011.pdf']
10.1038/303041a0,"Stuart, D., Gouet, P., , Viral envelope glycoproteins swing into action, Structure, 1995",cited-by,10.1016/S0969-2126(01)00199-X,Viral envelope glycoproteins swing into action,"[['David', '', 'Stuart'], ['Patrice', '', 'Gouet']]",Structure,1995,"[u'http://www.sciencedirect.com/science/article/pii/S096921260100199X', u'http://linkinghub.elsevier.com/retrieve/pii/S096921260100199X']"
10.1038/303041a0,"Lyn, D., Mazanec, M., Nedrud, J., et. al, Location of amino acid residues important for the structure and biological function of the haemagglutinin--neuraminidase glycoprotein of Sendai virus by analysis of escape mutants, Journal of General Virology, 1991",cited-by,10.1099/0022-1317-72-4-817,Location of amino acid residues important for the structure and biological function of the haemagglutinin--neuraminidase glycoprotein of Sendai virus by analysis of escape mutants,"[['Deborah', '', 'Lyn'], ['Mary', 'B.', 'Mazanec'], ['John', 'G.', 'Nedrud'], ['Allen', '', 'Portner']]",Journal of General Virology,1991,"[u'http://vir.sgmjournals.org/cgi/reprint/72/4/817.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-72-4-817']"
10.1038/303041a0,"Hamsikova, E., Zavadova, H., Zaoral, M., et. al, Immunogenicity of a Synthetic Peptide Corresponding to a Portion of the Heavy Chain of H3N2 Influenza Virus Haemagglutinin, Journal of General Virology, 1987",cited-by,10.1099/0022-1317-68-8-2249,Immunogenicity of a Synthetic Peptide Corresponding to a Portion of the Heavy Chain of H3N2 Influenza Virus Haemagglutinin,"[['E.', '', 'Hamsikova'], ['H.', '', 'Zavadova'], ['M.', '', 'Zaoral'], ['J.', '', 'Jezek'], ['K.', '', 'Blaha'], ['V.', '', 'Vonka']]",Journal of General Virology,1987,"[u'http://vir.sgmjournals.org/cgi/reprint/68/8/2249.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-68-8-2249']"
10.1038/303041a0,"Jindal, N., Chander, Y., Abin, M., et. al, Amplification of four genes of influenza A viruses using a degenerate primer set in a one step RT-PCR method, Journal of Virological Methods, 2009",cited-by,10.1016/j.jviromet.2009.05.003,Amplification of four genes of influenza A viruses using a degenerate primer set in a one step RT-PCR method,"[['Naresh', '', 'Jindal'], ['Yogesh', '', 'Chander'], ['Martha', 'de', 'Abin'], ['Srinand', '', 'Sreevatsan'], ['David', '', 'Stallknecht'], ['David', 'A.', 'Halvorson'], ['Sagar', 'M.', 'Goyal']]",Journal of Virological Methods,2009,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-33.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166093409002419', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093409002419']"
10.1038/303041a0,"Carlescu, I., Scutaru, D., Popa, M., et. al, Synthetic sialic-acid-containing polyvalent antiviral inhibitors, Medicinal Chemistry Research, 2009",cited-by,10.1007/s00044-008-9139-7,Synthetic sialic-acid-containing polyvalent antiviral inhibitors,"[['Irina', '', 'Carlescu'], ['Dan', '', 'Scutaru'], ['Marcel', '', 'Popa'], ['Constantin', 'V.', 'Uglea']]",Medicinal Chemistry Research,2009,"[u'http://www.springerlink.com/index/6127r24821227845.pdf', u'http://www.springerlink.com/content/6127r24821227845', u'http://www.springerlink.com/index/pdf/10.1007/s00044-008-9139-7', u'http://www.springerlink.com/index/10.1007/s00044-008-9139-7']"
10.1038/303041a0,"Wolkerstorfer, A., Kurz, H., Bachhofner, N., et. al, Glycyrrhizin inhibits influenza A virus uptake into the cell, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2009.04.012,Glycyrrhizin inhibits influenza A virus uptake into the cell,"[['Andrea', '', 'Wolkerstorfer'], ['Harald', '', 'Kurz'], ['Nicole', '', 'Bachhofner'], ['Oliver', 'H. J.', 'Szolar']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354209003222', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354209003222']"
10.1038/303041a0,"Aamir, U., Naeem, K., Ahmed, Z., et. al, Zoonotic potential of highly pathogenic avian H7N3 influenza viruses from Pakistan, Virology, 2009",cited-by,10.1016/j.virol.2009.05.008,Zoonotic potential of highly pathogenic avian H7N3 influenza viruses from Pakistan,"[['Uzma', 'B.', 'Aamir'], ['Khalid', '', 'Naeem'], ['Zaheer', '', 'Ahmed'], ['Caroline', 'A.', 'Obert'], ['John', '', 'Franks'], ['Scott', '', 'Krauss'], ['Patrick', '', 'Seiler'], ['Robert', 'G.', 'Webster']]",Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0042682209003109', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682209003109']"
10.1038/303041a0,"Yano, T., Nobusawa, E., Nagy, A., et. al, Effects of single-point amino acid substitutions on the structure and function neuraminidase proteins in influenza A virus, Microbiology and Immunology, 2008",cited-by,10.1111/j.1348-0421.2008.00034.x,Effects of single-point amino acid substitutions on the structure and function neuraminidase proteins in influenza A virus,"[['Takuya', '', 'Yano'], ['Eri', '', 'Nobusawa'], ['Alexander', '', 'Nagy'], ['Setsuko', '', 'Nakajima'], ['Katsuhisa', '', 'Nakajima']]",Microbiology and Immunology,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1348-0421.2008.00034.x']
10.1016~S0140-6736(00)02288-1,"Colman PM. Neuraminidase: enzyme and antigen. In: Krug RM, ed. The influenza viruses. New York: Plenum Press, 1989: 175–218.",references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,"von Itzstein M, Wu WY, Kok GB, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993; 363: 418–23.",references,10.1038/363418a0,Rational design of potent sialidase-based inhibitors of influenza virus replication,"[[u'Mark', u'von', u'Itzstein'], [u'Wen-Yang', u'', u'Wu'], [u'Gaik', u'B.', u'Kok'], [u'Michael', u'S.', u'Pegg'], [u'Jeffrey', u'C.', u'Dyason'], [u'Betty', u'', u'Jin'], [u'Tho', u'Van', u'Phan'], [u'Mark', u'L.', u'Smythe'], [u'Hume', u'F.', u'White'], [u'Stuart', u'W.', u'Oliver'], [u'Peter', u'M.', u'Colman'], [u'Joseph', u'N.', u'Varghese'], [u'D.', u'Michael', u'Ryan'], [u'Jacqueline', u'M.', u'Woods'], [u'Richard', u'C.', u'Bethell'], [u'Vanessa', u'J.', u'Hotham'], [u'Janet', u'M.', u'Cameron'], [u'Charles', u'R.', u'Penn']]",Nature,1993,[u'http://www.nature.com/doifinder/10.1038/363418a0'],./output/10.1016~S0140-6736(00)02288-1/10.1038~363418a0
10.1038/363418a0,"Chen, L., Willis, S., Wei, A., et. al, Differential Targeting of Prosurvival Bcl2 Proteins by Their BH3Only Ligands Allows Complementary Apoptotic Function, Molecular Cell, 2005",cited-by,10.1016/j.molcel.2004.12.030,Differential Targeting of Prosurvival Bcl2 Proteins by Their BH3Only Ligands Allows Complementary Apoptotic Function,"[['Lin', '', 'Chen'], ['Simon', 'N.', 'Willis'], ['Andrew', '', 'Wei'], ['Brian', 'J.', 'Smith'], ['Jamie', 'I.', 'Fletcher'], ['Mark', 'G.', 'Hinds'], ['Peter', 'M.', 'Colman'], ['Catherine', 'L.', 'Day'], ['Jerry', 'M.', 'Adams'], ['David', 'C. S.', 'Huang']]",Molecular Cell,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1097276505010403', u'http://linkinghub.elsevier.com/retrieve/pii/S1097276505010403', u'http://download.cell.com/molecular-cell/mmcs/journals/1097-2765/PIIS1097276505010403.mmc1.pdf']"
10.1038/363418a0,"Kiso, M., Mitamura, K., Sakai-Tagawa, Y., et. al, Resistant influenza A viruses in children treated with oseltamivir: descriptive study, Lancet, 2004",cited-by,10.1016/S0140-6736(04)16934-1,Resistant influenza A viruses in children treated with oseltamivir: descriptive study,"[['Maki', '', 'Kiso'], ['Keiko', '', 'Mitamura'], ['Yuko', '', 'Sakai-Tagawa'], ['Kyoko', '', 'Shiraishi'], ['Chiharu', '', 'Kawakami'], ['Kazuhiro', '', 'Kimura'], ['Frederick', 'G', 'Hayden'], ['Norio', '', 'Sugaya'], ['Yoshihiro', '', 'Kawaoka']]",Lancet,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0140673604169341', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-19.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673604169341']"
10.1038/363418a0,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, Lancet, 2000",cited-by,10.1016/S0140-6736(99)11433-8,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699114338', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699114338']"
10.1038/363418a0,"Jones, G., Willett, P., Glen, R., , Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation, Journal of Molecular Biology, 1995",cited-by,10.1016/S0022-2836(95)80037-9,Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation,"[['Gareth', '', 'Jones'], ['Peter', '', 'Willett'], ['Robert', 'C.', 'Glen']]",Journal of Molecular Biology,1995,"[u'http://www.sciencedirect.com/science/article/pii/S0022283695800379', u'http://linkinghub.elsevier.com/retrieve/pii/S0022283695800379']"
10.1038/363418a0,"Horimoto, T., Kawaoka, Y., , Influenza: lessons from past pandemics, warnings from current incidents, Nature Reviews Microbiology, 2005",cited-by,10.1038/nrmicro1208,"Influenza: lessons from past pandemics, warnings from current incidents","[['Taisuke', '', 'Horimoto'], ['Yoshihiro', '', 'Kawaoka']]",Nature Reviews Microbiology,2005,"[u'http://birdflubook.com/resources/0Horimoto91S.pdf', u'http://www.micab.umn.edu/current/horimoto.pdf', u'http://dx.doi.org/10.1038/nrmicro1208', u'http://www.nature.com/doifinder/10.1038/nrmicro1208']"
10.1038/363418a0,"Kelm, S., Schauer, R., , Sialic Acids in Molecular and Cellular Interactions, International Review of Cytology-a Survey of Cell Biology, 1997",cited-by,10.1016/S0074-7696(08)62127-0,Sialic Acids in Molecular and Cellular Interactions,"[['S\xc3\xb8rge', '', 'Kelm'], ['Roland', '', 'Schauer']]",International Review of Cytology-a Survey of Cell Biology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0074769608621270', u'http://linkinghub.elsevier.com/retrieve/pii/S0074769608621270']"
10.1038/363418a0,"HORIMOTO, T., KAWAOKA, Y., , Pandemic Threat Posed by Avian Influenza A Viruses, Clinical Microbiology Reviews, 2001",cited-by,10.1128/CMR.14.1.129-149.2001,Pandemic Threat Posed by Avian Influenza A Viruses,"[['TAISUKE', '', 'HORIMOTO'], ['YOSHIHIRO', '', 'KAWAOKA']]",Clinical Microbiology Reviews,2001,"[u'http://cmr.asm.org/cgi/reprint/14/1/129.pdf', u'http://birdflubook.com/resources/HORIMOTO129.pdf', u'http://www.col.ops-oms.org/prevencion/influenza/virus/Pandemia_virus_A.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.14.1.129-149.2001']"
10.1038/363418a0,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1038/363418a0,"Shoichet, B., , Virtual screening of chemical libraries, Nature, 2004",cited-by,10.1038/nature03197,Virtual screening of chemical libraries,"[['Brian', 'K.', 'Shoichet']]",Nature,2004,"[u'http://www.nature.com/doifinder/10.1038/nature03197', u'http://dx.doi.org/10.1038/nature03197']"
10.1038/363418a0,"Russell, R., Haire, L., Stevens, D., et. al, The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design, Nature, 2006",cited-by,10.1038/nature05114,The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design,"[['Rupert', 'J.', 'Russell'], ['Lesley', 'F.', 'Haire'], ['David', 'J.', 'Stevens'], ['Patrick', 'J.', 'Collins'], ['Yi', 'Pu', 'Lin'], ['G.', 'Michael', 'Blackburn'], ['Alan', 'J.', 'Hay'], ['Steven', 'J.', 'Gamblin'], ['John', 'J.', 'Skehel']]",Nature,2006,"[u'http://www.nature.com/doifinder/10.1038/nature05114', u'http://dx.doi.org/10.1038/nature05114']"
10.1038/363418a0,"Chen, J., Lee, K., Steinhauer, D., et. al, Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation, Cell, 1998",cited-by,10.1016/S0092-8674(00)81771-7,"Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation","[['Jue', '', 'Chen'], ['Kon', 'Ho', 'Lee'], ['David', 'A.', 'Steinhauer'], ['David', 'J.', 'Stevens'], ['John', 'J.', 'Skehel'], ['Don', 'C.', 'Wiley']]",Cell,1998,"[u'http://crystal.harvard.edu/lib-dcw/ChenJ-1998-Cell-95-409.pdf', u'http://www.sciencedirect.com/science/article/pii/S0092867400817717', u'http://crystal.med.harvard.edu/lib-dcw/ChenJ-1998-Cell-95-409.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0092867400817717']"
10.1038/363418a0,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']"
10.1038/363418a0,"McKimm-Breschkin, J., , Resistance of influenza viruses to neuraminidase inhibitors — a review, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00103-0,Resistance of influenza viruses to neuraminidase inhibitors — a review,"[['Jennifer', 'L.', 'McKimm-Breschkin']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001030', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-14.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001030']"
10.1038/363418a0,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, , 0",cited-by,12760434Influenza virus neuraminidase inhibitors,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",,0,[u'http://www.birdflumanual.com/resources/Medical_References/files/antineuraminidase%20therapy%20lancet.pdf']
10.1038/363418a0,"Asano, N., , Glycosidase inhibitors: update and perspectives on practical use, Glycobiology, 2003",cited-by,10.1093/glycob/cwg090,Glycosidase inhibitors: update and perspectives on practical use,"[['Naoki', '', 'Asano']]",Glycobiology,2003,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwg090v1.pdf', u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/cwg090']"
10.1038/363418a0,"Monto, A., McKimm-Breschkin, J., Macken, C., et. al, Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.01339-05,Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use,"[['Arnold', 'S.', 'Monto'], ['J.', 'L.', 'McKimm-Breschkin'], ['Catherine', '', 'Macken'], ['Alan', 'W.', 'Hampson'], ['Alan', '', 'Hay'], ['Alexander', '', 'Klimov'], ['Masato', '', 'Tashiro'], ['Robert', 'G.', 'Webster'], ['Michelle', '', 'Aymard'], ['Frederick', 'G.', 'Hayden'], ['Maria', '', 'Zambon']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01339-05', u'http://aac.asm.org/cgi/reprint/50/7/2395.pdf']"
10.1038/363418a0,"Karlsson, K., , Microbial recognition of target-cell glycoconjugates, Current Opinion in Structural Biology, 1995",cited-by,10.1016/0959-440X(95)80054-9,Microbial recognition of target-cell glycoconjugates,"[['Karl-Anders', '', 'Karlsson']]",Current Opinion in Structural Biology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0959440X95800549', u'http://linkinghub.elsevier.com/retrieve/pii/0959440X95800549']"
10.1038/363418a0,"McKimm-Breschkin, J., Trivedi, T., Hampson, A., et. al, Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir, Antimicrobial Agents and Chemotherapy, 2003",cited-by,10.1128/AAC.47.7.2264-2272.2003,Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir,"[['J.', '', 'McKimm-Breschkin'], ['T.', '', 'Trivedi'], ['A.', '', 'Hampson'], ['A.', '', 'Hay'], ['A.', '', 'Klimov'], ['M.', '', 'Tashiro'], ['F.', '', 'Hayden'], ['M.', '', 'Zambon']]",Antimicrobial Agents and Chemotherapy,2003,"[u'http://aac.highwire.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.7.2264-2272.2003']"
10.1038/363418a0,"MITNAUL, L., MATROSOVICH, M., CASTRUCCI, M., et. al, Balanced Hemagglutinin and Neuraminidase Activities Are Critical for Efficient Replication of Influenza A Virus, Journal of Virology, 2000",cited-by,10.1128/JVI.74.13.6015-6020.2000,Balanced Hemagglutinin and Neuraminidase Activities Are Critical for Efficient Replication of Influenza A Virus,"[['LYNDON', 'J.', 'MITNAUL'], ['MIKHAIL', 'N.', 'MATROSOVICH'], ['MARIA', 'R.', 'CASTRUCCI'], ['ALEXANDER', 'B.', 'TUZIKOV'], ['NIKOLAI', 'V.', 'BOVIN'], ['DARWYN', '', 'KOBASA'], ['YOSHIHIRO', '', 'KAWAOKA']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/13/6015.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.13.6015-6020.2000']"
10.1038/363418a0,"GOVORKOVA, E., LENEVA, I., GOLOUBEVA, O., et. al, Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.10.2723-2732.2001,"Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses","[['ELENA', 'A.', 'GOVORKOVA'], ['IRINA', 'A.', 'LENEVA'], ['OLGA', 'G.', 'GOLOUBEVA'], ['KAREN', '', 'BUSH'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/10/2723.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.10.2723-2732.2001']"
10.1038/363418a0,"Traving, C., Schauer, R., , Structure, function and metabolism of sialic acids, Experientia, 1998",cited-by,10.1007/s000180050258,"Structure, function and metabolism of sialic acids","[['C.', '', 'Traving'], ['R.', '', 'Schauer']]",Experientia,1998,"[u'http://www.springerlink.com/content/1fuk09u34tcrmfu2', u'http://www.springerlink.com/index/1fuk09u34tcrmfu2.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s000180050258', u'http://www.springerlink.com/index/pdf/10.1007/s000180050258']"
10.1038/363418a0,"Clercq, E., , Antivirals and antiviral strategies, Nature Reviews Microbiology, 2004",cited-by,10.1038/nrmicro975,Antivirals and antiviral strategies,"[['Erik', 'De', 'Clercq']]",Nature Reviews Microbiology,2004,"[u'http://dx.doi.org/10.1038/nrmicro975', u'http://www.nature.com/doifinder/10.1038/nrmicro975']"
10.1038/363418a0,"Clercq, E., , Strategies in the design of antiviral drugs, Nature Reviews Drug Discovery, 2002",cited-by,10.1038/nrd703,Strategies in the design of antiviral drugs,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2002,"[u'http://dx.doi.org/10.1038/nrd703', u'http://www.nature.com/doifinder/10.1038/nrd703']"
10.1038/363418a0,"Collins, P., Haire, L., Lin, Y., et. al, Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants, Nature, 2008",cited-by,10.1038/nature06956,Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants,"[['Patrick', 'J.', 'Collins'], ['Lesley', 'F.', 'Haire'], ['Yi', 'Pu', 'Lin'], ['Junfeng', '', 'Liu'], ['Rupert', 'J.', 'Russell'], ['Philip', 'A.', 'Walker'], ['John', 'J.', 'Skehel'], ['Stephen', 'R.', 'Martin'], ['Alan', 'J.', 'Hay'], ['Steven', 'J.', 'Gamblin']]",Nature,2008,"[u'http://www.nature.com/doifinder/10.1038/nature06956', u'http://dx.doi.org/10.1038/nature06956']"
10.1038/363418a0,"Vimr, E., Kalivoda, K., Deszo, E., et. al, Diversity of Microbial Sialic Acid Metabolism, Microbiology and Molecular Biology Reviews, 2004",cited-by,10.1128/MMBR.68.1.132-153.2004,Diversity of Microbial Sialic Acid Metabolism,"[['Eric', 'R.', 'Vimr'], ['Kathryn', 'A.', 'Kalivoda'], ['Eric', 'L.', 'Deszo'], ['Susan', 'M.', 'Steenbergen']]",Microbiology and Molecular Biology Reviews,2004,"[u'http://www.microbiologia.com.ar/aplicada/textos/sialic_acid_metabolism.pdf', u'http://mmbr.asm.org/cgi/doi/10.1128/MMBR.68.1.132-153.2004']"
10.1038/363418a0,"Mäkelä, M., Pauksens, K., Rostila, T., et. al, Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study, Journal of Infection, 2000",cited-by,10.1053/jinf.1999.0602,"Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study","[['M.', 'J.', 'M\xc3\xa4kel\xc3\xa4'], ['K.', '', 'Pauksens'], ['T.', '', 'Rostila'], ['D.', 'M.', 'Fleming'], ['C.', 'Y.', 'Man'], ['O.', 'N.', 'Keene'], ['A.', '', 'Webster']]",Journal of Infection,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0163445399906023', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445399906023', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-15.pdf']"
10.1038/363418a0,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf']
10.1038/363418a0,"Gaskell, A., Crennell, S., Taylor, G., , The three domains of a bacterial sialidase: a β-propeller, an immunoglobulin module and a galactose-binding jelly-roll, Structure, 1995",cited-by,10.1016/S0969-2126(01)00255-6,"The three domains of a bacterial sialidase: a β-propeller, an immunoglobulin module and a galactose-binding jelly-roll","[['Andrew', '', 'Gaskell'], ['Susan', '', 'Crennell'], ['Garry', '', 'Taylor']]",Structure,1995,"[u'http://www.sciencedirect.com/science/article/pii/S0969212601002556', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212601002556']"
10.1038/363418a0,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf']
10.1038/363418a0,"Wetherall, N., Trivedi, T., Zeller, J., et. al, Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network, Journal of Clinical Microbiology, 2003",cited-by,10.1128/JCM.41.2.742-750.2003,Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network,"[['N.', 'T.', 'Wetherall'], ['T.', '', 'Trivedi'], ['J.', '', 'Zeller'], ['C.', '', 'Hodges-Savola'], ['J.', 'L.', 'McKimm-Breschkin'], ['M.', '', 'Zambon'], ['F.', 'G.', 'Hayden']]",Journal of Clinical Microbiology,2003,"[u'http://jcm.asm.org/cgi/reprint/41/2/742.pdf', u'http://jcm.asm.org/cgi/doi/10.1128/JCM.41.2.742-750.2003']"
10.1038/363418a0,"Barnett, J., Lewis, A., Cadman, A., et. al, Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.1.78-87.2000,Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies,"[['J.', 'M.', 'Barnett'], ['A.', 'P.', 'Lewis'], ['A.', '', 'Cadman'], ['D.', '', 'Gor'], ['M.', '', 'Dempsey'], ['M.', '', 'Walters'], ['A.', '', 'Candlin'], ['M.', '', 'Tisdale'], ['Groot', 'de', 'R'], ['P.', 'J.', 'Morley'], ['I.', 'J.', 'Owens'], ['G.', 'F.', 'Rimmelzwaan'], ['R.', 'J.', 'Fenton'], ['E.', 'C. J.', 'Claas'], ['A.', 'D. M. E.', 'Osterhaus']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/reprint/44/1/78.pdf', u'http://publishing.eur.nl/ir/repub/asset/9217/10602727.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.1.78-87.2000']"
10.1038/363418a0,"Varghese, J., Smith, P., Sollis, S., et. al, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, Structure, 1998",cited-by,10.1016/S0969-2126(98)00075-6,Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase,"[['Joseph', 'N', 'Varghese'], ['Paul', 'W', 'Smith'], ['Steven', 'L', 'Sollis'], ['Tony', 'J', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Jennifer', 'L', 'McKimm-Breschkin'], ['Peter', 'M', 'Colman']]",Structure,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0969212698000756', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212698000756']"
10.1038/363418a0,"Sidwell, R., Huffman, J., Barnard, D., et. al, Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor, Antiviral Research, 1998",cited-by,10.1016/S0166-3542(97)00065-X,"Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor","[['Robert', 'W.', 'Sidwell'], ['John', 'H.', 'Huffman'], ['Dale', 'L.', 'Barnard'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Ann', '', 'Morrison'], ['Timothy', '', 'Syndergaard'], ['Choung', 'U.', 'Kim']]",Antiviral Research,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016635429700065X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635429700065X']"
10.1038/363418a0,"Zambon, M., Hays, J., Webster, A., et. al, Diagnosis of Influenza in the Community: Relationship of Clinical Diagnosis to Confirmed Virological, Serologic, or Molecular Detection of Influenza, Archives of Internal Medicine, 2001",cited-by,10.1001/archinte.161.17.2116,"Diagnosis of Influenza in the Community: Relationship of Clinical Diagnosis to Confirmed Virological, Serologic, or Molecular Detection of Influenza","[['Maria', '', 'Zambon'], ['John', '', 'Hays'], ['Alison', '', 'Webster'], ['Robert', '', 'Newman'], ['Oliver', '', 'Keene']]",Archives of Internal Medicine,2001,"[u'http://archinte.ama-assn.org/cgi/doi/10.1001/archinte.161.17.2116', u'http://archinte.ama-assn.org/cgi/reprint/161/17/2116.pdf']"
10.1038/363418a0,", Catalytic Asymmetric Hetero-Diels–Alder Reactions of Carbonyl Compounds and Imines, Angewandte Chemie-international Edition, 2000",cited-by,10.1002/1521-3773(20001016)39:20<3558::AID-ANIE3558>3.0.CO;2-I,Catalytic Asymmetric Hetero-Diels–Alder Reactions of Carbonyl Compounds and Imines,[],Angewandte Chemie-international Edition,2000,[u'http://doi.wiley.com/10.1002/1521-3773%2820001016%2939%3A20%3C3558%3A%3AAID-ANIE3558%3E3.0.CO%3B2-I']
10.1038/363418a0,"Taylor, G., , Sialidases: structures, biological significance and therapeutic potential, Current Opinion in Structural Biology, 1996",cited-by,10.1016/S0959-440X(96)80014-5,"Sialidases: structures, biological significance and therapeutic potential","[['Garry', '', 'Taylor']]",Current Opinion in Structural Biology,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0959440X96800145', u'http://linkinghub.elsevier.com/retrieve/pii/S0959440X96800145']"
10.1038/363418a0,"Clercq, E., , Antiviral agents active against influenza A viruses, Nature Reviews Drug Discovery, 2006",cited-by,10.1038/nrd2175,Antiviral agents active against influenza A viruses,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2006,"[u'http://dx.doi.org/10.1038/nrd2175', u'http://www.nature.com/doifinder/10.1038/nrd2175']"
10.1038/363418a0,"Morris, S., Price, G., Barnett, J., et. al, Role of neuraminidase in influenza virus-induced apoptosis, , 1999",cited-by,6297657Role of neuraminidase in influenza virus-induced apoptosis,Role of neuraminidase in influenza virus-induced apoptosis,"[['Susan', 'J.', 'Morris'], ['Graeme', 'E.', 'Price'], ['Jacqueline', 'M.', 'Barnett'], ['Steven', 'A.', 'Hiscox'], ['Harry', '', 'Smith'], ['Clive', '', 'Sweet']]",,1999,[u'http://vir.sgmjournals.org/cgi/reprint/80/1/137.pdf']
10.1038/363418a0,"MCKIMM-BRESCHKIN, J., BLICK, T., SAHASRABUDHE, A., et. al, Generation and Characterization of Variants of NWS/G70C Influenza Virus after In Vitro Passage in 4-Amino-Neu5Ac2en and 4-Guanidino-Neu5Ac2en, , 1996",cited-by,13518261Generation and Characterization of Variants of NWS/G70C Influenza Virus after In Vitro Passage in 4-Amino-Neu5Ac2en and 4-Guanidino-Neu5Ac2en,Generation and Characterization of Variants of NWS/G70C Influenza Virus after In Vitro Passage in 4-Amino-Neu5Ac2en and 4-Guanidino-Neu5Ac2en,"[['JENNIFER', 'L.', 'MCKIMM-BRESCHKIN'], ['TONY', 'J.', 'BLICK'], ['ANJALI', '', 'SAHASRABUDHE'], ['TAK', '', 'TIONG'], ['DEIDRE', '', 'MARSHALL'], ['GRAHAM', 'J.', 'HART'], ['RICHARD', 'C.', 'BETHELL'], ['ANDCHARLES', 'R.', 'PENN'], ['Glaxo', '', 'Wellcome']]",,1996,"[u'http://aac.highwire.org/cgi/reprint/40/1/40.pdf', u'http://aac.asm.org/cgi/reprint/40/1/40.pdf']"
10.1038/363418a0,"Mishin, V., Hayden, F., Gubareva, L., , Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.11.4515-4520.2005,Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors,"[['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Larisa', 'V.', 'Gubareva']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/11/4515.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.11.4515-4520.2005']"
10.1038/363418a0,"SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']"
10.1038/363418a0,"Itzstein, M., , The war against influenza: discovery and development of sialidase inhibitors, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2400,The war against influenza: discovery and development of sialidase inhibitors,"[['Mark', 'von', 'Itzstein']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2400', u'http://www.nature.com/doifinder/10.1038/nrd2400']"
10.1038/363418a0,"Monto, A., , The role of antivirals in the control of influenza, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00075-6,The role of antivirals in the control of influenza,"[['Arnold', 'S.', 'Monto']]",Vaccine,2003,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-18.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X03000756', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/prevention/prevention-8.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03000756']"
10.1038/363418a0,"MCKIMM-BRESCHKIN, J., SAHASRABUDHE, A., BLICK, T., et. al, Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors, , 1998",cited-by,13896013Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,"[['JENNIFER', 'L.', 'MCKIMM-BRESCHKIN'], ['ANJALI', '', 'SAHASRABUDHE'], ['TONY', 'J.', 'BLICK'], ['MANDY', '', 'MCDONALD'], ['PETER', 'M.', 'COLMAN'], ['GRAHAM', 'J.', 'HART'], ['RICHARD', 'C.', 'BETHELL'], ['JOSEPH', 'N.', 'VARGHESE']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/3/2456.pdf']
10.1038/363418a0,"Gasser, R., Newton, S., , Genomic and genetic research on bursate nematodes: significance, implications and prospects, International Journal for Parasitology, 2000",cited-by,10.1016/S0020-7519(00)00021-7,"Genomic and genetic research on bursate nematodes: significance, implications and prospects","[['Robin', 'B', 'Gasser'], ['Susan', 'E', 'Newton']]",International Journal for Parasitology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0020751900000217', u'http://linkinghub.elsevier.com/retrieve/pii/S0020751900000217']"
10.1038/363418a0,"Furuta, Y., Takahashi, K., Fukuda, Y., et. al, In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.977-981.2002,In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705,"[['Y.', '', 'Furuta'], ['K.', '', 'Takahashi'], ['Y.', '', 'Fukuda'], ['M.', '', 'Kuno'], ['T.', '', 'Kamiyama'], ['K.', '', 'Kozaki'], ['N.', '', 'Nomura'], ['H.', '', 'Egawa'], ['S.', '', 'Minami'], ['Y.', '', 'Watanabe'], ['H.', '', 'Narita'], ['K.', '', 'Shiraki']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://journals.pasteur.ac.ir/aac02/46(4)/977.pdf', u'http://aac.asm.org/cgi/reprint/46/4/977.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.977-981.2002']"
10.1038/363418a0,"Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']"
10.1038/363418a0,"Huang, Z., Panda, A., Elankumaran, S., et. al, The Hemagglutinin-Neuraminidase Protein of Newcastle Disease Virus Determines Tropism and Virulence, Journal of Virology, 2004",cited-by,10.1128/JVI.78.8.4176-4184.2004,The Hemagglutinin-Neuraminidase Protein of Newcastle Disease Virus Determines Tropism and Virulence,"[['Zhuhui', '', 'Huang'], ['Aruna', '', 'Panda'], ['Subbiah', '', 'Elankumaran'], ['Dhanasekaran', '', 'Govindarajan'], ['Daniel', 'D.', 'Rockemann'], ['Siba', 'K.', 'Samal']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/8/4176.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.8.4176-4184.2004']"
10.1038/363418a0,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf']
10.1038/363418a0,"Blick, T., Sahasrabudhe, A., McDonald, M., et. al, The Interaction of Neuraminidase and Hemagglutinin Mutations in Influenza Virus in Resistance to 4-Guanidino-Neu5Ac2en, Virology, 1998",cited-by,10.1006/viro.1998.9194,The Interaction of Neuraminidase and Hemagglutinin Mutations in Influenza Virus in Resistance to 4-Guanidino-Neu5Ac2en,"[['Tony', 'J.', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Mandy', '', 'McDonald'], ['Ian', 'J.', 'Owens'], ['Peter', 'J.', 'Morley'], ['Robert', 'J.', 'Fenton'], ['Jennifer', 'L.', 'McKimm-Breschkin']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0042682298991942', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682298991942']"
10.1038/363418a0,"Zambon, M., Hays, J., Webster, A., et. al, Diagnosis of Influenza in the Community Relationship of Clinical Diagnosis to Confirmed Virological, Serologic, or Molecular Detection of Influenza, , 0",cited-by,"12785073Diagnosis of Influenza in the Community Relationship of Clinical Diagnosis to Confirmed Virological, Serologic, or Molecular Detection of Influenza","Diagnosis of Influenza in the Community Relationship of Clinical Diagnosis to Confirmed Virological, Serologic, or Molecular Detection of Influenza","[['Maria', '', 'Zambon'], ['John', '', 'Hays'], ['Alison', '', 'Webster'], ['Robert', '', 'Newman'], ['Oliver', '', 'Keene']]",,0,[u'http://archinte.ama-assn.org/cgi/reprint/161/17/2116.pdf']
10.1038/363418a0,"Sears, P., Wong, C., , Enzyme action in glycoprotein synthesis, Experientia, 1998",cited-by,10.1007/s000180050146,Enzyme action in glycoprotein synthesis,"[['P.', '', 'Sears'], ['C.-H.', '', 'Wong']]",Experientia,1998,"[u'http://www.springerlink.com/index/dj9ypk3xnhdcw1t9.pdf', u'http://www.springerlink.com/content/dj9ypk3xnhdcw1t9', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s000180050146', u'http://www.springerlink.com/index/pdf/10.1007/s000180050146']"
10.1038/363418a0,"Kuhn, P., Wilson, K., Patch, M., et. al, The genesis of high-throughput structure-based drug discovery using protein crystallography, Current Opinion in Chemical Biology, 2002",cited-by,10.1016/S1367-5931(02)00361-7,The genesis of high-throughput structure-based drug discovery using protein crystallography,"[['Peter', '', 'Kuhn'], ['Keith', '', 'Wilson'], ['Marianne', 'G', 'Patch'], ['Raymond', 'C', 'Stevens']]",Current Opinion in Chemical Biology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1367593102003617', u'http://linkinghub.elsevier.com/retrieve/pii/S1367593102003617', u'http://www.osti.gov/servlets/purl/815941']"
10.1038/363418a0,"Rameix-Welti, M., Agou, F., Buchy, P., et. al, Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00645-06,Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir,"[['M.', 'A.', 'Rameix-Welti'], ['F.', '', 'Agou'], ['P.', '', 'Buchy'], ['S.', '', 'Mardy'], ['J.', 'T.', 'Aubin'], ['M.', '', 'Veron'], ['S.', 'van der', 'Werf'], ['N.', '', 'Naffakh']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://www.ctcd.edu/science/tanderson/documents/OseltamivirSensitivityH5N1.pdf', u'http://aac.asm.org/cgi/reprint/50/11/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00645-06']"
10.1038/363418a0,"LENEVA, I., GOLOUBEVA, O., FENTON, R., et. al, Efficacy of Zanamivir against Avian Influenza A Viruses That Possess Genes Encoding H5N1 Internal Proteins and Are Pathogenic in Mammals, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1216-1224.2001,Efficacy of Zanamivir against Avian Influenza A Viruses That Possess Genes Encoding H5N1 Internal Proteins and Are Pathogenic in Mammals,"[['IRINA', 'A.', 'LENEVA'], ['OLGA', '', 'GOLOUBEVA'], ['ROBERT', 'J.', 'FENTON'], ['MARGARET', '', 'TISDALE'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/4/1216.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1216-1224.2001']"
10.1038/363418a0,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
10.1038/363418a0,"Ferraris, O., Lina, B., , Mutations of neuraminidase implicated in neuraminidase inhibitors resistance, Journal of Clinical Virology, 2008",cited-by,10.1016/j.jcv.2007.10.020,Mutations of neuraminidase implicated in neuraminidase inhibitors resistance,"[['Olivier', '', 'Ferraris'], ['Bruno', '', 'Lina']]",Journal of Clinical Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1386653207003903', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653207003903']"
10.1038/363418a0,"Treanor, J., Falsey, A., , Respiratory viral infections in the elderly, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00062-5,Respiratory viral infections in the elderly,"[['John', '', 'Treanor'], ['Ann', '', 'Falsey']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000625', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000625']"
10.1038/363418a0,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']"
10.1038/363418a0,"Brown, E., , Influenza virus genetics, Biomedicine & Pharmacotherapy, 2000",cited-by,10.1016/S0753-3322(00)89026-5,Influenza virus genetics,"[['E.', 'G.', 'Brown']]",Biomedicine & Pharmacotherapy,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0753332200890265', u'http://linkinghub.elsevier.com/retrieve/pii/S0753332200890265']"
10.1038/363418a0,"Mahmoudian, M., Noble, D., Drake, C., et. al, An efficient process for production of n-acetylneuraminic acid using n-acetylneuraminic acid aldolase, Enzyme and Microbial Technology, 1997",cited-by,10.1016/S0141-0229(96)00180-9,An efficient process for production of n-acetylneuraminic acid using n-acetylneuraminic acid aldolase,"[['M.', '', 'Mahmoudian'], ['D.', '', 'Noble'], ['C.', 'S.', 'Drake'], ['R.', 'F.', 'Middleton'], ['D.', 'S.', 'Montgomery'], ['J.', 'E.', 'Piercey'], ['D.', '', 'Ramlakhan'], ['M.', '', 'Todd'], ['M.', 'J.', 'Dawson']]",Enzyme and Microbial Technology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0141022996001809', u'http://linkinghub.elsevier.com/retrieve/pii/S0141022996001809']"
10.1038/363418a0,"Obayashi, E., Yoshida, H., Kawai, F., et. al, The structural basis for an essential subunit interaction in influenza virus RNA polymerase, Nature, 2008",cited-by,10.1038/nature07225,The structural basis for an essential subunit interaction in influenza virus RNA polymerase,"[['Eiji', '', 'Obayashi'], ['Hisashi', '', 'Yoshida'], ['Fumihiro', '', 'Kawai'], ['Naoya', '', 'Shibayama'], ['Atsushi', '', 'Kawaguchi'], ['Kyosuke', '', 'Nagata'], ['Jeremy', 'R. H.', 'Tame'], ['Sam-Yong', '', 'Park']]",Nature,2008,"[u'http://www.nature.com/doifinder/10.1038/nature07225', u'http://adsabs.harvard.edu/abs/2008Natur.454.1127O', u'http://dx.doi.org/10.1038/nature07225']"
10.1038/363418a0,"Kati, W., Montgomery, D., Carrick, R., et. al, In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.1014-1021.2002,"In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication","[['Warren', 'M.', 'Kati'], ['Debra', '', 'Montgomery'], ['Robert', '', 'Carrick'], ['Larisa', '', 'Gubareva'], ['Clarence', '', 'Maring'], ['Keith', '', 'McDaniel'], ['Kevin', '', 'Steffy'], ['Akhteruzzaman', '', 'Molla'], ['Frederick', '', 'Hayden'], ['Dale', '', 'Kempf'], ['William', '', 'Kohlbrenner']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/1014.pdf', u'http://journals.pasteur.ac.ir/AAC02/46(4)/1014.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.1014-1021.2002']"
10.1038/363418a0,"Ferraris, O., Kessler, N., Lina, B., , Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice, Antiviral Research, 2005",cited-by,10.1016/j.antiviral.2005.07.004,Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice,"[['O.', '', 'Ferraris'], ['N.', '', 'Kessler'], ['B.', '', 'Lina']]",Antiviral Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205001427', u'http://birdflubook.com/resources/0Ferrarisxxx.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205001427']"
10.1038/363418a0,"ELIASSEN, T., Froystad, M., DANNEVIG, B., et. al, Initial Events in Infectious Salmon Anemia Virus Infection: Evidence for the Requirement of a Low-pH Step, Journal of Virology, 2000",cited-by,10.1128/JVI.74.1.218-227.2000,Initial Events in Infectious Salmon Anemia Virus Infection: Evidence for the Requirement of a Low-pH Step,"[['TRYGVE', 'MEUM', 'ELIASSEN'], ['M.', 'K.', 'Froystad'], ['BIRGIT', 'HELENE', 'DANNEVIG'], ['MONIKA', '', 'JANKOWSKA'], ['ANDREAS', '', 'BRECH'], ['KNUT', '', 'FALK'], ['K.', '', 'Romoren'], ['T.', '', 'Gjoen']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/1/218.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.1.218-227.2000']"
10.1038/363418a0,"Moscona, A., , Medical Management of Influenza Infection, Annual Review of Medicine, 2008",cited-by,10.1146/annurev.med.59.061506.213121,Medical Management of Influenza Infection,"[['Anne', '', 'Moscona']]",Annual Review of Medicine,2008,"[u'http://www.cornellpediatrics.org/bm~doc/medical-management-of-inf.pdf', u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.med.59.061506.213121']"
10.1038/363418a0,"Leyssen, P., Clercq, E., Neyts, J., , Molecular strategies to inhibit the replication of RNA viruses, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2008.01.004,Molecular strategies to inhibit the replication of RNA viruses,"[['Pieter', '', 'Leyssen'], ['Erik', 'De', 'Clercq'], ['Johan', '', 'Neyts']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208000247', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208000247']"
10.1038/363418a0,"Yen, H., Hoffmann, E., Taylor, G., et. al, Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses, Journal of Virology, 2006",cited-by,10.1128/JVI.00477-06,Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses,"[['Hui-Ling', '', 'Yen'], ['Erich', '', 'Hoffmann'], ['Garry', '', 'Taylor'], ['Christoph', '', 'Scholtissek'], ['Arnold', 'S.', 'Monto'], ['Robert', 'G.', 'Webster'], ['Elena', 'A.', 'Govorkova']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00477-06', u'http://jvi.asm.org/cgi/reprint/80/17/8787.pdf']"
10.1038/363418a0,"Mittl, P., Grütter, M., , Structural genomics: opportunities and challenges, Current Opinion in Chemical Biology, 2001",cited-by,10.1016/S1367-5931(00)00221-0,Structural genomics: opportunities and challenges,"[['Peer', 'R. E', 'Mittl'], ['Markus', 'G', 'Gr\xc3\xbctter']]",Current Opinion in Chemical Biology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1367593100002210', u'http://linkinghub.elsevier.com/retrieve/pii/S1367593100002210']"
10.1038/363418a0,"Congreve, M., Murray, C., Blundell, T., , Keynote review: Structural biology and drug discovery, Drug Discovery Today, 2005",cited-by,10.1016/S1359-6446(05)03484-7,Keynote review: Structural biology and drug discovery,"[['Miles', '', 'Congreve'], ['Christopher', 'W.', 'Murray'], ['Tom', 'L.', 'Blundell']]",Drug Discovery Today,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1359644605034847', u'http://linkinghub.elsevier.com/retrieve/pii/S1359644605034847']"
10.1038/363418a0,"Shoichet, B., Kuntz, I., , Predicting the structure of protein complexes: a step in the right direction, Chemistry & Biology, 1996",cited-by,10.1016/S1074-5521(96)90256-2,Predicting the structure of protein complexes: a step in the right direction,"[['Brian', 'K.', 'Shoichet'], ['Irwin', 'D.', 'Kuntz']]",Chemistry & Biology,1996,"[u'http://www.sciencedirect.com/science/article/pii/S1074552196902562', u'http://linkinghub.elsevier.com/retrieve/pii/S1074552196902562']"
10.1038/363418a0,"RYAN, D., TICEHURST, J., DEMPSEY, A., et. al, GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets, , 1995",cited-by,"14265528GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","GG167 (4Guanidino2,4-Dideoxy-2,3-Dehydro-N- Acetylneuraminic Acid) Is a Potent Inhibitor of Influenza Virus in Ferrets","[['D.', 'MICHAEL', 'RYAN'], ['JULIA', '', 'TICEHURST'], ['ANDMARIA', 'H.', 'DEMPSEY'], ['Glaxo', '', 'Wellcome']]",,1995,"[u'http://aac.asm.org/cgi/reprint/39/11/2583.pdf', u'http://aac.highwire.org/cgi/reprint/39/11/2583.pdf']"
10.1038/363418a0,"Davis, A., Murray, H., Handman, E., , Drugs against leishmaniasis: a synergy of technology and partnerships, Trends in Parasitology, 2004",cited-by,10.1016/j.pt.2003.11.006,Drugs against leishmaniasis: a synergy of technology and partnerships,"[['Antony', 'J.', 'Davis'], ['Henry', 'W.', 'Murray'], ['Emanuela', '', 'Handman']]",Trends in Parasitology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1471492203003180', u'http://linkinghub.elsevier.com/retrieve/pii/S1471492203003180']"
10.1038/363418a0,"Barnett, J., Cadman, A., Burrell, F., et. al, In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir, Virology, 1999",cited-by,10.1006/viro.1999.0058,In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir,"[['J.', 'M.', 'Barnett'], ['A.', '', 'Cadman'], ['F.', 'M.', 'Burrell'], ['S.', 'H.', 'Madar'], ['A.', 'P.', 'Lewis'], ['M.', '', 'Tisdale'], ['R.', '', 'Bethell']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299900582', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299900582']"
10.1038/363418a0,"Stephenson, I., Democratis, J., Lackenby, A., et. al, Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children, Clinical Infectious Diseases, 2009",cited-by,10.1086/596311,Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children,"[['Iain', '', 'Stephenson'], ['Jane', '', 'Democratis'], ['Angie', '', 'Lackenby'], ['Teresa', '', 'McNally'], ['James', '', 'Smith'], ['Manish', '', 'Pareek'], ['Joanna', '', 'Ellis'], ['Alison', '', 'Bermingham'], ['Karl', '', 'Nicholson'], ['Maria', '', 'Zambon']]",Clinical Infectious Diseases,2009,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/596311']
10.1038/363418a0,"Magnani, J., Ernst, B., , From carbohydrate leads to glycomimetic drugs, Nature Reviews Drug Discovery, 2009",cited-by,10.1038/nrd2852,From carbohydrate leads to glycomimetic drugs,"[['John', 'L.', 'Magnani'], ['Beat', '', 'Ernst']]",Nature Reviews Drug Discovery,2009,"[u'http://www.nature.com/doifinder/10.1038/nrd2852', u'http://dx.doi.org/10.1038/nrd2852']"
10.1038/363418a0,"GREENGARD, O., POLTORATSKAIA, N., LEIKINA, E., et. al, The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA, Journal of Virology, 2000",cited-by,10.1128/JVI.74.23.11108-11114.2000,The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA,"[['OLGA', '', 'GREENGARD'], ['NATALIA', '', 'POLTORATSKAIA'], ['EVGENIA', '', 'LEIKINA'], ['JOSHUA', '', 'ZIMMERBERG'], ['ANNE', '', 'MOSCONA']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/23/11108.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.23.11108-11114.2000']"
10.1038/363418a0,"Elinav, E., Strowig, T., Henao-Mejia, J., et. al, NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis, Cell, 2011",cited-by,10.1016/j.cell.2011.04.022,NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis,"[['Eran', '', 'Elinav'], ['Till', '', 'Strowig'], ['Jorge', '', 'Henao-Mejia'], ['John', '', 'Bertin']]",Cell,2011,[u'http://www.sciencedirect.com/science/article/pii/S0092867411004806']
10.1038/363418a0,"Mobley, D., Dill, K., , Binding of Small-Molecule Ligands to Proteins: “What You See” Is Not Always “What You Get”, Structure, 2009",cited-by,10.1016/j.str.2009.02.010,Binding of Small-Molecule Ligands to Proteins: “What You See” Is Not Always “What You Get”,"[['David', 'L.', 'Mobley'], ['Ken', 'A.', 'Dill']]",Structure,2009,"[u'http://www.dillgroup.ucsf.edu/dl_papers/StructureFold09.pdf', u'http://www.sciencedirect.com/science/article/pii/S0969212609000926', u'http://laplace.compbio.ucsf.edu/dl_papers/StructureFold09.pdf', u'http://www.dillgroup.ucsf.edu/~dmobley/my_papers/wysinwyg.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212609000926']"
10.1038/363418a0,"Russell, R., Kerry, P., Stevens, D., et. al, Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion, Proceedings of The National Academy of Sciences, 2008",cited-by,10.1073/pnas.0807142105,Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion,"[['Rupert', 'J.', 'Russell'], ['Philip', 'S.', 'Kerry'], ['David', 'J.', 'Stevens'], ['David', 'A.', 'Steinhauer'], ['Stephen', 'R.', 'Martin'], ['Steven', 'J.', 'Gamblin'], ['John', 'J.', 'Skehel']]",Proceedings of The National Academy of Sciences,2008,"[u'http://www.pnas.org/cgi/doi/10.1073/pnas.0807142105', u'http://alt.coxnewsweb.com/shared-blogs/austin/health/upload/2009/02/premier_flu_researcher_at_ut_s/PNAS-Chemical inhibitor against HA.pdf']"
10.1038/363418a0,"Zurcher, T., Yates, P., Daly, J., et. al, Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro, , 2006",cited-by,6952646Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro,Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro,"[['Thomas', '', 'Zurcher'], ['Phillip', 'J.', 'Yates'], ['Janet', '', 'Daly'], ['Anjali', '', 'Sahasrabudhe'], ['Matthew', '', 'Walters'], ['Laura', '', 'Dash'], ['Margaret', '', 'Tisdale']]",,2006,"[u'http://jac.oxfordjournals.org/cgi/reprint/58/4/723.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkl321v1.pdf']"
10.1038/363418a0,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671']
10.1038/363418a0,"Tondi, D., Slomczynska, U., Costi, M., et. al, Structure-based discovery and in-parallel optimization of novelcompetitive inhibitors of thymidylate synthase, Chemistry & Biology, 1999",cited-by,10.1016/S1074-5521(99)80077-5,Structure-based discovery and in-parallel optimization of novelcompetitive inhibitors of thymidylate synthase,"[['Donatella', '', 'Tondi'], ['Ursula', '', 'Slomczynska'], ['M.', 'Paola', 'Costi'], ['D.', 'Martin', 'Watterson'], ['Stefano', '', 'Ghelli'], ['Brian', 'K.', 'Shoichet']]",Chemistry & Biology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1074552199800775', u'http://linkinghub.elsevier.com/retrieve/pii/S1074552199800775']"
10.1038/363418a0,"BANTIA, S., GHATE, A., ANANTH, S., et. al, Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140, , 1998",cited-by,13869212Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140,Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140,"[['SHANTA', '', 'BANTIA'], ['ANITA', 'A.', 'GHATE'], ['SANDYA', 'L.', 'ANANTH'], ['Y.', 'SUDHAKAR', 'BABU'], ['GILLIAN', 'M.', 'AIR'], ['GERALD', 'M.', 'WALSH']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/4/801.pdf']
10.1038/363418a0,"Porotto, M., Murrell, M., Greengard, O., et. al, Inhibition of Parainfluenza Virus Type 3 and Newcastle Disease Virus Hemagglutinin-Neuraminidase Receptor Binding: Effect of Receptor Avidity and Steric Hindrance at the Inhibitor Binding Sites, Journal of Virology, 2004",cited-by,10.1128/JVI.78.24.13911-13919.2004,Inhibition of Parainfluenza Virus Type 3 and Newcastle Disease Virus Hemagglutinin-Neuraminidase Receptor Binding: Effect of Receptor Avidity and Steric Hindrance at the Inhibitor Binding Sites,"[['Matteo', '', 'Porotto'], ['Matthew', '', 'Murrell'], ['Olga', '', 'Greengard'], ['Michael', 'C.', 'Lawrence'], ['J.', 'L.', 'McKimm-Breschkin'], ['Anne', '', 'Moscona']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/24/13911.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.24.13911-13919.2004']"
10.1038/363418a0,"COCCHI, F., LOPEZ, M., DUBREUIL, P., et. al, Chimeric Nectin1Poliovirus Receptor Molecules Identify a Nectin1 Region Functional in Herpes Simplex Virus Entry, Journal of Virology, 2001",cited-by,10.1128/JVI.75.17.7987-7994.2001,Chimeric Nectin1Poliovirus Receptor Molecules Identify a Nectin1 Region Functional in Herpes Simplex Virus Entry,"[['FRANCESCA', '', 'COCCHI'], ['MARC', '', 'LOPEZ'], ['PATRICE', '', 'DUBREUIL'], ['GABRIELLA', 'CAMPADELLI', 'FIUME'], ['LAURA', '', 'MENOTTI']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/17/7987.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.17.7987-7994.2001']"
10.1038/363418a0,"DeMarco, M., Woods, R., , Structural glycobiology: A game of snakes and ladders, Glycobiology, 2008",cited-by,10.1093/glycob/cwn026,Structural glycobiology: A game of snakes and ladders,"[['Mari', 'L', 'DeMarco'], ['Robert', 'J', 'Woods']]",Glycobiology,2008,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwn026v1.pdf', u'http://glycob.oxfordjournals.org/cgi/reprint/18/6/426.pdf', u'http://www.glycob.oxfordjournals.org/cgi/doi/10.1093/glycob/cwn026']"
10.1038/363418a0,"Noah, J., Severson, W., Noah, D., et. al, A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals, Antiviral Research, 2007",cited-by,10.1016/j.antiviral.2006.07.006,A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals,"[['James', 'W.', 'Noah'], ['William', '', 'Severson'], ['Diana', 'L.', 'Noah'], ['Lynn', '', 'Rasmussen'], ['E.', 'Lucile', 'White'], ['Colleen', 'B.', 'Jonsson']]",Antiviral Research,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0166354206002075', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206002075']"
10.1038/363418a0,"Noah, D., Krug, R., , Influenza Virus Virulence and Its Molecular Determinants, Advances in Virus Research, 2005",cited-by,10.1016/S0065-3527(05)65004-X,Influenza Virus Virulence and Its Molecular Determinants,"[['Diana', 'L.', 'Noah'], ['Robert', 'M.', 'Krug']]",Advances in Virus Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S006535270565004X', u'http://linkinghub.elsevier.com/retrieve/pii/S006535270565004X']"
10.1038/363418a0,"Bowen, W., Cassey, B., Jones, P., et. al, Modelling the performance of membrane nanofiltration—application to an industrially relevant separation, Journal of Membrane Science, 2004",cited-by,10.1016/j.memsci.2004.04.028,Modelling the performance of membrane nanofiltration—application to an industrially relevant separation,"[['W.', 'Richard', 'Bowen'], ['Barrie', '', 'Cassey'], ['Peter', '', 'Jones'], ['Darren', 'L.', 'Oatley']]",Journal of Membrane Science,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0376738804003369', u'http://linkinghub.elsevier.com/retrieve/pii/S0376738804003369']"
10.1038/363418a0,"Laver, W., Bischofberger, N., Webster, R., , The Origin and Control of Pandemic Influenza, , 2000",cited-by,10259737The Origin and Control of Pandemic Influenza,The Origin and Control of Pandemic Influenza,"[['W.', 'Graeme', 'Laver'], ['Norbert', '', 'Bischofberger'], ['Robert', 'G.', 'Webster']]",,2000,"[u'http://birdflubook.com/resources/LAVER173.pdf', u'http://muse.jhu.edu/about/publishers.html/journals/perspectives_in_biology_and_medicine/v043/43.2laver.html']"
10.1038/363418a0,"Baigent, S., Bethell, R., McCauley, J., , Genetic Analysis Reveals That Both Haemagglutinin and Neuraminidase Determine the Sensitivity of Naturally Occurring Avian Influenza Viruses to Zanamivir in Vitro, Virology, 1999",cited-by,10.1006/viro.1999.9931,Genetic Analysis Reveals That Both Haemagglutinin and Neuraminidase Determine the Sensitivity of Naturally Occurring Avian Influenza Viruses to Zanamivir in Vitro,"[['S.', 'J.', 'Baigent'], ['R.', 'C.', 'Bethell'], ['J.', 'W.', 'McCauley']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299999312', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299999312']"
10.1038/363418a0,"Shibasaki, M., Kanai, M., , Synthetic Strategies for Oseltamivir Phosphate, European Journal of Organic Chemistry, 2008",cited-by,10.1002/ejoc.200800033,Synthetic Strategies for Oseltamivir Phosphate,"[['Masakatsu', '', 'Shibasaki'], ['Motomu', '', 'Kanai']]",European Journal of Organic Chemistry,2008,[u'http://doi.wiley.com/10.1002/ejoc.200800033']
10.1038/363418a0,"Amaya, M., Buschiazzo, A., Nguyen, T., et. al, The High Resolution Structures of Free and Inhibitor-bound Trypanosoma rangeli Sialidase and its Comparison with T. cruzi Trans-sialidase, Journal of Molecular Biology, 2003",cited-by,10.1016/S0022-2836(02)01306-2,The High Resolution Structures of Free and Inhibitor-bound Trypanosoma rangeli Sialidase and its Comparison with T. cruzi Trans-sialidase,"[['Maria', 'Fernanda', 'Amaya'], ['Alejandro', '', 'Buschiazzo'], ['Tong', '', 'Nguyen'], ['Pedro', 'M.', 'Alzari']]",Journal of Molecular Biology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0022283602013062', u'http://linkinghub.elsevier.com/retrieve/pii/S0022283602013062']"
10.1038/363418a0,"Hosfield, D., Palan, J., Hilgers, M., et. al, A fully integrated protein crystallization platform for small-molecule drug discovery, Journal of Structural Biology, 2003",cited-by,10.1016/S1047-8477(03)00051-0,A fully integrated protein crystallization platform for small-molecule drug discovery,"[['David', '', 'Hosfield'], ['John', '', 'Palan'], ['Mark', '', 'Hilgers'], ['Daniel', '', 'Scheibe'], ['Duncan', 'E.', 'McRee'], ['Raymond', 'C.', 'Stevens']]",Journal of Structural Biology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1047847703000510', u'http://linkinghub.elsevier.com/retrieve/pii/S1047847703000510']"
10.1038/363418a0,"Laver, G., Garman, E., , Pandemic influenza: its origin and control, Microbes and Infection, 2002",cited-by,10.1016/S1286-4579(02)00013-8,Pandemic influenza: its origin and control,"[['Graeme', '', 'Laver'], ['Elspeth', '', 'Garman']]",Microbes and Infection,2002,"[u'http://birdflubook.com/resources/laver1309.pdf', u'http://www.sciencedirect.com/science/article/pii/S1286457902000138', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-37.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457902000138']"
10.1038/363418a0,"Lukong, K., Chang, Y., Richard, C., et. al, Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex, Human Molecular Genetics, 2000",cited-by,10.1093/hmg/9.7.1075,Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex,"[['Kiven', 'E.', 'Lukong'], ['Yuan', '', 'Chang'], ['Catherine', '', 'Richard'], ['George', '', 'Thomas'], ['William', '', 'Carey'], ['Anna', '', 'Tylki-Szymanska'], ['Barbara', '', 'Czartoryska'], ['Tina', '', 'Buchholz'], ['Alexey', 'V.', 'Pshezhetsky']]",Human Molecular Genetics,2000,"[u'http://hmg.oxfordjournals.org/cgi/reprint/9/7/1075.pdf', u'http://www.hmg.oupjournals.org/cgi/doi/10.1093/hmg/9.7.1075']"
10.1038/363418a0,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']"
10.1038/363418a0,"Yan, X., Hollis, T., Svinth, M., et. al, Structure-based identification of a ricin inhibitor 1 1 Edited by R. Huber, Journal of Molecular Biology, 1997",cited-by,10.1006/jmbi.1996.0865,Structure-based identification of a ricin inhibitor 1 1 Edited by R. Huber,"[['Xinjian', '', 'Yan'], ['Thomas', '', 'Hollis'], ['Maria', '', 'Svinth'], ['Philip', '', 'Day'], ['Arthur', 'F.', 'Monzingo'], ['George', 'W. A.', 'Milne'], ['Jon', 'D.', 'Robertus']]",Journal of Molecular Biology,1997,"[u'http://robertus.cm.utexas.edu/papers/rta-pta.pdf', u'http://www.sciencedirect.com/science/article/pii/S0022283696908657', u'http://linkinghub.elsevier.com/retrieve/pii/S0022283696908657']"
10.1038/363418a0,"Colacino, J., Chirgadze, N., Garman, E., et. al, A Single Sequence Change Destabilizes the Influenza Virus Neuraminidase Tetramer, Virology, 1997",cited-by,10.1006/viro.1997.8709,A Single Sequence Change Destabilizes the Influenza Virus Neuraminidase Tetramer,"[['Joseph', 'M', 'Colacino'], ['Nickolay', 'Y', 'Chirgadze'], ['Elspeth', '', 'Garman'], ['K.', 'Gopal', 'Murti'], ['Richard', 'J', 'Loncharich'], ['Angela', 'J', 'Baxter'], ['Kirk', 'A', 'Staschke'], ['W.', 'Graeme', 'Laver']]",Virology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0042682297987092', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682297987092']"
10.1016~S0140-6736(00)02288-1,"Kim CU, Lew W, Williams MA, et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 1997; 119: 681–90.",references,10.1021/ja963036t,"Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site:  Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity","[[u'Choung', u'U.', u'Kim'], [u'Willard', u'', u'Lew'], [u'Matthew', u'A.', u'Williams'], [u'Hongtao', u'', u'Liu'], [u'Lijun', u'', u'Zhang'], [u'S.', u'', u'Swaminathan'], [u'Norbert', u'', u'Bischofberger'], [u'Ming', u'S.', u'Chen'], [u'Dirk', u'B.', u'Mendel'], [u'Chun', u'Y.', u'Tai'], [u'W.', u'Graeme', u'Laver'], [u'Raymond', u'C.', u'Stevens']]",Journal of The American Chemical Society,1997,[u'http://pubs.acs.org/doi/abs/10.1021/ja963036t'],./output/10.1016~S0140-6736(00)02288-1/10.1021~ja963036t
10.1021/ja963036t,"Kiso, M., Mitamura, K., Sakai-Tagawa, Y., et. al, Resistant influenza A viruses in children treated with oseltamivir: descriptive study, Lancet, 2004",cited-by,10.1016/S0140-6736(04)16934-1,Resistant influenza A viruses in children treated with oseltamivir: descriptive study,"[['Maki', '', 'Kiso'], ['Keiko', '', 'Mitamura'], ['Yuko', '', 'Sakai-Tagawa'], ['Kyoko', '', 'Shiraishi'], ['Chiharu', '', 'Kawakami'], ['Kazuhiro', '', 'Kimura'], ['Frederick', 'G', 'Hayden'], ['Norio', '', 'Sugaya'], ['Yoshihiro', '', 'Kawaoka']]",Lancet,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0140673604169341', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-19.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673604169341']"
10.1021/ja963036t,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, Lancet, 2000",cited-by,10.1016/S0140-6736(99)11433-8,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699114338', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699114338']"
10.1021/ja963036t,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1021/ja963036t,"Russell, R., Haire, L., Stevens, D., et. al, The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design, Nature, 2006",cited-by,10.1038/nature05114,The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design,"[['Rupert', 'J.', 'Russell'], ['Lesley', 'F.', 'Haire'], ['David', 'J.', 'Stevens'], ['Patrick', 'J.', 'Collins'], ['Yi', 'Pu', 'Lin'], ['G.', 'Michael', 'Blackburn'], ['Alan', 'J.', 'Hay'], ['Steven', 'J.', 'Gamblin'], ['John', 'J.', 'Skehel']]",Nature,2006,"[u'http://www.nature.com/doifinder/10.1038/nature05114', u'http://dx.doi.org/10.1038/nature05114']"
10.1021/ja963036t,"Bräse, S., Gil, C., Knepper, K., et. al, Organic Azides: An Exploding Diversity of a Unique Class of Compounds, Angewandte Chemie-international Edition, 2005",cited-by,10.1002/anie.200400657,Organic Azides: An Exploding Diversity of a Unique Class of Compounds,"[['Stefan', '', 'Br\xc3\xa4se'], ['Carmen', '', 'Gil'], ['Kerstin', '', 'Knepper'], ['Viktor', '', 'Zimmermann']]",Angewandte Chemie-international Edition,2005,[u'http://doi.wiley.com/10.1002/anie.200400657']
10.1021/ja963036t,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']"
10.1021/ja963036t,"Wagner, R., Matrosovich, M., Klenk, H., , Functional balance between haemagglutinin and neuraminidase in influenza virus infections, Reviews in Medical Virology, 2002",cited-by,10.1002/rmv.352,Functional balance between haemagglutinin and neuraminidase in influenza virus infections,"[['Ralf', '', 'Wagner'], ['Mikhail', '', 'Matrosovich'], ['Hans-Dieter', '', 'Klenk']]",Reviews in Medical Virology,2002,[u'http://doi.wiley.com/10.1002/rmv.352']
10.1021/ja963036t,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, , 0",cited-by,12760434Influenza virus neuraminidase inhibitors,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",,0,[u'http://www.birdflumanual.com/resources/Medical_References/files/antineuraminidase%20therapy%20lancet.pdf']
10.1021/ja963036t,"Ives, J., Carr, J., Mendel, D., et. al, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(02)00053-0,The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo,"[['J.', 'A. L.', 'Ives'], ['J.', 'A.', 'Carr'], ['D.', 'B.', 'Mendel'], ['C.', 'Y.', 'Tai'], ['R.', '', 'Lambkin'], ['L.', '', 'Kelly'], ['J.', 'S.', 'Oxford'], ['F.', 'G.', 'Hayden'], ['N.', 'A.', 'Roberts']]",Antiviral Research,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-20.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354202000530', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-21.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354202000530']"
10.1021/ja963036t,"Asano, N., , Glycosidase inhibitors: update and perspectives on practical use, Glycobiology, 2003",cited-by,10.1093/glycob/cwg090,Glycosidase inhibitors: update and perspectives on practical use,"[['Naoki', '', 'Asano']]",Glycobiology,2003,"[u'http://glycob.oxfordjournals.org/cgi/reprint/cwg090v1.pdf', u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/cwg090']"
10.1021/ja963036t,"McKimm-Breschkin, J., Trivedi, T., Hampson, A., et. al, Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir, Antimicrobial Agents and Chemotherapy, 2003",cited-by,10.1128/AAC.47.7.2264-2272.2003,Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir,"[['J.', '', 'McKimm-Breschkin'], ['T.', '', 'Trivedi'], ['A.', '', 'Hampson'], ['A.', '', 'Hay'], ['A.', '', 'Klimov'], ['M.', '', 'Tashiro'], ['F.', '', 'Hayden'], ['M.', '', 'Zambon']]",Antimicrobial Agents and Chemotherapy,2003,"[u'http://aac.highwire.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.7.2264-2272.2003']"
10.1021/ja963036t,"Clercq, E., , Antivirals and antiviral strategies, Nature Reviews Microbiology, 2004",cited-by,10.1038/nrmicro975,Antivirals and antiviral strategies,"[['Erik', 'De', 'Clercq']]",Nature Reviews Microbiology,2004,"[u'http://dx.doi.org/10.1038/nrmicro975', u'http://www.nature.com/doifinder/10.1038/nrmicro975']"
10.1021/ja963036t,"Clercq, E., , Strategies in the design of antiviral drugs, Nature Reviews Drug Discovery, 2002",cited-by,10.1038/nrd703,Strategies in the design of antiviral drugs,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2002,"[u'http://dx.doi.org/10.1038/nrd703', u'http://www.nature.com/doifinder/10.1038/nrd703']"
10.1021/ja963036t,"Collins, P., Haire, L., Lin, Y., et. al, Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants, Nature, 2008",cited-by,10.1038/nature06956,Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants,"[['Patrick', 'J.', 'Collins'], ['Lesley', 'F.', 'Haire'], ['Yi', 'Pu', 'Lin'], ['Junfeng', '', 'Liu'], ['Rupert', 'J.', 'Russell'], ['Philip', 'A.', 'Walker'], ['John', 'J.', 'Skehel'], ['Stephen', 'R.', 'Martin'], ['Alan', 'J.', 'Hay'], ['Steven', 'J.', 'Gamblin']]",Nature,2008,"[u'http://www.nature.com/doifinder/10.1038/nature06956', u'http://dx.doi.org/10.1038/nature06956']"
10.1021/ja963036t,"Karlsson, K., , Meaning and therapeutic potential of microbial recognition of host glycoconjugates, Molecular Microbiology, 1998",cited-by,10.1046/j.1365-2958.1998.00854.x,Meaning and therapeutic potential of microbial recognition of host glycoconjugates,"[['Karl-Anders', '', 'Karlsson']]",Molecular Microbiology,1998,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2958.1998.00854.x']
10.1021/ja963036t,"Oxford, J., , Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology, Reviews in Medical Virology, 2000",cited-by,10.1002/(SICI)1099-1654(200003/04)10:2<119::AID-RMV272>3.0.CO;2-O,"Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology","[['J.', 'S.', 'Oxford']]",Reviews in Medical Virology,2000,[u'http://doi.wiley.com/10.1002/%28SICI%291099-1654%28200003/04%2910%3A2%3C119%3A%3AAID-RMV272%3E3.0.CO%3B2-O']
10.1021/ja963036t,"Vilchez, R., McCurry, K., Dauber, J., et. al, Influenza Virus Infection in Adult Solid Organ Transplant Recipients, American Journal of Transplantation, 2002",cited-by,10.1034/j.1600-6143.2002.20315.x,Influenza Virus Infection in Adult Solid Organ Transplant Recipients,"[['Regis', 'A.', 'Vilchez'], ['Kenneth', '', 'McCurry'], ['James', '', 'Dauber'], ['Aldo', '', 'Iacono'], ['Bartley', '', 'Griffith'], ['John', '', 'Fung'], ['Shimon', '', 'Kusne']]",American Journal of Transplantation,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1600-6143.2002.20315.x']
10.1021/ja963036t,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf']
10.1021/ja963036t,"Tisdale, M., , Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors, Reviews in Medical Virology, 2000",cited-by,10.1002/(SICI)1099-1654(200001/02)10:1<45::AID-RMV265>3.0.CO;2-R,Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors,"[['Margaret', '', 'Tisdale']]",Reviews in Medical Virology,2000,[u'http://doi.wiley.com/10.1002/%28SICI%291099-1654%28200001/02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R']
10.1021/ja963036t,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
10.1021/ja963036t,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf']
10.1021/ja963036t,"Varghese, J., Smith, P., Sollis, S., et. al, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, Structure, 1998",cited-by,10.1016/S0969-2126(98)00075-6,Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase,"[['Joseph', 'N', 'Varghese'], ['Paul', 'W', 'Smith'], ['Steven', 'L', 'Sollis'], ['Tony', 'J', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Jennifer', 'L', 'McKimm-Breschkin'], ['Peter', 'M', 'Colman']]",Structure,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0969212698000756', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212698000756']"
10.1021/ja963036t,"Sidwell, R., Huffman, J., Barnard, D., et. al, Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor, Antiviral Research, 1998",cited-by,10.1016/S0166-3542(97)00065-X,"Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor","[['Robert', 'W.', 'Sidwell'], ['John', 'H.', 'Huffman'], ['Dale', 'L.', 'Barnard'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Ann', '', 'Morrison'], ['Timothy', '', 'Syndergaard'], ['Choung', 'U.', 'Kim']]",Antiviral Research,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016635429700065X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635429700065X']"
10.1021/ja963036t,"Coleman, R., Smyth, K., Cao, Q., et. al, Structure-based maximal affinity model predicts small-molecule druggability, Nature Biotechnology, 2007",cited-by,10.1038/nbt1273,Structure-based maximal affinity model predicts small-molecule druggability,"[['Ryan', 'G', 'Coleman'], ['Kathleen', 'T', 'Smyth'], ['Qing', '', 'Cao'], ['Patricia', '', 'Soulard'], ['Daniel', 'R', 'Caffrey'], ['Anna', 'C', 'Salzberg'], ['Enoch', 'S', 'Huang'], ['Alan', 'C', 'Cheng']]",Nature Biotechnology,2007,"[u'http://sws.bu.edu/eshuang/papers/Cheng07.pdf', u'http://www.nature.com/doifinder/10.1038/nbt1273', u'http://dx.doi.org/10.1038/nbt1273']"
10.1021/ja963036t,", Catalytic Asymmetric Hetero-Diels–Alder Reactions of Carbonyl Compounds and Imines, Angewandte Chemie-international Edition, 2000",cited-by,10.1002/1521-3773(20001016)39:20<3558::AID-ANIE3558>3.0.CO;2-I,Catalytic Asymmetric Hetero-Diels–Alder Reactions of Carbonyl Compounds and Imines,[],Angewandte Chemie-international Edition,2000,[u'http://doi.wiley.com/10.1002/1521-3773%2820001016%2939%3A20%3C3558%3A%3AAID-ANIE3558%3E3.0.CO%3B2-I']
10.1021/ja963036t,"Clercq, E., , Antiviral agents active against influenza A viruses, Nature Reviews Drug Discovery, 2006",cited-by,10.1038/nrd2175,Antiviral agents active against influenza A viruses,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2006,"[u'http://dx.doi.org/10.1038/nrd2175', u'http://www.nature.com/doifinder/10.1038/nrd2175']"
10.1021/ja963036t,"SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']"
10.1021/ja963036t,"Wang, M., Tai, C., Mendel, D., , Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.12.3809-3816.2002,Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir,"[['Michael', 'Z.', 'Wang'], ['Chun', 'Y.', 'Tai'], ['Dirk', 'B.', 'Mendel']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/12/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.12.3809-3816.2002']"
10.1021/ja963036t,"Itzstein, M., , The war against influenza: discovery and development of sialidase inhibitors, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2400,The war against influenza: discovery and development of sialidase inhibitors,"[['Mark', 'von', 'Itzstein']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2400', u'http://www.nature.com/doifinder/10.1038/nrd2400']"
10.1021/ja963036t,"MCKIMM-BRESCHKIN, J., SAHASRABUDHE, A., BLICK, T., et. al, Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors, , 1998",cited-by,13896013Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,"[['JENNIFER', 'L.', 'MCKIMM-BRESCHKIN'], ['ANJALI', '', 'SAHASRABUDHE'], ['TONY', 'J.', 'BLICK'], ['MANDY', '', 'MCDONALD'], ['PETER', 'M.', 'COLMAN'], ['GRAHAM', 'J.', 'HART'], ['RICHARD', 'C.', 'BETHELL'], ['JOSEPH', 'N.', 'VARGHESE']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/3/2456.pdf']
10.1021/ja963036t,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf']
10.1021/ja963036t,", Katalytische asymmetrische Hetero-Diels-Alder-Reaktionen von Carbonylverbindungen und Iminen, Angewandte Chemie, 2000",cited-by,10.1002/1521-3757(20001016)112:20<3702::AID-ANGE3702>3.0.CO;2-R,Katalytische asymmetrische Hetero-Diels-Alder-Reaktionen von Carbonylverbindungen und Iminen,[],Angewandte Chemie,2000,[u'http://doi.wiley.com/10.1002/1521-3757%2820001016%29112%3A20%3C3702%3A%3AAID-ANGE3702%3E3.0.CO%3B2-R']
10.1021/ja963036t,"Sears, P., Wong, C., , Enzyme action in glycoprotein synthesis, Experientia, 1998",cited-by,10.1007/s000180050146,Enzyme action in glycoprotein synthesis,"[['P.', '', 'Sears'], ['C.-H.', '', 'Wong']]",Experientia,1998,"[u'http://www.springerlink.com/index/dj9ypk3xnhdcw1t9.pdf', u'http://www.springerlink.com/content/dj9ypk3xnhdcw1t9', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s000180050146', u'http://www.springerlink.com/index/pdf/10.1007/s000180050146']"
10.1021/ja963036t,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']"
10.1021/ja963036t,"Kuhn, P., Wilson, K., Patch, M., et. al, The genesis of high-throughput structure-based drug discovery using protein crystallography, Current Opinion in Chemical Biology, 2002",cited-by,10.1016/S1367-5931(02)00361-7,The genesis of high-throughput structure-based drug discovery using protein crystallography,"[['Peter', '', 'Kuhn'], ['Keith', '', 'Wilson'], ['Marianne', 'G', 'Patch'], ['Raymond', 'C', 'Stevens']]",Current Opinion in Chemical Biology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1367593102003617', u'http://linkinghub.elsevier.com/retrieve/pii/S1367593102003617', u'http://www.osti.gov/servlets/purl/815941']"
10.1021/ja963036t,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']"
10.1021/ja963036t,"Obayashi, E., Yoshida, H., Kawai, F., et. al, The structural basis for an essential subunit interaction in influenza virus RNA polymerase, Nature, 2008",cited-by,10.1038/nature07225,The structural basis for an essential subunit interaction in influenza virus RNA polymerase,"[['Eiji', '', 'Obayashi'], ['Hisashi', '', 'Yoshida'], ['Fumihiro', '', 'Kawai'], ['Naoya', '', 'Shibayama'], ['Atsushi', '', 'Kawaguchi'], ['Kyosuke', '', 'Nagata'], ['Jeremy', 'R. H.', 'Tame'], ['Sam-Yong', '', 'Park']]",Nature,2008,"[u'http://www.nature.com/doifinder/10.1038/nature07225', u'http://adsabs.harvard.edu/abs/2008Natur.454.1127O', u'http://dx.doi.org/10.1038/nature07225']"
10.1021/ja963036t,"Serruto, D., Rappuoli, R., , Post-genomic vaccine development, Febs Letters, 2006",cited-by,10.1016/j.febslet.2006.04.084,Post-genomic vaccine development,"[['Davide', '', 'Serruto'], ['Rino', '', 'Rappuoli']]",Febs Letters,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0014579306005412', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-15.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0014579306005412']"
10.1021/ja963036t,"Bräse, S., Gil, C., Knepper, K., et. al, Organische Azide - explodierende Vielfalt bei einer einzigartigen Substanzklasse, Angewandte Chemie, 2005",cited-by,10.1002/ange.200400657,Organische Azide - explodierende Vielfalt bei einer einzigartigen Substanzklasse,"[['Stefan', '', 'Br\xc3\xa4se'], ['Carmen', '', 'Gil'], ['Kerstin', '', 'Knepper'], ['Viktor', '', 'Zimmermann']]",Angewandte Chemie,2005,[u'http://doi.wiley.com/10.1002/ange.200400657']
10.1021/ja963036t,"Ishikawa, H., Suzuki, T., Hayashi, Y., , High-Yielding Synthesis of the Anti-Influenza Neuramidase Inhibitor (−)-Oseltamivir by Three “One-Pot” Operations, Angewandte Chemie-international Edition, 2009",cited-by,10.1002/anie.200804883,High-Yielding Synthesis of the Anti-Influenza Neuramidase Inhibitor (−)-Oseltamivir by Three “One-Pot” Operations,"[['Hayato', '', 'Ishikawa'], ['Takaki', '', 'Suzuki'], ['Yujiro', '', 'Hayashi']]",Angewandte Chemie-international Edition,2009,[u'http://doi.wiley.com/10.1002/anie.200804883']
10.1021/ja963036t,"Reece, P., , Neuraminidase inhibitor resistance in influenza viruses, Journal of Medical Virology, 2007",cited-by,10.1002/jmv.20951,Neuraminidase inhibitor resistance in influenza viruses,"[['Phillip', 'Andrew', 'Reece']]",Journal of Medical Virology,2007,[u'http://doi.wiley.com/10.1002/jmv.20951']
10.1021/ja963036t,"Ikeda, M., , Towards bacterial strains overproducing l -tryptophan and other aromatics by metabolic engineering, Applied Microbiology and Biotechnology, 2006",cited-by,10.1007/s00253-005-0252-y,Towards bacterial strains overproducing l -tryptophan and other aromatics by metabolic engineering,"[['Masato', '', 'Ikeda']]",Applied Microbiology and Biotechnology,2006,"[u'http://www.springerlink.com/content/71185513831uk3u0', u'http://www.springerlink.com/index/71185513831uk3u0.pdf', u'http://www.springerlink.com/index/10.1007/s00253-005-0252-y', u'http://www.springerlink.com/index/pdf/10.1007/s00253-005-0252-y']"
10.1021/ja963036t,"Satoh, N., Akiba, T., Yokoshima, S., et. al, A Practical Synthesis of (−)-Oseltamivir, Angewandte Chemie-international Edition, 2007",cited-by,10.1002/anie.200701754,A Practical Synthesis of (−)-Oseltamivir,"[['Nobuhiro', '', 'Satoh'], ['Takahiro', '', 'Akiba'], ['Satoshi', '', 'Yokoshima'], ['Tohru', '', 'Fukuyama']]",Angewandte Chemie-international Edition,2007,"[u'http://doi.wiley.com/10.1002/anie.200701754', u'https://netfiles.uiuc.edu/jsmoore/www/09fa/notes/Fukuyama07.pdf']"
10.1021/ja963036t,"Moscona, A., , Medical Management of Influenza Infection, Annual Review of Medicine, 2008",cited-by,10.1146/annurev.med.59.061506.213121,Medical Management of Influenza Infection,"[['Anne', '', 'Moscona']]",Annual Review of Medicine,2008,"[u'http://www.cornellpediatrics.org/bm~doc/medical-management-of-inf.pdf', u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.med.59.061506.213121']"
10.1021/ja963036t,"Leyssen, P., Clercq, E., Neyts, J., , Molecular strategies to inhibit the replication of RNA viruses, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2008.01.004,Molecular strategies to inhibit the replication of RNA viruses,"[['Pieter', '', 'Leyssen'], ['Erik', 'De', 'Clercq'], ['Johan', '', 'Neyts']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208000247', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208000247']"
10.1021/ja963036t,"Magnani, J., Ernst, B., , From carbohydrate leads to glycomimetic drugs, Nature Reviews Drug Discovery, 2009",cited-by,10.1038/nrd2852,From carbohydrate leads to glycomimetic drugs,"[['John', 'L.', 'Magnani'], ['Beat', '', 'Ernst']]",Nature Reviews Drug Discovery,2009,"[u'http://www.nature.com/doifinder/10.1038/nrd2852', u'http://dx.doi.org/10.1038/nrd2852']"
10.1021/ja963036t,"Elinav, E., Strowig, T., Henao-Mejia, J., et. al, NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis, Cell, 2011",cited-by,10.1016/j.cell.2011.04.022,NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis,"[['Eran', '', 'Elinav'], ['Till', '', 'Strowig'], ['Jorge', '', 'Henao-Mejia'], ['John', '', 'Bertin']]",Cell,2011,[u'http://www.sciencedirect.com/science/article/pii/S0092867411004806']
10.1021/ja963036t,"Russell, R., Kerry, P., Stevens, D., et. al, Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion, Proceedings of The National Academy of Sciences, 2008",cited-by,10.1073/pnas.0807142105,Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion,"[['Rupert', 'J.', 'Russell'], ['Philip', 'S.', 'Kerry'], ['David', 'J.', 'Stevens'], ['David', 'A.', 'Steinhauer'], ['Stephen', 'R.', 'Martin'], ['Steven', 'J.', 'Gamblin'], ['John', 'J.', 'Skehel']]",Proceedings of The National Academy of Sciences,2008,"[u'http://www.pnas.org/cgi/doi/10.1073/pnas.0807142105', u'http://alt.coxnewsweb.com/shared-blogs/austin/health/upload/2009/02/premier_flu_researcher_at_ut_s/PNAS-Chemical inhibitor against HA.pdf']"
10.1021/ja963036t,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']"
10.1021/ja963036t,"Zurcher, T., Yates, P., Daly, J., et. al, Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro, , 2006",cited-by,6952646Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro,Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro,"[['Thomas', '', 'Zurcher'], ['Phillip', 'J.', 'Yates'], ['Janet', '', 'Daly'], ['Anjali', '', 'Sahasrabudhe'], ['Matthew', '', 'Walters'], ['Laura', '', 'Dash'], ['Margaret', '', 'Tisdale']]",,2006,"[u'http://jac.oxfordjournals.org/cgi/reprint/58/4/723.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkl321v1.pdf']"
10.1021/ja963036t,"Clercq, E., Field, H., , Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy, British Journal of Pharmacology, 2006",cited-by,10.1038/sj.bjp.0706446,Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy,"[['Erik', 'De', 'Clercq'], ['Hugh', 'J', 'Field']]",British Journal of Pharmacology,2006,[u'http://blackwell-synergy.com/doi/abs/10.1038/sj.bjp.0706446']
10.1021/ja963036t,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf']
10.1021/ja963036t,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671']
10.1021/ja963036t,"Zhang, T., , A Concise Synthesis of (−)-Oseltamivir, Angewandte Chemie-international Edition, 2008",cited-by,10.1002/anie.200800282,A Concise Synthesis of (−)-Oseltamivir,"[['Ting', '', 'Zhang']]",Angewandte Chemie-international Edition,2008,[u'http://doi.wiley.com/10.1002/anie.200800282']
10.1021/ja963036t,"Singer, A., Nunn, M., Gould, E., et. al, Potential Risks Associated with the Proposed Widespread Use of Tamiflu, Environmental Health Perspectives, 2006",cited-by,10.1289/ehp.9574,Potential Risks Associated with the Proposed Widespread Use of Tamiflu,"[['Andrew', 'C.', 'Singer'], ['Miles', 'A.', 'Nunn'], ['Ernest', 'A.', 'Gould'], ['Andrew', 'C.', 'Johnson']]",Environmental Health Perspectives,2006,[u'http://www.ehponline.org/ambra-doi-resolver/10.1289/ehp.9574']
10.1021/ja963036t,"Li, C., Yu, Q., Ye, Z., et. al, A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir, Cell Research, 2007",cited-by,10.1038/cr.2007.27,A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir,"[['Chuan-Yun', '', 'Li'], ['Quan', '', 'Yu'], ['Zhi-Qiang', '', 'Ye'], ['Ying', '', 'Sun'], ['Quanyuan', '', 'He'], ['Xiao-Mo', '', 'Li'], ['Wuxue', '', 'Zhang'], ['Jingchu', '', 'Luo'], ['Xiaocheng', '', 'Gu'], ['Xiaofeng', '', 'Zheng'], ['Liping', '', 'Wei']]",Cell Research,2007,"[u'http://www.nature.com/doifinder/10.1038/cr.2007.27', u'http://dx.doi.org/10.1038/cr.2007.27']"
10.1021/ja963036t,"Noah, D., Krug, R., , Influenza Virus Virulence and Its Molecular Determinants, Advances in Virus Research, 2005",cited-by,10.1016/S0065-3527(05)65004-X,Influenza Virus Virulence and Its Molecular Determinants,"[['Diana', 'L.', 'Noah'], ['Robert', 'M.', 'Krug']]",Advances in Virus Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S006535270565004X', u'http://linkinghub.elsevier.com/retrieve/pii/S006535270565004X']"
10.1021/ja963036t,"Crain, S., Shen, K., , Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice, Brain Research, 2004",cited-by,10.1016/j.brainres.2003.09.068,"Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice","[['Stanley', 'M.', 'Crain'], ['Ke-Fei', '', 'Shen']]",Brain Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0006899303038460', u'http://linkinghub.elsevier.com/retrieve/pii/S0006899303038460']"
10.1021/ja963036t,"Laver, W., Bischofberger, N., Webster, R., , The Origin and Control of Pandemic Influenza, , 2000",cited-by,10259737The Origin and Control of Pandemic Influenza,The Origin and Control of Pandemic Influenza,"[['W.', 'Graeme', 'Laver'], ['Norbert', '', 'Bischofberger'], ['Robert', 'G.', 'Webster']]",,2000,"[u'http://birdflubook.com/resources/LAVER173.pdf', u'http://muse.jhu.edu/about/publishers.html/journals/perspectives_in_biology_and_medicine/v043/43.2laver.html']"
10.1021/ja963036t,"Bouvier, N., Lowen, A., Palese, P., , Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol, Journal of Virology, 2008",cited-by,10.1128/JVI.01226-08,Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol,"[['Nicole', 'M.', 'Bouvier'], ['Anice', 'C.', 'Lowen'], ['Peter', '', 'Palese']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10052.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01226-08']"
10.1021/ja963036t,"Shibasaki, M., Kanai, M., , Synthetic Strategies for Oseltamivir Phosphate, European Journal of Organic Chemistry, 2008",cited-by,10.1002/ejoc.200800033,Synthetic Strategies for Oseltamivir Phosphate,"[['Masakatsu', '', 'Shibasaki'], ['Motomu', '', 'Kanai']]",European Journal of Organic Chemistry,2008,[u'http://doi.wiley.com/10.1002/ejoc.200800033']
10.1021/ja963036t,"Hosfield, D., Palan, J., Hilgers, M., et. al, A fully integrated protein crystallization platform for small-molecule drug discovery, Journal of Structural Biology, 2003",cited-by,10.1016/S1047-8477(03)00051-0,A fully integrated protein crystallization platform for small-molecule drug discovery,"[['David', '', 'Hosfield'], ['John', '', 'Palan'], ['Mark', '', 'Hilgers'], ['Daniel', '', 'Scheibe'], ['Duncan', 'E.', 'McRee'], ['Raymond', 'C.', 'Stevens']]",Journal of Structural Biology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1047847703000510', u'http://linkinghub.elsevier.com/retrieve/pii/S1047847703000510']"
10.1021/ja963036t,"Laver, G., Garman, E., , Pandemic influenza: its origin and control, Microbes and Infection, 2002",cited-by,10.1016/S1286-4579(02)00013-8,Pandemic influenza: its origin and control,"[['Graeme', '', 'Laver'], ['Elspeth', '', 'Garman']]",Microbes and Infection,2002,"[u'http://birdflubook.com/resources/laver1309.pdf', u'http://www.sciencedirect.com/science/article/pii/S1286457902000138', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-37.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457902000138']"
10.1021/ja963036t,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']"
10.1021/ja963036t,"Rinaudo, C., Telford, J., Rappuoli, R., et. al, Vaccinology in the genome era, Journal of Clinical Investigation, 2009",cited-by,10.1172/JCI38330,Vaccinology in the genome era,"[['C.', 'Daniela', 'Rinaudo'], ['John', 'L.', 'Telford'], ['Rino', '', 'Rappuoli'], ['Kate', 'L.', 'Seib']]",Journal of Clinical Investigation,2009,[u'http://www.jci.org/articles/view/38330']
10.1021/ja963036t,"Xu, X., Zhu, X., Dwek, R., et. al, Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase, Journal of Virology, 2008",cited-by,10.1128/JVI.00959-08,Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase,"[['Xiaojin', '', 'Xu'], ['Xueyong', '', 'Zhu'], ['Raymond', 'A.', 'Dwek'], ['James', '', 'Stevens'], ['Ian', 'A.', 'Wilson']]",Journal of Virology,2008,"[u'http://www.medicasur.com.mx/work/sites/Medica_en_linea/resources/LocalContent/8797/38/STRUCTURAL_CHARACTERIZATION_OF_THE_1918_INFLUENZA_VIRUS_H1N1_NEURAMINIDASE_10493_2008.pdf', u'http://jvi.asm.org/cgi/reprint/82/21/10493.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00959-08']"
10.1021/ja963036t,"McKimm-Breschkin, J., , Neuraminidase inhibitors for the treatment and prevention of influenza, Expert Opinion on Pharmacotherapy, 2002",cited-by,10.1517/14656566.3.2.103,Neuraminidase inhibitors for the treatment and prevention of influenza,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Expert Opinion on Pharmacotherapy,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.3.2.103']
10.1021/ja963036t,"Yun, N., Linde, N., Zacks, M., et. al, Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1), Virology, 2008",cited-by,10.1016/j.virol.2007.12.029,"Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)","[['Nadezhda', 'E.', 'Yun'], ['Nathaniel', 'S.', 'Linde'], ['Michele', 'A.', 'Zacks'], ['Ian', 'G.', 'Barr'], ['Aeron', 'C.', 'Hurt'], ['Jeanon', 'N.', 'Smith'], ['Natallia', '', 'Dziuba'], ['Michael', 'R.', 'Holbrook'], ['Lifang', '', 'Zhang'], ['John', 'M.', 'Kilpatrick'], ['C.', 'Shane', 'Arnold'], ['Slobodan', '', 'Paessler']]",Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0042682207008562', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682207008562']"
10.1021/ja963036t,"Du, Q., Wang, S., Chou, K., , Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus, Biochemical and Biophysical Research Communications, 2007",cited-by,10.1016/j.bbrc.2007.08.025,Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus,"[['Qi-Shi', '', 'Du'], ['Shu-Qing', '', 'Wang'], ['Kuo-Chen', '', 'Chou']]",Biochemical and Biophysical Research Communications,2007,"[u'http://people.virginia.edu/~fc8b/kchou/new/paper/BBRC_H5N1_150_loop_2007.pdf', u'http://www.sciencedirect.com/science/article/pii/S0006291X07017317', u'http://linkinghub.elsevier.com/retrieve/pii/S0006291X07017317']"
10.1021/ja963036t,"Varghese, J., , Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Development Research, 1999",cited-by,10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6,Development of neuraminidase inhibitors as anti-influenza virus drugs,"[['Joseph', 'N.', 'Varghese']]",Drug Development Research,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291098-2299%28199903/04%2946%3A3/4%3C176%3A%3AAID-DDR4%3E3.0.CO%3B2-6']
10.1021/ja963036t,", A Concise and Flexible Synthesis of the Potent Anti‐Influenza Agents Tamiflu and Tamiphosphor, Angewandte Chemie-international Edition, 2008",cited-by,10.1002/anie.200801959,A Concise and Flexible Synthesis of the Potent Anti‐Influenza Agents Tamiflu and Tamiphosphor,[],Angewandte Chemie-international Edition,2008,[u'http://doi.wiley.com/10.1002/anie.200801959']
10.1021/ja963036t,"Morrissey, B., Downard, K., , A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry, Proteomics, 2006",cited-by,10.1002/pmic.200500642,A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry,"[['Bethny', '', 'Morrissey'], ['Kevin', 'M.', 'Downard']]",Proteomics,2006,[u'http://doi.wiley.com/10.1002/pmic.200500642']
10.1021/ja963036t,"Kubinyi, H., , Structure-based design of enzyme inhibitors and receptor ligands, , 0",cited-by,11607428Structure-based design of enzyme inhibitors and receptor ligands,Structure-based design of enzyme inhibitors and receptor ligands,"[['Hugo', '', 'Kubinyi']]",,0,[u'http://www.kubinyi.de/coddd-1.pdf']
10.1021/ja963036t,"Sweet, C., Jakeman, K., Bush, K., et. al, Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.996-1004.2002,Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection,"[['Clive', '', 'Sweet'], ['Kenneth', 'J.', 'Jakeman'], ['Karen', '', 'Bush'], ['Pamela', 'C.', 'Wagaman'], ['Linda', 'A.', 'Mckown'], ['Anthony', 'J.', 'Streeter'], ['Daksha', '', 'Desai-Krieger'], ['Pooran', '', 'Chand'], ['Yarlagadda', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/996.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.996-1004.2002']"
10.1021/ja963036t,"Englund, J., , Antiviral therapy of influenza, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.122999,Antiviral therapy of influenza,"[['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500571', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500571']"
10.1021/ja963036t,"Williams, S., Davies, G., , Protein–carbohydrate interactions: learning lessons from nature, Trends in Biotechnology, 2001",cited-by,10.1016/S0167-7799(01)01699-7,Protein–carbohydrate interactions: learning lessons from nature,"[['Spencer', 'J.', 'Williams'], ['Gideon', 'J.', 'Davies']]",Trends in Biotechnology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0167779901016997', u'http://linkinghub.elsevier.com/retrieve/pii/S0167779901016997']"
10.1021/ja963036t,"Wang, B., Dwyer, D., Blyth, C., et. al, Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections, Antiviral Research, 2010",cited-by,10.1016/j.antiviral.2010.04.002,Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections,"[['Bin', '', 'Wang'], ['Dominic', 'E.', 'Dwyer'], ['Christopher', 'C.', 'Blyth'], ['Maly', '', 'Soedjono'], ['Haijing', '', 'Shi'], ['Alison', '', 'Kesson'], ['Mala', '', 'Ratnamohan'], ['Ken', '', 'McPhie'], ['Anthony', 'L.', 'Cunningham'], ['Nitin', 'K.', 'Saksena']]",Antiviral Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0166354210005723', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354210005723']"
10.1021/ja963036t,"Hung, H., Tseng, C., Yang, J., et. al, Aurintricarboxylic acid inhibits influenza virus neuraminidase, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.006,Aurintricarboxylic acid inhibits influenza virus neuraminidase,"[['Hui-Chen', '', 'Hung'], ['Ching-Ping', '', 'Tseng'], ['Jinn-Moon', '', 'Yang'], ['Yi-Wei', '', 'Ju'], ['Sung-Nain', '', 'Tseng'], ['Yen-Fu', '', 'Chen'], ['Yu-Sheng', '', 'Chao'], ['Hsing-Pang', '', 'Hsieh'], ['Shin-Ru', '', 'Shih'], ['John', 'T.-A.', 'Hsu']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004300', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004300']"
10.1021/ja963036t,"Lagoja, I., Clercq, E., , Anti-influenza virus agents: Synthesis and mode of action, Medicinal Research Reviews, 2008",cited-by,10.1002/med.20096,Anti-influenza virus agents: Synthesis and mode of action,"[['Irene', 'M.', 'Lagoja'], ['Erik', 'De', 'Clercq']]",Medicinal Research Reviews,2008,[u'http://doi.wiley.com/10.1002/med.20096']
10.1021/ja963036t,"Chutinimitkul, S., Suwannakarn, K., Chieochansin, T., et. al, H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes, Journal of Virological Methods, 2007",cited-by,10.1016/j.jviromet.2006.09.007,H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes,"[['Salin', '', 'Chutinimitkul'], ['Kamol', '', 'Suwannakarn'], ['Thaweesak', '', 'Chieochansin'], ['Le', 'Quynh', 'Mai'], ['Sudarat', '', 'Damrongwatanapokin'], ['Arunee', '', 'Chaisingh'], ['Alongkorn', '', 'Amonsin'], ['Olfert', '', 'Landt'], ['Thaweesak', '', 'Songserm'], ['Apiradee', '', 'Theamboonlers'], ['Yong', '', 'Poovorawan']]",Journal of Virological Methods,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0166093406003302', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093406003302']"
10.1021/ja963036t,"McKimm-Breschkin, J., , Management of Influenza Virus Infections with Neuraminidase Inhibitors, Treatments in Respiratory Medicine, 2005",cited-by,10.2165/00151829-200504020-00004,Management of Influenza Virus Infections with Neuraminidase Inhibitors,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Treatments in Respiratory Medicine,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00151829-200504020-00004']
10.1021/ja963036t,"Magden, J., Kääriäinen, L., Ahola, T., , Inhibitors of virus replication: recent developments and prospects, Applied Microbiology and Biotechnology, 2005",cited-by,10.1007/s00253-004-1783-3,Inhibitors of virus replication: recent developments and prospects,"[['Julia', '', 'Magden'], ['Leevi', '', 'K\xc3\xa4\xc3\xa4ri\xc3\xa4inen'], ['Tero', '', 'Ahola']]",Applied Microbiology and Biotechnology,2005,"[u'http://www.springerlink.com/content/kcuwdwknb57f5buy', u'http://www.springerlink.com/index/kcuwdwknb57f5buy.pdf', u'http://www.springerlink.com/index/10.1007/s00253-004-1783-3', u'http://www.springerlink.com/index/pdf/10.1007/s00253-004-1783-3']"
10.1021/ja963036t,"Aramini, J., Ma, L., Krug, R., et. al, Structures of influenza A proteins and insights into antiviral drug targets, Nature Structural & Molecular Biology, 2010",cited-by,10.1038/nsmb.1779,Structures of influenza A proteins and insights into antiviral drug targets,"[['James', 'M', 'Aramini'], ['Li-Chung', '', 'Ma'], ['Robert', 'M', 'Krug'], ['Eddy', '', 'Arnold'], ['Kalyan', '', 'Das']]",Nature Structural & Molecular Biology,2010,"[u'http://www.nature.com/doifinder/10.1038/nsmb.1779', u'http://dx.doi.org/10.1038/nsmb.1779']"
10.1021/ja963036t,"Collins, P., Haire, L., Lin, Y., et. al, Structural basis for oseltamivir resistance of influenza viruses, Vaccine, 2009",cited-by,10.1016/j.vaccine.2009.07.017,Structural basis for oseltamivir resistance of influenza viruses,"[['P.', 'J.', 'Collins'], ['L.', 'F.', 'Haire'], ['Y.', 'P.', 'Lin'], ['J.', '', 'Liua'], ['R.', 'J.', 'Russell'], ['P.', 'A.', 'Walker'], ['S.', 'R.', 'Martin'], ['R.', 'S.', 'Daniels'], ['V.', '', 'Gregory'], ['J.', 'J.', 'Skehel'], ['S.', 'J.', 'Gamblin'], ['A.', 'J.', 'Hay']]",Vaccine,2009,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-51.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X09010299', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-53.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X09010299']"
10.1021/ja963036t,"Gloster, T., Davies, G., , Glycosidase inhibition: assessing mimicry of the transition state, Organic & Biomolecular Chemistry, 2010",cited-by,10.1039/b915870g,Glycosidase inhibition: assessing mimicry of the transition state,"[['Tracey', 'M.', 'Gloster'], ['Gideon', 'J.', 'Davies']]",Organic & Biomolecular Chemistry,2010,[u'http://xlink.rsc.org/?DOI=b915870g']
10.1021/ja963036t,"Yamatsugu, K., Yin, L., Kamijo, S., et. al, A Synthesis of Tamiflu by Using a Barium-Catalyzed Asymmetric Diels-Alder-Type Reaction, Angewandte Chemie-international Edition, 2009",cited-by,10.1002/anie.200804777,A Synthesis of Tamiflu by Using a Barium-Catalyzed Asymmetric Diels-Alder-Type Reaction,"[['Kenzo', '', 'Yamatsugu'], ['Liang', '', 'Yin'], ['Shin', '', 'Kamijo'], ['Yasuaki', '', 'Kimura'], ['Motomu', '', 'Kanai'], ['Masakatsu', '', 'Shibasaki']]",Angewandte Chemie-international Edition,2009,[u'http://doi.wiley.com/10.1002/anie.200804777']
10.1021/ja963036t,"Gibson, J., Thomas, P., Thomas, J., et. al, Benzene-Free Synthesis of Phenol, Angewandte Chemie-international Edition, 2001",cited-by,10.1002/1521-3773(20010518)40:10<1945::AID-ANIE1945>3.0.CO;2-5,Benzene-Free Synthesis of Phenol,"[['James', 'M.', 'Gibson'], ['Phillip', 'S.', 'Thomas'], ['Joshua', 'D.', 'Thomas'], ['Jessica', 'L.', 'Barker'], ['Sunil', 'S.', 'Chandran'], ['Mason', 'K.', 'Harrup'], ['Karen', 'M.', 'Draths'], ['John', 'W.', 'Frost']]",Angewandte Chemie-international Edition,2001,[u'http://doi.wiley.com/10.1002/1521-3773%2820010518%2940%3A10%3C1945%3A%3AAID-ANIE1945%3E3.0.CO%3B2-5']
10.1021/ja963036t,"Du, Q., Huang, R., Wei, Y., et. al, Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design, Journal of Computational Chemistry, 2009",cited-by,10.1002/jcc.21056,Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design,"[['Qi-Shi', '', 'Du'], ['Ri-bo', '', 'Huang'], ['Yu-tuo', '', 'Wei'], ['Zong-wen', '', 'Pang'], ['Li-qin', '', 'Du'], ['Kuo-chen', '', 'Chou']]",Journal of Computational Chemistry,2009,"[u'http://doi.wiley.com/10.1002/jcc.21056', u'http://www.informatik.uni-trier.de/~ley/db/journals/jcc/jcc30.html#DuHWPDC09', u'http://dx.doi.org/10.1002/jcc.21056']"
10.1021/ja963036t,"Sullivan, B., Carrera, I., Drouin, M., et. al, Symmetry-Based Design for the Chemoenzymatic Synthesis of Oseltamivir (Tamiflu) from Ethyl Benzoate, Angewandte Chemie-international Edition, 2009",cited-by,10.1002/anie.200901345,Symmetry-Based Design for the Chemoenzymatic Synthesis of Oseltamivir (Tamiflu) from Ethyl Benzoate,"[['Bradford', '', 'Sullivan'], ['Ignacio', '', 'Carrera'], ['Melissa', '', 'Drouin'], ['Tomas', '', 'Hudlicky']]",Angewandte Chemie-international Edition,2009,"[u'http://www.brocku.ca/chemistry/faculty/Hudlicky/ACIE-2009,48,23,4229-4231.pdf', u'http://doi.wiley.com/10.1002/anie.200901345']"
10.1021/ja963036t,"Abe, S., Ishihara, K., Adachi, M., et. al, Professional oral care reduces influenza infection in elderly, Archives of Gerontology and Geriatrics, 2006",cited-by,10.1016/j.archger.2005.10.004,Professional oral care reduces influenza infection in elderly,"[['Shu', '', 'Abe'], ['Kazuyuki', '', 'Ishihara'], ['Mieko', '', 'Adachi'], ['Hidetada', '', 'Sasaki'], ['Kouko', '', 'Tanaka'], ['Katsuji', '', 'Okuda']]",Archives of Gerontology and Geriatrics,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0167494305001330', u'http://linkinghub.elsevier.com/retrieve/pii/S0167494305001330']"
10.1021/ja963036t,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.1021/ja963036t,"Johansson, L., Lindskog, A., Silfversparre, G., et. al, Shikimic acid production by a modified strain ofE. coli (W3110.shik1) under phosphate-limited and carbon-limited conditions, Biotechnology and Bioengineering, 2005",cited-by,10.1002/bit.20546,Shikimic acid production by a modified strain ofE. coli (W3110.shik1) under phosphate-limited and carbon-limited conditions,"[['Louise', '', 'Johansson'], ['Anna', '', 'Lindskog'], ['Gustav', '', 'Silfversparre'], ['Christian', '', 'Cimander'], ['Kristian', 'Fog', 'Nielsen'], ['Gunnar', '', 'Lid\xc3\xa9n']]",Biotechnology and Bioengineering,2005,[u'http://doi.wiley.com/10.1002/bit.20546']
10.1021/ja963036t,"Karlsson, K., , Pathogen-Host Protein-Carbohydrate Interactions as the Basis of Important Infections, , 0",cited-by,10.1007/978-1-4615-1267-7_28,Pathogen-Host Protein-Carbohydrate Interactions as the Basis of Important Infections,"[['Karl-Anders', '', 'Karlsson']]",,0,"[u'http://www.springerlink.com/index/mr111226p7m17337.pdf', u'http://www.springerlink.com/content/mr111226p7m17337']"
10.1021/ja963036t,"Mihajlovic, M., Mitrasinovic, P., , Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs), Molecular Simulation, 2009",cited-by,10.1080/08927020802430752,Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs),"[['Marija', 'L.', 'Mihajlovic'], ['Petar', 'M.', 'Mitrasinovic']]",Molecular Simulation,2009,"[u'http://www.informaworld.com/openurl?genre=article&doi=10.1080/08927020802430752&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3', u'http://dx.doi.org/10.1080/08927020802430752']"
10.1021/ja963036t,"Morrissey, B., Streamer, M., Downard, K., , Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry, Journal of Virological Methods, 2007",cited-by,10.1016/j.jviromet.2007.05.015,Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry,"[['Bethny', '', 'Morrissey'], ['Margaret', '', 'Streamer'], ['Kevin', 'M.', 'Downard']]",Journal of Virological Methods,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0166093407001796', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093407001796']"
10.1021/ja963036t,"Armstrong, K., Tidor, B., Cheng, A., , Optimal Charges in Lead Progression:  A Structure-Based Neuraminidase Case Study, Journal of Medicinal Chemistry, 2006",cited-by,10.1021/jm051105l,Optimal Charges in Lead Progression:  A Structure-Based Neuraminidase Case Study,"[['Kathryn', 'A.', 'Armstrong'], ['Bruce', '', 'Tidor'], ['Alan', 'C.', 'Cheng']]",Journal of Medicinal Chemistry,2006,"[u'http://people.brandeis.edu/~acheng/publications/2006_JMC_ChargeOptNeuraminidase.pdf', u'http://pubs.acs.org/doi/abs/10.1021/jm051105l']"
10.1021/ja963036t,"Masuda, T., Yoshida, S., Arai, M., et. al, Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives, Chemical & Pharmaceutical Bulletin, 2003",cited-by,10.1248/cpb.51.1386,Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives,"[['Takeshi', '', 'Masuda'], ['Shuku', '', 'Yoshida'], ['Masami', '', 'Arai'], ['Satoru', '', 'Kaneko'], ['Makoto', '', 'Yamashita'], ['Takeshi', '', 'Honda']]",Chemical & Pharmaceutical Bulletin,2003,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/cpb/51.1386?from=CrossRef']
10.1021/ja963036t,"Krug, R., Aramini, J., , Emerging antiviral targets for influenza A virus, Trends in Pharmacological Sciences, 2009",cited-by,10.1016/j.tips.2009.03.002,Emerging antiviral targets for influenza A virus,"[['Robert', 'M.', 'Krug'], ['James', 'M.', 'Aramini']]",Trends in Pharmacological Sciences,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0165614709000558', u'http://linkinghub.elsevier.com/retrieve/pii/S0165614709000558']"
10.1021/ja963036t,"Song, J., Park, K., Lee, K., et. al, Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives, Antiviral Research, 2007",cited-by,10.1016/j.antiviral.2007.07.001,Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives,"[['Jae', 'Min', 'Song'], ['Ki', 'Duk', 'Park'], ['Kwang', 'Hee', 'Lee'], ['Young', 'Ho', 'Byun'], ['Ju', 'Hee', 'Park'], ['Sung', 'Han', 'Kim'], ['Jae', 'Hong', 'Kim'], ['Baik', 'Lin', 'Seong']]",Antiviral Research,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0166354207003713', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354207003713']"
10.1021/ja963036t,"Abed, Y., Boivin, G., , Treatment of respiratory virus infections, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.01.006,Treatment of respiratory virus infections,"[['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016635420600026X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420600026X']"
10.1016~S0140-6736(00)02288-1,"Woods JM, Bethell RC, Coates JAV, et al. 4-guanidino-2,4-dideoxy2,3 dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob Agents Chemother 1993; 37: 1473–79.",references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,"Mendel DB, Tai CY, Escarpe PA, et al. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS4071 protects mice and ferrets against influenza infection. Antimicrob Agents Chemother 1998; 42: 640–46.",references,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[[u'DIRK', u'B.', u'MENDEL'], [u'CHUN', u'Y.', u'TAI'], [u'PAUL', u'A.', u'ESCARPE'], [u'WEIXING', u'', u'LI'], [u'ROBERT', u'W.', u'SIDWELL'], [u'JOHN', u'H.', u'HUFFMAN'], [u'CLIVE', u'', u'SWEET'], [u'KENNETH', u'J.', u'JAKEMAN'], [u'JAMES', u'', u'MERSON'], [u'STEVEN', u'A.', u'LACY'], [u'WILLARD', u'', u'LEW'], [u'MATTHEW', u'A.', u'WILLIAMS'], [u'LIJUN', u'', u'ZHANG'], [u'MING', u'S.', u'CHEN'], [u'NORBERT', u'', u'BISCHOFBERGER'], [u'CHOUNG', u'U.', u'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/10.1016~S0140-6736(00)02288-1/7023591
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Palese, P., , Influenza: old and new threats, Nature Medicine, 2004",cited-by,10.1038/nm1141,Influenza: old and new threats,"[['Peter', '', 'Palese']]",Nature Medicine,2004,"[u'http://dx.doi.org/10.1038/nm1141', u'http://www.nature.com/doifinder/10.1038/nm1141']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"McKimm-Breschkin, J., , Resistance of influenza viruses to neuraminidase inhibitors — a review, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00103-0,Resistance of influenza viruses to neuraminidase inhibitors — a review,"[['Jennifer', 'L.', 'McKimm-Breschkin']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001030', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-14.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001030']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Ives, J., Carr, J., Mendel, D., et. al, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(02)00053-0,The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo,"[['J.', 'A. L.', 'Ives'], ['J.', 'A.', 'Carr'], ['D.', 'B.', 'Mendel'], ['C.', 'Y.', 'Tai'], ['R.', '', 'Lambkin'], ['L.', '', 'Kelly'], ['J.', 'S.', 'Oxford'], ['F.', 'G.', 'Hayden'], ['N.', 'A.', 'Roberts']]",Antiviral Research,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-20.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354202000530', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-21.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354202000530']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"GOVORKOVA, E., LENEVA, I., GOLOUBEVA, O., et. al, Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.10.2723-2732.2001,"Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses","[['ELENA', 'A.', 'GOVORKOVA'], ['IRINA', 'A.', 'LENEVA'], ['OLGA', 'G.', 'GOLOUBEVA'], ['KAREN', '', 'BUSH'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/10/2723.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.10.2723-2732.2001']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Clercq, E., , Strategies in the design of antiviral drugs, Nature Reviews Drug Discovery, 2002",cited-by,10.1038/nrd703,Strategies in the design of antiviral drugs,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2002,"[u'http://dx.doi.org/10.1038/nrd703', u'http://www.nature.com/doifinder/10.1038/nrd703']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Herlocher, M., Carr, J., Ives, J., et. al, Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00214-5,Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets,"[['M.', 'L', 'Herlocher'], ['J', '', 'Carr'], ['J', '', 'Ives'], ['S', '', 'Elias'], ['R', '', 'Truscon'], ['N', '', 'Roberts'], ['A.', 'S', 'Monto']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201002145', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201002145']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Govorkova, E., Ilyushina, N., Boltz, D., et. al, Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01312-06,Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus,"[['Elena', 'A.', 'Govorkova'], ['Natalia', 'A.', 'Ilyushina'], ['David', 'A.', 'Boltz'], ['Alan', '', 'Douglas'], ['Neziha', '', 'Yilmaz'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/4/1414.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01312-06']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Mishin, V., Hayden, F., Gubareva, L., , Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.11.4515-4520.2005,Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors,"[['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Larisa', 'V.', 'Gubareva']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/11/4515.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.11.4515-4520.2005']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Furuta, Y., Takahashi, K., Fukuda, Y., et. al, In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.977-981.2002,In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705,"[['Y.', '', 'Furuta'], ['K.', '', 'Takahashi'], ['Y.', '', 'Fukuda'], ['M.', '', 'Kuno'], ['T.', '', 'Kamiyama'], ['K.', '', 'Kozaki'], ['N.', '', 'Nomura'], ['H.', '', 'Egawa'], ['S.', '', 'Minami'], ['Y.', '', 'Watanabe'], ['H.', '', 'Narita'], ['K.', '', 'Shiraki']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://journals.pasteur.ac.ir/aac02/46(4)/977.pdf', u'http://aac.asm.org/cgi/reprint/46/4/977.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.977-981.2002']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Leneva, I., Roberts, N., Govorkova, E., et. al, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[['Irina', 'A.', 'Leneva'], ['Noel', '', 'Roberts'], ['Elena', 'A.', 'Govorkova'], ['Olga', 'G.', 'Goloubeva'], ['Robert', 'G.', 'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Malakhov, M., Aschenbrenner, L., Smee, D., et. al, Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.50.4.1470-1479.2006,Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection,"[['Michael', 'P.', 'Malakhov'], ['Laura', 'M.', 'Aschenbrenner'], ['Donald', 'F.', 'Smee'], ['Miles', 'K.', 'Wandersee'], ['Robert', 'W.', 'Sidwell'], ['Larisa', 'V.', 'Gubareva'], ['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Do', 'Hyong', 'Kim'], ['Alice', '', 'Ing'], ['Erin', 'R.', 'Campbell'], ['Mang', '', 'Yu'], ['Fang', '', 'Fang']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/4/1470.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.50.4.1470-1479.2006']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"NOYOLA, D., CLARK, B., O'DONNELL, F., et. al, Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens, , 2000",cited-by,"13918606Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","[['DANIEL', 'E.', 'NOYOLA'], ['BRUCE', '', 'CLARK'], ['FREDERICK', 'T.', ""O'DONNELL""], ['ROBERT', 'L.', 'ATMAR'], ['JEWEL', '', 'GREER'], ['GAIL', 'J.', 'DEMMLER']]",,2000,[u'http://jcm.asm.org/cgi/reprint/38/3/1161.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Rameix-Welti, M., Agou, F., Buchy, P., et. al, Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00645-06,Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir,"[['M.', 'A.', 'Rameix-Welti'], ['F.', '', 'Agou'], ['P.', '', 'Buchy'], ['S.', '', 'Mardy'], ['J.', 'T.', 'Aubin'], ['M.', '', 'Veron'], ['S.', 'van der', 'Werf'], ['N.', '', 'Naffakh']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://www.ctcd.edu/science/tanderson/documents/OseltamivirSensitivityH5N1.pdf', u'http://aac.asm.org/cgi/reprint/50/11/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00645-06']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kati, W., Montgomery, D., Carrick, R., et. al, In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.1014-1021.2002,"In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication","[['Warren', 'M.', 'Kati'], ['Debra', '', 'Montgomery'], ['Robert', '', 'Carrick'], ['Larisa', '', 'Gubareva'], ['Clarence', '', 'Maring'], ['Keith', '', 'McDaniel'], ['Kevin', '', 'Steffy'], ['Akhteruzzaman', '', 'Molla'], ['Frederick', '', 'Hayden'], ['Dale', '', 'Kempf'], ['William', '', 'Kohlbrenner']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/1014.pdf', u'http://journals.pasteur.ac.ir/AAC02/46(4)/1014.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.1014-1021.2002']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., Barnard, D., Day, C., et. al, Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01051-06,Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice,"[['Robert', 'W.', 'Sidwell'], ['Dale', 'L.', 'Barnard'], ['Craig', 'W.', 'Day'], ['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['John', 'D.', 'Morrey'], ['Yousuke', '', 'Furuta']]",Antimicrobial Agents and Chemotherapy,2007,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01051-06']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"SIDWELL, R., SMEE, D., HUFFMAN, J., et. al, In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.749-757.2001,In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201,"[['ROBERT', 'W.', 'SIDWELL'], ['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['DALE', 'L.', 'BARNARD'], ['KEVIN', 'W.', 'BAILEY'], ['JOHN', 'D.', 'MORREY'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/3/749.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.749-757.2001']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Noah, D., Krug, R., , Influenza Virus Virulence and Its Molecular Determinants, Advances in Virus Research, 2005",cited-by,10.1016/S0065-3527(05)65004-X,Influenza Virus Virulence and Its Molecular Determinants,"[['Diana', 'L.', 'Noah'], ['Robert', 'M.', 'Krug']]",Advances in Virus Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S006535270565004X', u'http://linkinghub.elsevier.com/retrieve/pii/S006535270565004X']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Laver, W., Bischofberger, N., Webster, R., , The Origin and Control of Pandemic Influenza, , 2000",cited-by,10259737The Origin and Control of Pandemic Influenza,The Origin and Control of Pandemic Influenza,"[['W.', 'Graeme', 'Laver'], ['Norbert', '', 'Bischofberger'], ['Robert', 'G.', 'Webster']]",,2000,"[u'http://birdflubook.com/resources/LAVER173.pdf', u'http://muse.jhu.edu/about/publishers.html/journals/perspectives_in_biology_and_medicine/v043/43.2laver.html']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Yun, N., Linde, N., Zacks, M., et. al, Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1), Virology, 2008",cited-by,10.1016/j.virol.2007.12.029,"Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)","[['Nadezhda', 'E.', 'Yun'], ['Nathaniel', 'S.', 'Linde'], ['Michele', 'A.', 'Zacks'], ['Ian', 'G.', 'Barr'], ['Aeron', 'C.', 'Hurt'], ['Jeanon', 'N.', 'Smith'], ['Natallia', '', 'Dziuba'], ['Michael', 'R.', 'Holbrook'], ['Lifang', '', 'Zhang'], ['John', 'M.', 'Kilpatrick'], ['C.', 'Shane', 'Arnold'], ['Slobodan', '', 'Paessler']]",Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0042682207008562', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682207008562']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Alymova, I., Taylor, G., Takimoto, T., et. al, Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.5.1495-1502.2004,Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo,"[['Irina', 'V.', 'Alymova'], ['Garry', '', 'Taylor'], ['Toru', '', 'Takimoto'], ['Tsu-Hsing', '', 'Lin'], ['Pooran', '', 'Chand'], ['Y.', 'Sudhakara', 'Babu'], ['Chenghong', '', 'Li'], ['Xiaoping', '', 'Xiong'], ['Allen', '', 'Portner']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/5/1495.pdf', u'http://aac.highwire.org/cgi/reprint/48/5/1495.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.5.1495-1502.2004']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Schentag, J., Hill, G., Chu, T., et. al, Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects, Journal of Clinical Pharmacology, 2007",cited-by,10.1177/0091270007299761,Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects,"[['Jerome', 'J.', 'Schentag'], ['George', '', 'Hill'], ['Tom', '', 'Chu'], ['Craig', 'R.', 'Rayner']]",Journal of Clinical Pharmacology,2007,"[u'http://dx.doi.org/10.1177/0091270007299761', u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270007299761']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sweet, C., Jakeman, K., Bush, K., et. al, Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.996-1004.2002,Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection,"[['Clive', '', 'Sweet'], ['Kenneth', 'J.', 'Jakeman'], ['Karen', '', 'Bush'], ['Pamela', 'C.', 'Wagaman'], ['Linda', 'A.', 'Mckown'], ['Anthony', 'J.', 'Streeter'], ['Daksha', '', 'Desai-Krieger'], ['Pooran', '', 'Chand'], ['Yarlagadda', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/996.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.996-1004.2002']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Hung, H., Tseng, C., Yang, J., et. al, Aurintricarboxylic acid inhibits influenza virus neuraminidase, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.006,Aurintricarboxylic acid inhibits influenza virus neuraminidase,"[['Hui-Chen', '', 'Hung'], ['Ching-Ping', '', 'Tseng'], ['Jinn-Moon', '', 'Yang'], ['Yi-Wei', '', 'Ju'], ['Sung-Nain', '', 'Tseng'], ['Yen-Fu', '', 'Chen'], ['Yu-Sheng', '', 'Chao'], ['Hsing-Pang', '', 'Hsieh'], ['Shin-Ru', '', 'Shih'], ['John', 'T.-A.', 'Hsu']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004300', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004300']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Jackson, D., Barclay, W., Zurcher, T., , Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations, , 2005",cited-by,6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,"[['David', '', 'Jackson'], ['Wendy', '', 'Barclay'], ['Thomas', '', 'Zurcher']]",,2005,[u'http://jac.oxfordjournals.org/cgi/reprint/55/2/162.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Robson, R., Buttimore, A., Lynn, K., et. al, The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis, , 2006",cited-by,10077451The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,"[['Richard', '', 'Robson'], ['Adrian', '', 'Buttimore'], ['Kelvin', '', 'Lynn'], ['Mike', '', 'Brewster'], ['Penelope', '', 'Ward']]",,2006,"[u'http://www.kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://ndt.oxfordjournals.org/cgi/reprint/21/9/2556.pdf']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Smee, D., Sidwell, R., Morrison, A., et. al, Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00168-1,Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201,"[['Donald', 'F', 'Smee'], ['Robert', 'W', 'Sidwell'], ['Ann', 'C', 'Morrison'], ['Kevin', 'W', 'Bailey'], ['Ellen', 'Z', 'Baum'], ['Linh', '', 'Ly'], ['Pamela', 'C', 'Wagaman']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001681', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001681']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Holodniy, M., Penzak, S., Straight, T., et. al, Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00047-08,Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid,"[['Mark', '', 'Holodniy'], ['Scott', 'R.', 'Penzak'], ['Timothy', 'M.', 'Straight'], ['Richard', 'T.', 'Davey'], ['Kelvin', 'K.', 'Lee'], ['Matthew', 'Bidwell', 'Goetz'], ['Dennis', 'W.', 'Raisch'], ['Francesca', '', 'Cunningham'], ['Emil', 'T.', 'Lin'], ['Noemi', '', 'Olivo'], ['Lawrence', 'R.', 'Deyton']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/9/3013.pdf', u'http://www.apuabrasil.org.br/arquivos/influenza25.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00047-08']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Krug, R., Aramini, J., , Emerging antiviral targets for influenza A virus, Trends in Pharmacological Sciences, 2009",cited-by,10.1016/j.tips.2009.03.002,Emerging antiviral targets for influenza A virus,"[['Robert', 'M.', 'Krug'], ['James', 'M.', 'Aramini']]",Trends in Pharmacological Sciences,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0165614709000558', u'http://linkinghub.elsevier.com/retrieve/pii/S0165614709000558']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Smee, D., Bailey, K., Wong, M., et. al, Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2008.06.003,Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N,"[['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Barry', 'R.', 'O\xe2\x80\x99Keefe'], ['Kirk', 'R.', 'Gustafson'], ['Vasiliy', 'P.', 'Mishin'], ['Larisa', 'V.', 'Gubareva']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208003239', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208003239']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Myc, A., Anderson, M., Jr, J., , Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents, Journal of Virological Methods, 1999",cited-by,10.1016/S0166-0934(98)00150-5,Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents,"[['Andrzej', '', 'Myc'], ['Marie', 'J', 'Anderson'], ['James', 'R Baker', 'Jr']]",Journal of Virological Methods,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498001505', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498001505']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Itzstein, M., Thomson, R., , Anti-Influenza Drugs: The Development of Sialidase Inhibitors, , 0",cited-by,10.1007/978-3-540-79086-0_5,Anti-Influenza Drugs: The Development of Sialidase Inhibitors,"[['Mark', 'von', 'Itzstein'], ['Robin', '', 'Thomson']]",,0,"[u'http://www.springerlink.com/index/q7q766196t171341.pdf', u'http://www.springerlink.com/content/q7q766196t171341']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Jancel, T., Penzak, S., , Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia, Seminars in Hematology, 2009",cited-by,10.1053/j.seminhematol.2009.03.004,"Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia","[['Timothy', '', 'Jancel'], ['Scott', 'R.', 'Penzak']]",Seminars in Hematology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0037196309000596', u'http://linkinghub.elsevier.com/retrieve/pii/S0037196309000596']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Brewster, M., Smith, J., Dutkowski, R., et. al, Active metabolite from Tamiflu ® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.05.080,"Active metabolite from Tamiflu ® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study","[['M.', '', 'Brewster'], ['J.', 'R.', 'Smith'], ['R.', '', 'Dutkowski'], ['R.', '', 'Robson']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06006396', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06006396']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Carroll, T., Matzinger, S., Genesca, M., et. al, Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1, , 0",cited-by,12122205Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1,Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1,"[['Timothy', 'D.', 'Carroll'], ['Shannon', 'R.', 'Matzinger'], ['Meritxell', '', 'Genesca'], ['Linda', '', 'Fritts'], ['Roxana', '', 'Colon'], ['Michael', 'B.', 'McChesney'], ['Christopher', 'J.', 'Miller']]",,0,[u'http://www.jimmunol.org/cgi/reprint/180/4/2385.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"SAWABUCHI, T., SUZUKI, S., IWASE, K., et. al, Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza, Respirology, 2009",cited-by,10.1111/j.1440-1843.2009.01639.x,Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza,"[['Takako', '', 'SAWABUCHI'], ['Satoshi', '', 'SUZUKI'], ['Kazuhiro', '', 'IWASE'], ['Chika', '', 'ITO'], ['Dai', '', 'MIZUNO'], ['Hajime', '', 'TOGARI'], ['Isamu', '', 'WATANABE'], ['Sadiqur', 'R.', 'TALUKDER'], ['Junji', '', 'CHIDA'], ['Hiroshi', '', 'KIDO']]",Respirology,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1440-1843.2009.01639.x']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kulkarni, A., Weiss, A., Iyer, S., , Glycan-based high-affinity ligands for toxins and pathogen receptors, Medicinal Research Reviews, 2010",cited-by,10.1002/med.20196,Glycan-based high-affinity ligands for toxins and pathogen receptors,"[['Ashish', 'A.', 'Kulkarni'], ['Alison', 'A.', 'Weiss'], ['Suri', 'S.', 'Iyer']]",Medicinal Research Reviews,2010,[u'http://doi.wiley.com/10.1002/med.20196']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2008.11.014,"Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273608003842', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273608003842']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sauerbrei, A., Haertl, A., Brandstaedt, A., et. al, Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors, Medical Microbiology and Immunology, 2006",cited-by,10.1007/s00430-005-0002-x,Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors,"[['A.', '', 'Sauerbrei'], ['A.', '', 'Haertl'], ['A.', '', 'Brandstaedt'], ['M.', '', 'Schmidtke'], ['P.', '', 'Wutzler']]",Medical Microbiology and Immunology,2006,"[u'http://www.springerlink.com/index/m37932425096l606.pdf', u'http://www.springerlink.com/content/m37932425096l606', u'http://www.springerlink.com/index/10.1007/s00430-005-0002-x', u'http://www.springerlink.com/index/pdf/10.1007/s00430-005-0002-x']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Oxford, J., , Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza, Influenza and Other Respiratory Viruses, 2007",cited-by,10.1111/j.1750-2659.2006.00006.x,Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza,"[['John', 'S.', 'Oxford']]",Influenza and Other Respiratory Viruses,2007,[u'http://doi.wiley.com/10.1111/j.1750-2659.2006.00006.x']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lu, F., Tseng, S., Li, M., et. al, In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid, Archives of Virology, 2002",cited-by,10.1007/s705-002-8319-5,In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid,"[['F.-J.', '', 'Lu'], ['S.-N.', '', 'Tseng'], ['M.-L.', '', 'Li'], ['S.-R.', '', 'Shih']]",Archives of Virology,2002,"[u'http://www.springerlink.com/content/ajvvqnn6jcjmg9bc', u'http://www.springerlink.com/index/ajvvqnn6jcjmg9bc.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s705-002-8319-5', u'http://www.springerlink.com/index/pdf/10.1007/s705-002-8319-5']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., , A consideration of animal models used for study of influenza virus inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00388-0,A consideration of animal models used for study of influenza virus inhibitors,"[['Robert', 'W', 'Sidwell']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003880', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003880']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Xu, Z., Li, H., Luo, H., et. al, Graphite nanosheets doped with Fe, Ni, and N, synthesized in one step, and their unique magnetic performance, Solid State Communications, 2011",cited-by,10.1016/j.ssc.2011.01.020,"Graphite nanosheets doped with Fe, Ni, and N, synthesized in one step, and their unique magnetic performance","[['Zhanwei', '', 'Xu'], ['Hejun', '', 'Li'], ['Huijuan', '', 'Luo'], ['Huihui', '', 'Sun'], ['Qinglin', '', 'Zhang'], ['Gaoxiang', '', 'Cao'], ['Kezhi', '', 'Li']]",Solid State Communications,2011,"[u'http://www.sciencedirect.com/science/article/pii/S0038109811000494', u'http://adsabs.harvard.edu/abs/2011SSCom.151..643X']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Welliver, R., Monto, A., Carewicz, O., , Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in, , 2010",cited-by,13851601Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,"[['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz']]",,2010,[u'http://jama.ama-assn.org/cgi/reprint/285/6/748.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lindemann, L., Jacobsen, H., Schuhbauer, D., et. al, In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu ®) and active metabolite, European Journal of Pharmacology, 2010",cited-by,10.1016/j.ejphar.2009.11.020,In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu ®) and active metabolite,"[['Lothar', '', 'Lindemann'], ['Helmut', '', 'Jacobsen'], ['Diana', '', 'Schuhbauer'], ['Frederic', '', 'Knoflach'], ['Silvia', '', 'Gatti'], ['Joseph', 'G.', 'Wettstein'], ['Hansruedi', '', 'Loetscher'], ['Tom', '', 'Chu'], ['Martin', '', 'Ebeling'], ['James', 'C.', 'Paulson'], ['Eric', '', 'Prinssen'], ['Manfred', '', 'Brockhaus']]",European Journal of Pharmacology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0014299909010358', u'http://linkinghub.elsevier.com/retrieve/pii/S0014299909010358']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Fusco, D., Liu, X., Savage, C., et. al, Echinacea purpurea aerial extract alters course of influenza infection in mice, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.03.047,Echinacea purpurea aerial extract alters course of influenza infection in mice,"[['Dahlene', '', 'Fusco'], ['Xinyan', '', 'Liu'], ['Caroline', '', 'Savage'], ['Ying', '', 'Taur'], ['Weilie', '', 'Xiao'], ['Edward', '', 'Kennelly'], ['Jianda', '', 'Yuan'], ['Barrie', '', 'Cassileth'], ['Mirella', '', 'Salvatore'], ['Genovefa', 'A.', 'Papanicolaou']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10004470', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10004470']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"West, M., Hanigan, M., , γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells, Archives of Biochemistry and Biophysics, 2010",cited-by,10.1016/j.abb.2010.08.019,γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells,"[['Matthew', 'B.', 'West'], ['Marie', 'H.', 'Hanigan']]",Archives of Biochemistry and Biophysics,2010,[u'http://www.sciencedirect.com/science/article/pii/S0003986110003656']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Andrea, I., Santarelli, S., Alleva, E., et. al, P.1.f.004 Communal nest reduces vulnerability to depression-like behaviour and enhances brain dopamine function in adult male mice, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70412-0,P.1.f.004 Communal nest reduces vulnerability to depression-like behaviour and enhances brain dopamine function in adult male mice,"[['I.', '', ""D'Andrea""], ['S.', '', 'Santarelli'], ['E.', '', 'Alleva'], ['I.', '', 'Branchi']]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10704120']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Meltzer, H., Karayal, O., Miceli, J., et. al, P.3.c.051 The effect of ziprasidone on the QTc interval when used in combination with lithium, valproate or lamotrigine, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70721-5,"P.3.c.051 The effect of ziprasidone on the QTc interval when used in combination with lithium, valproate or lamotrigine","[['H.', '', 'Meltzer'], ['O.', 'N.', 'Karayal'], ['J.', '', 'Miceli'], ['S.', '', 'Kolluri'], ['C.', '', ""O'Gorman""]]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10707215']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kissi, Y., Laaroussi, M., Gaabout, S., et. al, P.3.e.007 Sexual activity and marital relationships in Tunisian schizophrenic patients: comparison with healthy controls, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70762-8,P.3.e.007 Sexual activity and marital relationships in Tunisian schizophrenic patients: comparison with healthy controls,"[['Y.', 'El', 'Kissi'], ['M.', '', 'Laaroussi'], ['S.', '', 'Gaabout'], ['M.', '', 'Ayachi'], ['J.', '', 'Nakhli'], ['B.', 'Ben Hadj', 'Ali']]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10707628']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2009.04.014,"Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273609001345', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273609001345']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lipatov, A., Govorkova, E., Webby, R., et. al, MINIREVIEW Influenza: Emergence and Control, , 2004",cited-by,12108822MINIREVIEW Influenza: Emergence and Control,MINIREVIEW Influenza: Emergence and Control,"[['Aleksandr', 'S.', 'Lipatov'], ['Elena', 'A.', 'Govorkova'], ['Richard', 'J.', 'Webby'], ['Hiroichi', '', 'Ozaki'], ['Malik', '', 'Peiris'], ['Yi', '', 'Guan'], ['Leo', '', 'Poon'], ['Robert', 'G.', 'Webster']]",,2004,"[u'http://jvi.highwire.org/cgi/reprint/78/17/8951.pdf', u'http://jvi.asm.org/cgi/reprint/78/17/8951.pdf']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Massarella, J., He, G., Dorr, A., et. al, The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers, Journal of Clinical Pharmacology, 2000",cited-by,10.1177/009127000004000804,The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers,"[['Joseph', 'W.', 'Massarella'], ['George', 'Z.', 'He'], ['Albert', '', 'Dorr'], ['Keith', '', 'Nieforth'], ['Penelope', '', 'Ward'], ['Andy', '', 'Brown']]",Journal of Clinical Pharmacology,2000,[u'http://dx.doi.org/10.1177/009127000004000804']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Leitzke, S., , Die Therapie der Influenza mit Neuraminidase-Inhibitoren, Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz, 1999",cited-by,10.1007/s001030050275,Die Therapie der Influenza mit Neuraminidase-Inhibitoren,"[['S.', '', 'Leitzke']]",Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz,1999,"[u'http://www.springerlink.com/index/aubc4t0cmtk1megk.pdf', u'http://www.springerlink.com/content/aubc4t0cmtk1megk', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s001030050275', u'http://www.springerlink.com/index/pdf/10.1007/s001030050275']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Pleschka, S., Ludwig, S., Wolff, T., et. al, Anti-viral approaches against influenza viruses, , 0",cited-by,10.1007/978-0-387-31047-3_5,Anti-viral approaches against influenza viruses,"[['Stephan', '', 'Pleschka'], ['Stephan', '', 'Ludwig'], ['Thorsten', '', 'Wolff'], ['Oliver', '', 'Planz']]",,0,"[u'http://www.springerlink.com/index/um10454n7482018j.pdf', u'http://www.springerlink.com/content/um10454n7482018j']"
10.1016~S0140-6736(00)02288-1,Management of Influenza in the Southern Hemisphere Trialists Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 1998; 352: 1877–81.,references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,"Li W, Escarpe PA, Eisenberg EJ, et al. Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother 1998; 42: 647–53.",references,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[[u'WEIXING', u'', u'LI'], [u'PAUL', u'A.', u'ESCARPE'], [u'EUGENE', u'J.', u'EISENBERG'], [u'KENNETH', u'C.', u'CUNDY'], [u'CLIVE', u'', u'SWEET'], [u'KENNETH', u'J.', u'JAKEMAN'], [u'JAMES', u'', u'MERSON'], [u'WILLARD', u'', u'LEW'], [u'MATT', u'', u'WILLIAMS'], [u'LIJUN', u'', u'ZHANG'], [u'CHOUNG', u'U.', u'KIM'], [u'NORBERT', u'', u'BISCHOFBERGER'], [u'MING', u'S.', u'CHEN'], [u'DIRK', u'B.', u'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf'],./output/10.1016~S0140-6736(00)02288-1/11215168
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"McKimm-Breschkin, J., , Resistance of influenza viruses to neuraminidase inhibitors — a review, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00103-0,Resistance of influenza viruses to neuraminidase inhibitors — a review,"[['Jennifer', 'L.', 'McKimm-Breschkin']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001030', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-14.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001030']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, , 0",cited-by,12760434Influenza virus neuraminidase inhibitors,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",,0,[u'http://www.birdflumanual.com/resources/Medical_References/files/antineuraminidase%20therapy%20lancet.pdf']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,", Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice, Journal of Infectious Diseases, 2005",cited-by,10.1086/432008,Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice,[],Journal of Infectious Diseases,2005,"[u'http://birdflubook.com/resources/0yen665.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/432008']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Gubareva, L., Webster, R., Hayden, F., , Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00192-9,Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay,"[['Larisa', 'V.', 'Gubareva'], ['Robert', 'G.', 'Webster'], ['Frederick', 'G.', 'Hayden']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001929', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001929']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Wang, M., Tai, C., Mendel, D., , Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.12.3809-3816.2002,Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir,"[['Michael', 'Z.', 'Wang'], ['Chun', 'Y.', 'Tai'], ['Dirk', 'B.', 'Mendel']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/12/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.12.3809-3816.2002']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Rameix-Welti, M., Agou, F., Buchy, P., et. al, Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00645-06,Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir,"[['M.', 'A.', 'Rameix-Welti'], ['F.', '', 'Agou'], ['P.', '', 'Buchy'], ['S.', '', 'Mardy'], ['J.', 'T.', 'Aubin'], ['M.', '', 'Veron'], ['S.', 'van der', 'Werf'], ['N.', '', 'Naffakh']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://www.ctcd.edu/science/tanderson/documents/OseltamivirSensitivityH5N1.pdf', u'http://aac.asm.org/cgi/reprint/50/11/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00645-06']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Ferraris, O., Lina, B., , Mutations of neuraminidase implicated in neuraminidase inhibitors resistance, Journal of Clinical Virology, 2008",cited-by,10.1016/j.jcv.2007.10.020,Mutations of neuraminidase implicated in neuraminidase inhibitors resistance,"[['Olivier', '', 'Ferraris'], ['Bruno', '', 'Lina']]",Journal of Clinical Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1386653207003903', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653207003903']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"SIDWELL, R., SMEE, D., HUFFMAN, J., et. al, In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.749-757.2001,In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201,"[['ROBERT', 'W.', 'SIDWELL'], ['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['DALE', 'L.', 'BARNARD'], ['KEVIN', 'W.', 'BAILEY'], ['JOHN', 'D.', 'MORREY'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/3/749.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.749-757.2001']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Ferraris, O., Kessler, N., Lina, B., , Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice, Antiviral Research, 2005",cited-by,10.1016/j.antiviral.2005.07.004,Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice,"[['O.', '', 'Ferraris'], ['N.', '', 'Kessler'], ['B.', '', 'Lina']]",Antiviral Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205001427', u'http://birdflubook.com/resources/0Ferrarisxxx.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205001427']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Sweet, C., Jakeman, K., Bush, K., et. al, Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.996-1004.2002,Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection,"[['Clive', '', 'Sweet'], ['Kenneth', 'J.', 'Jakeman'], ['Karen', '', 'Bush'], ['Pamela', 'C.', 'Wagaman'], ['Linda', 'A.', 'Mckown'], ['Anthony', 'J.', 'Streeter'], ['Daksha', '', 'Desai-Krieger'], ['Pooran', '', 'Chand'], ['Yarlagadda', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/996.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.996-1004.2002']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Hung, H., Tseng, C., Yang, J., et. al, Aurintricarboxylic acid inhibits influenza virus neuraminidase, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.006,Aurintricarboxylic acid inhibits influenza virus neuraminidase,"[['Hui-Chen', '', 'Hung'], ['Ching-Ping', '', 'Tseng'], ['Jinn-Moon', '', 'Yang'], ['Yi-Wei', '', 'Ju'], ['Sung-Nain', '', 'Tseng'], ['Yen-Fu', '', 'Chen'], ['Yu-Sheng', '', 'Chao'], ['Hsing-Pang', '', 'Hsieh'], ['Shin-Ru', '', 'Shih'], ['John', 'T.-A.', 'Hsu']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004300', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004300']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Jackson, D., Barclay, W., Zurcher, T., , Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations, , 2005",cited-by,6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,"[['David', '', 'Jackson'], ['Wendy', '', 'Barclay'], ['Thomas', '', 'Zurcher']]",,2005,[u'http://jac.oxfordjournals.org/cgi/reprint/55/2/162.pdf']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"FENTON, R., MORLEY, P., OWENS, I., et. al, Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract, , 1999",cited-by,"14046363Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract","Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract","[['ROBERT', 'J.', 'FENTON'], ['PETER', 'J.', 'MORLEY'], ['IAN', 'J.', 'OWENS'], ['DAVID', '', 'GOWER'], ['SIMON', '', 'PARRY'], ['LEE', '', 'CROSSMAN'], ['TONY', '', 'WONG'], ['Glaxo', '', 'Wellcome']]",,1999,[u'http://aac.asm.org/cgi/reprint/43/11/2642.pdf']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"McSharry, J., McDonough, A., Olson, B., et. al, Phenotypic Drug Susceptibility Assay for Influenza Virus Neuraminidase Inhibitors, Clinical and Vaccine Immunology, 2004",cited-by,10.1128/CDLI.11.1.21-28.2004,Phenotypic Drug Susceptibility Assay for Influenza Virus Neuraminidase Inhibitors,"[['James', 'J.', 'McSharry'], ['Ann', 'C.', 'McDonough'], ['Betty', 'A.', 'Olson'], ['George', 'L.', 'Drusano']]",Clinical and Vaccine Immunology,2004,"[u'http://cvi.asm.org/cgi/reprint/11/1/21.pdf', u'http://cdli.asm.org/cgi/reprint/11/1/21.pdf', u'http://cdli.asm.org/cgi/doi/10.1128/CDLI.11.1.21-28.2004']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Kacergius, T., Ambrozaitis, A., Deng, Y., et. al, Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferon-activated RAW 264.7 macrophages, , 0",cited-by,14007994Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferon-activated RAW 264.7 macrophages,Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferon-activated RAW 264.7 macrophages,"[['Tomas', '', 'Kacergius'], ['Arvydas', '', 'Ambrozaitis'], ['Yuping', '', 'Deng'], ['Stefan', '', 'Gravenstein']]",,0,[u'http://www.if-pan.krakow.pl/pjp/pdf/2006/6_924.pdf']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Smee, D., Hurst, B., Wong, M., et. al, Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice, Antiviral Research, 2010",cited-by,10.1016/j.antiviral.2010.07.003,Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice,"[['Donald', 'F.', 'Smee'], ['Brett', 'L.', 'Hurst'], ['Min-Hui', '', 'Wong'], ['E.', 'Bart', 'Tarbet'], ['Y.', 'S.', 'Babu'], ['Klaus', '', 'Klumpp'], ['John', 'D.', 'Morrey']]",Antiviral Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0166354210006674', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354210006674']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Ferraris, O., Kessler, N., Valette, M., et. al, Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.05.050,Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005,"[['Olivier', '', 'Ferraris'], ['Nicole', '', 'Kessler'], ['Martine', '', 'Valette'], ['Bruno', '', 'Lina']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06006384', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06006384']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Hatori, A., Arai, T., Yanamoto, K., et. al, Biodistribution and metabolism of the anti-influenza drug [ 11C]oseltamivir and its active metabolite [ 11C]Ro 64-0802 in mice, Nuclear Medicine and Biology, 2009",cited-by,10.1016/j.nucmedbio.2008.10.008,Biodistribution and metabolism of the anti-influenza drug [ 11C]oseltamivir and its active metabolite [ 11C]Ro 64-0802 in mice,"[['Akiko', '', 'Hatori'], ['Takuya', '', 'Arai'], ['Kazuhiko', '', 'Yanamoto'], ['Tomoteru', '', 'Yamasaki'], ['Kazunori', '', 'Kawamura'], ['Joji', '', 'Yui'], ['Fujiko', '', 'Konno'], ['Ryuji', '', 'Nakao'], ['Kazutoshi', '', 'Suzuki'], ['Ming-Rong', '', 'Zhang']]",Nuclear Medicine and Biology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0969805108002308', u'http://linkinghub.elsevier.com/retrieve/pii/S0969805108002308']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Richard, M., Deléage, C., Barthélémy, M., et. al, Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors, Journal of Clinical Virology, 2008",cited-by,10.1016/j.jcv.2007.10.021,"Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors","[['Mathilde', '', 'Richard'], ['Claire', '', 'Del\xc3\xa9age'], ['Mendy', '', 'Barth\xc3\xa9l\xc3\xa9my'], ['Yi', 'Pu', 'Lin'], ['Alan', '', 'Hay'], ['Bruno', '', 'Lina'], ['Olivier', '', 'Ferraris']]",Journal of Clinical Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1386653207003915', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653207003915']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Wutzler, P., Vogel, G., , Neuraminidase Inhibitors in the Treatment of Influenza A and B – Overview and Case Reports, Infection, 2000",cited-by,10.1007/s150100070016,Neuraminidase Inhibitors in the Treatment of Influenza A and B – Overview and Case Reports,"[['P.', '', 'Wutzler'], ['G.', '', 'Vogel']]",Infection,2000,"[u'http://www.springerlink.com/index/2whqp8gpfwfm57c0.pdf', u'http://www.springerlink.com/content/2whqp8gpfwfm57c0', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s150100070016', u'http://www.springerlink.com/index/pdf/10.1007/s150100070016']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Bowden, T., Aricescu, A., Gilbert, R., et. al, Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2, Nature Structural & Molecular Biology, 2008",cited-by,10.1038/nsmb.1435,Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2,"[['Thomas', 'A', 'Bowden'], ['A', 'Radu', 'Aricescu'], ['Robert', 'J C', 'Gilbert'], ['Jonathan', 'M', 'Grimes'], ['E', 'Yvonne', 'Jones'], ['David', 'I', 'Stuart']]",Nature Structural & Molecular Biology,2008,[u'http://dx.doi.org/10.1038/nsmb.1435']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2008.11.014,"Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273608003842', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273608003842']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Sriwilaijaroen, N., Wilairat, P., Hiramatsu, H., et. al, Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities, Virology Journal, 2009",cited-by,10.1186/1743-422X-6-124,Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities,"[['Nongluk', '', 'Sriwilaijaroen'], ['Prapon', '', 'Wilairat'], ['Hiroaki', '', 'Hiramatsu'], ['Tadanobu', '', 'Takahashi'], ['Takashi', '', 'Suzuki'], ['Morihiro', '', 'Ito'], ['Yasuhiko', '', 'Ito'], ['Masato', '', 'Tashiro'], ['Yasuo', '', 'Suzuki']]",Virology Journal,2009,"[u'http://www.virologyj.com/content/6/1/124', u'http://www.springerlink.com/index/j637180476x44107.pdf', u'http://www.biomedcentral.com/content/pdf/1743-422X-6-124.pdf', u'http://www.springerlink.com/content/j637180476x44107']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Alymova, I., Watanabe, M., Mishin, V., et. al, Loss of the N-Linked Glycan at Residue 173 of Human Parainfluenza Virus Type 1 Hemagglutinin-Neuraminidase Exposes a Second Receptor-Binding Site, Journal of Virology, 2008",cited-by,10.1128/JVI.00474-08,Loss of the N-Linked Glycan at Residue 173 of Human Parainfluenza Virus Type 1 Hemagglutinin-Neuraminidase Exposes a Second Receptor-Binding Site,"[['Irina', 'V.', 'Alymova'], ['M.', '', 'Watanabe'], ['Vasiliy', 'P.', 'Mishin'], ['J.', '', 'DeVincenzo'], ['K.', 'Gopal', 'Murti'], ['A.', '', 'Portner'], ['Y.', 'Sudhakara', 'Babu']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/17/8400.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00474-08', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02331-09']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Meloni, D., Monaci, R., Rombi, E., et. al, Synthesis and characterization of MCM-22 zeolites for the N 2O oxidation of benzene to phenol, Studies in Surface Science and Catalysis, 2002",cited-by,10.1016/S0167-2991(02)80025-8,Synthesis and characterization of MCM-22 zeolites for the N 2O oxidation of benzene to phenol,"[['D.', '', 'Meloni'], ['R.', '', 'Monaci'], ['E.', '', 'Rombi'], ['C.', '', 'Guimon'], ['H.', '', 'Martinez'], ['I.', '', 'Fechete'], ['E.', '', 'Dumitriu']]",Studies in Surface Science and Catalysis,2002,[u'http://www.sciencedirect.com/science/article/pii/S0167299102800258']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"McKimm-Breschkin, J., Sahasrabudhe, A., Blick, T., et. al, Mechanisms of resistance of influenza virus to neuraminidase inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00364-8,Mechanisms of resistance of influenza virus to neuraminidase inhibitors,"[['Jennifer', '', 'McKimm-Breschkin'], ['Anjali', '', 'Sahasrabudhe'], ['Tony', '', 'Blick'], ['Mandy', '', 'McDonald']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003648', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003648']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Colacino, J., Staschke, K., Laver, W., , Approaches and strategies for the treatment of influenza virus infections, , 0",cited-by,11571009Approaches and strategies for the treatment of influenza virus infections,Approaches and strategies for the treatment of influenza virus infections,"[['Joseph', 'M', 'Colacino'], ['Kirk', 'A', 'Staschke'], ['W', 'Graeme', 'Laver']]",,0,[u'http://arbidol.org/Approaches-and-strategies-for-the-treatment-of-influenza.pdf']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Stella, V., , Prodrug Strategies for Improving Drug-Like Properties, , 0",cited-by,10.1007/978-0-387-44961-6_10,Prodrug Strategies for Improving Drug-Like Properties,"[['Valentino', 'J.', 'Stella']]",,0,"[u'http://www.springerlink.com/content/r8685x15644w6676', u'http://www.springerlink.com/index/r8685x15644w6676.pdf']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Ilyushina, N., Seiler, J., Rehg, J., et. al, Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets, PLOS Pathogens, 2010",cited-by,10.1371/journal.ppat.1000933,Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets,"[['Natalia', 'A.', 'Ilyushina'], ['Jon', 'P.', 'Seiler'], ['Jerold', 'E.', 'Rehg'], ['Robert', 'G.', 'Webster'], ['Elena', 'A.', 'Govorkova']]",PLOS Pathogens,2010,[u'http://dx.doi.org/10.1371/journal.ppat.1000933']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2009.04.014,"Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273609001345', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273609001345']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Li, Z., Sun, J., Liang, G., et. al, On Three-Dimensional Holographic Vector of Atomic Interaction Field Analysis for Influenza Neuraminidase Inhibitors, Chemical Biology & Drug Design, 2009",cited-by,10.1111/j.1747-0285.2008.00767.x,On Three-Dimensional Holographic Vector of Atomic Interaction Field Analysis for Influenza Neuraminidase Inhibitors,"[['Zhiliang', 'S.', 'Li'], ['Jiaying', 'Y.', 'Sun'], ['Guizhao', 'Z.', 'Liang'], ['Fenglin', 'L.', 'Lu'], ['Wanping', 'P.', 'Zhu'], ['Mengjun', 'J.', 'Zhang'], ['Yonghong', '', 'Zhang'], ['Shanbin', 'B.', 'Yang'], ['Mao', '', 'Shu'], ['Guohua', 'H.', 'Chen'], ['Tingting', 'T.', 'Lu']]",Chemical Biology & Drug Design,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1747-0285.2008.00767.x']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Park, Y., Woo, S., Jung, M., et. al, Pharmacokinetics and bioavailability of oral cephalosporins, KR984055 and its prodrugs, KR999001 and KR999002, in the rat, Archives of Pharmacal Research, 2003",cited-by,10.1007/BF03179937,"Pharmacokinetics and bioavailability of oral cephalosporins, KR984055 and its prodrugs, KR999001 and KR999002, in the rat","[['Yong', 'Soon', 'Park'], ['Su', 'Kyung', 'Woo'], ['Myung', 'Hee', 'Jung'], ['Kwang-il', '', 'Kwon']]",Archives of Pharmacal Research,2003,"[u'http://www.springerlink.com/index/r755544631538u36.pdf', u'http://www.springerlink.com/content/r755544631538u36', u'http://www.springerlink.com/index/10.1007/BF03179937', u'http://www.springerlink.com/index/pdf/10.1007/BF03179937']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Massarella, J., He, G., Dorr, A., et. al, The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers, Journal of Clinical Pharmacology, 2000",cited-by,10.1177/009127000004000804,The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers,"[['Joseph', 'W.', 'Massarella'], ['George', 'Z.', 'He'], ['Albert', '', 'Dorr'], ['Keith', '', 'Nieforth'], ['Penelope', '', 'Ward'], ['Andy', '', 'Brown']]",Journal of Clinical Pharmacology,2000,[u'http://dx.doi.org/10.1177/009127000004000804']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Lee, K., Seong, B., , Current status for influenza control, Biotechnology and Bioprocess Engineering, 1999",cited-by,10.1007/BF02931921,Current status for influenza control,"[['Kwang-Hee', '', 'Lee'], ['Baik', 'L.', 'Seong']]",Biotechnology and Bioprocess Engineering,1999,"[u'http://www.springerlink.com/content/840102417644j556', u'http://www.springerlink.com/index/840102417644j556.pdf', u'http://www.springerlink.com/index/10.1007/BF02931921', u'http://www.springerlink.com/index/pdf/10.1007/BF02931921']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Leitzke, S., , Die Therapie der Influenza mit Neuraminidase-Inhibitoren, Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz, 1999",cited-by,10.1007/s001030050275,Die Therapie der Influenza mit Neuraminidase-Inhibitoren,"[['S.', '', 'Leitzke']]",Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz,1999,"[u'http://www.springerlink.com/index/aubc4t0cmtk1megk.pdf', u'http://www.springerlink.com/content/aubc4t0cmtk1megk', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s001030050275', u'http://www.springerlink.com/index/pdf/10.1007/s001030050275']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Ferraris, O., Kessler, N., Lina, B., , Short communication Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice, , 0",cited-by,10760728Short communication Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice,Short communication Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice,"[['O.', '', 'Ferraris'], ['N.', '', 'Kessler'], ['B.', '', 'Lina']]",,0,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-11.pdf']
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Stella, V., , Prodrug Approaches to Enhancing the Oral Delivery of Poorly Permeable Drugs, , 0",cited-by,10.1007/978-0-387-49785-3_2,Prodrug Approaches to Enhancing the Oral Delivery of Poorly Permeable Drugs,"[['Valentino', 'J.', 'Stella']]",,0,"[u'http://www.springerlink.com/content/g042x331103w6610', u'http://www.springerlink.com/index/g042x331103w6610.pdf']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Eisenberg, E., , Case Study: Oseltamivir: An Orally Bioavailable Ester Prodrug of Oseltamivir Carboxylate, , 0",cited-by,10.1007/978-0-387-49785-3_50,Case Study: Oseltamivir: An Orally Bioavailable Ester Prodrug of Oseltamivir Carboxylate,"[['Eugene', 'J.', 'Eisenberg']]",,0,"[u'http://www.springerlink.com/index/qp8122385lu86756.pdf', u'http://www.springerlink.com/content/qp8122385lu86756']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Tisdale, M., , Influenza M2 Ion-Channel and Neuraminidase Inhibitors, , 0",cited-by,10.1007/978-1-59745-180-2_31,Influenza M2 Ion-Channel and Neuraminidase Inhibitors,"[['Margaret', '', 'Tisdale']]",,0,"[u'http://www.springerlink.com/index/th812t5r62661uh4.pdf', u'http://www.springerlink.com/content/th812t5r62661uh4']"
11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"Pleschka, S., Ludwig, S., Wolff, T., et. al, Anti-viral approaches against influenza viruses, , 0",cited-by,10.1007/978-0-387-31047-3_5,Anti-viral approaches against influenza viruses,"[['Stephan', '', 'Pleschka'], ['Stephan', '', 'Ludwig'], ['Thorsten', '', 'Wolff'], ['Oliver', '', 'Planz']]",,0,"[u'http://www.springerlink.com/index/um10454n7482018j.pdf', u'http://www.springerlink.com/content/um10454n7482018j']"
10.1016~S0140-6736(00)02288-1,"Sidwell RW, Huffman JH, Barnard DL, et al. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res 1998; 37: 107–20.",references,10.1016/S0166-3542(97)00065-X,"Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor","[[u'Robert', u'W.', u'Sidwell'], [u'John', u'H.', u'Huffman'], [u'Dale', u'L.', u'Barnard'], [u'Kevin', u'W.', u'Bailey'], [u'Min-Hui', u'', u'Wong'], [u'Ann', u'', u'Morrison'], [u'Timothy', u'', u'Syndergaard'], [u'Choung', u'U.', u'Kim']]",Antiviral Research,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016635429700065X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635429700065X']",./output/10.1016~S0140-6736(00)02288-1/10.1016~S0166-3542(97)00065-X
10.1016/S0166-3542(97)00065-X,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
10.1016/S0166-3542(97)00065-X,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1016/S0166-3542(97)00065-X,"Suzuki, Y., , Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses, Biological & Pharmaceutical Bulletin, 2005",cited-by,10.1248/bpb.28.399,Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses,"[['Yasuo', '', 'Suzuki']]",Biological & Pharmaceutical Bulletin,2005,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/28.399?from=CrossRef']
10.1016/S0166-3542(97)00065-X,"GOVORKOVA, E., LENEVA, I., GOLOUBEVA, O., et. al, Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.10.2723-2732.2001,"Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses","[['ELENA', 'A.', 'GOVORKOVA'], ['IRINA', 'A.', 'LENEVA'], ['OLGA', 'G.', 'GOLOUBEVA'], ['KAREN', '', 'BUSH'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/10/2723.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.10.2723-2732.2001']"
10.1016/S0166-3542(97)00065-X,"MENDEL, D., TAI, C., ESCARPE, P., et. al, Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection, , 1998",cited-by,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[['DIRK', 'B.', 'MENDEL'], ['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['WEIXING', '', 'LI'], ['ROBERT', 'W.', 'SIDWELL'], ['JOHN', 'H.', 'HUFFMAN'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['STEVEN', 'A.', 'LACY'], ['WILLARD', '', 'LEW'], ['MATTHEW', 'A.', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['MING', 'S.', 'CHEN'], ['NORBERT', '', 'BISCHOFBERGER'], ['CHOUNG', 'U.', 'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf']
10.1016/S0166-3542(97)00065-X,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf']
10.1016/S0166-3542(97)00065-X,"Zambon, M., Hayden, F., , Position statement: global neuraminidase inhibitor susceptibility network, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00124-3,Position statement: global neuraminidase inhibitor susceptibility network,"[['Maria', '', 'Zambon'], ['Frederick', 'G.', 'Hayden']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001243', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001243']"
10.1016/S0166-3542(97)00065-X,"SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']"
10.1016/S0166-3542(97)00065-X,"Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']"
10.1016/S0166-3542(97)00065-X,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf']
10.1016/S0166-3542(97)00065-X,"Smee, D., Bailey, K., Wong, M., et. al, Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00159-0,Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice,"[['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Robert', 'W.', 'Sidwell']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001590', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001590']"
10.1016/S0166-3542(97)00065-X,"Leneva, I., Roberts, N., Govorkova, E., et. al, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[['Irina', 'A.', 'Leneva'], ['Noel', '', 'Roberts'], ['Elena', 'A.', 'Govorkova'], ['Olga', 'G.', 'Goloubeva'], ['Robert', 'G.', 'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']"
10.1016/S0166-3542(97)00065-X,"NOYOLA, D., CLARK, B., O'DONNELL, F., et. al, Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens, , 2000",cited-by,"13918606Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","[['DANIEL', 'E.', 'NOYOLA'], ['BRUCE', '', 'CLARK'], ['FREDERICK', 'T.', ""O'DONNELL""], ['ROBERT', 'L.', 'ATMAR'], ['JEWEL', '', 'GREER'], ['GAIL', 'J.', 'DEMMLER']]",,2000,[u'http://jcm.asm.org/cgi/reprint/38/3/1161.pdf']
10.1016/S0166-3542(97)00065-X,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']"
10.1016/S0166-3542(97)00065-X,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
10.1016/S0166-3542(97)00065-X,"Sidwell, R., Barnard, D., Day, C., et. al, Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01051-06,Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice,"[['Robert', 'W.', 'Sidwell'], ['Dale', 'L.', 'Barnard'], ['Craig', 'W.', 'Day'], ['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['John', 'D.', 'Morrey'], ['Yousuke', '', 'Furuta']]",Antimicrobial Agents and Chemotherapy,2007,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01051-06']
10.1016/S0166-3542(97)00065-X,"Sidwell, R., Bailey, K., Wong, M., et. al, In vitro and in vivo influenza virus-inhibitory effects of viramidine, Antiviral Research, 2005",cited-by,10.1016/j.antiviral.2005.06.003,In vitro and in vivo influenza virus-inhibitory effects of viramidine,"[['Robert', 'W.', 'Sidwell'], ['K.', 'W.', 'Bailey'], ['M.-H.', '', 'Wong'], ['D.', 'L.', 'Barnard'], ['D.', 'F.', 'Smee']]",Antiviral Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S016635420500121X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420500121X']"
10.1016/S0166-3542(97)00065-X,"SIDWELL, R., SMEE, D., HUFFMAN, J., et. al, In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.749-757.2001,In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201,"[['ROBERT', 'W.', 'SIDWELL'], ['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['DALE', 'L.', 'BARNARD'], ['KEVIN', 'W.', 'BAILEY'], ['JOHN', 'D.', 'MORREY'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/3/749.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.749-757.2001']"
10.1016/S0166-3542(97)00065-X,"Kawai, N., Ikematsu, H., Iwaki, N., et. al, A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons, Clinical Infectious Diseases, 2006",cited-by,10.1086/505868,A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons,"[['Naoki', '', 'Kawai'], ['Hideyuki', '', 'Ikematsu'], ['Norio', '', 'Iwaki'], ['Tetsunari', '', 'Maeda'], ['Ietaka', '', 'Satoh'], ['Nobuo', '', 'Hirotsu'], ['Seizaburo', '', 'Kashiwagi']]",Clinical Infectious Diseases,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/505868']
10.1016/S0166-3542(97)00065-X,"Kawai, N., Ikematsu, H., Iwaki, N., et. al, Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002–2003 Influenza Season, Clinical Infectious Diseases, 2005",cited-by,10.1086/429241,Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002–2003 Influenza Season,"[['Naoki', '', 'Kawai'], ['Hideyuki', '', 'Ikematsu'], ['Norio', '', 'Iwaki'], ['Ietaka', '', 'Satoh'], ['Takashi', '', 'Kawashima'], ['Tetsunari', '', 'Maeda'], ['Kiyomitsu', '', 'Miyachi'], ['Nobuo', '', 'Hirotsu'], ['Takeshi', '', 'Shigematsu'], ['Seizaburo', '', 'Kashiwagi']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/429241']
10.1016/S0166-3542(97)00065-X,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']"
10.1016/S0166-3542(97)00065-X,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf']
10.1016/S0166-3542(97)00065-X,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671']
10.1016/S0166-3542(97)00065-X,"Lu, X., Jin, X., Lee, A., et. al, DAS181, A Novel Sialidase Fusion Protein, Protects Mice from Lethal Avian Influenza H5N1 Virus Infection, Journal of Infectious Diseases, 2007",cited-by,10.1086/522609,"DAS181, A Novel Sialidase Fusion Protein, Protects Mice from Lethal Avian Influenza H5N1 Virus Infection","[['Xiuhua', '', 'Lu'], ['Xiaoping', '', 'Jin'], ['Alice', '', 'Lee'], ['Stephen', '', 'Hawley'], ['Mang', '', 'Yu'], ['Fang', '', 'Fang']]",Journal of Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/522609']
10.1016/S0166-3542(97)00065-X,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']"
10.1016/S0166-3542(97)00065-X,"Jackson, D., Barclay, W., Zurcher, T., , Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations, , 2005",cited-by,6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,"[['David', '', 'Jackson'], ['Wendy', '', 'Barclay'], ['Thomas', '', 'Zurcher']]",,2005,[u'http://jac.oxfordjournals.org/cgi/reprint/55/2/162.pdf']
10.1016/S0166-3542(97)00065-X,"Boltz, D., Ilyushina, N., Arnold, C., et. al, Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2008.05.012,Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice,"[['David', 'A.', 'Boltz'], ['Natalia', 'A.', 'Ilyushina'], ['C.', 'Shane', 'Arnold'], ['Y.', 'Sudhakar', 'Babu'], ['Robert', 'G.', 'Webster'], ['Elena', 'A.', 'Govorkova']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208003185', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208003185']"
10.1016/S0166-3542(97)00065-X,"Sidwell, R., Smee, D., Huffman, J., et. al, Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00149-8,"Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201","[['Robert', 'W', 'Sidwell'], ['Donald', 'F', 'Smee'], ['John', 'H', 'Huffman'], ['Dale', 'L', 'Barnard'], ['John', 'D', 'Morrey'], ['Kevin', 'W', 'Bailey'], ['W.-C', '', 'Feng'], ['Y.', 'S', 'Babu'], ['Karen', '', 'Bush']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001498', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001498']"
10.1016/S0166-3542(97)00065-X,"FENTON, R., MORLEY, P., OWENS, I., et. al, Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract, , 1999",cited-by,"14046363Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract","Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory Tract","[['ROBERT', 'J.', 'FENTON'], ['PETER', 'J.', 'MORLEY'], ['IAN', 'J.', 'OWENS'], ['DAVID', '', 'GOWER'], ['SIMON', '', 'PARRY'], ['LEE', '', 'CROSSMAN'], ['TONY', '', 'WONG'], ['Glaxo', '', 'Wellcome']]",,1999,[u'http://aac.asm.org/cgi/reprint/43/11/2642.pdf']
10.1016/S0166-3542(97)00065-X,"Barrera, C., Reyes-Terán, G., , Influenza: Forecast for a Pandemic, Archives of Medical Research, 2005",cited-by,10.1016/j.arcmed.2005.05.002,Influenza: Forecast for a Pandemic,"[['Claudia', 'Alvarado de la', 'Barrera'], ['Gustavo', '', 'Reyes-Ter\xc3\xa1n']]",Archives of Medical Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0188440905001876', u'http://linkinghub.elsevier.com/retrieve/pii/S0188440905001876']"
10.1016/S0166-3542(97)00065-X,"Reyes-Teran, G., , Influenza: Forecast for a Pandemic, , 2005",cited-by,5508018Influenza: Forecast for a Pandemic,Influenza: Forecast for a Pandemic,"[['Gustavo', '', 'Reyes-Teran']]",,2005,"[u'http://birdflubook.com/resources/0barrera628.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-32.pdf']"
10.1016/S0166-3542(97)00065-X,"Hidari, K., Tsujii, E., Hiroi, J., et. al, In Vitro and in Vivo Inhibitory Effects of Disodium Cromoglycate on Influenza Virus Infection, Biological & Pharmaceutical Bulletin, 2004",cited-by,10.1248/bpb.27.825,In Vitro and in Vivo Inhibitory Effects of Disodium Cromoglycate on Influenza Virus Infection,"[['Kazuya', 'I. P. J.', 'Hidari'], ['Eisaku', '', 'Tsujii'], ['Jun', '', 'Hiroi'], ['Eriko', '', 'Mano'], ['Akihiko', '', 'Miyatake'], ['Daisei', '', 'Miyamoto'], ['Takashi', '', 'Suzuki'], ['Yasuo', '', 'Suzuki']]",Biological & Pharmaceutical Bulletin,2004,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/27.825?from=CrossRef']
10.1016/S0166-3542(97)00065-X,"Hidari, K., Murata, T., Yoshida, K., et. al, Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection, Glycobiology, 2008",cited-by,10.1093/glycob/cwn067,"Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection","[['Kazuya', 'I P J', 'Hidari'], ['Takeomi', '', 'Murata'], ['Kazuhiro', '', 'Yoshida'], ['Yoshiharu', '', 'Takahashi'], ['Yo-hei', '', 'Minamijima'], ['Yoshinobu', '', 'Miwa'], ['Satoshi', '', 'Adachi'], ['Makoto', '', 'Ogata'], ['Taiichi', '', 'Usui'], ['Yasuo', '', 'Suzuki'], ['Takashi', '', 'Suzuki']]",Glycobiology,2008,"[u'http://glycob.oxfordjournals.org/cgi/reprint/18/10/779.pdf', u'http://www.glycob.oxfordjournals.org/cgi/doi/10.1093/glycob/cwn067']"
10.1016/S0166-3542(97)00065-X,"Whitley, R., , The role of oseltamivir in the treatment and prevention of influenza in children, Expert Opinion on Drug Metabolism & Toxicology, 2007",cited-by,10.1517/17425225.3.5.755,The role of oseltamivir in the treatment and prevention of influenza in children,"[['Richard', 'J', 'Whitley']]",Expert Opinion on Drug Metabolism & Toxicology,2007,[u'http://www.expertopin.com/doi/abs/10.1517/17425225.3.5.755']
10.1016/S0166-3542(97)00065-X,"Liu, J., Mei, W., Xu, A., et. al, Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates, Antiviral Research, 2004",cited-by,10.1016/j.antiviral.2003.12.004,"Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates","[['Jie', '', 'Liu'], ['Wen-Jie', '', 'Mei'], ['An-Wu', '', 'Xu'], ['Cai-Ping', '', 'Tan'], ['Shuo', '', 'Shi'], ['Liang-Nian', '', 'Ji']]",Antiviral Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0166354203003000', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354203003000']"
10.1016/S0166-3542(97)00065-X,"Smee, D., Bailey, K., Sidwell, R., , Comparative Effects of Cidofovir and Cyclic HPMPC on Lethal Cowpox and Vaccinia Virus Respiratory Infections in Mice, Chemotherapy, 2003",cited-by,10.1159/000070618,Comparative Effects of Cidofovir and Cyclic HPMPC on Lethal Cowpox and Vaccinia Virus Respiratory Infections in Mice,"[['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Robert', 'W.', 'Sidwell']]",Chemotherapy,2003,"[u'http://www.online.karger.com/doi/10.1159/000070618', u'http://www.karger.com/doi/10.1159/000070618']"
10.1016/S0166-3542(97)00065-X,"Miyamoto, D., Hasegawa, S., Sriwilaijaroen, N., et. al, Clarithromycin Inhibits Progeny Virus Production from Human Influenza Virus-Infected Host Cells, Biological & Pharmaceutical Bulletin, 2008",cited-by,10.1248/bpb.31.217,Clarithromycin Inhibits Progeny Virus Production from Human Influenza Virus-Infected Host Cells,"[['Daisei', '', 'Miyamoto'], ['Sayaka', '', 'Hasegawa'], ['Nongluk', '', 'Sriwilaijaroen'], ['Sangchai', '', 'Yingsakmongkon'], ['Hiroaki', '', 'Hiramatsu'], ['Tadanobu', '', 'Takahashi'], ['Kazuya', '', 'Hidari'], ['Chao-Tan', '', 'Guo'], ['Yuichi', '', 'Sakano'], ['Takashi', '', 'Suzuki'], ['Yasuo', '', 'Suzuki']]",Biological & Pharmaceutical Bulletin,2008,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/31.217?from=CrossRef']
10.1016/S0166-3542(97)00065-X,"Ono, H., Nagano, Y., Matsunami, N., et. al, Oseltamivir, an Anti-influenza Virus Drug, Produces Hypothermia in Mice, Biological & Pharmaceutical Bulletin, 2008",cited-by,10.1248/bpb.31.638,"Oseltamivir, an Anti-influenza Virus Drug, Produces Hypothermia in Mice","[['Hideki', '', 'Ono'], ['Yuko', '', 'Nagano'], ['Noriaki', '', 'Matsunami'], ['Shinichi', '', 'Sugiyama'], ['Shohei', '', 'Yamamoto'], ['Mitsuo', '', 'Tanabe']]",Biological & Pharmaceutical Bulletin,2008,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/bpb/31.638?from=CrossRef']
10.1016/S0166-3542(97)00065-X,"Pu, X., Liang, J., Wang, X., et. al, Anti-influenza A virus effect of Hypericum perforatum L. extract, Virologica Sinica, 2009",cited-by,10.1007/s12250-009-2983-x,Anti-influenza A virus effect of Hypericum perforatum L. extract,"[['Xiu-ying', '', 'Pu'], ['Jian-ping', '', 'Liang'], ['Xue-hong', '', 'Wang'], ['Tao', '', 'Xu'], ['Lan-ying', '', 'Hua'], ['Ruo-feng', '', 'Shang'], ['Yu', '', 'Liu'], ['Yan-mei', '', 'Xing']]",Virologica Sinica,2009,"[u'http://www.springerlink.com/content/f6652mq1k78x4023', u'http://www.springerlink.com/index/f6652mq1k78x4023.pdf', u'http://www.springerlink.com/index/10.1007/s12250-009-2983-x', u'http://www.springerlink.com/index/pdf/10.1007/s12250-009-2983-x']"
10.1016/S0166-3542(97)00065-X,"Leneva, I., Russell, R., Boriskin, Y., et. al, Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.009,Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol,"[['Irina', 'A.', 'Leneva'], ['Rupert', 'J.', 'Russell'], ['Yury', 'S.', 'Boriskin'], ['Alan', 'J.', 'Hay']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004312', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004312']"
10.1016/S0166-3542(97)00065-X,"Wyde, P., , Chemotherapy of respiratory viruses: prospects and challenges, Drug Resistance Updates, 1999",cited-by,10.1054/drup.1999.0091,Chemotherapy of respiratory viruses: prospects and challenges,"[['Philip', 'R.', 'Wyde']]",Drug Resistance Updates,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1368764699900912', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764699900912']"
10.1016/S0166-3542(97)00065-X,"Sauerbrei, A., Haertl, A., Brandstaedt, A., et. al, Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors, Medical Microbiology and Immunology, 2006",cited-by,10.1007/s00430-005-0002-x,Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors,"[['A.', '', 'Sauerbrei'], ['A.', '', 'Haertl'], ['A.', '', 'Brandstaedt'], ['M.', '', 'Schmidtke'], ['P.', '', 'Wutzler']]",Medical Microbiology and Immunology,2006,"[u'http://www.springerlink.com/index/m37932425096l606.pdf', u'http://www.springerlink.com/content/m37932425096l606', u'http://www.springerlink.com/index/10.1007/s00430-005-0002-x', u'http://www.springerlink.com/index/pdf/10.1007/s00430-005-0002-x']"
10.1016/S0166-3542(97)00065-X,"Yokozawa, T., Sekiya, M., Cho, E., et. al, Effect of Wen-Pi-Tang extract on lung damage by influenza virus infection, Phytomedicine, 2004",cited-by,10.1016/j.phymed.2003.05.006,Effect of Wen-Pi-Tang extract on lung damage by influenza virus infection,"[['T.', '', 'Yokozawa'], ['M.', '', 'Sekiya'], ['E.', 'J.', 'Cho'], ['M.', '', 'Kurokawa'], ['K.', '', 'Shiraki']]",Phytomedicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0944711304000315', u'http://linkinghub.elsevier.com/retrieve/pii/S0944711304000315']"
10.1016/S0166-3542(97)00065-X,"Huang, H., Li, H., Zhou, P., et. al, Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice, Cytokine, 2010",cited-by,10.1016/j.cyto.2010.04.001,Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice,"[['Hai', '', 'Huang'], ['Hong', '', 'Li'], ['Pei', '', 'Zhou'], ['Dianwen', '', 'Ju']]",Cytokine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1043466610000967', u'http://linkinghub.elsevier.com/retrieve/pii/S1043466610000967']"
10.1016/S0166-3542(97)00065-X,"Oxford, J., , Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza, Influenza and Other Respiratory Viruses, 2007",cited-by,10.1111/j.1750-2659.2006.00006.x,Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza,"[['John', 'S.', 'Oxford']]",Influenza and Other Respiratory Viruses,2007,[u'http://doi.wiley.com/10.1111/j.1750-2659.2006.00006.x']
10.1016/S0166-3542(97)00065-X,"Lu, F., Tseng, S., Li, M., et. al, In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid, Archives of Virology, 2002",cited-by,10.1007/s705-002-8319-5,In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid,"[['F.-J.', '', 'Lu'], ['S.-N.', '', 'Tseng'], ['M.-L.', '', 'Li'], ['S.-R.', '', 'Shih']]",Archives of Virology,2002,"[u'http://www.springerlink.com/content/ajvvqnn6jcjmg9bc', u'http://www.springerlink.com/index/ajvvqnn6jcjmg9bc.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s705-002-8319-5', u'http://www.springerlink.com/index/pdf/10.1007/s705-002-8319-5']"
10.1016/S0166-3542(97)00065-X,"Sidwell, R., , A consideration of animal models used for study of influenza virus inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00388-0,A consideration of animal models used for study of influenza virus inhibitors,"[['Robert', 'W', 'Sidwell']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003880', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003880']"
10.1016/S0166-3542(97)00065-X,"Khare, M., Sharland, M., , Influenza, Expert Opinion on Pharmacotherapy, 2000",cited-by,10.1517/14656566.1.3.367,Influenza,"[['Milind', 'D', 'Khare'], ['Mike', '', 'Sharland']]",Expert Opinion on Pharmacotherapy,2000,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.1.3.367']
10.1016/S0166-3542(97)00065-X,"Welliver, R., Monto, A., Carewicz, O., , Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in, , 2010",cited-by,13851601Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,"[['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz']]",,2010,[u'http://jama.ama-assn.org/cgi/reprint/285/6/748.pdf']
10.1016/S0166-3542(97)00065-X,"Leibbrandt, A., Meier, C., König-Schuster, M., et. al, Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection, PLOS One, 2010",cited-by,10.1371/journal.pone.0014320,Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection,"[['Andreas', '', 'Leibbrandt'], ['Christiane', '', 'Meier'], ['Marielle', '', 'K\xc3\xb6nig-Schuster'], ['Regina', '', 'Weinm\xc3\xbcllner'], ['Donata', '', 'Kalthoff'], ['Bettina', '', 'Pflugfelder'], ['Philipp', '', 'Graf'], ['Britta', '', 'Frank-Gehrke'], ['Martin', '', 'Beer'], ['Tamas', '', 'Fazekas'], ['Hermann', '', 'Unger'], ['Eva', '', 'Prieschl-Grassauer'], ['Andreas', '', 'Grassauer'], ['Man-Seong', '', 'Park']]",PLOS One,2010,"[u'http://adsabs.harvard.edu/abs/2010PLoSO...514320L', u'http://dx.doi.org/10.1371/journal.pone.0014320']"
10.1016/S0166-3542(97)00065-X,"Whitley, R., , The role of oseltamivir in the treatment and prevention of influenza in children, Expert Opinion on Drug Metabolism & Toxicology, 2007",cited-by,10.1517/17425255.3.5.755,The role of oseltamivir in the treatment and prevention of influenza in children,"[['Richard', 'J', 'Whitley']]",Expert Opinion on Drug Metabolism & Toxicology,2007,[u'http://informahealthcare.com/doi/abs/10.1517/17425255.3.5.755']
10.1016/S0166-3542(97)00065-X,"Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737']
10.1016/S0166-3542(97)00065-X,"Lipatov, A., Govorkova, E., Webby, R., et. al, MINIREVIEW Influenza: Emergence and Control, , 2004",cited-by,12108822MINIREVIEW Influenza: Emergence and Control,MINIREVIEW Influenza: Emergence and Control,"[['Aleksandr', 'S.', 'Lipatov'], ['Elena', 'A.', 'Govorkova'], ['Richard', 'J.', 'Webby'], ['Hiroichi', '', 'Ozaki'], ['Malik', '', 'Peiris'], ['Yi', '', 'Guan'], ['Leo', '', 'Poon'], ['Robert', 'G.', 'Webster']]",,2004,"[u'http://jvi.highwire.org/cgi/reprint/78/17/8951.pdf', u'http://jvi.asm.org/cgi/reprint/78/17/8951.pdf']"
10.1016/S0166-3542(97)00065-X,"Munoz, F., , Antiviral agents in the critically ill child, Seminars in Pediatric Infectious Diseases, 2000",cited-by,10.1053/spid.0110035,Antiviral agents in the critically ill child,"[['Flor', 'M.', 'Munoz']]",Seminars in Pediatric Infectious Diseases,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1045187000700239', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187000700239']"
10.1016/S0166-3542(97)00065-X,"Massarella, J., He, G., Dorr, A., et. al, The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers, Journal of Clinical Pharmacology, 2000",cited-by,10.1177/009127000004000804,The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers,"[['Joseph', 'W.', 'Massarella'], ['George', 'Z.', 'He'], ['Albert', '', 'Dorr'], ['Keith', '', 'Nieforth'], ['Penelope', '', 'Ward'], ['Andy', '', 'Brown']]",Journal of Clinical Pharmacology,2000,[u'http://dx.doi.org/10.1177/009127000004000804']
10.1016/S0166-3542(97)00065-X,"Dowle, M., Howes, P., , Recent advances in sialidase inhibitors, Expert Opinion on Therapeutic Patents, 1998",cited-by,10.1517/13543776.8.11.1461,Recent advances in sialidase inhibitors,"[['Michael', 'D', 'Dowle'], ['Peter', 'D', 'Howes']]",Expert Opinion on Therapeutic Patents,1998,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.8.11.1461']
10.1016~S0140-6736(00)02288-1,"Hayden FG, Treanor JT, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized, controlled trials for prevention and treatment. JAMA 1999; 282: 1240–46.",references,10.1001/jama.282.13.1240,Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza: Randomized Controlled Trials for Prevention and Treatment,"[[u'F.', u'G.', u'Hayden']]",Jama-journal of The American Medical Association,1999,[u'http://jama.ama-assn.org/cgi/doi/10.1001/jama.282.13.1240'],./output/10.1016~S0140-6736(00)02288-1/10.1001~jama.282.13.1240
10.1001/jama.282.13.1240,"Bartlett, J., Dowell, S., Mandell, L., et. al, Practice Guidelines for the Management of Community‐Acquired Pneumonia in Adults, Clinical Infectious Diseases, 2000",cited-by,10.1086/313954,Practice Guidelines for the Management of Community‐Acquired Pneumonia in Adults,"[['John', 'G.', 'Bartlett'], ['Scott', 'F.', 'Dowell'], ['Lionel', 'A.', 'Mandell'], ['Daniel', 'M.', 'Musher'], ['Michael', 'J.', 'Fine']]",Clinical Infectious Diseases,2000,"[u'http://www.gata.edu.tr/dahilibilimler/ailehekimligi/dosyalar/111.pdf', u'http://www2.medicine.wisc.edu/home/files/domfiles/infectiousdisease/CommunityAcquiredAdultPneumonia.pdf', u'http://www.gata.edu.tr/dahilibilimler/nefroloji/dosyalar/111.pdf', u'http://www.antiinfectieux.org/antiinfectieux/Assets/PTS/infections-respiratoires/pneumonie/CAP-IDSA-guideline.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/313954']"
10.1001/jama.282.13.1240,"Mandell, L., Wunderink, R., Anzueto, A., et. al, Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community‐Acquired Pneumonia in Adults, Clinical Infectious Diseases, 2007",cited-by,10.1086/511159,Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community‐Acquired Pneumonia in Adults,"[['Lionel', 'A.', 'Mandell'], ['Richard', 'G.', 'Wunderink'], ['Antonio', '', 'Anzueto'], ['John', 'G.', 'Bartlett'], ['G.', 'Douglas', 'Campbell'], ['Nathan', 'C.', 'Dean'], ['Scott', 'F.', 'Dowell'], ['Daniel', 'M.', 'Musher'], ['Michael', 'S.', 'Niederman'], ['Antonio', '', 'Torres'], ['Cynthia', 'G.', 'Whitney']]",Clinical Infectious Diseases,2007,"[u'http://www.med.unc.edu/medselect/files/ATSguidelinesforpnuemonia.pdf', u'http://www.thoracic.org/sections/publications/statements/resources/idsaats-cap.pdf', u'http://www.grg-bs.it/usr_files/eventi/journal_club/programma/CAPadulti2007ATS.pdf', u'http://www.co.washington.wi.us/uploads/docs/CHN_IDSA-ATS_CAP.pdf', u'https://maine.gov/dhhs/boh/41620.web.pdf', u'http://www.svneumo.org/html/informacion/GUIA-ATS-2007.pdf', u'https://www.med.unc.edu/medselect/files/ATSguidelinesforpnuemonia.pdf', u'http://www.state.me.us/dhhs/boh/41620.web.pdf', u'http://maladiesinfectieuses.hug-ge.ch/_library/pdf/communityaquiredpneumonia.pdf', u'http://maladiesinfectieuses.hug-ge.ch/cahier_interne/jurc/ConsensusGuidelinesCAP.pdf', u'http://www.acutemed.co.uk/docs/pneumonia_extra.pdf', u'http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/idsacap2007.pdf', u'http://www.dhmc.org/dhmc-internet-upload/file_collection/CAParticle.pdf', u'http://www.matheny.info/clinical/CAP_ISD_AATS_2007.pdf', u'http://maladiesinfectieuses.hug-ge.ch/_library/pdf/GuidelinesPneumonia.pdf', u'http://www.thoracic.org/statements/resources/mtpi/idsaats-cap.pdf', u'http://www.sbpt.org.br/downloads/arquivos/Dir_Infec_Int/Consensus_Guidelines_Management_Community_Acquired_Pneumonia_Adults_IDSA_ATS_2007.pdf', u'http://www.sh.lsuhsc.edu/pharmacy/antibiotic%20guidelines/cap.pdf', u'http://www.sepeap.org/archivos/pdf/10476.pdf', u'http://scalpel.stanford.edu/2007-2008/articles/CAP,%20ATS%202007.pdf', u'http://www.bago.com/Bolivia/html/doc_pdf/management_cap.pdf', u'http://chicago.medicine.uic.edu/userfiles/servers/server_442934/file/pulmonary/recommended%20reading%202009-10/infections%20and%20sepsis/community%20acquired%20pneumonia.pdf', u'http://www.maine.gov/dhhs/boh/41620.web.pdf', u'http://www.courses.ahc.umn.edu/pharmacy/6124/handouts/IDSACAPGUIDELINES.pdf', u'http://inf-diseases.ru/2010/1400/1404.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/511159']"
10.1001/jama.282.13.1240,"Mandell, L., Bartlett, J., Dowell, S., et. al, Update of Practice Guidelines for the Management of Community‐Acquired Pneumonia in Immunocompetent Adults, Clinical Infectious Diseases, 2003",cited-by,10.1086/380488,Update of Practice Guidelines for the Management of Community‐Acquired Pneumonia in Immunocompetent Adults,"[['Lionel', 'A.', 'Mandell'], ['John', 'G.', 'Bartlett'], ['Scott', 'F.', 'Dowell'], ['Daniel', 'M.', 'Musher'], ['Cynthia', '', 'Whitney']]",Clinical Infectious Diseases,2003,"[u'http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/idsacap2003.pdf', u'http://www2.medicine.wisc.edu/home/files/domfiles/infectiousdisease/CommunityAcquiredPneumoniae.pdf', u'http://medicine.georgetown.edu/residency/IDarticles/cap.pdf', u'http://pharm.cch.org.tw/files/antimicro/32441.web.pdf', u'http://intmedweb.wfubmc.edu/core_competencies/common/Update%20of%20Practice%20Guidlines%20for%20the%20Mgmt%20of%20CAP.pdf', u'http://pediatrics.uchicago.edu/chiefs/ID/documents/Community-acquiredpneumonia.pdf', u'http://www2.cch.org.tw/medical/infectious/teaching%20files%20and%20guidelines/32441.web%20(%20cid%202003%E7%BE%8E%E5%9C%8Bidsa%E7%A4%BE%E5%8D%80%E6%80%A7%E8%82%BA%E7%82%8E%E6%B2%BB%E7%99%82%E6%8C%87%E5%BC%95).pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/380488']"
10.1001/jama.282.13.1240,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
10.1001/jama.282.13.1240,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1001/jama.282.13.1240,"Monto, A., Gravenstein, S., Elliott, M., et. al, Clinical Signs and Symptoms Predicting Influenza Infection, , 2000",cited-by,14312063Clinical Signs and Symptoms Predicting Influenza Infection,Clinical Signs and Symptoms Predicting Influenza Infection,"[['Arnold', 'S.', 'Monto'], ['Stefan', '', 'Gravenstein'], ['Michael', '', 'Elliott'], ['Michael', '', 'Colopy'], ['Jo', '', 'Schweinle']]",,2000,[u'http://archinte.ama-assn.org/cgi/reprint/160/21/3243.pdf']
10.1001/jama.282.13.1240,"Elden, L., Nijhuis, M., Schipper, P., et. al, Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.1.196-200.2001,Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR,"[['L.', 'J. R. van', 'Elden'], ['M.', '', 'Nijhuis'], ['P.', '', 'Schipper'], ['R.', '', 'Schuurman'], ['A.', 'M. van', 'Loon']]",Journal of Clinical Microbiology,2001,[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.1.196-200.2001']
10.1001/jama.282.13.1240,"Carrat, F., Vergu, E., Ferguson, N., et. al, Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies, , 2008",cited-by,6557572Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies,Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies,"[['Fabrice', '', 'Carrat'], ['Elisabeta', '', 'Vergu'], ['Neil', 'M.', 'Ferguson'], ['Magali', '', 'Lemaitre'], ['Simon', '', 'Cauchemez'], ['Steve', '', 'Leach'], ['Alain-Jacques', '', 'Valleron']]",,2008,"[u'http://aje.oxfordjournals.org/cgi/reprint/kwm375v1.pdf', u'http://195.134.113.71/hygiene/images/carrat%20%20am%20j%20epidemiol%202008.pdf', u'http://aje.oxfordjournals.org/cgi/reprint/167/7/775.pdf']"
10.1001/jama.282.13.1240,"Tablan, O., Anderson, L., Besser, R., et. al, GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By, , 0",cited-by,"13520052GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By","GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By","[['Ofelia', 'C.', 'Tablan'], ['Larry', 'J.', 'Anderson'], ['Richard', '', 'Besser'], ['Carolyn', '', 'Bridges'], ['Rana', '', 'Hajjeh']]",,0,"[u'http://origin.cdc.gov/hicpac/pdf/guidelines/hapneu2003guidelines.pdf', u'http://www.cdc.gov/hicpac/pdf/guidelines/hapneu2003guidelines.pdf']"
10.1001/jama.282.13.1240,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']"
10.1001/jama.282.13.1240,"Boivin, G., Hardy, I., Tellier, G., et. al, Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition, Clinical Infectious Diseases, 2000",cited-by,10.1086/317425,Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition,"[['Guy', '', 'Boivin'], ['Isabelle', '', 'Hardy'], ['Guy', '', 'Tellier'], ['Jean', '', 'Maziade']]",Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/317425']
10.1001/jama.282.13.1240,"Nichols, W., Guthrie, K., Corey, L., et. al, Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy, Clinical Infectious Diseases, 2004",cited-by,10.1086/425004,"Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy","[['W.', 'Garrett', 'Nichols'], ['Katherine', 'A.', 'Guthrie'], ['Lawrence', '', 'Corey'], ['Michael', '', 'Boeckh']]",Clinical Infectious Diseases,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/425004']
10.1001/jama.282.13.1240,"GOVORKOVA, E., LENEVA, I., GOLOUBEVA, O., et. al, Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.10.2723-2732.2001,"Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses","[['ELENA', 'A.', 'GOVORKOVA'], ['IRINA', 'A.', 'LENEVA'], ['OLGA', 'G.', 'GOLOUBEVA'], ['KAREN', '', 'BUSH'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/10/2723.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.10.2723-2732.2001']"
10.1001/jama.282.13.1240,"Cauchemez, S., Carrat, F., Viboud, C., et. al, A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data, Statistics in Medicine, 2004",cited-by,10.1002/sim.1912,A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data,"[['S.', '', 'Cauchemez'], ['F.', '', 'Carrat'], ['C.', '', 'Viboud'], ['A.', 'J.', 'Valleron'], ['P.', 'Y.', 'Bo\xc3\xablle']]",Statistics in Medicine,2004,[u'http://doi.wiley.com/10.1002/sim.1912']
10.1001/jama.282.13.1240,"Clercq, E., , Strategies in the design of antiviral drugs, Nature Reviews Drug Discovery, 2002",cited-by,10.1038/nrd703,Strategies in the design of antiviral drugs,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2002,"[u'http://dx.doi.org/10.1038/nrd703', u'http://www.nature.com/doifinder/10.1038/nrd703']"
10.1001/jama.282.13.1240,"Baccam, P., Beauchemin, C., Macken, C., et. al, Kinetics of Influenza A Virus Infection in Humans, Journal of Virology, 2006",cited-by,10.1128/JVI.01623-05,Kinetics of Influenza A Virus Infection in Humans,"[['Prasith', '', 'Baccam'], ['Catherine', '', 'Beauchemin'], ['Catherine', 'A.', 'Macken'], ['Frederick', 'G.', 'Hayden'], ['Alan', 'S.', 'Perelson']]",Journal of Virology,2006,"[u'http://www.ctcd.edu/science/tanderson/documents/KineticsofInflAinfection.pdf', u'http://jvi.asm.org/cgi/reprint/80/15/7590.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01623-05']"
10.1001/jama.282.13.1240,"GUBAREVA, L., WEBSTER, R., HAYDEN, F., , Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.12.3403-3408.2001,"Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants","[['LARISA', 'V.', 'GUBAREVA'], ['ROBERT', 'G.', 'WEBSTER'], ['FREDERICK', 'G.', 'HAYDEN']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/12/3403.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.12.3403-3408.2001']"
10.1001/jama.282.13.1240,"Cunney, R., Bialachowski, A., Thornley, D., et. al, An Outbreak of Influenza A in a Neonatal Intensive Care Unit, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501786,An Outbreak of Influenza A in a Neonatal Intensive Care Unit,"[['Robert', 'J.', 'Cunney'], ['Anne', '', 'Bialachowski'], ['Diane', '', 'Thornley'], ['Fiona', 'M.', 'Smaill'], ['Ross', 'A.', 'Pennie']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501786']
10.1001/jama.282.13.1240,"Gubareva, L., Webster, R., Hayden, F., , Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00192-9,Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay,"[['Larisa', 'V.', 'Gubareva'], ['Robert', 'G.', 'Webster'], ['Frederick', 'G.', 'Hayden']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001929', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001929']"
10.1001/jama.282.13.1240,"Lee, N., Wong, E., , Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza, Journal of Infectious Diseases, 2009",cited-by,10.1086/600383,Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza,"[['Nelson', '', 'Lee'], ['Eric', '', 'Wong']]",Journal of Infectious Diseases,2009,"[u'http://www.srlf.org/Data/upload/file/Grippe%20A/103%20-%20Excr%C3%A9tion%20virale%20Grippes%20hospital%20-%20JID%2009.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/600383']"
10.1001/jama.282.13.1240,"Mishin, V., Hayden, F., Gubareva, L., , Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.11.4515-4520.2005,Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors,"[['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Larisa', 'V.', 'Gubareva']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/11/4515.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.11.4515-4520.2005']"
10.1001/jama.282.13.1240,"Bowles, S., Lee, W., Simor, A., et. al, Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999â2000, Journal of The American Geriatrics Society, 2002",cited-by,10.1046/j.1532-5415.2002.50153.x,"Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999â2000","[['Susan', 'K.', 'Bowles'], ['Wayne', '', 'Lee'], ['Andrew', 'E.', 'Simor'], ['Mary', '', 'Vearncombe'], ['Mark', '', 'Loeb'], ['Susan', '', 'Tamblyn'], ['Margaret', '', 'Fearon'], ['Yan', '', 'Li'], ['Allison', '', 'McGeer']]",Journal of The American Geriatrics Society,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2002.50153.x']
10.1001/jama.282.13.1240,"SMEE, D., HUFFMAN, J., MORRISON, A., et. al, Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.743-748.2001,Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities,"[['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['ANN', 'C.', 'MORRISON'], ['DALE', 'L.', 'BARNARD'], ['ROBERT', 'W.', 'SIDWELL']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://journals.pasteur.ac.ir/AAC01/45(3)/743.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.743-748.2001']"
10.1001/jama.282.13.1240,"Ferguson, N., Mallett, S., Jackson, H., et. al, A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals, , 2003",cited-by,6946003A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals,A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals,"[['Neil', 'M.', 'Ferguson'], ['Susan', '', 'Mallett'], ['Helen', '', 'Jackson'], ['Noel', '', 'Roberts'], ['Penelope', '', 'Ward']]",,2003,"[u'http://jac.oxfordjournals.org/cgi/reprint/51/4/977.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkg136v1.pdf']"
10.1001/jama.282.13.1240,"Gravenstein, S., , Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America, Clinical Infectious Diseases, 2009",cited-by,10.1086/598513,"Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America","[['Stefan', '', 'Gravenstein']]",Clinical Infectious Diseases,2009,"[u'http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/idsainfluenza2009.pdf', u'http://linmed.files.wordpress.com/2009/05/flu_guideline_2009.pdf', u'http://maladiesinfectieuses.hug-ge.ch/_library/pdf/influenza.pdf', u'http://www.srlf.org/Data/upload/file/Grippe%20A/(26)%20-%20Recos%20Flu%20IDSA%202009.pdf', u'http://www.maine.gov/dhhs/boh/ddc/epi/influenzatoolkit/Supporting%20documents/IDSA%20Seasonal%20Guidelines.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/598513']"
10.1001/jama.282.13.1240,"Lee, P., Matchar, D., Clements, D., et. al, Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, , 2002",cited-by,5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,"[['Patrick', 'Y.', 'Lee'], ['David', 'B.', 'Matchar'], ['Dennis', 'A.', 'Clements'], ['Joel', '', 'Huber'], ['John', 'D.', 'Hamilton'], ['Eric', 'D.', 'Peterson']]",,2002,[u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Lee_2002.pdf']
10.1001/jama.282.13.1240,"Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']"
10.1001/jama.282.13.1240,"Baskin, C., Garcia-Sastre, A., Tumpey, T., et. al, Integration of Clinical Data, Pathology, and cDNA Microarrays in Influenza Virus-Infected Pigtailed Macaques (Macaca nemestrina), Journal of Virology, 2004",cited-by,10.1128/JVI.78.19.10420-10432.2004,"Integration of Clinical Data, Pathology, and cDNA Microarrays in Influenza Virus-Infected Pigtailed Macaques (Macaca nemestrina)","[['C.', 'R.', 'Baskin'], ['A.', '', 'Garcia-Sastre'], ['T.', 'M.', 'Tumpey'], ['H.', '', 'Bielefeldt-Ohmann'], ['V.', 'S.', 'Carter'], ['E.', '', 'Nistal-Villan'], ['M.', 'G.', 'Katze']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/19/10420.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.19.10420-10432.2004']"
10.1001/jama.282.13.1240,"Machado, C., Boas, L., Mendes, A., et. al, Use of Oseltamivir to control influenza complications after bone marrow transplantation, Bone Marrow Transplantation, 2004",cited-by,10.1038/sj.bmt.1704534,Use of Oseltamivir to control influenza complications after bone marrow transplantation,"[['C', 'M', 'Machado'], ['L', 'S V', 'Boas'], ['A', 'V A', 'Mendes'], ['I', 'F da', 'Rocha'], ['D', '', 'Sturaro'], ['F', 'L', 'Dulley'], ['C', 'S', 'Pannuti']]",Bone Marrow Transplantation,2004,"[u'http://dx.doi.org/10.1038/sj.bmt.1704534', u'http://www.nature.com/doifinder/10.1038/sj.bmt.1704534']"
10.1001/jama.282.13.1240,"Rothberg, M., Rose, D., , Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis, American Journal of Medicine, 2005",cited-by,10.1016/j.amjmed.2004.03.044,Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis,"[['Michael', 'B.', 'Rothberg'], ['David', 'N.', 'Rose']]",American Journal of Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0002934304006291', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-5.pdf', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/vaccination/vaccination-8.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934304006291']"
10.1001/jama.282.13.1240,"Scuffham, P., West, P., , Economic evaluation of strategies for the control and management of influenza in Europe, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00154-8,Economic evaluation of strategies for the control and management of influenza in Europe,"[['P.', 'A.', 'Scuffham'], ['P.', 'A.', 'West']]",Vaccine,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/prevention/prevention-2.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X02001548', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/preparedness/preparedness-17.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001548']"
10.1001/jama.282.13.1240,"BOIVIN, G., HARDY, I., KRESS, A., , Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.2.730-732.2001,Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,"[['GUY', '', 'BOIVIN'], ['ISABELLE', '', 'HARDY'], ['ANDREW', '', 'KRESS']]",Journal of Clinical Microbiology,2001,"[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.2.730-732.2001', u'http://jcm.asm.org/cgi/reprint/39/2/730.pdf']"
10.1001/jama.282.13.1240,"Viboud, C., Boëlle, P., Cauchemez, S., et. al, Risk factors of influenza transmission in households, International Congress Series, 2004",cited-by,10.1016/j.ics.2004.01.013,Risk factors of influenza transmission in households,"[['C\xc3\xa9cile', '', 'Viboud'], ['Pierre-Yves', '', 'Bo\xc3\xablle'], ['Simon', '', 'Cauchemez'], ['Audrey', '', 'Lavenu'], ['Alain-Jacques', '', 'Valleron'], ['Antoine', '', 'Flahault'], ['Fabrice', '', 'Carrat']]",International Congress Series,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0531513104000147', u'http://origem.info/FIC/pdf/Viboud%20et%20al%20Risk%20Factors_Br%20J%20Gen%20Pract%2004.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513104000147']"
10.1001/jama.282.13.1240,"Kaiser, L., Keene, O., Hammond, J., et. al, Impact of Zanamivir on Antibiotic Use for Respiratory Events Following Acute Influenza in Adolescents and Adults, , 2000",cited-by,13631010Impact of Zanamivir on Antibiotic Use for Respiratory Events Following Acute Influenza in Adolescents and Adults,Impact of Zanamivir on Antibiotic Use for Respiratory Events Following Acute Influenza in Adolescents and Adults,"[['Laurent', '', 'Kaiser'], ['Oliver', 'N.', 'Keene'], ['Janet', 'M. J.', 'Hammond'], ['Mike', '', 'Elliott'], ['Frederick', 'G.', 'Hayden']]",,2000,"[u'http://archinte.ama-assn.org/cgi/reprint/160/21/3234.pdf', u'http://archinte.highwire.org/cgi/reprint/160/21/3234.pdf']"
10.1001/jama.282.13.1240,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
10.1001/jama.282.13.1240,"SIDWELL, R., SMEE, D., HUFFMAN, J., et. al, In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.749-757.2001,In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201,"[['ROBERT', 'W.', 'SIDWELL'], ['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['DALE', 'L.', 'BARNARD'], ['KEVIN', 'W.', 'BAILEY'], ['JOHN', 'D.', 'MORREY'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/3/749.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.749-757.2001']"
10.1001/jama.282.13.1240,"Reece, P., , Neuraminidase inhibitor resistance in influenza viruses, Journal of Medical Virology, 2007",cited-by,10.1002/jmv.20951,Neuraminidase inhibitor resistance in influenza viruses,"[['Phillip', 'Andrew', 'Reece']]",Journal of Medical Virology,2007,[u'http://doi.wiley.com/10.1002/jmv.20951']
10.1001/jama.282.13.1240,"Leekha, S., Zitterkopf, N., Espy, M., et. al, Duration of Influenza A Virus Shedding in Hospitalized Patients and Implications for Infection Control, Infection Control and Hospital Epidemiology, 2007",cited-by,10.1086/520101,Duration of Influenza A Virus Shedding in Hospitalized Patients and Implications for Infection Control,"[['Surbhi', '', 'Leekha'], ['Nicole', 'L.', 'Zitterkopf'], ['Mark', 'J.', 'Espy'], ['Thomas', 'F.', 'Smith'], ['Rodney', 'L.', 'Thompson'], ['Priya', '', 'Sampathkumar']]",Infection Control and Hospital Epidemiology,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/520101']
10.1001/jama.282.13.1240,"Vynnycky, E., Trindall, A., Mangtani, P., , Estimates of the reproduction numbers of Spanish influenza using morbidity data, , 2007",cited-by,6816772Estimates of the reproduction numbers of Spanish influenza using morbidity data,Estimates of the reproduction numbers of Spanish influenza using morbidity data,"[['Emilia', '', 'Vynnycky'], ['Amy', '', 'Trindall'], ['Punam', '', 'Mangtani']]",,2007,"[u'http://ije.oxfordjournals.org/cgi/reprint/36/4/881.pdf', u'http://ije.oxfordjournals.org/cgi/reprint/dym071v1.pdf']"
10.1001/jama.282.13.1240,"Carrat, F., Luong, J., Lao, H., et. al, A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics, BMC Medicine, 2006",cited-by,10.1186/1741-7015-4-26,A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics,"[['Fabrice', '', 'Carrat'], ['Julie', '', 'Luong'], ['Herv\xc3\xa9', '', 'Lao'], ['Anne-Violaine', '', 'Sall\xc3\xa9'], ['Christian', '', 'Lajaunie'], ['Hans', '', 'Wackernagel']]",BMC Medicine,2006,"[u'http://www.springerlink.com/content/p143430087461258', u'http://www.springerlink.com/index/p143430087461258.pdf', u'http://www.biomedcentral.com/1741-7015/4/26', u'http://www.biomedcentral.com/content/pdf/1741-7015-4-26.pdf', u'http://www.hal.inserm.fr/docs/00/12/21/40/PDF/1741-7015-4-26.pdf']"
10.1001/jama.282.13.1240,"Vu, D., Peck, A., Nichols, W., et. al, Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case‐Control Study, Clinical Infectious Diseases, 2007",cited-by,10.1086/518985,Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case‐Control Study,"[['Debie', '', 'Vu'], ['Angela', 'J.', 'Peck'], ['W.', 'Garrett', 'Nichols'], ['Cara', '', 'Varley'], ['Janet', 'A.', 'Englund'], ['Lawrence', '', 'Corey'], ['Michael', '', 'Boeckh']]",Clinical Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/518985']
10.1001/jama.282.13.1240,"BOIVIN, G., HARDY, I., KRESS, A., , Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR, , 0",cited-by,11106017Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,"[['GUY', '', 'BOIVIN'], ['ISABELLE', '', 'HARDY'], ['ANDREW', '', 'KRESS']]",,0,[u'http://jcm.asm.org/cgi/reprint/39/2/730.pdf']
10.1001/jama.282.13.1240,"McCaw, J., McVernon, J., , Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic, Mathematical Biosciences, 2007",cited-by,10.1016/j.mbs.2007.02.003,Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic,"[['James', 'M.', 'McCaw'], ['Jodie', '', 'McVernon']]",Mathematical Biosciences,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0025556407000302', u'http://linkinghub.elsevier.com/retrieve/pii/S0025556407000302', u'http://mathmodelling.sph.unimelb.edu.au/publications/McCaw-MathBiosci-2007.pdf']"
10.1001/jama.282.13.1240,"Sato, M., Hosoya, M., Kato, K., et. al, VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS, Pediatric Infectious Disease Journal, 2005",cited-by,10.1097/01.inf.0000180976.81055.ce,VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS,"[['Masatoki', '', 'Sato'], ['Mitsuaki', '', 'Hosoya'], ['Kazuo', '', 'Kato'], ['Hitoshi', '', 'Suzuki']]",Pediatric Infectious Disease Journal,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200510000-00019']
10.1001/jama.282.13.1240,"Kitler, M., Gavinio, P., Lavanchy, D., , Influenza and the work of the World Health Organization, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00121-4,Influenza and the work of the World Health Organization,"[['M.', 'E', 'Kitler'], ['P', '', 'Gavinio'], ['D', '', 'Lavanchy']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02001214', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001214']"
10.1001/jama.282.13.1240,"To, K., Chan, K., Li, I., et. al, Viral load in patients infected with pandemic H1N1 2009 influenza A virus, Journal of Medical Virology, 2010",cited-by,10.1002/jmv.21664,Viral load in patients infected with pandemic H1N1 2009 influenza A virus,"[['Kelvin', 'K. W.', 'To'], ['Kwok-Hung', '', 'Chan'], ['Iris', 'W. S.', 'Li'], ['Tak-Yin', '', 'Tsang'], ['Herman', '', 'Tse'], ['Jasper', 'F. W.', 'Chan'], ['Ivan', 'F. N.', 'Hung'], ['Sik-To', '', 'Lai'], ['Chi-Wai', '', 'Leung'], ['Yat-Wah', '', 'Kwan'], ['Yu-Lung', '', 'Lau'], ['Tak-Keung', '', 'Ng'], ['Vincent', 'C. C.', 'Cheng'], ['Joseph', 'S. M.', 'Peiris'], ['Kwok-Yung', '', 'Yuen']]",Journal of Medical Virology,2010,[u'http://doi.wiley.com/10.1002/jmv.21664']
10.1001/jama.282.13.1240,"Weiss, E., Houri-Haddad, Y., Greenbaum, E., et. al, Cranberry juice constituents affect influenza virus adhesion and infectivity, Antiviral Research, 2005",cited-by,10.1016/j.antiviral.2004.12.011,Cranberry juice constituents affect influenza virus adhesion and infectivity,"[['E.', 'I.', 'Weiss'], ['Y.', '', 'Houri-Haddad'], ['E.', '', 'Greenbaum'], ['N.', '', 'Hochman'], ['I.', '', 'Ofek'], ['Z.', '', 'Zakay-Rones']]",Antiviral Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205000057', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205000057']"
10.1001/jama.282.13.1240,"Langley, J., Faughnan, M., , Prevention of influenza in the general population, , 2004",cited-by,14345011Prevention of influenza in the general population,Prevention of influenza in the general population,"[['Joanne', 'M.', 'Langley'], ['Marie', 'E.', 'Faughnan']]",,2004,[u'http://www.cmaj.ca/cgi/reprint/171/10/1213.pdf']
10.1001/jama.282.13.1240,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf']
10.1001/jama.282.13.1240,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671']
10.1001/jama.282.13.1240,"File, T., Niederman, M., , Antimicrobial therapy of community-acquired pneumonia, Infectious Disease Clinics of North America, 2004",cited-by,10.1016/j.idc.2004.07.011,Antimicrobial therapy of community-acquired pneumonia,"[['Thomas', 'M.', 'File'], ['Michael', 'S.', 'Niederman']]",Infectious Disease Clinics of North America,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0891552004001035', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552004001035']"
10.1001/jama.282.13.1240,"Bouvier, N., Lowen, A., Palese, P., , Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol, Journal of Virology, 2008",cited-by,10.1128/JVI.01226-08,Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol,"[['Nicole', 'M.', 'Bouvier'], ['Anice', 'C.', 'Lowen'], ['Peter', '', 'Palese']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10052.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01226-08']"
10.1001/jama.282.13.1240,"Gravenstein, S., Drinka, P., Osterweil, D., et. al, Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.006,Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population,"[['Stefan', '', 'Gravenstein'], ['Paul', '', 'Drinka'], ['Dan', '', 'Osterweil'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult'], ['Arvydas', '', 'Ambrozaitis'], ['Ruth', '', 'Kandel'], ['Ellen', '', 'Binder'], ['Janet', '', 'Hammond'], ['Janet', '', 'McElhaney'], ['Nancy', '', 'Flack'], ['Janet', '', 'Daly'], ['Oliver', '', 'Keene']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005323', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005323']"
10.1001/jama.282.13.1240,"Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']"
10.1001/jama.282.13.1240,"McKimm-Breschkin, J., , Neuraminidase inhibitors for the treatment and prevention of influenza, Expert Opinion on Pharmacotherapy, 2002",cited-by,10.1517/14656566.3.2.103,Neuraminidase inhibitors for the treatment and prevention of influenza,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Expert Opinion on Pharmacotherapy,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.3.2.103']
10.1001/jama.282.13.1240,"Rahman, M., Vandermause, M., Kieke, B., et. al, Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season, Diagnostic Microbiology and Infectious Disease, 2008",cited-by,10.1016/j.diagmicrobio.2007.10.012,Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season,"[['Mahbubur', '', 'Rahman'], ['Mary', 'F.', 'Vandermause'], ['Burney', 'A.', 'Kieke'], ['Edward', 'A.', 'Belongia']]",Diagnostic Microbiology and Infectious Disease,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0732889307004725', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889307004725']"
10.1001/jama.282.13.1240,"Alymova, I., Taylor, G., Takimoto, T., et. al, Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.5.1495-1502.2004,Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo,"[['Irina', 'V.', 'Alymova'], ['Garry', '', 'Taylor'], ['Toru', '', 'Takimoto'], ['Tsu-Hsing', '', 'Lin'], ['Pooran', '', 'Chand'], ['Y.', 'Sudhakara', 'Babu'], ['Chenghong', '', 'Li'], ['Xiaoping', '', 'Xiong'], ['Allen', '', 'Portner']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/5/1495.pdf', u'http://aac.highwire.org/cgi/reprint/48/5/1495.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.5.1495-1502.2004']"
10.1001/jama.282.13.1240,"Ramsey, P., Ramin, K., , PNEUMONIA IN PREGNANCY, Obstetrics and Gynecology Clinics of North America, 2001",cited-by,10.1016/S0889-8545(05)70217-5,PNEUMONIA IN PREGNANCY,"[['Patrick', 'S.', 'Ramsey'], ['Kirk', 'D.', 'Ramin']]",Obstetrics and Gynecology Clinics of North America,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0889854505702175', u'http://linkinghub.elsevier.com/retrieve/pii/S0889854505702175']"
10.1001/jama.282.13.1240,"Beigel, J., , Influenza, Critical Care Medicine, 2008",cited-by,10.1097/CCM.0b013e318180b039,Influenza,"[['John', 'H.', 'Beigel']]",Critical Care Medicine,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-200809000-00025']
10.1001/jama.282.13.1240,"Englund, J., , Antiviral therapy of influenza, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.122999,Antiviral therapy of influenza,"[['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500571', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500571']"
10.1001/jama.282.13.1240,"SAGRERA, X., GINOVART, G., RASPALL, F., et. al, Outbreaks of influenza A virus infection in neonatal intensive care units, Pediatric Infectious Disease Journal, 2002",cited-by,10.1097/00006454-200203000-00007,Outbreaks of influenza A virus infection in neonatal intensive care units,"[['XAVIER', '', 'SAGRERA'], ['GEMMA', '', 'GINOVART'], ['FREDERIC', '', 'RASPALL'], ['NURIA', '', 'RABELLA'], ['PERE', '', 'SALA'], ['MONTSERRAT', '', 'SIERRA'], ['XAVIER', '', 'DEMESTRE'], ['CLARA', '', 'VILA']]",Pediatric Infectious Disease Journal,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200203000-00007']
10.1001/jama.282.13.1240,"Wang, B., Dwyer, D., Blyth, C., et. al, Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections, Antiviral Research, 2010",cited-by,10.1016/j.antiviral.2010.04.002,Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections,"[['Bin', '', 'Wang'], ['Dominic', 'E.', 'Dwyer'], ['Christopher', 'C.', 'Blyth'], ['Maly', '', 'Soedjono'], ['Haijing', '', 'Shi'], ['Alison', '', 'Kesson'], ['Mala', '', 'Ratnamohan'], ['Ken', '', 'McPhie'], ['Anthony', 'L.', 'Cunningham'], ['Nitin', 'K.', 'Saksena']]",Antiviral Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0166354210005723', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354210005723']"
10.1001/jama.282.13.1240,"Jackson, D., Barclay, W., Zurcher, T., , Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations, , 2005",cited-by,6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,"[['David', '', 'Jackson'], ['Wendy', '', 'Barclay'], ['Thomas', '', 'Zurcher']]",,2005,[u'http://jac.oxfordjournals.org/cgi/reprint/55/2/162.pdf']
10.1001/jama.282.13.1240,"Robson, R., Buttimore, A., Lynn, K., et. al, The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis, , 2006",cited-by,10077451The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,"[['Richard', '', 'Robson'], ['Adrian', '', 'Buttimore'], ['Kelvin', '', 'Lynn'], ['Mike', '', 'Brewster'], ['Penelope', '', 'Ward']]",,2006,"[u'http://www.kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://ndt.oxfordjournals.org/cgi/reprint/21/9/2556.pdf']"
10.1001/jama.282.13.1240,"McKimm-Breschkin, J., , Management of Influenza Virus Infections with Neuraminidase Inhibitors, Treatments in Respiratory Medicine, 2005",cited-by,10.2165/00151829-200504020-00004,Management of Influenza Virus Infections with Neuraminidase Inhibitors,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Treatments in Respiratory Medicine,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00151829-200504020-00004']
10.1001/jama.282.13.1240,"Rawlinson, W., Waliuzzaman, Z., Fennell, M., et. al, New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults, Journal of Medical Virology, 2004",cited-by,10.1002/jmv.20155,New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults,"[['William', 'D.', 'Rawlinson'], ['Zubair', 'M.', 'Waliuzzaman'], ['Michael', '', 'Fennell'], ['James', 'R.', 'Appleman'], ['Craig', 'D.', 'Shimasaki'], ['Ian', 'W.', 'Carter']]",Journal of Medical Virology,2004,[u'http://doi.wiley.com/10.1002/jmv.20155']
10.1001/jama.282.13.1240,"Lockman, J., Fischer, W., Perl, T., et. al, The critically ill child with novel H1N1 influenza A: A case series, Pediatric Critical Care Medicine, 2010",cited-by,10.1097/PCC.0b013e3181ccedae,The critically ill child with novel H1N1 influenza A: A case series,"[['Justin', 'L.', 'Lockman'], ['William', 'A.', 'Fischer'], ['Trish', 'M.', 'Perl'], ['Alexandra', '', 'Valsamakis'], ['David', 'G.', 'Nichols']]",Pediatric Critical Care Medicine,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00130478-201003000-00001']
10.1001/jama.282.13.1240,"Cheng, S., Vainionpaa, R., Zhao, P., et. al, Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.018,Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation,"[['Sheau-Mei', '', 'Cheng'], ['Raija', '', 'Vainionpaa'], ['Ping', '', 'Zhao'], ['Fenglan', '', 'Li'], ['Aizhong', '', 'Hu'], ['Bruce', '', 'Forrest'], ['Ruth', '', 'Rappaport']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204001170', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001170']"
10.1001/jama.282.13.1240,"Gubareva, L., Nedyalkova, M., Novikov, D., et. al, A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site, , 2002",cited-by,6949716A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site,A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site,"[['Larisa', 'V.', 'Gubareva'], ['Marina', 'S.', 'Nedyalkova'], ['Dmitri', 'V.', 'Novikov'], ['K.', 'Gopal', 'Murti'], ['Erich', '', 'Hoffmann'], ['Frederick', 'G.', 'Hayden']]",,2002,[u'http://vir.sgmjournals.org/cgi/reprint/83/11/2683.pdf']
10.1001/jama.282.13.1240,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']"
10.1001/jama.282.13.1240,"Hansel, T., Leckie, M., Bryan, S., et. al, Novel therapy for asthma, Expert Opinion on Investigational Drugs, 2000",cited-by,10.1517/13543784.9.1.25,Novel therapy for asthma,"[['Trevor', 'T', 'Hansel'], ['Maggie', 'J', 'Leckie'], ['Shannon', 'A', 'Bryan'], ['Peter', 'J', 'Barnes']]",Expert Opinion on Investigational Drugs,2000,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.9.1.25']
10.1001/jama.282.13.1240,"Poehling, K., Griffin, M., Dittus, R., et. al, Bedside Diagnosis of Influenzavirus Infections in Hospitalized Children, , 2010",cited-by,6770783Bedside Diagnosis of Influenzavirus Infections in Hospitalized Children,Bedside Diagnosis of Influenzavirus Infections in Hospitalized Children,"[['Katherine', 'A.', 'Poehling'], ['Marie', 'R.', 'Griffin'], ['Robert', 'S.', 'Dittus'], ['Yi-Wei', '', 'Tang'], ['Kathy', '', 'Holland'], ['Haijing', '', 'Li'], ['Kathryn', 'M.', 'Edwards']]",,2010,[u'http://pediatrics.aappublications.org/cgi/reprint/110/1/83.pdf']
10.1001/jama.282.13.1240,"Wattanagoon, Y., Stepniewska, K., Lindegardh, N., et. al, Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.00588-08,Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers,"[['Y.', '', 'Wattanagoon'], ['K.', '', 'Stepniewska'], ['N.', '', 'Lindegardh'], ['S.', '', 'Pukrittayakamee'], ['U.', '', 'Silachamroon'], ['W.', '', 'Piyaphanee'], ['T.', '', 'Singtoroj'], ['W.', '', 'Hanpithakpong'], ['G.', '', 'Davies'], ['J.', '', 'Tarning'], ['W.', '', 'Pongtavornpinyo'], ['C.', '', 'Fukuda'], ['P.', '', 'Singhasivanon'], ['N.', 'P. J.', 'Day'], ['N.', 'J.', 'White']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.asm.org/cgi/reprint/53/3/945.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00588-08']"
10.1001/jama.282.13.1240,"Nichols, W., , Management of Infectious Complications in the Hematopoietic Stem Cell Transplant Recipient, Journal of Intensive Care Medicine, 2003",cited-by,10.1177/0885066603258009,Management of Infectious Complications in the Hematopoietic Stem Cell Transplant Recipient,"[['W.', 'Garrett', 'Nichols']]",Journal of Intensive Care Medicine,2003,"[u'http://jic.sagepub.com/cgi/reprint/18/6/295.pdf', u'http://jic.sagepub.com/cgi/doi/10.1177/0885066603258009', u'http://dx.doi.org/10.1177/0885066603258009']"
10.1001/jama.282.13.1240,"Gillissen, A., Höffken, G., , Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment, Medical Microbiology and Immunology, 2002",cited-by,10.1007/s00430-002-0139-9,Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment,"[['Adrian', '', 'Gillissen'], ['Gert', '', 'H\xc3\xb6ffken']]",Medical Microbiology and Immunology,2002,"[u'http://www.springerlink.com/content/ne9acyfcbbr8ca48', u'http://www.springerlink.com/index/ne9acyfcbbr8ca48.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00430-002-0139-9', u'http://www.springerlink.com/index/pdf/10.1007/s00430-002-0139-9']"
10.1001/jama.282.13.1240,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.1001/jama.282.13.1240,"Kaplan, V., Angus, D., , Community-acquired pneumonia in the elderly, Critical Care Clinics, 2003",cited-by,10.1016/S0749-0704(03)00057-5,Community-acquired pneumonia in the elderly,"[['Vladimir', '', 'Kaplan'], ['Derek', 'C', 'Angus']]",Critical Care Clinics,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0749070403000575', u'http://linkinghub.elsevier.com/retrieve/pii/S0749070403000575']"
10.1001/jama.282.13.1240,"Suess, T., Buchholz, U., Dupke, S., et. al, Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009, American Journal of Epidemiology, 2010",cited-by,10.1093/aje/kwq071,"Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009","[['T.', '', 'Suess'], ['U.', '', 'Buchholz'], ['S.', '', 'Dupke'], ['R.', '', 'Grunow'], ['Matthias', 'an der', 'Heiden'], ['A.', '', 'Heider'], ['B.', '', 'Biere'], ['B.', '', 'Schweiger'], ['W.', '', 'Haas'], ['G.', '', 'Krause']]",American Journal of Epidemiology,2010,[u'http://aje.oxfordjournals.org/cgi/doi/10.1093/aje/kwq071']
10.1001/jama.282.13.1240,"Voirin, N., Barret, B., Metzger, M., et. al, Hospital-acquired influenza: a synthesis using the Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) statement, Journal of Hospital Infection, 2009",cited-by,10.1016/j.jhin.2008.08.013,Hospital-acquired influenza: a synthesis using the Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) statement,"[['N.', '', 'Voirin'], ['B.', '', 'Barret'], ['M.-H.', '', 'Metzger'], ['P.', '', 'Vanhems']]",Journal of Hospital Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0195670108003538', u'http://linkinghub.elsevier.com/retrieve/pii/S0195670108003538']"
10.1001/jama.282.13.1240,"Haidari, M., Ali, M., III, S., et. al, Pomegranate ( Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir, Phytomedicine, 2009",cited-by,10.1016/j.phymed.2009.06.002,Pomegranate ( Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir,"[['Mehran', '', 'Haidari'], ['Muzammil', '', 'Ali'], ['Samuel', 'Ward Casscells', 'III'], ['Mohammad', '', 'Madjid']]",Phytomedicine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0944711309001652', u'http://linkinghub.elsevier.com/retrieve/pii/S0944711309001652']"
10.1001/jama.282.13.1240,"Bartels, P., Jr., W., , The environmental fate of the antiviral drug oseltamivir carboxylate in different waters, Science of The Total Environment, 2008",cited-by,10.1016/j.scitotenv.2008.06.032,The environmental fate of the antiviral drug oseltamivir carboxylate in different waters,"[['Peter', '', 'Bartels'], ['Wolf', 'von T\xc3\xbcmpling', 'Jr.']]",Science of The Total Environment,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0048969708006864', u'http://linkinghub.elsevier.com/retrieve/pii/S0048969708006864']"
10.1001/jama.282.13.1240,"McVernon, J., Mathews, J., , Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning, Influenza and Other Respiratory Viruses, 2007",cited-by,10.1111/j.1750-2659.2007.00008.x,Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning,"[['J', '', 'McVernon'], ['JD', '', 'Mathews']]",Influenza and Other Respiratory Viruses,2007,"[u'http://mathmodelling.sph.unimelb.edu.au/publications/McVernon-InfluenzaandOtherRespiratoryViruses-2007.pdf', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1750-2659.2007.00008.x']"
10.1001/jama.282.13.1240,"McCullers, J., , Antiviral therapy of influenza, Expert Opinion on Investigational Drugs, 2005",cited-by,10.1517/13543784.14.3.305,Antiviral therapy of influenza,"[['Jonathan', 'A', 'McCullers']]",Expert Opinion on Investigational Drugs,2005,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.14.3.305']
10.1001/jama.282.13.1240,"Ferguson, G., , Update on Pharmacologic Therapy for Chronic Obstructive Pulmonary Disease, Clinics in Chest Medicine, 2000",cited-by,10.1016/S0272-5231(05)70180-5,Update on Pharmacologic Therapy for Chronic Obstructive Pulmonary Disease,"[['Gary', 'T.', 'Ferguson']]",Clinics in Chest Medicine,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0272523105701805', u'http://linkinghub.elsevier.com/retrieve/pii/S0272523105701805']"
10.1001/jama.282.13.1240,"Olshaker, J., , Influenza, Emergency Medicine Clinics of North America, 2003",cited-by,10.1016/S0733-8627(03)00018-X,Influenza,"[['Jonathan', 'S', 'Olshaker']]",Emergency Medicine Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S073386270300018X', u'http://linkinghub.elsevier.com/retrieve/pii/S073386270300018X']"
10.1001/jama.282.13.1240,"Oliveira, E., Lee, B., Colice, G., , Influenza in the Intensive Care Unit, Journal of Intensive Care Medicine, 2003",cited-by,10.1177/0885066602250368,Influenza in the Intensive Care Unit,"[['Eduardo', 'C.', 'Oliveira'], ['Burton', '', 'Lee'], ['Gene', 'L.', 'Colice']]",Journal of Intensive Care Medicine,2003,"[u'http://jic.sagepub.com/cgi/doi/10.1177/0885066602250368', u'http://dx.doi.org/10.1177/0885066602250368']"
10.1001/jama.282.13.1240,"Whitley, R., , The role of oseltamivir in the treatment and prevention of influenza in children, Expert Opinion on Drug Metabolism & Toxicology, 2007",cited-by,10.1517/17425225.3.5.755,The role of oseltamivir in the treatment and prevention of influenza in children,"[['Richard', 'J', 'Whitley']]",Expert Opinion on Drug Metabolism & Toxicology,2007,[u'http://www.expertopin.com/doi/abs/10.1517/17425225.3.5.755']
10.1001/jama.282.13.1240,"Neuzil, K., , Influenza: New insights into an old disease, Current Infectious Disease Reports, 2000",cited-by,10.1007/s11908-000-0039-3,Influenza: New insights into an old disease,"[['Kathleen', 'M.', 'Neuzil']]",Current Infectious Disease Reports,2000,"[u'http://www.springerlink.com/index/0765517834762225.pdf', u'http://www.springerlink.com/content/0765517834762225', u'http://www.springerlink.com/index/10.1007/s11908-000-0039-3', u'http://www.springerlink.com/index/pdf/10.1007/s11908-000-0039-3']"
10.1001/jama.282.13.1240,"Maroto, M., Fernandez, Y., Ortin, J., et. al, Development of an HTS Assay for the Search of Anti-influenza Agents Targeting the Interaction of Viral RNA with the NS1 Protein, Journal of Biomolecular Screening, 2008",cited-by,10.1177/1087057108318754,Development of an HTS Assay for the Search of Anti-influenza Agents Targeting the Interaction of Viral RNA with the NS1 Protein,"[['Marta', '', 'Maroto'], ['Yolanda', '', 'Fernandez'], ['Juan', '', 'Ortin'], ['Fernando', '', 'Pelaez'], ['M.', 'Angerles', 'Cabello']]",Journal of Biomolecular Screening,2008,"[u'http://jbx.sagepub.com/cgi/doi/10.1177/1087057108318754', u'http://dx.doi.org/10.1177/1087057108318754']"
10.1001/jama.282.13.1240,"Gums, J., Pelletier, E., Blumentals, W., , Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children, Expert Opinion on Pharmacotherapy, 2008",cited-by,10.1517/14656566.9.2.151,"Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children","[['John', 'G', 'Gums'], ['Elise', 'M', 'Pelletier'], ['William', 'A', 'Blumentals']]",Expert Opinion on Pharmacotherapy,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.9.2.151']
10.1001/jama.282.13.1240,"Suzuki, E., Ichihara, K., , The course of fever following influenza virus infection in children treated with oseltamivir, Journal of Medical Virology, 2008",cited-by,10.1002/jmv.21144,The course of fever following influenza virus infection in children treated with oseltamivir,"[['Eitaro', '', 'Suzuki'], ['Kiyoshi', '', 'Ichihara']]",Journal of Medical Virology,2008,[u'http://doi.wiley.com/10.1002/jmv.21144']
10.1001/jama.282.13.1240,"Vynnycky, E., Trindall, A., Mangtani, P., , Estimates of the reproduction numbers of Spanish influenza using morbidity data, International Journal of Epidemiology, 2007",cited-by,10.1093/ije/dym071,Estimates of the reproduction numbers of Spanish influenza using morbidity data,"[['E.', '', 'Vynnycky'], ['A.', '', 'Trindall'], ['P.', '', 'Mangtani']]",International Journal of Epidemiology,2007,[u'http://www.ije.oxfordjournals.org/cgi/doi/10.1093/ije/dym071']
10.1001/jama.282.13.1240,"Wang, G., , Recent advances in the discovery and development of anti-influenza drugs, Expert Opinion on Therapeutic Patents, 2002",cited-by,10.1517/13543776.12.6.845,Recent advances in the discovery and development of anti-influenza drugs,"[['Gary', 'T', 'Wang']]",Expert Opinion on Therapeutic Patents,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.12.6.845']
10.1001/jama.282.13.1240,"AJELLI, M., MERLER, S., PUGLIESE, A., et. al, Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy, Epidemiology and Infection, 2010",cited-by,10.1017/S0950268810001317,Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy,"[['M.', '', 'AJELLI'], ['S.', '', 'MERLER'], ['A.', '', 'PUGLIESE'], ['C.', '', 'RIZZO']]",Epidemiology and Infection,2010,[u'http://www.journals.cambridge.org/abstract_S0950268810001317']
10.1001/jama.282.13.1240,"Aoki, F., Boivin, G., , Influenza virus shedding—Excretion patterns and effects of antiviral treatment, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2009.01.010,Influenza virus shedding—Excretion patterns and effects of antiviral treatment,"[['Fred', 'Y.', 'Aoki'], ['Guy', '', 'Boivin']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1386653209000444', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653209000444']"
10.1001/jama.282.13.1240,"Martin, E., Kuypers, J., Heugel, J., et. al, Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus, Diagnostic Microbiology and Infectious Disease, 2008",cited-by,10.1016/j.diagmicrobio.2008.08.002,Clinical disease and viral load in children infected with respiratory syncytial virus or human metapneumovirus,"[['Emily', 'T.', 'Martin'], ['Jane', '', 'Kuypers'], ['Judson', '', 'Heugel'], ['Janet', 'A.', 'Englund']]",Diagnostic Microbiology and Infectious Disease,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0732889308003477', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889308003477']"
10.1001/jama.282.13.1240,"Rahman, M., Kieke, B., Vandermause, M., et. al, Performance of Directigen flu A+B enzyme immunoassay and direct fluorescent assay for detection of influenza infection during the 2004–2005 season, Diagnostic Microbiology and Infectious Disease, 2007",cited-by,10.1016/j.diagmicrobio.2007.03.011,Performance of Directigen flu A+B enzyme immunoassay and direct fluorescent assay for detection of influenza infection during the 2004–2005 season,"[['Mahbubur', '', 'Rahman'], ['Burney', 'A.', 'Kieke'], ['Mary', 'F.', 'Vandermause'], ['Paul', 'D.', 'Mitchell'], ['Robert', 'T.', 'Greenlee'], ['Edward', 'A.', 'Belongia']]",Diagnostic Microbiology and Infectious Disease,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0732889307001459', u'http://linkinghub.elsevier.com/retrieve/pii/S0732889307001459']"
10.1001/jama.282.13.1240,"Orzeck, E., Shi, N., Blumentals, W., , Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes, Clinical Therapeutics, 2007",cited-by,10.1016/j.clinthera.2007.10.001,Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes,"[['Eric', 'A.', 'Orzeck'], ['Nianwen', '', 'Shi'], ['William', 'A.', 'Blumentals']]",Clinical Therapeutics,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0149291807003165', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291807003165']"
10.1001/jama.282.13.1240,"Ruijs, W., Meijer, A., Cools, H., et. al, Use of oseltamivir in Dutch nursing homes during the 2004–2005 influenza season, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.05.049,Use of oseltamivir in Dutch nursing homes during the 2004–2005 influenza season,"[['Wilhelmina', 'L. M.', 'Ruijs'], ['Adam', '', 'Meijer'], ['Herman', 'J. M.', 'Cools'], ['Simone', 'M. van der', 'Plas']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06006402', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06006402']"
10.1001/jama.282.13.1240,"Rosenbaum, J., Sepkowitz, K., , Infectious Disease Experimentation Involving Human Volunteers, Clinical Infectious Diseases, 2002",cited-by,10.1086/339328,Infectious Disease Experimentation Involving Human Volunteers,"[['Julie', 'Rothstein', 'Rosenbaum'], ['Kent', 'A.', 'Sepkowitz']]",Clinical Infectious Diseases,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/339328']
10.1016~S0140-6736(00)02288-1,"Dowdle WN, Kendal AP, Noble GR. Influenza viruses. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures for viral, rickettsial, and chlamydial infections, 5th edn. Washington, DC: American Public Health Association, 1979: 603–05.",references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,"Hayden FG, Osterhaus ADME, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997; 337: 874–80.",references,10.1056/NEJM199709253371302,Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections,"[[u'Frederick', u'G.', u'Hayden'], [u'Albert', u'D. M. E.', u'Osterhaus'], [u'John', u'J.', u'Treanor'], [u'Douglas', u'M.', u'Fleming'], [u'Fred', u'Y.', u'Aoki'], [u'Karl', u'G.', u'Nicholson'], [u'Arthur', u'M.', u'Bohnen'], [u'Hilary', u'M.', u'Hirst'], [u'Oliver', u'', u'Keene'], [u'Kevin', u'', u'Wightman']]",New England Journal of Medicine,1997,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199709253371302'],./output/10.1016~S0140-6736(00)02288-1/10.1056~NEJM199709253371302
10.1056/NEJM199709253371302,"Bartlett, J., Dowell, S., Mandell, L., et. al, Practice Guidelines for the Management of Community‐Acquired Pneumonia in Adults, Clinical Infectious Diseases, 2000",cited-by,10.1086/313954,Practice Guidelines for the Management of Community‐Acquired Pneumonia in Adults,"[['John', 'G.', 'Bartlett'], ['Scott', 'F.', 'Dowell'], ['Lionel', 'A.', 'Mandell'], ['Daniel', 'M.', 'Musher'], ['Michael', 'J.', 'Fine']]",Clinical Infectious Diseases,2000,"[u'http://www.gata.edu.tr/dahilibilimler/ailehekimligi/dosyalar/111.pdf', u'http://www2.medicine.wisc.edu/home/files/domfiles/infectiousdisease/CommunityAcquiredAdultPneumonia.pdf', u'http://www.gata.edu.tr/dahilibilimler/nefroloji/dosyalar/111.pdf', u'http://www.antiinfectieux.org/antiinfectieux/Assets/PTS/infections-respiratoires/pneumonie/CAP-IDSA-guideline.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/313954']"
10.1056/NEJM199709253371302,"Nicholson, K., Wood, J., Zambon, M., , Influenza, Lancet, 2003",cited-by,10.1016/S0140-6736(03)14854-4,Influenza,"[['Karl', 'G', 'Nicholson'], ['John', 'M', 'Wood'], ['Maria', '', 'Zambon']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603148544', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603148544']"
10.1056/NEJM199709253371302,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, Lancet, 2000",cited-by,10.1016/S0140-6736(99)11433-8,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699114338', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699114338']"
10.1056/NEJM199709253371302,"Cox, N., Subbarao, K., , Influenza, Lancet, 1999",cited-by,10.1016/S0140-6736(99)01241-6,Influenza,"[['Nancy', 'J', 'Cox'], ['Kanta', '', 'Subbarao']]",Lancet,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699012416', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699012416']"
10.1056/NEJM199709253371302,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1056/NEJM199709253371302,"Elden, L., Nijhuis, M., Schipper, P., et. al, Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.1.196-200.2001,Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR,"[['L.', 'J. R. van', 'Elden'], ['M.', '', 'Nijhuis'], ['P.', '', 'Schipper'], ['R.', '', 'Schuurman'], ['A.', 'M. van', 'Loon']]",Journal of Clinical Microbiology,2001,[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.1.196-200.2001']
10.1056/NEJM199709253371302,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']"
10.1056/NEJM199709253371302,"Boivin, G., Hardy, I., Tellier, G., et. al, Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition, Clinical Infectious Diseases, 2000",cited-by,10.1086/317425,Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition,"[['Guy', '', 'Boivin'], ['Isabelle', '', 'Hardy'], ['Guy', '', 'Tellier'], ['Jean', '', 'Maziade']]",Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/317425']
10.1056/NEJM199709253371302,"UYEKI, T., , Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza, Pediatric Infectious Disease Journal, 2003",cited-by,10.1097/01.inf.0000050458.35010.b6,Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza,"[['TIMOTHY', 'M.', 'UYEKI']]",Pediatric Infectious Disease Journal,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200302000-00015']
10.1056/NEJM199709253371302,"HEDRICK, J., BARZILAI, A., BEHRE, U., et. al, Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial, Pediatric Infectious Disease Journal, 2000",cited-by,10.1097/00006454-200005000-00005,Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial,"[['JAMES', 'A.', 'HEDRICK'], ['ASHER', '', 'BARZILAI'], ['ULRICH', '', 'BEHRE'], ['FREDERICK', 'W.', 'HENDERSON'], ['JANET', '', 'HAMMOND'], ['LUCY', '', 'REILLY'], ['OLIVER', '', 'KEENE']]",Pediatric Infectious Disease Journal,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200005000-00005']
10.1056/NEJM199709253371302,"Ward, C., Dempseyb, M., Ring, C., et. al, Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement, Journal of Clinical Virology, 2004",cited-by,10.1016/S1386-6532(03)00122-7,Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement,"[['C.', 'L.', 'Ward'], ['M.', 'H.', 'Dempseyb'], ['C.', 'J. A', 'Ring'], ['R.', 'E', 'Kempson'], ['L', '', 'Zhang'], ['D', '', 'Gor'], ['B.', 'W', 'Snowden'], ['M', '', 'Tisdale']]",Journal of Clinical Virology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1386653203001227', u'http://www.hvidovre-hospital.dk/HHmikrobiologisk.nsf/pics/Influenza1.pdf/$FILE/Influenza1.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653203001227']"
10.1056/NEJM199709253371302,"Rimmelzwaan, G., Baars, M., Claas, E., et. al, Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro, Journal of Virological Methods, 1998",cited-by,10.1016/S0166-0934(98)00071-8,"Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro","[['G.', 'F', 'Rimmelzwaan'], ['M', '', 'Baars'], ['E.', 'C. J', 'Claas'], ['A.', 'D. M. E', 'Osterhaus']]",Journal of Virological Methods,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498000718', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498000718']"
10.1056/NEJM199709253371302,"Cunney, R., Bialachowski, A., Thornley, D., et. al, An Outbreak of Influenza A in a Neonatal Intensive Care Unit, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501786,An Outbreak of Influenza A in a Neonatal Intensive Care Unit,"[['Robert', 'J.', 'Cunney'], ['Anne', '', 'Bialachowski'], ['Diane', '', 'Thornley'], ['Fiona', 'M.', 'Smaill'], ['Ross', 'A.', 'Pennie']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501786']
10.1056/NEJM199709253371302,"Varghese, J., Smith, P., Sollis, S., et. al, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, Structure, 1998",cited-by,10.1016/S0969-2126(98)00075-6,Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase,"[['Joseph', 'N', 'Varghese'], ['Paul', 'W', 'Smith'], ['Steven', 'L', 'Sollis'], ['Tony', 'J', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Jennifer', 'L', 'McKimm-Breschkin'], ['Peter', 'M', 'Colman']]",Structure,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0969212698000756', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212698000756']"
10.1056/NEJM199709253371302,"PELTOLA, V., MCCULLERS, J., , Respiratory viruses predisposing to bacterial infections: role of neuraminidase, Pediatric Infectious Disease Journal, 2004",cited-by,10.1097/01.inf.0000108197.81270.35,Respiratory viruses predisposing to bacterial infections: role of neuraminidase,"[['VILLE', 'T.', 'PELTOLA'], ['JONATHAN', 'A.', 'MCCULLERS']]",Pediatric Infectious Disease Journal,2004,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200401001-00013']
10.1056/NEJM199709253371302,"Heikkinen, T., Marttila, J., Salmi, A., et. al, Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses, Journal of Clinical Microbiology, 2002",cited-by,10.1128/JCM.40.11.4337-4339.2002,Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,"[['Terho', '', 'Heikkinen'], ['Jane', '', 'Marttila'], ['Aimo', 'A.', 'Salmi'], ['Olli', '', 'Ruuskanen']]",Journal of Clinical Microbiology,2002,"[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.40.11.4337-4339.2002', u'http://jcm.asm.org/cgi/reprint/40/11/4337.pdf']"
10.1056/NEJM199709253371302,"Heikkinen, T., Chonmaitree, T., , Importance of Respiratory Viruses in Acute Otitis Media, Clinical Microbiology Reviews, 2003",cited-by,10.1128/CMR.16.2.230-241.2003,Importance of Respiratory Viruses in Acute Otitis Media,"[['Terho', '', 'Heikkinen'], ['Tasnee', '', 'Chonmaitree']]",Clinical Microbiology Reviews,2003,[u'http://cmr.asm.org/cgi/doi/10.1128/CMR.16.2.230-241.2003']
10.1056/NEJM199709253371302,"Jefferson, T., Jones, M., Doshi, P., et. al, Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis, British Medical Journal, 2009",cited-by,10.1136/bmj.b5106,Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis,"[['Tom', '', 'Jefferson'], ['Mark', '', 'Jones'], ['Peter', '', 'Doshi'], ['Chris', 'Del', 'Mar']]",British Medical Journal,2009,"[u'http://www.bmj.com/cgi/reprint/339/dec07_2/b5106.pdf', u'http://dx.doi.org/10.1136/bmj.b5106', u'http://www.bmj.com/cgi/doi/10.1136/bmj.b5106']"
10.1056/NEJM199709253371302,"Furuta, Y., Takahashi, K., Fukuda, Y., et. al, In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.977-981.2002,In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705,"[['Y.', '', 'Furuta'], ['K.', '', 'Takahashi'], ['Y.', '', 'Fukuda'], ['M.', '', 'Kuno'], ['T.', '', 'Kamiyama'], ['K.', '', 'Kozaki'], ['N.', '', 'Nomura'], ['H.', '', 'Egawa'], ['S.', '', 'Minami'], ['Y.', '', 'Watanabe'], ['H.', '', 'Narita'], ['K.', '', 'Shiraki']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://journals.pasteur.ac.ir/aac02/46(4)/977.pdf', u'http://aac.asm.org/cgi/reprint/46/4/977.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.977-981.2002']"
10.1056/NEJM199709253371302,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf']
10.1056/NEJM199709253371302,"BOIVIN, G., HARDY, I., KRESS, A., , Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.2.730-732.2001,Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,"[['GUY', '', 'BOIVIN'], ['ISABELLE', '', 'HARDY'], ['ANDREW', '', 'KRESS']]",Journal of Clinical Microbiology,2001,"[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.2.730-732.2001', u'http://jcm.asm.org/cgi/reprint/39/2/730.pdf']"
10.1056/NEJM199709253371302,"Stiver, G., , The treatment of influenza with antiviral drugs, , 0",cited-by,10332941The treatment of influenza with antiviral drugs,The treatment of influenza with antiviral drugs,"[['Grant', '', 'Stiver']]",,0,"[u'http://www.ualberta.ca/~mlalu/ref03.pdf', u'http://www.ualberta.ca/~mlalu/CMAJantiviral.pdf', u'http://www.cmaj.ca/cgi/reprint/168/1/49.pdf']"
10.1056/NEJM199709253371302,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
10.1056/NEJM199709253371302,"Khan, K., , Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults, Clinical Infectious Diseases, 2001",cited-by,10.1086/324491,Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults,"[['Kamran', '', 'Khan']]",Clinical Infectious Diseases,2001,"[u'http://www.pceo.org/pubs/CID%20Article.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/324491']"
10.1056/NEJM199709253371302,"Treanor, J., Falsey, A., , Respiratory viral infections in the elderly, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00062-5,Respiratory viral infections in the elderly,"[['John', '', 'Treanor'], ['Ann', '', 'Falsey']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000625', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000625']"
10.1056/NEJM199709253371302,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']"
10.1056/NEJM199709253371302,"Heikkinen, T., Marttila, J., Salmi, A., et. al, Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses, , 0",cited-by,10724682Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,"[['Terho', '', 'Heikkinen'], ['Jane', '', 'Marttila'], ['Aimo', 'A.', 'Salmi'], ['Olli', '', 'Ruuskanen']]",,0,[u'http://jcm.asm.org/cgi/reprint/40/11/4337.pdf']
10.1056/NEJM199709253371302,"Smith, K., Roberts, M., , Cost-effectiveness of newer treatment strategies for influenza, American Journal of Medicine, 2002",cited-by,10.1016/S0002-9343(02)01222-6,Cost-effectiveness of newer treatment strategies for influenza,"[['Kenneth', 'J', 'Smith'], ['Mark', 'S', 'Roberts']]",American Journal of Medicine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0002934302012226', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934302012226']"
10.1056/NEJM199709253371302,"Walsh, E., Cox, C., Falsey, A., , Clinical Features of Influenza A Virus Infection in Older Hospitalized Persons, Journal of The American Geriatrics Society, 2002",cited-by,10.1046/j.1532-5415.2002.50404.x,Clinical Features of Influenza A Virus Infection in Older Hospitalized Persons,"[['Edward', 'E.', 'Walsh'], ['Christopher', '', 'Cox'], ['Ann', 'R.', 'Falsey']]",Journal of The American Geriatrics Society,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2002.50404.x']
10.1056/NEJM199709253371302,"Lee, C., Loeb, M., Phillips, A., et. al, Zanamivir Use During Transmission of Amantadine‐Resistant Influenza A in a Nursing Home, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501727,Zanamivir Use During Transmission of Amantadine‐Resistant Influenza A in a Nursing Home,"[['Christine', '', 'Lee'], ['Mark', '', 'Loeb'], ['Anne', '', 'Phillips'], ['Judy', '', 'Nesbitt'], ['Karen', '', 'Smith'], ['Margaret', '', 'Fearon'], ['Margaret', 'A.', 'McArthur'], ['Tony', '', 'Mazzulli'], ['Yan', '', 'Li'], ['Allison', '', 'McGeer']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501727']
10.1056/NEJM199709253371302,"Barnett, J., Cadman, A., Burrell, F., et. al, In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir, Virology, 1999",cited-by,10.1006/viro.1999.0058,In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir,"[['J.', 'M.', 'Barnett'], ['A.', '', 'Cadman'], ['F.', 'M.', 'Burrell'], ['S.', 'H.', 'Madar'], ['A.', 'P.', 'Lewis'], ['M.', '', 'Tisdale'], ['R.', '', 'Bethell']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299900582', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299900582']"
10.1056/NEJM199709253371302,"BOIVIN, G., HARDY, I., KRESS, A., , Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR, , 0",cited-by,11106017Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,"[['GUY', '', 'BOIVIN'], ['ISABELLE', '', 'HARDY'], ['ANDREW', '', 'KRESS']]",,0,[u'http://jcm.asm.org/cgi/reprint/39/2/730.pdf']
10.1056/NEJM199709253371302,"Boeckh, M., , The challenge of respiratory virus infections in hematopoietic cell transplant recipients, British Journal of Haematology, 2008",cited-by,10.1111/j.1365-2141.2008.07295.x,The challenge of respiratory virus infections in hematopoietic cell transplant recipients,"[['Michael', '', 'Boeckh']]",British Journal of Haematology,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2141.2008.07295.x']
10.1056/NEJM199709253371302,"Sato, M., Hosoya, M., Kato, K., et. al, VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS, Pediatric Infectious Disease Journal, 2005",cited-by,10.1097/01.inf.0000180976.81055.ce,VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS,"[['Masatoki', '', 'Sato'], ['Mitsuaki', '', 'Hosoya'], ['Kazuo', '', 'Kato'], ['Hitoshi', '', 'Suzuki']]",Pediatric Infectious Disease Journal,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200510000-00019']
10.1056/NEJM199709253371302,"Stamboulian, D., Bonvehí, P., Nacinovich, F., et. al, INFLUENZA, Infectious Disease Clinics of North America, 2000",cited-by,10.1016/S0891-5520(05)70222-1,INFLUENZA,"[['Daniel', '', 'Stamboulian'], ['Pablo', 'E.', 'Bonveh\xc3\xad'], ['Francisco', 'M.', 'Nacinovich'], ['Nancy', '', 'Cox']]",Infectious Disease Clinics of North America,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0891552005702221', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552005702221']"
10.1056/NEJM199709253371302,"Murphy, K., Eivindson, A., Pauksens, K., et. al, Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study, Clinical Drug Investigation, 2000",cited-by,10.2165/00044011-200020050-00005,"Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study","[['Kevin', 'R.', 'Murphy'], ['Arne', '', 'Eivindson'], ['Karlis', '', 'Pauksens'], ['William', 'J.', 'Stein'], ['Guy', '', 'Tellier'], ['Richard', '', 'Watts'], ['Stephen', 'J.', 'Sharp'], ['Elke', '', 'Loeschel']]",Clinical Drug Investigation,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200020050-00005']
10.1056/NEJM199709253371302,"Kaiser, L., Henry, D., Flack, N., et. al, Short‐Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo‐Controlled Study, Clinical Infectious Diseases, 2000",cited-by,10.1086/313696,Short‐Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo‐Controlled Study,"[['Laurent', '', 'Kaiser'], ['Dan', '', 'Henry'], ['Nancy', 'P.', 'Flack'], ['Oliver', '', 'Keene'], ['Frederick', 'G.', 'Hayden']]",Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/313696']
10.1056/NEJM199709253371302,"Arden, N., , Control of Influenza in the Long‐Term–Care Facility: A Review of Established Approaches and Newer Options, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501702,Control of Influenza in the Long‐Term–Care Facility: A Review of Established Approaches and Newer Options,"[['Nancy', 'H.', 'Arden']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501702']
10.1056/NEJM199709253371302,"Johny, A., Clark, A., Price, N., et. al, The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation, Bone Marrow Transplantation, 2002",cited-by,10.1038/sj.bmt.1703343,The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation,"[['AA', '', 'Johny'], ['A', '', 'Clark'], ['N', '', 'Price'], ['D', '', 'Carrington'], ['A', '', 'Oakhill'], ['DI', '', 'Marks']]",Bone Marrow Transplantation,2002,"[u'http://dx.doi.org/10.1038/sj.bmt.1703343', u'http://www.nature.com/doifinder/10.1038/sj.bmt.1703343']"
10.1056/NEJM199709253371302,"Boivin, G., Goyette, N., , Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00219-4,Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors,"[['Guy', '', 'Boivin'], ['Nathalie', '', 'Goyette']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201002194', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201002194']"
10.1056/NEJM199709253371302,"Zalman, L., Brothers, M., Dragovich, P., et. al, Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.5.1236-1241.2000,"Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor","[['L.', 'S.', 'Zalman'], ['M.', 'A.', 'Brothers'], ['P.', 'S.', 'Dragovich'], ['R.', '', 'Zhou'], ['T.', 'J.', 'Prins'], ['S.', 'T.', 'Worland'], ['A.', 'K.', 'Patick']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.5.1236-1241.2000', u'http://aac.asm.org/cgi/reprint/44/5/1236.pdf']"
10.1056/NEJM199709253371302,"Church, D., Davies, H., Mitton, C., et. al, Clinical and Economic Evaluation of Rapid Influenza A Virus Testing in Nursing Homes in Calgary, Canada, Clinical Infectious Diseases, 2002",cited-by,10.1086/338960,"Clinical and Economic Evaluation of Rapid Influenza A Virus Testing in Nursing Homes in Calgary, Canada","[['Deirdre', 'L.', 'Church'], ['H.', 'Dele', 'Davies'], ['Craig', '', 'Mitton'], ['Heather', '', 'Semeniuk'], ['Melissa', '', 'Logue'], ['Colleen', '', 'Maxwell'], ['Cam', '', 'Donaldson']]",Clinical Infectious Diseases,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/338960']
10.1056/NEJM199709253371302,"Billings, J., Hertz, M., Wendt, C., , Community respiratory virus infections following lung transplantation, Transplant Infectious Disease, 2001",cited-by,10.1034/j.1399-3062.2001.003003138.x,Community respiratory virus infections following lung transplantation,"[['J.', 'L.', 'Billings'], ['M.', 'I.', 'Hertz'], ['C.', 'H.', 'Wendt']]",Transplant Infectious Disease,2001,[u'http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-3062.2001.003003138.x']
10.1056/NEJM199709253371302,"Villar, E., Barroso, I., , Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview, Glycoconjugate Journal, 2006",cited-by,10.1007/s10719-006-5433-0,Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview,"[['Enrique', '', 'Villar'], ['Isabel', 'Mu\xc3\xb1oz', 'Barroso']]",Glycoconjugate Journal,2006,"[u'http://www.springerlink.com/index/n549v716hp2mr30p.pdf', u'http://www.springerlink.com/content/n549v716hp2mr30p', u'http://www.springerlink.com/index/10.1007/s10719-006-5433-0', u'http://www.springerlink.com/index/pdf/10.1007/s10719-006-5433-0']"
10.1056/NEJM199709253371302,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']"
10.1056/NEJM199709253371302,"Gravenstein, S., Drinka, P., Osterweil, D., et. al, Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.006,Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population,"[['Stefan', '', 'Gravenstein'], ['Paul', '', 'Drinka'], ['Dan', '', 'Osterweil'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult'], ['Arvydas', '', 'Ambrozaitis'], ['Ruth', '', 'Kandel'], ['Ellen', '', 'Binder'], ['Janet', '', 'Hammond'], ['Janet', '', 'McElhaney'], ['Nancy', '', 'Flack'], ['Janet', '', 'Daly'], ['Oliver', '', 'Keene']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005323', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005323']"
10.1056/NEJM199709253371302,"Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']"
10.1056/NEJM199709253371302,"McKimm-Breschkin, J., , Neuraminidase inhibitors for the treatment and prevention of influenza, Expert Opinion on Pharmacotherapy, 2002",cited-by,10.1517/14656566.3.2.103,Neuraminidase inhibitors for the treatment and prevention of influenza,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Expert Opinion on Pharmacotherapy,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.3.2.103']
10.1056/NEJM199709253371302,"CASS, L., GUNAWARDENA, K., MACMAHON, M., et. al, Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir, Respiratory Medicine, 2000",cited-by,10.1053/rmed.1999.0718,Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir,"[['L.', 'M. R.', 'CASS'], ['K.', 'A.', 'GUNAWARDENA'], ['M.', 'M.', 'MACMAHON'], ['A.', '', 'BYE']]",Respiratory Medicine,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0954611199907187', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611199907187']"
10.1056/NEJM199709253371302,"Oxford, J., Bossuyt, S., Balasingam, S., et. al, Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors, Clinical Microbiology and Infection, 2003",cited-by,10.1046/j.1469-0691.2003.00564.x,Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors,"[['J.', 'S.', 'Oxford'], ['S.', '', 'Bossuyt'], ['S.', '', 'Balasingam'], ['A.', '', 'Mann'], ['P.', '', 'Novelli'], ['R.', '', 'Lambkin']]",Clinical Microbiology and Infection,2003,"[u'http://birdflubook.com/resources/Oxford1.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1469-0691.2003.00564.x']"
10.1056/NEJM199709253371302,"Varghese, J., , Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Development Research, 1999",cited-by,10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6,Development of neuraminidase inhibitors as anti-influenza virus drugs,"[['Joseph', 'N.', 'Varghese']]",Drug Development Research,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291098-2299%28199903/04%2946%3A3/4%3C176%3A%3AAID-DDR4%3E3.0.CO%3B2-6']
10.1056/NEJM199709253371302,"Gavin, P., Thomson, R., , Review of Rapid Diagnostic Tests for Influenza, , 2003",cited-by,5357707Review of Rapid Diagnostic Tests for Influenza,Review of Rapid Diagnostic Tests for Influenza,"[['Patrick', 'J', 'Gavin'], ['Richard', 'B', 'Thomson']]",,2003,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/diagnosis/diagnosis-4.pdf']
10.1056/NEJM199709253371302,"Beigel, J., , Influenza, Critical Care Medicine, 2008",cited-by,10.1097/CCM.0b013e318180b039,Influenza,"[['John', 'H.', 'Beigel']]",Critical Care Medicine,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-200809000-00025']
10.1056/NEJM199709253371302,"Englund, J., , Antiviral therapy of influenza, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.122999,Antiviral therapy of influenza,"[['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500571', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500571']"
10.1056/NEJM199709253371302,"SAGRERA, X., GINOVART, G., RASPALL, F., et. al, Outbreaks of influenza A virus infection in neonatal intensive care units, Pediatric Infectious Disease Journal, 2002",cited-by,10.1097/00006454-200203000-00007,Outbreaks of influenza A virus infection in neonatal intensive care units,"[['XAVIER', '', 'SAGRERA'], ['GEMMA', '', 'GINOVART'], ['FREDERIC', '', 'RASPALL'], ['NURIA', '', 'RABELLA'], ['PERE', '', 'SALA'], ['MONTSERRAT', '', 'SIERRA'], ['XAVIER', '', 'DEMESTRE'], ['CLARA', '', 'VILA']]",Pediatric Infectious Disease Journal,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200203000-00007']
10.1056/NEJM199709253371302,"BRADLEY, J., , Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines, Pediatric Infectious Disease Journal, 2002",cited-by,10.1097/00006454-200206000-00035,Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines,"[['JOHN', 'S.', 'BRADLEY']]",Pediatric Infectious Disease Journal,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200206000-00035']
10.1056/NEJM199709253371302,"Kawai, N., Ikematsu, H., Iwaki, N., et. al, A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2007.09.002,A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B,"[['Naoki', '', 'Kawai'], ['Hideyuki', '', 'Ikematsu'], ['Norio', '', 'Iwaki'], ['Tetsunari', '', 'Maeda'], ['Hideo', '', 'Kanazawa'], ['Takashi', '', 'Kawashima'], ['Osame', '', 'Tanaka'], ['Satoshi', '', 'Yamauchi'], ['Kenichi', '', 'Kawamura'], ['Toru', '', 'Nagai'], ['Satsuki', '', 'Horii'], ['Nobuo', '', 'Hirotsu'], ['Seizaburo', '', 'Kashiwagi']]",Journal of Infection,2008,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-25.pdf', u'http://www.sciencedirect.com/science/article/pii/S0163445307007578', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445307007578']"
10.1056/NEJM199709253371302,"Carr, M., Sayre, N., Duffy, M., et. al, Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses, Journal of Virological Methods, 2008",cited-by,10.1016/j.jviromet.2008.07.011,Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses,"[['Michael', 'J.', 'Carr'], ['Naomi', '', 'Sayre'], ['Margaret', '', 'Duffy'], ['Jeff', '', 'Connell'], ['William', 'W.', 'Hall']]",Journal of Virological Methods,2008,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-4.pdf', u'http://www.sciencedirect.com/science/article/pii/S016609340800253X', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S016609340800253X']"
10.1056/NEJM199709253371302,"Neuzil, K., O’Connor, T., Gorse, G., et. al, Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine, Clinical Infectious Diseases, 2003",cited-by,10.1086/345668,Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine,"[['Kathleen', 'M.', 'Neuzil'], ['Theresa', 'Z.', 'O\xe2\x80\x99Connor'], ['Geoffrey', 'J.', 'Gorse'], ['Kristin', 'L.', 'Nichol']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/345668']
10.1056/NEJM199709253371302,"Smith, K., Roberts, M., , Cost-effectiveness of Newer Treatment Strategies for Influenza, , 0",cited-by,5139943Cost-effectiveness of Newer Treatment Strategies for Influenza,Cost-effectiveness of Newer Treatment Strategies for Influenza,"[['Kenneth', 'J.', 'Smith'], ['Mark', 'S.', 'Roberts']]",,0,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-13.pdf']
10.1056/NEJM199709253371302,"Jr, J., Michaelis, M., Doerr, H., , The threat of avian influenza A (H5N1). Part III: antiviral therapy, Medical Microbiology and Immunology, 2007",cited-by,10.1007/s00430-007-0048-z,The threat of avian influenza A (H5N1). Part III: antiviral therapy,"[['Jindrich', 'Cinatl', 'Jr'], ['Martin', '', 'Michaelis'], ['Hans', 'W.', 'Doerr']]",Medical Microbiology and Immunology,2007,"[u'http://www.springerlink.com/index/41xpm470518281m7.pdf', u'http://www.springerlink.com/content/41xpm470518281m7', u'http://www.springerlink.com/index/10.1007/s00430-007-0048-z', u'http://www.springerlink.com/index/pdf/10.1007/s00430-007-0048-z']"
10.1056/NEJM199709253371302,"Rawlinson, W., Waliuzzaman, Z., Fennell, M., et. al, New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults, Journal of Medical Virology, 2004",cited-by,10.1002/jmv.20155,New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults,"[['William', 'D.', 'Rawlinson'], ['Zubair', 'M.', 'Waliuzzaman'], ['Michael', '', 'Fennell'], ['James', 'R.', 'Appleman'], ['Craig', 'D.', 'Shimasaki'], ['Ian', 'W.', 'Carter']]",Journal of Medical Virology,2004,[u'http://doi.wiley.com/10.1002/jmv.20155']
10.1056/NEJM199709253371302,"Dharnidharka, V., Harmon, W., , Management of pediatric postrenal transplantation infections, Seminars in Nephrology, 2001",cited-by,10.1053/snep.2001.24947,Management of pediatric postrenal transplantation infections,"[['Vikas', 'R.', 'Dharnidharka'], ['William', 'E.', 'Harmon']]",Seminars in Nephrology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270929501700514', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=asnep0210521']"
10.1056/NEJM199709253371302,"Monto, A., Moult, A., Sharp, S., , Effect of zanamivir on duration and resolution of influenza symptoms, Clinical Therapeutics, 2000",cited-by,10.1016/S0149-2918(00)83026-X,Effect of zanamivir on duration and resolution of influenza symptoms,"[['Arnold', 'S.', 'Monto'], ['Andrew', 'B.', 'Moult'], ['Stephen', 'J.', 'Sharp']]",Clinical Therapeutics,2000,"[u'http://www.sciencedirect.com/science/article/pii/S014929180083026X', u'http://linkinghub.elsevier.com/retrieve/pii/S014929180083026X']"
10.1056/NEJM199709253371302,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']"
10.1056/NEJM199709253371302,"Low, D., , Reducing antibiotic use in influenza: challenges and rewards, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2007.01910.x,Reducing antibiotic use in influenza: challenges and rewards,"[['D.', '', 'Low']]",Clinical Microbiology and Infection,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01910.x']
10.1056/NEJM199709253371302,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.1056/NEJM199709253371302,"Unoshima, M., Iwasaka, H., Eto, J., et. al, Antiviral Effects of Geranylgeranylacetone: Enhancement of MxA Expression and Phosphorylation of PKR during Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2003",cited-by,10.1128/AAC.47.9.2914-2921.2003,Antiviral Effects of Geranylgeranylacetone: Enhancement of MxA Expression and Phosphorylation of PKR during Influenza Virus Infection,"[['Masako', '', 'Unoshima'], ['Hideo', '', 'Iwasaka'], ['Junko', '', 'Eto'], ['Yoshiko', '', 'Takita-Sonoda'], ['Takayuki', '', 'Noguchi'], ['Akira', '', 'Nishizono']]",Antimicrobial Agents and Chemotherapy,2003,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.9.2914-2921.2003']
10.1056/NEJM199709253371302,"Suess, T., Buchholz, U., Dupke, S., et. al, Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009, American Journal of Epidemiology, 2010",cited-by,10.1093/aje/kwq071,"Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009","[['T.', '', 'Suess'], ['U.', '', 'Buchholz'], ['S.', '', 'Dupke'], ['R.', '', 'Grunow'], ['Matthias', 'an der', 'Heiden'], ['A.', '', 'Heider'], ['B.', '', 'Biere'], ['B.', '', 'Schweiger'], ['W.', '', 'Haas'], ['G.', '', 'Krause']]",American Journal of Epidemiology,2010,[u'http://aje.oxfordjournals.org/cgi/doi/10.1093/aje/kwq071']
10.1056/NEJM199709253371302,"McCullers, J., , Antiviral therapy of influenza, Expert Opinion on Investigational Drugs, 2005",cited-by,10.1517/13543784.14.3.305,Antiviral therapy of influenza,"[['Jonathan', 'A', 'McCullers']]",Expert Opinion on Investigational Drugs,2005,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.14.3.305']
10.1056/NEJM199709253371302,"Rothbarth, P., Groen, J., Bohnen, A., et. al, Influenza virus serology—a comparative study, Journal of Virological Methods, 1999",cited-by,10.1016/S0166-0934(98)00174-8,Influenza virus serology—a comparative study,"[['Philip', 'H', 'Rothbarth'], ['Jan', '', 'Groen'], ['Arthur', 'M', 'Bohnen'], ['Ronald', 'de', 'Groot'], ['Albert', 'D. M. E', 'Osterhaus']]",Journal of Virological Methods,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498001748', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498001748']"
10.1056/NEJM199709253371302,"Abed, Y., Boivin, G., , Treatment of respiratory virus infections, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.01.006,Treatment of respiratory virus infections,"[['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016635420600026X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420600026X']"
10.1056/NEJM199709253371302,"Ambrozaitis, A., Gravenstein, S., Essen, G., et. al, Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.007,Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population,"[['Arvydas', '', 'Ambrozaitis'], ['Stefan', '', 'Gravenstein'], ['Gerrit', 'A. van', 'Essen'], ['Ethan', '', 'Rubinstein'], ['Ligita', '', 'Balciuniene'], ['Ausra', '', 'Stikleryte'], ['Catriona', '', 'Crawford'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005335', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005335']"
10.1056/NEJM199709253371302,"Olshaker, J., , Influenza, Emergency Medicine Clinics of North America, 2003",cited-by,10.1016/S0733-8627(03)00018-X,Influenza,"[['Jonathan', 'S', 'Olshaker']]",Emergency Medicine Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S073386270300018X', u'http://linkinghub.elsevier.com/retrieve/pii/S073386270300018X']"
10.1056/NEJM199709253371302,"Horváth, A., Andersen, I., Junker, K., et. al, Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00158-9,Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies,"[['A', '', 'Horv\xc3\xa1th'], ['I', '', 'Andersen'], ['K', '', 'Junker'], ['B', 'Lyck', 'Fogh-Schultz'], ['E', 'Holm', 'Nielsen'], ['S', '', 'Gizurarson'], ['O', '', 'Andersen'], ['J', '', 'K\xc3\xa1rm\xc3\xa1n'], ['E', '', 'Rajnav\xc3\xb6lgyi'], ['A', '', 'Erdei'], ['S.-E', '', 'Svehag']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001589', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001589']"
10.1056/NEJM199709253371302,"Awofeso, N., Fennell, M., Waliuzzaman, Z., et. al, Influenza outbreak in a correctional facility, Australian and New Zealand Journal of Public Health, 2001",cited-by,10.1111/j.1467-842X.2001.tb00655.x,Influenza outbreak in a correctional facility,"[['Niyi', '', 'Awofeso'], ['Michael', '', 'Fennell'], ['Zubair', '', 'Waliuzzaman'], ['Caroline', '', ""O'Connor""], ['Debbie', '', 'Pittam'], ['Leng', '', 'Boonwaat'], ['Sophie', '', 'Kantzow'], ['William', 'D.', 'Rawlinson']]",Australian and New Zealand Journal of Public Health,2001,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1467-842X.2001.tb00655.x']
10.1056/NEJM199709253371302,"Colman, P., , Zanamivir: an influenza virus neuraminidase inhibitor, Expert Review of Anti-infective Therapy, 2005",cited-by,10.1586/14787210.3.2.191,Zanamivir: an influenza virus neuraminidase inhibitor,"[['PM', '', 'Colman']]",Expert Review of Anti-infective Therapy,2005,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.3.2.191']
10.1056/NEJM199709253371302,"Snelgrove, R., Williams, A., Thorpe, C., et. al, Manipulation of immunity to and pathology of respiratory infections, Expert Review of Anticancer Therapy, 2004",cited-by,10.1586/14787210.2.3.413,Manipulation of immunity to and pathology of respiratory infections,"[['Robert', '', 'Snelgrove'], ['Andrew', '', 'Williams'], ['Callum', '', 'Thorpe'], ['Tracy', '', 'Hussell']]",Expert Review of Anticancer Therapy,2004,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.2.3.413']
10.1056/NEJM199709253371302,"Simor, A., , Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?, Infection Control and Hospital Epidemiology, 2002",cited-by,10.1086/501971,Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?,"[['Andrew', '', 'Simor']]",Infection Control and Hospital Epidemiology,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501971']
10.1056/NEJM199709253371302,"Plakokefalos, E., Markoulatos, P., Spyrou, N., et. al, Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type A (H3N2) viral isolates in Southern Greece, Archives of Virology, 2001",cited-by,10.1007/s007050170041,Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type A (H3N2) viral isolates in Southern Greece,"[['E.', 'T.', 'Plakokefalos'], ['P.', '', 'Markoulatos'], ['N.', '', 'Spyrou'], ['T.', 'A.', 'Bei'], ['N.', 'C.', 'Vamvakopoulos']]",Archives of Virology,2001,"[u'http://www.springerlink.com/index/g02fkr4ufxg76ccf.pdf', u'http://www.springerlink.com/content/g02fkr4ufxg76ccf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s007050170041', u'http://www.springerlink.com/index/pdf/10.1007/s007050170041']"
10.1056/NEJM199709253371302,"Neuzil, K., , Influenza: New insights into an old disease, Current Infectious Disease Reports, 2000",cited-by,10.1007/s11908-000-0039-3,Influenza: New insights into an old disease,"[['Kathleen', 'M.', 'Neuzil']]",Current Infectious Disease Reports,2000,"[u'http://www.springerlink.com/index/0765517834762225.pdf', u'http://www.springerlink.com/content/0765517834762225', u'http://www.springerlink.com/index/10.1007/s11908-000-0039-3', u'http://www.springerlink.com/index/pdf/10.1007/s11908-000-0039-3']"
10.1056/NEJM199709253371302,"Sahasrabudhe, A., Lawrence, L., Epa, V., et. al, Substrate, Inhibitor, or Antibody Stabilizes the Glu 119 Gly Mutant Influenza Virus Neuraminidase, Virology, 1998",cited-by,10.1006/viro.1998.9222,"Substrate, Inhibitor, or Antibody Stabilizes the Glu 119 Gly Mutant Influenza Virus Neuraminidase","[['Anjali', '', 'Sahasrabudhe'], ['Lynne', '', 'Lawrence'], ['V.', 'Chandana', 'Epa'], ['Joseph', 'N.', 'Varghese'], ['Peter', 'M.', 'Colman'], ['Jennifer', 'L.', 'McKimm-Breschkin']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0042682298992224', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682298992224']"
10.1056/NEJM199709253371302,"Klumpp, K., , Recent advances in the discovery and development of anti-influenza drugs, Expert Opinion on Therapeutic Patents, 2004",cited-by,10.1517/13543776.14.8.1153,Recent advances in the discovery and development of anti-influenza drugs,"[['Klaus', '', 'Klumpp']]",Expert Opinion on Therapeutic Patents,2004,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.14.8.1153']
10.1056/NEJM199709253371302,"Colman, P., , Neuraminidase inhibitors as antivirals, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00132-9,Neuraminidase inhibitors as antivirals,"[['P.', 'M', 'Colman']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02001329', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001329']"
10.1056/NEJM199709253371302,"Monto, A., Fendrick, A., , Developments in Influenza Prevention and Treatment: A Managed Care Perspective, Disease Management & Health Outcomes, 2000",cited-by,10.2165/00115677-200007050-00001,Developments in Influenza Prevention and Treatment: A Managed Care Perspective,"[['Arnold', 'S.', 'Monto'], ['A.', 'Mark', 'Fendrick']]",Disease Management & Health Outcomes,2000,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00115677-200007050-00001', u'http://diseasemanagement.adisonline.com/pt/re/dmo/pdfhandler.00115677-200007050-00001.pdf', u'http://diseasemanagement.adisonline.com/pt/re/dmo/fulltext.00115677-200007050-00001.htm']"
10.1056/NEJM199709253371302,"Drinka, P., Gravenstein, S., Schilling, M., et. al, Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols, , 0",cited-by,12341046Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols,Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols,"[['Paul', 'J.', 'Drinka'], ['Stefan', '', 'Gravenstein'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Barbara', 'A.', 'Miller'], ['Peter', '', 'Shult']]",,0,"[u'http://archinte.ama-assn.org/cgi/reprint/158/19/2155.pdf', u'http://archinte.highwire.org/cgi/reprint/158/19/2155.pdf']"
10.1056/NEJM199709253371302,"Ishizuka, H., Yoshiba, S., Okabe, H., et. al, Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers, Journal of Clinical Pharmacology, 2010",cited-by,10.1177/0091270009356297,"Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers","[['Hitoshi', '', 'Ishizuka'], ['Satoshi', '', 'Yoshiba'], ['Hiromi', '', 'Okabe'], ['Kazutaka', '', 'Yoshihara']]",Journal of Clinical Pharmacology,2010,"[u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270009356297', u'http://dx.doi.org/10.1177/0091270009356297']"
10.1056/NEJM199709253371302,"Ruf, B., Szucs, T., , Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy, Infection, 2009",cited-by,10.1007/s15010-009-8241-1,Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy,"[['B.', 'R.', 'Ruf'], ['T.', '', 'Szucs']]",Infection,2009,"[u'http://www.springerlink.com/index/880245655hpk7483.pdf', u'http://www.springerlink.com/content/880245655hpk7483', u'http://www.springerlink.com/index/10.1007/s15010-009-8241-1', u'http://www.springerlink.com/index/pdf/10.1007/s15010-009-8241-1']"
10.1056/NEJM199709253371302,"Imuta, F., Toyoda, M., Toyoda, T., , New application method of zanamivir with a straw, Pediatrics International, 2003",cited-by,10.1046/j.1442-200X.2003.01724.x,New application method of zanamivir with a straw,"[['Fusae', '', 'Imuta'], ['Michiko', '', 'Toyoda'], ['Tetsuya', '', 'Toyoda']]",Pediatrics International,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1442-200X.2003.01724.x']
10.1056/NEJM199709253371302,"Kaiser, L., Couch, R., Galasso, G., et. al, First International Symposium on Influenza and Other Respiratory Viruses: summary and overview, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00034-0,First International Symposium on Influenza and Other Respiratory Viruses: summary and overview,"[['Laurent', '', 'Kaiser'], ['Robert', 'B', 'Couch'], ['George', 'J', 'Galasso'], ['W.', 'Paul', 'Glezen'], ['Robert', 'G', 'Webster'], ['Peter', 'F', 'Wright'], ['Frederick', 'G', 'Hayden']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000340', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000340']"
10.1056/NEJM199709253371302,"Cianci, C., Krystal, M., , Development of antivirals against influenza, Expert Opinion on Investigational Drugs, 1998",cited-by,10.1517/13543784.7.2.149,Development of antivirals against influenza,"[['Christopher', '', 'Cianci'], ['Mark', '', 'Krystal']]",Expert Opinion on Investigational Drugs,1998,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.7.2.149']
10.1056/NEJM199709253371302,"Barbani, M., Gorgievski-Hrisoho, M., , Rapid detection of respiratory picornaviruses in nasopharyngeal aspirates by immunofluorescence assay, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2009.05.008,Rapid detection of respiratory picornaviruses in nasopharyngeal aspirates by immunofluorescence assay,"[['Maria', 'Teresa', 'Barbani'], ['Meri', '', 'Gorgievski-Hrisoho']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1386653209002030', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653209002030']"
10.1056/NEJM199709253371302,"Salzberger, B., Plentz, A., Ehrenstein, B., et. al, Influenza, Der Pneumologe, 2006",cited-by,10.1007/s10405-005-0074-8,Influenza,"[['B.', '', 'Salzberger'], ['A.', '', 'Plentz'], ['B.', '', 'Ehrenstein'], ['W.', '', 'Jilg']]",Der Pneumologe,2006,"[u'http://www.springerlink.com/content/7g3g89680n3t5q3n', u'http://www.springerlink.com/index/pdf/10.1007/s10405-005-0074-8', u'http://www.springerlink.com/index/10.1007/s10405-005-0074-8']"
10.1056/NEJM199709253371302,"Townsend, K., Eiland, L., , Combating Influenza with Antiviral Therapy in the Pediatric Population, Pharmacotherapy, 2006",cited-by,10.1592/phco.2006.26.1.95,Combating Influenza with Antiviral Therapy in the Pediatric Population,"[['Kara', 'A.', 'Townsend'], ['Lea', 'S.', 'Eiland']]",Pharmacotherapy,2006,[u'http://www.atypon-link.com/PPI/doi/abs/10.1592/phco.2006.26.1.95']
10.1056/NEJM199709253371302,"Genugten, M., Heijnen, M., , The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.007,The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands,"[['Marianne', 'L. L van', 'Genugten'], ['Marie-Louise', 'A', 'Heijnen']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204001066', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001066']"
10.1056/NEJM199709253371302,"Schwarzinger, M., Lacombe, K., Carrat, F., , Economic evaluations of neuraminidase inhibitors to control influenza, , 2003",cited-by,10.1586/14737167.3.2.147,Economic evaluations of neuraminidase inhibitors to control influenza,"[['Michael', '', 'Schwarzinger'], ['Karine', '', 'Lacombe'], ['Fabrice', '', 'Carrat']]",,2003,[u'http://www.future-drugs.com/doi/abs/10.1586/14737167.3.2.147']
10.1056/NEJM199709253371302,"Kuijper, E., Meer, J., Jong, M., et. al, Usefulness of Gram Stain for Diagnosis of Lower Respiratory Tract Infection or Urinary Tract Infection and as an Aid in Guiding Treatment, Carcinogenesis, 2003",cited-by,10.1007/s10096-003-0892-8,Usefulness of Gram Stain for Diagnosis of Lower Respiratory Tract Infection or Urinary Tract Infection and as an Aid in Guiding Treatment,"[['E.', 'J.', 'Kuijper'], ['J.', 'van der', 'Meer'], ['M.', 'D. de', 'Jong'], ['P.', '', 'Speelman'], ['J.', '', 'Dankert']]",Carcinogenesis,2003,"[u'http://www.springerlink.com/index/hwdml44mxdu3dynr.pdf', u'http://www.springerlink.com/content/hwdml44mxdu3dynr']"
10.1056/NEJM199709253371302,"Höffken, G., Gillissen, A., , Efficacy and safety of zanamivir in patients with influenza - impact of age, severity of infections and specific risk factors, Medical Microbiology and Immunology, 2002",cited-by,10.1007/s00430-002-0140-3,"Efficacy and safety of zanamivir in patients with influenza - impact of age, severity of infections and specific risk factors","[['Gert', '', 'H\xc3\xb6ffken'], ['Adrian', '', 'Gillissen']]",Medical Microbiology and Immunology,2002,"[u'http://www.springerlink.com/content/xw6cyvhlgd0majnf', u'http://www.springerlink.com/index/xw6cyvhlgd0majnf.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00430-002-0140-3', u'http://www.springerlink.com/index/pdf/10.1007/s00430-002-0140-3']"
10.1056/NEJM199709253371302,"Hayden, F., , Influenza virus neuraminidase inhibitors: clinical aspects, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00358-2,Influenza virus neuraminidase inhibitors: clinical aspects,"[['Frederick', 'G.', 'Hayden']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003582', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003582']"
10.1056/NEJM199709253371302,"Kuehnert, M., Cardo, D., , Infections associated with health-care personnel: Vaccine-preventable diseases and bloodborne pathogens, Current Infectious Disease Reports, 2000",cited-by,10.1007/s11908-000-0047-3,Infections associated with health-care personnel: Vaccine-preventable diseases and bloodborne pathogens,"[['Matthew', 'J.', 'Kuehnert'], ['Denise', 'M.', 'Cardo']]",Current Infectious Disease Reports,2000,"[u'http://www.springerlink.com/content/w448u2457558425h', u'http://www.springerlink.com/index/w448u2457558425h.pdf', u'http://www.springerlink.com/index/pdf/10.1007/s11908-000-0047-3', u'http://www.springerlink.com/index/10.1007/s11908-000-0047-3']"
10.1016~S0140-6736(00)02288-1,"Smith AP, Thomas M, Brockman P, Kent J, Nicholson KG. Effect of influenza virus B infection on human performance. BMJ 1993; 306: 760–61.",references,10.1136/bmj.306.6880.760,Effect of influenza B virus infection on human performance,"[[u'A', u'P', u'Smith'], [u'M', u'', u'Thomas'], [u'P', u'', u'Brockman'], [u'J', u'', u'Kent'], [u'K', u'G', u'Nicholson']]",British Medical Journal,1993,"[u'http://www.bmj.com/cgi/doi/10.1136/bmj.306.6880.760', u'http://dx.doi.org/']",./output/10.1016~S0140-6736(00)02288-1/10.1136~bmj.306.6880.760
10.1136/bmj.306.6880.760,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1136/bmj.306.6880.760,"Nichol, K., , Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza, , 2001",cited-by,2905336Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,"[['Kristin', 'L.', 'Nichol']]",,2001,"[u'http://archinte.ama-assn.org/cgi/reprint/161/5/749.pdf', u'http://tudor.szote.u-szeged.hu/webtext/letolt/anyag/CASPi_200212/day4/4.2.3.%20nichol%20paper.pdf']"
10.1136/bmj.306.6880.760,"Yirmiya, R., Weidenfeld, J., Pollak, Y., et. al, Cytokines, “Depression Due to A General Medical Condition,” and Antidepressant Drugs, , 0",cited-by,10.1007/978-0-585-37970-8_16,"Cytokines, “Depression Due to A General Medical Condition,” and Antidepressant Drugs","[['Raz', '', 'Yirmiya'], ['Joseph', '', 'Weidenfeld'], ['Yehuda', '', 'Pollak'], ['Michal', '', 'Morag'], ['Avraham', '', 'Morag'], ['Ronit', '', 'Avitsur'], ['Ohr', '', 'Barak'], ['Edna', '', 'Cohen'], ['Yehuda', '', 'Shavit'], ['Haim', '', 'Ovadia']]",,0,"[u'http://www.springerlink.com/index/jw2v456q221000r1.pdf', u'http://www.springerlink.com/content/jw2v456q221000r1']"
10.1136/bmj.306.6880.760,"Keech, M., Scott, A., Ryan, P., , The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population, Occupational Medicine-oxford, 1998",cited-by,10.1093/occmed/48.2.85,The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population,"[['M.', '', 'Keech'], ['A.', 'J.', 'Scott'], ['P.', 'J. J.', 'Ryan']]",Occupational Medicine-oxford,1998,"[u'http://occmed.oxfordjournals.org/cgi/reprint/48/2/85.pdf', u'http://occmed.oxfordjournals.org/cgi/doi/10.1093/occmed/48.2.85']"
10.1136/bmj.306.6880.760,"Nichol, K., Mallon, K., Mendelman, P., , Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00029-X,"Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine","[['Kristin', 'L', 'Nichol'], ['Kenneth', 'P', 'Mallon'], ['Paul', 'M', 'Mendelman']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0300029X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0300029X']"
10.1136/bmj.306.6880.760,"Blank, P., Schwenkglenks, M., Szucs, T., , Vaccination coverage rates in eleven European countries during two consecutive influenza seasons, Journal of Infection, 2009",cited-by,10.1016/j.jinf.2009.04.001,Vaccination coverage rates in eleven European countries during two consecutive influenza seasons,"[['Patricia', 'R.', 'Blank'], ['Matthias', '', 'Schwenkglenks'], ['Thomas', 'D.', 'Szucs']]",Journal of Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0163445309001157', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445309001157']"
10.1136/bmj.306.6880.760,"Nichol, K., D’Heilly, S., Ehlinger, E., , Colds and Influenza‐Like Illnesses in University Students: Impact on Health, Academic and Work Performance, and Health Care Use, Clinical Infectious Diseases, 2005",cited-by,10.1086/429237,"Colds and Influenza‐Like Illnesses in University Students: Impact on Health, Academic and Work Performance, and Health Care Use","[['Kristin', 'L.', 'Nichol'], ['Sarah', '', 'D\xe2\x80\x99Heilly'], ['Edward', '', 'Ehlinger']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/429237']
10.1136/bmj.306.6880.760,"Pollak, Y., Orion, E., Goshen, I., et. al, Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis’, Brain Behavior and Immunity, 2002",cited-by,10.1016/S0889-1591(02)00010-7,Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis’,"[['Y', '', 'Pollak'], ['E', '', 'Orion'], ['I', '', 'Goshen'], ['H', '', 'Ovadia'], ['R', '', 'Yirmiya']]",Brain Behavior and Immunity,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0889159102000107', u'http://linkinghub.elsevier.com/retrieve/pii/S0889159102000107']"
10.1136/bmj.306.6880.760,"Hall, S., Smith, A., , Investigation of the effects and aftereffects of naturally occurring upper respiratory tract illnesses on mood and performance, Physiology & Behavior, 1996",cited-by,10.1016/0031-9384(95)02112-4,Investigation of the effects and aftereffects of naturally occurring upper respiratory tract illnesses on mood and performance,"[['Sara', '', 'Hall'], ['Andrew', '', 'Smith']]",Physiology & Behavior,1996,"[u'http://www.sciencedirect.com/science/article/pii/0031938495021124', u'http://linkinghub.elsevier.com/retrieve/pii/0031938495021124']"
10.1136/bmj.306.6880.760,"Keech, M., Beardsworth, P., , The Impact of Influenza on Working Days Lost: A Review of the Literature, Pharmacoeconomics, 2008",cited-by,10.2165/00019053-200826110-00004,The Impact of Influenza on Working Days Lost: A Review of the Literature,"[['Martin', '', 'Keech'], ['Paul', '', 'Beardsworth']]",Pharmacoeconomics,2008,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019053-200826110-00004', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200826110-00004.htm', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/pdfhandler.00019053-200826110-00004.pdf']"
10.1136/bmj.306.6880.760,"Smith, A., Thomas, M., Kent, J., et. al, EFFECTS OF THE COMMON COLD ON MOOD AND PERFORMANCE, Psychoneuroendocrinology, 1998",cited-by,10.1016/S0306-4530(98)00042-0,EFFECTS OF THE COMMON COLD ON MOOD AND PERFORMANCE,"[['Andrew', '', 'Smith'], ['Marie', '', 'Thomas'], ['Julie', '', 'Kent'], ['Karl', '', 'Nicholson']]",Psychoneuroendocrinology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0306453098000420', u'http://linkinghub.elsevier.com/retrieve/pii/S0306453098000420']"
10.1136/bmj.306.6880.760,"MacLullich, A., Ferguson, K., Miller, T., et. al, Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses, Journal of Psychosomatic Research, 2008",cited-by,10.1016/j.jpsychores.2008.05.019,Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses,"[['Alasdair', 'M. J.', 'MacLullich'], ['Karen', 'J.', 'Ferguson'], ['Thomas', '', 'Miller'], ['Sophia', 'E. J. A. de', 'Rooij'], ['Colm', '', 'Cunningham']]",Journal of Psychosomatic Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0022399908002407', u'http://linkinghub.elsevier.com/retrieve/pii/S0022399908002407']"
10.1136/bmj.306.6880.760,"Nichol, K., , Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00110-3,Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults,"[['Kristin', 'L', 'Nichol']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001103', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001103']"
10.1136/bmj.306.6880.760,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.1136/bmj.306.6880.760,"Bucks, R., Gidron, Y., Harris, P., et. al, Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: A prospective study, Brain Behavior and Immunity, 2008",cited-by,10.1016/j.bbi.2007.09.005,"Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: A prospective study","[['Romola', 'S.', 'Bucks'], ['Yori', '', 'Gidron'], ['Petra', '', 'Harris'], ['Jessica', '', 'Teeling'], ['Keith', 'A.', 'Wesnes'], ['V.', 'Hugh', 'Perry']]",Brain Behavior and Immunity,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0889159107002462', u'http://linkinghub.elsevier.com/retrieve/pii/S0889159107002462']"
10.1136/bmj.306.6880.760,"Poland, G., Johnson, D., , Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season, American Journal of Medicine, 2008",cited-by,10.1016/j.amjmed.2008.05.002,Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season,"[['Gregory', 'A.', 'Poland'], ['David', 'R.', 'Johnson']]",American Journal of Medicine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0002934308004658', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934308004658']"
10.1136/bmj.306.6880.760,"Engler, R., Nelson, M., Klote, M., et. al, Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses, , 0",cited-by,"13620392Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses","Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses","[['Renata', 'J. M.', 'Engler'], ['Michael', 'R.', 'Nelson'], ['Mary', 'M.', 'Klote'], ['Mark', 'J.', 'VanRaden'], ['Chiung-Yu', '', 'Huang'], ['Nancy', 'J.', 'Cox'], ['Alexander', '', 'Klimov'], ['Wendy', 'A.', 'Keitel'], ['Kristin', 'L.', 'Nichol'], ['Warner', 'W.', 'Carr'], ['John', 'J.', 'Treanor']]",,0,[u'http://archinte.highwire.org/cgi/reprint/168/22/2405.pdf']
10.1136/bmj.306.6880.760,"LaVela, S., Goldstein, B., Smith, B., et. al, Working with symptoms of a respiratory infection: Staff who care for high-risk individuals, American Journal of Infection Control, 2007",cited-by,10.1016/j.ajic.2006.12.005,Working with symptoms of a respiratory infection: Staff who care for high-risk individuals,"[['Sherri', '', 'LaVela'], ['Barry', '', 'Goldstein'], ['Bridget', '', 'Smith'], ['Frances', 'M.', 'Weaver']]",American Journal of Infection Control,2007,"[u'http://www.sciencedirect.com/science/article/pii/S019665530700096X', u'http://linkinghub.elsevier.com/retrieve/pii/S019665530700096X']"
10.1136/bmj.306.6880.760,"Chalmers, C., , Understanding healthcare worker uptake of influenza vaccination: a survey, British Journal of Infection Control, 2006",cited-by,10.1177/14690446060070020501,Understanding healthcare worker uptake of influenza vaccination: a survey,"[['C.', '', 'Chalmers']]",British Journal of Infection Control,2006,"[u'http://bji.sagepub.com/cgi/doi/10.1177/14690446060070020501', u'http://dx.doi.org/10.1177/14690446060070020501']"
10.1136/bmj.306.6880.760,"Fleming, D., , The management of influenza in people of working age, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.259,The management of influenza in people of working age,"[['D.', 'M.', 'Fleming']]",Occupational Medicine-oxford,2002,"[u'http://occmed.oxfordjournals.org/cgi/reprint/52/5/259.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.259']"
10.1136/bmj.306.6880.760,"Souza, M., , Influenza, Journal of Exotic Pet Medicine, 2011",cited-by,10.1053/j.jepm.2010.11.003,Influenza,"[['Marcy', 'J.', 'Souza']]",Journal of Exotic Pet Medicine,2011,"[u'http://www.sheffield.ac.uk/content/1/c6/01/28/99/flu1.pdf', u'http://www.sciencedirect.com/science/article/pii/S1557506310002090']"
10.1136/bmj.306.6880.760,"Chalmers, C., , Double-blind peer reviewed paper The role of healthcare workers in influenza prevention: Part one, British Journal of Infection Control, 2006",cited-by,10.1177/14690446060070010601,Double-blind peer reviewed paper The role of healthcare workers in influenza prevention: Part one,"[['C.', '', 'Chalmers']]",British Journal of Infection Control,2006,"[u'http://bji.sagepub.com/cgi/doi/10.1177/14690446060070010601', u'http://dx.doi.org/10.1177/14690446060070010601']"
10.1136/bmj.306.6880.760,"Smith, A., Thomas, M., Whitney, H., , Effects of upper respiratory tract illnesses on mood and performance over the working day, Ergonomics, 2000",cited-by,10.1080/001401300404724,Effects of upper respiratory tract illnesses on mood and performance over the working day,"[['Andrew', '', 'Smith'], ['Marie', '', 'Thomas'], ['Helen', '', 'Whitney']]",Ergonomics,2000,[u'http://dx.doi.org/10.1080/001401300404724']
10.1136/bmj.306.6880.760,"Thomas, M., Whitney, H., , After-effects of the common cold on mood and performance, Ergonomics, 2000",cited-by,10.1080/001401300421789,After-effects of the common cold on mood and performance,"[['Marie', '', 'Thomas'], ['Helen', '', 'Whitney']]",Ergonomics,2000,[u'http://dx.doi.org/10.1080/001401300421789']
10.1136/bmj.306.6880.760,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
10.1016~S0140-6736(00)02288-1,Ogilvie MM. Antiviral prophylaxis and treatment in chickenpox: a review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998;,references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,(suppl 1): 31–38.,references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,"Wood MJ, Shukla S, Fiddian AP, Crooks RJ. Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48–72 h) therapy with acyclovir and valaciclovir on prolonged pain. J Infect Dis 1998;",references,10.1086/514271,Treatment of Acute Herpes Zoster: Effect of Early (<48 h) versus Late (48–72 h) Therapy with Acyclovir and Valaciclovir on Prolonged Pain,"[[u'M.', u'J.', u'Wood'], [u'S.', u'', u'Shukla'], [u'A.', u'P.', u'Fiddian'], [u'R.', u'J.', u'Crooks']]",Journal of Infectious Diseases,1998,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/514271'],./output/10.1016~S0140-6736(00)02288-1/10.1086~514271
10.1086/514271,"Dworkin, R., Johnson, R., Breuer, J., et. al, Recommendations for the Management of Herpes Zoster, Clinical Infectious Diseases, 2007",cited-by,10.1086/510206,Recommendations for the Management of Herpes Zoster,"[['Robert', 'H.', 'Dworkin'], ['Robert', 'W.', 'Johnson'], ['Judith', '', 'Breuer'], ['John', 'W.', 'Gnann'], ['Myron', 'J.', 'Levin'], ['Miroslav', '', 'Backonja'], ['Robert', 'F.', 'Betts'], ['Anne', 'A.', 'Gershon'], ['Maija', 'L.', 'Haanpaa'], ['Michael', 'W.', 'McKendrick'], ['Turo', 'J.', 'Nurmikko'], ['Anne', 'Louise', 'Oaklander'], ['Michael', 'N.', 'Oxman'], ['Karin', 'L.', 'Petersen'], ['Michael', 'C.', 'Rowbotham'], ['Kenneth', 'E.', 'Schmader'], ['Brett', 'R.', 'Stacey'], ['Stephen', 'K.', 'Tyring'], ['Albert', 'J. M. van', 'Wijck'], ['Mark', 'S.', 'Wallace'], ['Sawko', 'W.', 'Wassilew'], ['Richard', 'J.', 'Whitley']]",Clinical Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/510206']
10.1086/514271,"Decroix, J., Partsch, H., Gonzalez, R., et. al, Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir, Journal of The European Academy of Dermatology and Venereology, 2000",cited-by,10.1046/j.1468-3083.2000.00020.x,Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir,"[['J', '', 'Decroix'], ['H', '', 'Partsch'], ['R', '', 'Gonzalez'], ['H', '', 'Mobacken'], ['Cl', '', 'Goh'], ['Jb', '', 'Walsh'], ['S', '', 'Shukla'], ['B', '', 'Naisbett']]",Journal of The European Academy of Dermatology and Venereology,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1468-3083.2000.00020.x']
10.1086/514271,"Rothberg, M., Bennish, M., Kao, J., et. al, Do the Benefits of Varicella Vaccination Outweigh the Long‐Term Risks? A Decision‐Analytic Model for Policymakers and Pediatricians, Clinical Infectious Diseases, 2002",cited-by,10.1086/338956,Do the Benefits of Varicella Vaccination Outweigh the Long‐Term Risks? A Decision‐Analytic Model for Policymakers and Pediatricians,"[['Michael', '', 'Rothberg'], ['Michael', 'L.', 'Bennish'], ['Jack', 'S.', 'Kao'], ['John', 'B.', 'Wong']]",Clinical Infectious Diseases,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/338956']
10.1086/514271,"Tenser, R., , Herpes zoster infection and postherpetic neuralgia, Current Neurology and Neuroscience Reports, 2001",cited-by,10.1007/s11910-001-0057-z,Herpes zoster infection and postherpetic neuralgia,"[['Richard', 'B.', 'Tenser']]",Current Neurology and Neuroscience Reports,2001,"[u'http://www.springerlink.com/content/j716288136457776', u'http://www.springerlink.com/index/j716288136457776.pdf', u'http://www.springerlink.com/index/10.1007/s11910-001-0057-z', u'http://www.springerlink.com/index/pdf/10.1007/s11910-001-0057-z']"
10.1086/514271,"Gialloreti, L., Merito, M., Pezzotti, P., et. al, Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study, BMC Infectious Diseases, 2010",cited-by,10.1186/1471-2334-10-230,"Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study","[['Leonardo', 'Emberti', 'Gialloreti'], ['Monica', '', 'Merito'], ['Patrizio', '', 'Pezzotti'], ['Luigi', '', 'Naldi'], ['Antonio', '', 'Gatti'], ['Maud', '', 'Beillat'], ['Laurence', '', 'Serradell'], ['Rafaelle', 'di', 'Marzo'], ['Antonio', '', 'Volpi']]",BMC Infectious Diseases,2010,"[u'http://www.springerlink.com/content/n6u3274h23266j3p', u'http://www.biomedcentral.com/1471-2334/10/230', u'http://www.biomedcentral.com/content/pdf/1471-2334-10-230.pdf', u'http://www.springerlink.com/index/n6u3274h23266j3p.pdf']"
10.1086/514271,"Kempfa, W., Meylanb, P., Gerberc, S., et. al, Swiss recommendations for the management of varicella zoster virus infections1, , 0",cited-by,12406069Swiss recommendations for the management of varicella zoster virus infections1,Swiss recommendations for the management of varicella zoster virus infections1,"[['W.', '', 'Kempfa'], ['P.', '', 'Meylanb'], ['S.', '', 'Gerberc'], ['C.', '', 'Aebid'], ['R.', '', 'Agostie'], ['S.', '', 'B\xc3\xbcchnerf'], ['B.', '', 'Coradig'], ['H.', 'H.', 'Hirschi'], ['C.', '', 'Kind'], ['U.', '', 'Lauperk'], ['S.', '', 'Lautenschlagerl'], ['P.', '', 'Reusserm'], ['W.', '', 'Wunderlio'], ['D.', '', 'Nadalp'], ['J.', '', 'Garweg']]",,0,[u'http://www.smw.ch/docs/pdf200x/2007/17/smw-11721.pdf']
10.1086/514271,"Morrow, M., , Bell’s palsy and herpes zoster oticus, Current Treatment Options in Neurology, 2000",cited-by,10.1007/s11940-000-0039-5,Bell’s palsy and herpes zoster oticus,"[['Mark', 'J.', 'Morrow']]",Current Treatment Options in Neurology,2000,"[u'http://www.springerlink.com/index/7g405w23240r0t66.pdf', u'http://www.springerlink.com/content/7g405w23240r0t66', u'http://www.springerlink.com/index/10.1007/s11940-000-0039-5', u'http://www.springerlink.com/index/pdf/10.1007/s11940-000-0039-5']"
10.1086/514271,"Ballantyne, J., , The Acute Facial Palsies, Journal of Neurology Neurosurgery and Psychiatry, 1978",cited-by,10.1136/jnnp.41.12.1149,The Acute Facial Palsies,"[['J.', 'P.', 'Ballantyne']]",Journal of Neurology Neurosurgery and Psychiatry,1978,"[u'http://jnnp.bmj.com/cgi/doi/10.1136/jnnp.41.12.1149', u'http://dx.doi.org/']"
10.1086/514271,"Khan, J., Mazari, F., Rahman, M., et. al, Patients' Perspective of Functional Outcome After Elective Abdominal Aortic Aneurysm Repair: A Questionnaire Survey, Annals of Vascular Surgery, 2011",cited-by,10.1016/j.avsg.2011.05.013,Patients' Perspective of Functional Outcome After Elective Abdominal Aortic Aneurysm Repair: A Questionnaire Survey,"[['Junaid', 'A.', 'Khan'], ['Fayyaz', 'A.', 'Mazari'], ['M.', 'N. A. Abdul', 'Rahman'], ['Katherine', '', 'Mockford'], ['Ian', 'C.', 'Chetter'], ['Peter', 'T.', 'McCollum']]",Annals of Vascular Surgery,2011,[u'http://www.sciencedirect.com/science/article/pii/S0890509611002780']
10.1086/514271,"Devaleenal, D., Ahilasamy, N., Solomon, S., et. al, Ramsay hunt syndrome in a person with HIV disease, Indian Journal of Otolaryngology and Head & Neck Surgery, 2008",cited-by,10.1007/s12070-008-0041-x,Ramsay hunt syndrome in a person with HIV disease,"[['Daniel', 'Bella', 'Devaleenal'], ['Nagalingeswaran', '', 'Ahilasamy'], ['Suniti', '', 'Solomon'], ['Nagalingeswaran', '', 'Kumarasamy']]",Indian Journal of Otolaryngology and Head & Neck Surgery,2008,"[u'http://www.springerlink.com/index/g166344034p12m30.pdf', u'http://www.springerlink.com/content/g166344034p12m30', u'http://www.springerlink.com/index/10.1007/s12070-008-0041-x', u'http://www.springerlink.com/index/pdf/10.1007/s12070-008-0041-x']"
10.1086/514271,"Mahler, V., , Evidence-based treatment of skin diseases caused by herpesvirus, Hautarzt, 2005",cited-by,10.1007/s00105-005-0899-4,Evidence-based treatment of skin diseases caused by herpesvirus,"[['V.', '', 'Mahler']]",Hautarzt,2005,"[u'http://www.springerlink.com/index/10.1007/s00105-005-0899-4', u'http://www.springerlink.com/index/pdf/10.1007/s00105-005-0899-4']"
10.1086/514271,"ATHWAL, G., BARTSICH, S., WEILAND, A., , Herpes Zoster in the Ulnar Nerve Distribution, Journal of Hand Surgery-british and European Volume, 2005",cited-by,10.1016/J.JHSB.2005.04.010,Herpes Zoster in the Ulnar Nerve Distribution,"[['G.', 'S.', 'ATHWAL'], ['S.', 'A.', 'BARTSICH'], ['A.', 'J.', 'WEILAND']]",Journal of Hand Surgery-british and European Volume,2005,[u'http://dx.doi.org/10.1016/J.JHSB.2005.04.010']
10.1086/514271,"Modi, S., Pereira, J., Mackey, J., , The cancer patient with chronic pain due to herpes zoster, Current Pain and Headache Reports, 2000",cited-by,10.1007/s11916-000-0066-7,The cancer patient with chronic pain due to herpes zoster,"[['Shanu', '', 'Modi'], ['Jose', '', 'Pereira'], ['John', 'R.', 'Mackey']]",Current Pain and Headache Reports,2000,"[u'http://www.springerlink.com/index/huw8q1246072hqv1.pdf', u'http://www.springerlink.com/content/huw8q1246072hqv1']"
10.1086/514271,"Oakes, S., , Advisory Board Reviewer, , 0",cited-by,10935482Advisory Board Reviewer,Advisory Board Reviewer,"[['Scott', 'Andre', 'Oakes']]",,0,[u'http://www.mymedcases.com/_mem_bin/pdfs/Backgrounder.pdf']
10.1086/514271,"Garweg, J., , Schweizer Empfehlungen für das Management der Varicella-Zoster-Virus-Infektion, , 0",cited-by,12900316Schweizer Empfehlungen für das Management der Varicella-Zoster-Virus-Infektion,Schweizer Empfehlungen für das Management der Varicella-Zoster-Virus-Infektion,"[['J.', '', 'Garweg']]",,0,[u'http://www.medicalforum.ch/pdf/pdf_d/2007/2007-44/2007-44-259.pdf']
10.1016~S0140-6736(00)02288-1,(suppl 1): 81–4.,references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,"Nicholson KG. Human influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford: Blackwell Science, 1998: 219–64.",references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,"Glezen WP, Decker M, Joseph SW, Mercready RG Jr. Acute respiratory disease associated with influenza epidemics in Houston, 1981–83. J Infect Dis 1987; 155: 1119–26.",references,NOT found in MAS
10.1016~S0140-6736(00)02288-1,"He G, Massarella J, Ward P. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet 1999; 37: 471–84. ARTICLES 1850 THE LANCET • Vol 355 • May 27, 2000",references,10.2165/00003088-199937060-00003,Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802,"[[u'George', u'', u'He'], [u'Joseph', u'', u'Massarella'], [u'Penelope', u'', u'Ward']]",Clinical Pharmacokinetics,1999,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003088-199937060-00003'],
10.2165/00003088-199937060-00003,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
10.2165/00003088-199937060-00003,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.2165/00003088-199937060-00003,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
10.2165/00003088-199937060-00003,"HILL, G., CIHLAR, T., OO, C., et. al, The Anti-Influenza Drug Oseltamivir Exhibits Low Potential to Induce Pharmacokinetic Drug Interactions via Renal Secretion---Correlation of in Vivo and in Vitro Studies, Drug Metabolism and Disposition, 2002",cited-by,10.1124/dmd.30.1.13,The Anti-Influenza Drug Oseltamivir Exhibits Low Potential to Induce Pharmacokinetic Drug Interactions via Renal Secretion---Correlation of in Vivo and in Vitro Studies,"[['GEORGE', '', 'HILL'], ['TOMAS', '', 'CIHLAR'], ['CHARLES', '', 'OO'], ['EDMUND', 'S.', 'HO'], ['KEN', '', 'PRIOR'], ['HUGH', '', 'WILTSHIRE'], ['JO', '', 'BARRETT'], ['BAULIAN', '', 'LIU'], ['PENNY', '', 'WARD']]",Drug Metabolism and Disposition,2002,"[u'http://dmd.aspetjournals.org/cgi/doi/10.1124/dmd.30.1.13', u'http://www.birdflumanual.com/resources/Medical_References/files/Hill%20G%20Etal%20Oseltamivir%20Renal%20Secretion%20Drug%20Met%20Dis%202002%20301.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/tamiflu%20drug%20interactions%20probenecid.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Tamaflu%20and%20Probenecid%20Renal%20Effects.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Tamiflu%20pharmacokenetics.pdf']"
10.2165/00003088-199937060-00003,"Tanaka, T., Nakajima, K., Murashima, A., et. al, Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women, , 2009",cited-by,13194948Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women,Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women,"[['Toshihiro', '', 'Tanaka'], ['Ken', '', 'Nakajima'], ['Atsuko', '', 'Murashima'], ['Facundo', '', 'Garcia-Bournissen'], ['Gideon', '', 'Koren'], ['Shinya', '', 'Ito']]",,2009,"[u'http://www.health.nt.gov.au/library/scripts/objectifymedia.aspx?file=pdf/37/88.pdf&amp;siteid=1&amp;str_title=use%20of%20antivirals%20in%20pregnancy%20cmaj%20jun09.pdf', u'http://www.cmaj.ca/cgi/rapidpdf/cmaj.090866v1.pdf']"
10.2165/00003088-199937060-00003,"Reece, P., , Neuraminidase inhibitor resistance in influenza viruses, Journal of Medical Virology, 2007",cited-by,10.1002/jmv.20951,Neuraminidase inhibitor resistance in influenza viruses,"[['Phillip', 'Andrew', 'Reece']]",Journal of Medical Virology,2007,[u'http://doi.wiley.com/10.1002/jmv.20951']
10.2165/00003088-199937060-00003,"Shi, D., Yang, J., Yang, D., et. al, Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel, Journal of Pharmacology and Experimental Therapeutics, 2006",cited-by,10.1124/jpet.106.111807,"Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel","[['Deshi', '', 'Shi'], ['Jian', '', 'Yang'], ['Dongfang', '', 'Yang'], ['Edward', 'L.', 'LeCluyse'], ['Chris', '', 'Black'], ['L.', '', 'You'], ['F.', '', 'Akhlaghi'], ['B.', '', 'Yan']]",Journal of Pharmacology and Experimental Therapeutics,2006,"[u'http://www.uri.edu/pharmacy/faculty/aps/akhlaghi/my%20papers/Shi%20et%20al%202006,%20JPET.pdf', u'http://jpet.aspetjournals.org/cgi/doi/10.1124/jpet.106.111807']"
10.2165/00003088-199937060-00003,"Kalgutkar, A., Soglia, J., , Minimising the potential for metabolic activation in drug discovery, Expert Opinion on Drug Metabolism & Toxicology, 2005",cited-by,10.1517/17425255.1.1.91,Minimising the potential for metabolic activation in drug discovery,"[['Amit', 'S', 'Kalgutkar'], ['John', 'R', 'Soglia']]",Expert Opinion on Drug Metabolism & Toxicology,2005,[u'http://informahealthcare.com/doi/abs/10.1517/17425255.1.1.91']
10.2165/00003088-199937060-00003,"Magnani, J., Ernst, B., , From carbohydrate leads to glycomimetic drugs, Nature Reviews Drug Discovery, 2009",cited-by,10.1038/nrd2852,From carbohydrate leads to glycomimetic drugs,"[['John', 'L.', 'Magnani'], ['Beat', '', 'Ernst']]",Nature Reviews Drug Discovery,2009,"[u'http://www.nature.com/doifinder/10.1038/nrd2852', u'http://dx.doi.org/10.1038/nrd2852']"
10.2165/00003088-199937060-00003,"Izumi, Y., Tokuda, K., O’Dell, K., et. al, Neuroexcitatory actions of Tamiflu and its carboxylate metabolite, Neuroscience Letters, 2007",cited-by,10.1016/j.neulet.2007.08.054,Neuroexcitatory actions of Tamiflu and its carboxylate metabolite,"[['Yukitoshi', '', 'Izumi'], ['Kazuhiro', '', 'Tokuda'], ['Kazuko', 'A.', 'O\xe2\x80\x99Dell'], ['Charles', 'F.', 'Zorumski'], ['Toshio', '', 'Narahashi']]",Neuroscience Letters,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0304394007009044', u'http://linkinghub.elsevier.com/retrieve/pii/S0304394007009044']"
10.2165/00003088-199937060-00003,"Gruber, P., Gomersall, C., Joynt, G., , Avian influenza (H5N1): implications for intensive care, Intensive Care Medicine, 2006",cited-by,10.1007/s00134-006-0148-z,Avian influenza (H5N1): implications for intensive care,"[['Pascale', 'C.', 'Gruber'], ['Charles', 'D.', 'Gomersall'], ['Gavin', 'M.', 'Joynt']]",Intensive Care Medicine,2006,"[u'http://www.springerlink.com/content/1168845000263220', u'http://www.springerlink.com/index/1168845000263220.pdf', u'http://www.springerlink.com/index/10.1007/s00134-006-0148-z', u'http://www.springerlink.com/index/pdf/10.1007/s00134-006-0148-z']"
10.2165/00003088-199937060-00003,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671']
10.2165/00003088-199937060-00003,"Singer, A., Nunn, M., Gould, E., et. al, Potential Risks Associated with the Proposed Widespread Use of Tamiflu, Environmental Health Perspectives, 2006",cited-by,10.1289/ehp.9574,Potential Risks Associated with the Proposed Widespread Use of Tamiflu,"[['Andrew', 'C.', 'Singer'], ['Miles', 'A.', 'Nunn'], ['Ernest', 'A.', 'Gould'], ['Andrew', 'C.', 'Johnson']]",Environmental Health Perspectives,2006,[u'http://www.ehponline.org/ambra-doi-resolver/10.1289/ehp.9574']
10.2165/00003088-199937060-00003,"Arabi, Y., Gomersall, C., Ahmed, Q., et. al, The critically ill avian influenza A (H5N1) patient, Critical Care Medicine, 2007",cited-by,10.1097/01.CCM.0000262940.34596.4B,The critically ill avian influenza A (H5N1) patient,"[['Yaseen', '', 'Arabi'], ['Charles', 'D.', 'Gomersall'], ['Qanta', 'A.', 'Ahmed'], ['Bruce', 'R.', 'Boynton'], ['Ziad', 'A.', 'Memish']]",Critical Care Medicine,2007,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-200705000-00028']
10.2165/00003088-199937060-00003,"Oo, C., Hill, G., Dorr, A., et. al, Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years, European Journal of Clinical Pharmacology, 2003",cited-by,10.1007/s00228-003-0639-6,Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years,"[['Charles', '', 'Oo'], ['George', '', 'Hill'], ['Albert', '', 'Dorr'], ['Baolian', '', 'Liu'], ['Samuel', '', 'Boellner'], ['Penelope', '', 'Ward']]",European Journal of Clinical Pharmacology,2003,"[u'http://www.springerlink.com/content/u2u6ufaxht4qgjgl', u'http://www.springerlink.com/index/u2u6ufaxht4qgjgl.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00228-003-0639-6', u'http://www.springerlink.com/index/pdf/10.1007/s00228-003-0639-6']"
10.2165/00003088-199937060-00003,"McKimm-Breschkin, J., , Neuraminidase inhibitors for the treatment and prevention of influenza, Expert Opinion on Pharmacotherapy, 2002",cited-by,10.1517/14656566.3.2.103,Neuraminidase inhibitors for the treatment and prevention of influenza,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Expert Opinion on Pharmacotherapy,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.3.2.103']
10.2165/00003088-199937060-00003,"Toovey, S., Rayner, C., Prinssen, E., et. al, Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: A Comprehensive Review, Drug Safety, 2008",cited-by,10.2165/0002018-200831120-00006,Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: A Comprehensive Review,"[['Stephen', '', 'Toovey'], ['Craig', '', 'Rayner'], ['Eric', '', 'Prinssen'], ['Tom', '', 'Chu'], ['Barbara', '', 'Donner'], ['Bharat', '', 'Thakrar'], ['Regina', '', 'Dutkowski'], ['Gerhard', '', 'Hoffmann'], ['Alexander', '', 'Breidenbach'], ['Lothar', '', 'Lindemann'], ['Ellen', '', 'Carey'], ['Lauren', '', 'Boak'], ['Ronald', '', 'Gieschke'], ['Susan', '', 'Sacks'], ['Jonathan', '', 'Solsky'], ['Ian', '', 'Small'], ['David', '', 'Reddy']]",Drug Safety,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002018-200831120-00006']
10.2165/00003088-199937060-00003,"Hurt, A., Ho, H., Barr, I., , Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors, Expert Review of Anti-infective Therapy, 2006",cited-by,10.1586/14787210.4.5.795,Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors,"[['Aeron', 'C', 'Hurt'], ['Hui-Ting', '', 'Ho'], ['Ian', '', 'Barr']]",Expert Review of Anti-infective Therapy,2006,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.4.5.795']
10.2165/00003088-199937060-00003,"Schentag, J., Hill, G., Chu, T., et. al, Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects, Journal of Clinical Pharmacology, 2007",cited-by,10.1177/0091270007299761,Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects,"[['Jerome', 'J.', 'Schentag'], ['George', '', 'Hill'], ['Tom', '', 'Chu'], ['Craig', 'R.', 'Rayner']]",Journal of Clinical Pharmacology,2007,"[u'http://dx.doi.org/10.1177/0091270007299761', u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270007299761']"
10.2165/00003088-199937060-00003,"Robson, R., Buttimore, A., Lynn, K., et. al, The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis, , 2006",cited-by,10077451The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,"[['Richard', '', 'Robson'], ['Adrian', '', 'Buttimore'], ['Kelvin', '', 'Lynn'], ['Mike', '', 'Brewster'], ['Penelope', '', 'Ward']]",,2006,"[u'http://www.kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://ndt.oxfordjournals.org/cgi/reprint/21/9/2556.pdf']"
10.2165/00003088-199937060-00003,"Wattanagoon, Y., Stepniewska, K., Lindegardh, N., et. al, Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.00588-08,Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers,"[['Y.', '', 'Wattanagoon'], ['K.', '', 'Stepniewska'], ['N.', '', 'Lindegardh'], ['S.', '', 'Pukrittayakamee'], ['U.', '', 'Silachamroon'], ['W.', '', 'Piyaphanee'], ['T.', '', 'Singtoroj'], ['W.', '', 'Hanpithakpong'], ['G.', '', 'Davies'], ['J.', '', 'Tarning'], ['W.', '', 'Pongtavornpinyo'], ['C.', '', 'Fukuda'], ['P.', '', 'Singhasivanon'], ['N.', 'P. J.', 'Day'], ['N.', 'J.', 'White']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.asm.org/cgi/reprint/53/3/945.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00588-08']"
10.2165/00003088-199937060-00003,"Holmes, R., Cox, L., VandeBerg, J., , Mammalian carboxylesterase 5: Comparative biochemistry and genomics, Comparative Biochemistry and Physiology D-genomics & Proteomics, 2008",cited-by,10.1016/j.cbd.2008.05.002,Mammalian carboxylesterase 5: Comparative biochemistry and genomics,"[['Roger', 'S.', 'Holmes'], ['Laura', 'A.', 'Cox'], ['John', 'L.', 'VandeBerg']]",Comparative Biochemistry and Physiology D-genomics & Proteomics,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1744117X08000373', u'http://linkinghub.elsevier.com/retrieve/pii/S1744117X08000373']"
10.2165/00003088-199937060-00003,"Yoshino, T., Nisijima, K., Shioda, K., et. al, Oseltamivir (Tamiflu ®) increases dopamine levels in the rat medial prefrontal cortex, Neuroscience Letters, 2008",cited-by,10.1016/j.neulet.2008.04.011,Oseltamivir (Tamiflu ®) increases dopamine levels in the rat medial prefrontal cortex,"[['Tatsuki', '', 'Yoshino'], ['Koichi', '', 'Nisijima'], ['Katsutoshi', '', 'Shioda'], ['Kunio', '', 'Yui'], ['Satoshi', '', 'Kato']]",Neuroscience Letters,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0304394008004710', u'http://linkinghub.elsevier.com/retrieve/pii/S0304394008004710']"
10.2165/00003088-199937060-00003,"Bartels, P., Jr., W., , The environmental fate of the antiviral drug oseltamivir carboxylate in different waters, Science of The Total Environment, 2008",cited-by,10.1016/j.scitotenv.2008.06.032,The environmental fate of the antiviral drug oseltamivir carboxylate in different waters,"[['Peter', '', 'Bartels'], ['Wolf', 'von T\xc3\xbcmpling', 'Jr.']]",Science of The Total Environment,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0048969708006864', u'http://linkinghub.elsevier.com/retrieve/pii/S0048969708006864']"
10.2165/00003088-199937060-00003,"Smith, J., Ariano, R., Toovey, S., , The use of antiviral agents for the management of severe influenza, Critical Care Medicine, 2010",cited-by,10.1097/CCM.0b013e3181c85229,The use of antiviral agents for the management of severe influenza,"[['James', 'R.', 'Smith'], ['Robert', 'E.', 'Ariano'], ['Stephen', '', 'Toovey']]",Critical Care Medicine,2010,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-201004001-00006', u'http://www.sopemi.org.pe/file/articulos/201004/The use of antiviral agents for the management of severe influenza.pdf']"
10.2165/00003088-199937060-00003,"Jhee, S., Yen, M., Ereshefsky, L., et. al, Low Penetration of Oseltamivir and Its Carboxylate into Cerebrospinal Fluid in Healthy Japanese and Caucasian Volunteers, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00327-08,Low Penetration of Oseltamivir and Its Carboxylate into Cerebrospinal Fluid in Healthy Japanese and Caucasian Volunteers,"[['S.', 'S.', 'Jhee'], ['M.', '', 'Yen'], ['L.', '', 'Ereshefsky'], ['M.', '', 'Leibowitz'], ['M.', '', 'Schulte'], ['B.', '', 'Kaeser'], ['L.', '', 'Boak'], ['A.', '', 'Patel'], ['G.', '', 'Hoffmann'], ['E.', 'P.', 'Prinssen'], ['C.', 'R.', 'Rayner']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/10/3687.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00327-08']"
10.2165/00003088-199937060-00003,"Worley, K., Roberts, S., Bawdon, R., , The Metabolism and Transplacental Transfer of Oseltamivir in the Ex Vivo Human Model, Infectious Diseases in Obstetrics & Gynecology, 2008",cited-by,10.1155/2008/927574,The Metabolism and Transplacental Transfer of Oseltamivir in the Ex Vivo Human Model,"[['Kevin', 'C.', 'Worley'], ['Scott', 'W.', 'Roberts'], ['Roger', 'E.', 'Bawdon']]",Infectious Diseases in Obstetrics & Gynecology,2008,"[u'http://www.hindawi.com/journals/idog/2008/927574.pdf', u'http://www.hindawi.com/journals/idog/2008/927574.html']"
10.2165/00003088-199937060-00003,"Lindegardh, N., Davies, G., Hien, T., et. al, Rapid Degradation of Oseltamivir Phosphate in Clinical Samples by Plasma Esterases, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00500-06,Rapid Degradation of Oseltamivir Phosphate in Clinical Samples by Plasma Esterases,"[['Niklas', '', 'Lindegardh'], ['Geraint', 'R.', 'Davies'], ['Tran', 'Tinh', 'Hien'], ['Jeremy', '', 'Farrar'], ['Pratap', '', 'Singhasivanon'], ['Nicholas', 'P. J.', 'Day'], ['Nicholas', 'J.', 'White']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/9/3197.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00500-06']"
10.2165/00003088-199937060-00003,"Snell, P., Dave, N., Wilson, K., et. al, Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate, British Journal of Clinical Pharmacology, 2005",cited-by,10.1111/j.1365-2125.2005.02340.x,Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate,"[['Paul', '', 'Snell'], ['Nisha', '', 'Dave'], ['Katie', '', 'Wilson'], ['Lucy', '', 'Rowell'], ['Angelica', '', 'Weil'], ['Lawrence', '', 'Galitz'], ['Richard', '', 'Robson']]",British Journal of Clinical Pharmacology,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2125.2005.02340.x']
10.2165/00003088-199937060-00003,"Whitley, R., , The role of oseltamivir in the treatment and prevention of influenza in children, Expert Opinion on Drug Metabolism & Toxicology, 2007",cited-by,10.1517/17425225.3.5.755,The role of oseltamivir in the treatment and prevention of influenza in children,"[['Richard', 'J', 'Whitley']]",Expert Opinion on Drug Metabolism & Toxicology,2007,[u'http://www.expertopin.com/doi/abs/10.1517/17425225.3.5.755']
10.2165/00003088-199937060-00003,"Itzstein, M., Thomson, R., , Anti-Influenza Drugs: The Development of Sialidase Inhibitors, , 0",cited-by,10.1007/978-3-540-79086-0_5,Anti-Influenza Drugs: The Development of Sialidase Inhibitors,"[['Mark', 'von', 'Itzstein'], ['Robin', '', 'Thomson']]",,0,"[u'http://www.springerlink.com/index/q7q766196t171341.pdf', u'http://www.springerlink.com/content/q7q766196t171341']"
10.2165/00003088-199937060-00003,"Jancel, T., Penzak, S., , Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia, Seminars in Hematology, 2009",cited-by,10.1053/j.seminhematol.2009.03.004,"Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia","[['Timothy', '', 'Jancel'], ['Scott', 'R.', 'Penzak']]",Seminars in Hematology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0037196309000596', u'http://linkinghub.elsevier.com/retrieve/pii/S0037196309000596']"
10.2165/00003088-199937060-00003,"Lindegardh, N., Davies, G., Hien, T., et. al, Importance of Collection Tube during Clinical Studies of Oseltamivir, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01534-06,Importance of Collection Tube during Clinical Studies of Oseltamivir,"[['Niklas', '', 'Lindegardh'], ['Geraint', 'R.', 'Davies'], ['Tran', 'Tinh', 'Hien'], ['Jeremy', '', 'Farrar'], ['Pratap', '', 'Singhasivanon'], ['Nicholas', 'P. J.', 'Day'], ['Nicholas', 'J.', 'White']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/5/1835.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01534-06']"
10.2165/00003088-199937060-00003,"Oo, C., Barrett, J., Dorr, A., et. al, Lack of Pharmacokinetic Interaction between the Oral Anti-Influenza Prodrug Oseltamivir and Aspirin, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.6.1993-1995.2002,Lack of Pharmacokinetic Interaction between the Oral Anti-Influenza Prodrug Oseltamivir and Aspirin,"[['Charles', '', 'Oo'], ['Joanne', '', 'Barrett'], ['Albert', '', 'Dorr'], ['Baolian', '', 'Liu'], ['Penelope', '', 'Ward']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/6/1993.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.6.1993-1995.2002']"
10.2165/00003088-199937060-00003,"Dutkowski, R., Smith, J., Davies, B., , Safety and pharmacokinetics of oseltamivir at standard and high dosages, International Journal of Antimicrobial Agents, 2010",cited-by,10.1016/j.ijantimicag.2009.12.023,Safety and pharmacokinetics of oseltamivir at standard and high dosages,"[['R.', '', 'Dutkowski'], ['J.', 'R.', 'Smith'], ['B.', 'E.', 'Davies']]",International Journal of Antimicrobial Agents,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0924857910000385', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857910000385']"
10.2165/00003088-199937060-00003,"Rayner, C., Chanu, P., Gieschke, R., et. al, Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid, Journal of Clinical Pharmacology, 2008",cited-by,10.1177/0091270008320317,Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid,"[['Craig', 'R.', 'Rayner'], ['Pascal', '', 'Chanu'], ['Ronald', '', 'Gieschke'], ['Lauren', 'M.', 'Boak'], ['E.', 'Niclas', 'Jonsson']]",Journal of Clinical Pharmacology,2008,"[u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270008320317', u'http://dx.doi.org/10.1177/0091270008320317']"
10.2165/00003088-199937060-00003,"Hayden, F., , Influenza virus neuraminidase inhibitors: clinical aspects, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00358-2,Influenza virus neuraminidase inhibitors: clinical aspects,"[['Frederick', 'G.', 'Hayden']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003582', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003582']"
10.2165/00003088-199937060-00003,"Donner, B., Niranjan, V., Hoffmann, G., , Safety of Oseltamivir in Pregnancy: A Review of Preclinical and Clinical Data, Drug Safety, 2010",cited-by,10.2165/11536370-000000000-00000,Safety of Oseltamivir in Pregnancy: A Review of Preclinical and Clinical Data,"[['Barbara', '', 'Donner'], ['Viswanathan', '', 'Niranjan'], ['Gerhard', '', 'Hoffmann']]",Drug Safety,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002018-201033080-00003']
10.2165/00003088-199937060-00003,"Winther, B., Block, S., Reisinger, K., et. al, Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza, International Journal of Pediatric Otorhinolaryngology, 2010",cited-by,10.1016/j.ijporl.2010.03.024,Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza,"[['Birgit', '', 'Winther'], ['Stan', 'L.', 'Block'], ['Keith', '', 'Reisinger'], ['Regina', '', 'Dutkowski']]",International Journal of Pediatric Otorhinolaryngology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0165587610001199', u'http://linkinghub.elsevier.com/retrieve/pii/S0165587610001199']"
10.2165/00003088-199937060-00003,"Chang, Q., Chow, M., Zuo, Z., , Studies on the influence of esterase inhibitor to the pharmacokinetic profiles of oseltamivir and oseltamivir carboxylate in rats using an improved LC/MS/MS method, Biomedical Chromatography, 2009",cited-by,10.1002/bmc.1195,Studies on the influence of esterase inhibitor to the pharmacokinetic profiles of oseltamivir and oseltamivir carboxylate in rats using an improved LC/MS/MS method,"[['Qi', '', 'Chang'], ['Moses', 'S. S.', 'Chow'], ['Zhong', '', 'Zuo']]",Biomedical Chromatography,2009,[u'http://doi.wiley.com/10.1002/bmc.1195']
10.2165/00003088-199937060-00003,"Holmes, R., Cox, L., VandeBerg, J., , A new class of mammalian carboxylesterase CES6, Comparative Biochemistry and Physiology D-genomics & Proteomics, 2009",cited-by,10.1016/j.cbd.2009.03.002,A new class of mammalian carboxylesterase CES6,"[['Roger', 'S.', 'Holmes'], ['Laura', 'A.', 'Cox'], ['John', 'L.', 'VandeBerg']]",Comparative Biochemistry and Physiology D-genomics & Proteomics,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1744117X09000306', u'http://linkinghub.elsevier.com/retrieve/pii/S1744117X09000306']"
10.2165/00003088-199937060-00003,"Izumi, Y., Tokuda, K., O’Dell, K., et. al, Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants, Human & Experimental Toxicology, 2008",cited-by,10.1177/0960327109102367,Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants,"[['Y', '', 'Izumi'], ['K', '', 'Tokuda'], ['KA', '', 'O\xe2\x80\x99Dell'], ['CF', '', 'Zorumski'], ['T', '', 'Narahashi']]",Human & Experimental Toxicology,2008,"[u'http://het.sagepub.com/cgi/doi/10.1177/0960327109102367', u'http://dx.doi.org/10.1177/0960327109102367']"
10.2165/00003088-199937060-00003,"Sauerbrei, A., Haertl, A., Brandstaedt, A., et. al, Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors, Medical Microbiology and Immunology, 2006",cited-by,10.1007/s00430-005-0002-x,Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors,"[['A.', '', 'Sauerbrei'], ['A.', '', 'Haertl'], ['A.', '', 'Brandstaedt'], ['M.', '', 'Schmidtke'], ['P.', '', 'Wutzler']]",Medical Microbiology and Immunology,2006,"[u'http://www.springerlink.com/index/m37932425096l606.pdf', u'http://www.springerlink.com/content/m37932425096l606', u'http://www.springerlink.com/index/10.1007/s00430-005-0002-x', u'http://www.springerlink.com/index/pdf/10.1007/s00430-005-0002-x']"
10.2165/00003088-199937060-00003,"GOMES, L., , Fatores de risco e medidas profiláticas nas pneumonias adquiridas na comunidade, , 0",cited-by,12000320Fatores de risco e medidas profiláticas nas pneumonias adquiridas na comunidade,Fatores de risco e medidas profiláticas nas pneumonias adquiridas na comunidade,"[['LUCY', '', 'GOMES']]",,0,[u'http://www.scielo.br/pdf/jpneu/v27n2/9240.pdf']
10.2165/00003088-199937060-00003,"Massie, J., Shahine, L., Milki, A., et. al, Ovarian stimulation and the risk of aneuploid conceptions, Fertility and Sterility, 2011",cited-by,10.1016/j.fertnstert.2010.07.1088,Ovarian stimulation and the risk of aneuploid conceptions,"[['Jamie', 'A. M.', 'Massie'], ['Lora', 'K.', 'Shahine'], ['Amin', 'A.', 'Milki'], ['Lynn', 'M.', 'Westphal'], ['Ruth', 'B.', 'Lathi']]",Fertility and Sterility,2011,[u'http://www.sciencedirect.com/science/article/pii/S0015028210022144']
10.2165/00003088-199937060-00003,"Ison, M., , Influenza, including the novel H1N1, in organ transplant patients, Current Opinion in Infectious Diseases, 2010",cited-by,10.1097/QCO.0b013e32833bc1c3,"Influenza, including the novel H1N1, in organ transplant patients","[['Michael', 'G', 'Ison']]",Current Opinion in Infectious Diseases,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-201008000-00012']
10.2165/00003088-199937060-00003,"Escher, B., Bramaz, N., Lienert, J., et. al, Mixture toxicity of the antiviral drug Tamiflu ® (oseltamivir ethylester) and its active metabolite oseltamivir acid, Aquatic Toxicology, 2010",cited-by,10.1016/j.aquatox.2009.10.020,Mixture toxicity of the antiviral drug Tamiflu ® (oseltamivir ethylester) and its active metabolite oseltamivir acid,"[['Beate', 'I.', 'Escher'], ['Nadine', '', 'Bramaz'], ['Judit', '', 'Lienert'], ['Judith', '', 'Neuwoehner'], ['J\xc3\xbcrg', 'Oliver', 'Straub']]",Aquatic Toxicology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0166445X09003646', u'http://linkinghub.elsevier.com/retrieve/pii/S0166445X09003646']"
10.2165/00003088-199937060-00003,"Freichel, C., Prinssen, E., Hoffmann, G., et. al, Oseltamivir is Devoid of Specific Behavioral and Other Central Nervous System Effects in Juvenile Rats at Supratherapeutic Oral Doses, International Journal of Virology, 2009",cited-by,10.3923/ijv.2009.119.130,Oseltamivir is Devoid of Specific Behavioral and Other Central Nervous System Effects in Juvenile Rats at Supratherapeutic Oral Doses,"[['C.', '', 'Freichel'], ['E.', '', 'Prinssen'], ['G.', '', 'Hoffmann'], ['L.', '', 'Gand'], ['M.', '', 'Beck'], ['T.', '', 'Weiser'], ['A.', '', 'Breidenbac']]",International Journal of Virology,2009,[u'http://www.scialert.net/abstract/?doi=ijv.2009.119.130']
10.2165/00003088-199937060-00003,"Yamazaki, Y., Doy, M., Yamato, S., et. al, Effects of oseltamivir phosphate (Tamiflu ® ) in human sera on results of microneutralization and hemagglutinin-inhibition tests for H5N2 avian influenza virus, Archives of Virology, 2008",cited-by,10.1007/s00705-008-0038-5,Effects of oseltamivir phosphate (Tamiflu ® ) in human sera on results of microneutralization and hemagglutinin-inhibition tests for H5N2 avian influenza virus,"[['Yoshinao', '', 'Yamazaki'], ['M.', '', 'Doy'], ['S.', '', 'Yamato'], ['Y.', '', 'Kawada'], ['T.', '', 'Ogata']]",Archives of Virology,2008,"[u'http://www.springerlink.com/content/407um410288kk526', u'http://www.springerlink.com/index/407um410288kk526.pdf', u'http://www.springerlink.com/index/10.1007/s00705-008-0038-5', u'http://www.springerlink.com/index/pdf/10.1007/s00705-008-0038-5']"
10.2165/00003088-199937060-00003,"Oxford, J., , Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza, Influenza and Other Respiratory Viruses, 2007",cited-by,10.1111/j.1750-2659.2006.00006.x,Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza,"[['John', 'S.', 'Oxford']]",Influenza and Other Respiratory Viruses,2007,[u'http://doi.wiley.com/10.1111/j.1750-2659.2006.00006.x']
10.2165/00003088-199937060-00003,"Telgmann, R., Kleist, M., Huisinga, W., , Software Supported Modelling in Pharmacokinetics, , 2006",cited-by,10.1007/11875741_21,Software Supported Modelling in Pharmacokinetics,"[['Regina', '', 'Telgmann'], ['Max', 'Von', 'Kleist'], ['Wilhelm', '', 'Huisinga']]",,2006,"[u'http://compphysiol.mi.fu-berlin.de/pub/SoftSuppModell16May06.pdf', u'http://www.springerlink.com/index/n1449m8028925505.pdf', u'http://www.springerlink.com/content/n1449m8028925505', u'http://dx.doi.org/10.1007/11875741_21', u'http://www.informatik.uni-trier.de/~ley/db/conf/complife/complife2006.html#TelgmannKH06', u'http://biocomputing.mi.fu-berlin.de/publications/TeKlHu06.pdf']"
10.2165/00003088-199937060-00003,"Snell, P., Oo, C., Dorr, A., et. al, Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids: Oseltamivir and antacids - lack of kinetic interaction, British Journal of Clinical Pharmacology, 2002",cited-by,10.1046/j.1365-2125.2002.01678.x,Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids: Oseltamivir and antacids - lack of kinetic interaction,"[['Paul', '', 'Snell'], ['Charles', '', 'Oo'], ['Al', '', 'Dorr'], ['Joanne', '', 'Barrett']]",British Journal of Clinical Pharmacology,2002,[u'http://doi.wiley.com/10.1046/j.1365-2125.2002.01678.x']
10.2165/00003088-199937060-00003,"Eschenauer, G., Lam, S., , Supratherapeutic oseltamivir levels during continuous dialysis: an expected risk, Intensive Care Medicine, 2011",cited-by,10.1007/s00134-010-2080-5,Supratherapeutic oseltamivir levels during continuous dialysis: an expected risk,"[['Gregory', 'A.', 'Eschenauer'], ['Simon', 'W.', 'Lam']]",Intensive Care Medicine,2011,"[u'http://www.springerlink.com/index/04lw6343tj3n44g4.pdf', u'http://www.springerlink.com/content/04lw6343tj3n44g4']"
10.2165/00003088-199937060-00003,"Ho, C., Chan, C., Wo, S., et. al, Nitrile assisted, Brønsted acid catalyzed regio and stereoselective diarylphosphonylation of allyl silyl ethers, Organic & Biomolecular Chemistry, 2010",cited-by,10.1039/c001660h,"Nitrile assisted, Brønsted acid catalyzed regio and stereoselective diarylphosphonylation of allyl silyl ethers","[['Chun-Yu', '', 'Ho'], ['Chun-Wa', '', 'Chan'], ['Siu-Kwan', '', 'Wo'], ['Zhong', '', 'Zuo'], ['Lai-Ying', '', 'Chan']]",Organic & Biomolecular Chemistry,2010,[u'http://xlink.rsc.org/?DOI=c001660h']
10.2165/00003088-199937060-00003,"Taylor, W., Burhan, E., Wertheim, H., et. al, Avian influenza – A review for doctors in travel medicine, Travel Medicine and Infectious Disease, 2010",cited-by,10.1016/j.tmaid.2009.11.006,Avian influenza – A review for doctors in travel medicine,"[['W.', 'R. J.', 'Taylor'], ['E.', '', 'Burhan'], ['H.', '', 'Wertheim'], ['P.', 'Z.', 'Soepandi'], ['P.', '', 'Horby'], ['A.', '', 'Fox'], ['R.', '', 'Benamore'], ['L.', 'de', 'Simone'], ['T.', 'T.', 'Hien'], ['F.', '', 'Chappuis']]",Travel Medicine and Infectious Disease,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1477893909001628', u'http://linkinghub.elsevier.com/retrieve/pii/S1477893909001628']"
10.2165/00003088-199937060-00003,"Sethi, S., , H1N1 infection: a pediatric nephrologist’s perspective, Clinical and Experimental Nephrology, 2010",cited-by,10.1007/s10157-010-0281-4,H1N1 infection: a pediatric nephrologist’s perspective,"[['Sidharth', 'Kumar', 'Sethi']]",Clinical and Experimental Nephrology,2010,"[u'http://www.springerlink.com/index/03l113863t5j5m3u.pdf', u'http://www.springerlink.com/content/03l113863t5j5m3u', u'http://www.springerlink.com/index/10.1007/s10157-010-0281-4', u'http://www.springerlink.com/index/pdf/10.1007/s10157-010-0281-4']"
10.2165/00003088-199937060-00003,"Lindemann, L., Jacobsen, H., Schuhbauer, D., et. al, In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu ®) and active metabolite, European Journal of Pharmacology, 2010",cited-by,10.1016/j.ejphar.2009.11.020,In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu ®) and active metabolite,"[['Lothar', '', 'Lindemann'], ['Helmut', '', 'Jacobsen'], ['Diana', '', 'Schuhbauer'], ['Frederic', '', 'Knoflach'], ['Silvia', '', 'Gatti'], ['Joseph', 'G.', 'Wettstein'], ['Hansruedi', '', 'Loetscher'], ['Tom', '', 'Chu'], ['Martin', '', 'Ebeling'], ['James', 'C.', 'Paulson'], ['Eric', '', 'Prinssen'], ['Manfred', '', 'Brockhaus']]",European Journal of Pharmacology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0014299909010358', u'http://linkinghub.elsevier.com/retrieve/pii/S0014299909010358']"
10.2165/00003088-199937060-00003,"Hurt, A., Lowther, S., Middleton, D., et. al, Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model, Antiviral Research, 2010",cited-by,10.1016/j.antiviral.2010.06.009,Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model,"[['Aeron', 'C.', 'Hurt'], ['Sue', '', 'Lowther'], ['Deborah', '', 'Middleton'], ['Ian', 'G.', 'Barr']]",Antiviral Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S016635421000642X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635421000642X']"
10.2165/00003088-199937060-00003,"Masola, B., Ngubane, N., , The activity of phosphate-dependent glutaminase from the rat small intestine is modulated by ADP and is dependent on integrity of mitochondria, Archives of Biochemistry and Biophysics, 2010",cited-by,10.1016/j.abb.2010.09.002,The activity of phosphate-dependent glutaminase from the rat small intestine is modulated by ADP and is dependent on integrity of mitochondria,"[['B.', '', 'Masola'], ['N.', 'P.', 'Ngubane']]",Archives of Biochemistry and Biophysics,2010,[u'http://www.sciencedirect.com/science/article/pii/S000398611000370X']
10.2165/00003088-199937060-00003,"Wildschut, E., Hoog, M., Ahsman, M., et. al, Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support, PLOS One, 2010",cited-by,10.1371/journal.pone.0010938,Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support,"[['Enno', 'D.', 'Wildschut'], ['Matthijs', 'de', 'Hoog'], ['Maurice', 'J.', 'Ahsman'], ['Dick', '', 'Tibboel'], ['Albert', 'D. M. E.', 'Osterhaus'], ['Pieter', 'L. A.', 'Fraaij'], ['Qamaruddin', '', 'Nizami']]",PLOS One,2010,"[u'http://adsabs.harvard.edu/abs/2010PLoSO...510938W', u'http://dx.doi.org/10.1371/journal.pone.0010938']"
10.2165/00003088-199937060-00003,"Marfo, K., Chapochnick-Friedmann, J., Akalin, E., et. al, Postexposure Prophylaxis of H1N1 With Oseltamivir in a Newly Transplanted Kidney Recipient Receiving Intense Immunosuppressive Therapy, Transplantation Proceedings, 2009",cited-by,10.1016/j.transproceed.2009.09.052,Postexposure Prophylaxis of H1N1 With Oseltamivir in a Newly Transplanted Kidney Recipient Receiving Intense Immunosuppressive Therapy,"[['K.', '', 'Marfo'], ['J.', '', 'Chapochnick-Friedmann'], ['E.', '', 'Akalin'], ['A.', '', 'Lu']]",Transplantation Proceedings,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0041134509013025', u'http://linkinghub.elsevier.com/retrieve/pii/S0041134509013025']"
10.2165/00003088-199937060-00003,"Toovey, S., Rayner, C., Prinssen, E., et. al, Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: A Comprehensive Review, Drug Safety, 2008",cited-by,10.2165/0002018-200832120-00006,Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: A Comprehensive Review,"[['Stephen', '', 'Toovey'], ['Craig', '', 'Rayner'], ['Eric', '', 'Prinssen'], ['Tom', '', 'Chu'], ['Barbara', '', 'Donner'], ['Bharat', '', 'Thakrar'], ['Regina', '', 'Dutkowski'], ['Gerhard', '', 'Hoffmann'], ['Alexander', '', 'Breidenbach'], ['Lothar', '', 'Lindemann'], ['Ellen', '', 'Carey'], ['Lauren', '', 'Boak'], ['Ronald', '', 'Gieschke'], ['Susan', '', 'Sacks'], ['Jonathan', '', 'Solsky'], ['Ian', '', 'Small'], ['David', '', 'Reddy']]",Drug Safety,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002018-200832120-00006']
10.2165/00003088-199937060-00003,"Taylor, W., Thinh, B., Anh, G., et. al, Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza, PLOS One, 2008",cited-by,10.1371/journal.pone.0003410,Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza,"[['Walter', 'R. J.', 'Taylor'], ['Bui', 'Nghia', 'Thinh'], ['Giang', 'Thuc', 'Anh'], ['Peter', '', 'Horby'], ['Heiman', '', 'Wertheim'], ['Niklas', '', 'Lindegardh'], ['Menno', 'D. de', 'Jong'], ['Kasia', '', 'Stepniewska'], ['Tran', 'Thuy', 'Hanh'], ['Nguyen', 'Duc', 'Hien'], ['Ngo', 'Minh', 'Bien'], ['Ngo', 'Quy', 'Chau'], ['Annette', '', 'Fox'], ['Nghiem', 'My', 'Ngoc'], ['Martin', '', 'Crusat'], ['Jeremy', 'J.', 'Farrar'], ['Nicholas', 'J.', 'White'], ['Nguyen', 'Hong', 'Ha'], ['Trinh', 'Thi', 'Lien'], ['Nguyen', 'Vu', 'Trung'], ['Nicholas', '', 'Day'], ['Nguyen', 'Gia', 'Binh'], ['Sean', '', 'Emery']]",PLOS One,2008,"[u'http://adsabs.harvard.edu/abs/2008PLoSO...3.3410T', u'http://dx.doi.org/10.1371/journal.pone.0003410']"
10.2165/00003088-199937060-00003,"Whitley, R., , The role of oseltamivir in the treatment and prevention of influenza in children, Expert Opinion on Drug Metabolism & Toxicology, 2007",cited-by,10.1517/17425255.3.5.755,The role of oseltamivir in the treatment and prevention of influenza in children,"[['Richard', 'J', 'Whitley']]",Expert Opinion on Drug Metabolism & Toxicology,2007,[u'http://informahealthcare.com/doi/abs/10.1517/17425255.3.5.755']
10.2165/00003088-199937060-00003,"Kamps, B., Reyes-Terán, G., , INFLUENCA 2006, , 2006",cited-by,13120455INFLUENCA 2006,INFLUENCA 2006,"[['Bernd', 'Sebastian', 'Kamps'], ['Gustavo', '', 'Reyes-Ter\xc3\xa1n']]",,2006,[u'http://www.gripa.hr/images/documents/knjiga_o_gripi.pdf']
10.2165/00003088-199937060-00003,"Mezghenna, K., Péraldi-Roux, S., Dubois, G., et. al, P1-152 - High sucrose feeding-induced abnormalities of neuronal NO synthase in rat pancreatic bêta-cells and skeletal muscle, Annales D Endocrinologie, 2006",cited-by,10.1016/S0003-4266(06)72805-0,P1-152 - High sucrose feeding-induced abnormalities of neuronal NO synthase in rat pancreatic bêta-cells and skeletal muscle,"[['K.', '', 'Mezghenna'], ['S.', '', 'P\xc3\xa9raldi-Roux'], ['G.', '', 'Dubois'], ['M.', '', 'Manteghetti'], ['M.', '', 'Tournier'], ['B.', '', 'Nguyen'], ['J.', '', 'Boyer'], ['R.', '', 'Gross'], ['A.-D.', '', 'Lajoix']]",Annales D Endocrinologie,2006,[u'http://www.sciencedirect.com/science/article/pii/S0003426606728050']
10.2165/00003088-199937060-00003,"OMES, L., , Fatores de risco e medidas profiláticas nas pneumonias adquiridas na comunidade, , 2001",cited-by,6640921Fatores de risco e medidas profiláticas nas pneumonias adquiridas na comunidade,Fatores de risco e medidas profiláticas nas pneumonias adquiridas na comunidade,"[['L', 'UCY G', 'OMES']]",,2001,[u'http://www.jornaldepneumologia.com.br/pdf/2001_27_2_5_portugues.pdf']
10.2165/00003088-199937060-00003,"Massarella, J., He, G., Dorr, A., et. al, The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers, Journal of Clinical Pharmacology, 2000",cited-by,10.1177/009127000004000804,The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers,"[['Joseph', 'W.', 'Massarella'], ['George', 'Z.', 'He'], ['Albert', '', 'Dorr'], ['Keith', '', 'Nieforth'], ['Penelope', '', 'Ward'], ['Andy', '', 'Brown']]",Journal of Clinical Pharmacology,2000,[u'http://dx.doi.org/10.1177/009127000004000804']
10.2165/00003088-199937060-00003,"Wattanagoon, Y., Stepniewska, K., Lindegårdh, N., et. al, Running title; Pharmacokinetics of oseltamivir, , 0",cited-by,11703983Running title; Pharmacokinetics of oseltamivir,Running title; Pharmacokinetics of oseltamivir,"[['Y.', '', 'Wattanagoon'], ['K', '', 'Stepniewska'], ['N.', '', 'Lindeg\xc3\xa5rdh'], ['S', '', 'Pukrittayakamee'], ['U', '', 'Silachamroon']]",,0,[u'http://www.infectologia.org.br/anexos/PEC-SBI_Influe_Pharmacokinetics%20of%20high%20dose%20oseltamivir%20in%20healthy%20volunteers.pdf']
10.2165/00003088-199937060-00003,"Eisenberg, E., , Case Study: Oseltamivir: An Orally Bioavailable Ester Prodrug of Oseltamivir Carboxylate, , 0",cited-by,10.1007/978-0-387-49785-3_50,Case Study: Oseltamivir: An Orally Bioavailable Ester Prodrug of Oseltamivir Carboxylate,"[['Eugene', 'J.', 'Eisenberg']]",,0,"[u'http://www.springerlink.com/index/qp8122385lu86756.pdf', u'http://www.springerlink.com/content/qp8122385lu86756']"
10.2165/00003088-199937060-00003,"Tisdale, M., , Influenza M2 Ion-Channel and Neuraminidase Inhibitors, , 0",cited-by,10.1007/978-1-59745-180-2_31,Influenza M2 Ion-Channel and Neuraminidase Inhibitors,"[['Margaret', '', 'Tisdale']]",,0,"[u'http://www.springerlink.com/index/th812t5r62661uh4.pdf', u'http://www.springerlink.com/content/th812t5r62661uh4']"
10.2165/00003088-199937060-00003,"Maag, H., , Prodrugs of Carboxylic Acids, , 0",cited-by,10.1007/978-0-387-49785-3_20,Prodrugs of Carboxylic Acids,"[['Hans', '', 'Maag']]",,0,"[u'http://www.springerlink.com/index/v7766200l3485717.pdf', u'http://www.springerlink.com/content/v7766200l3485717']"
